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If —    
by Rudyard Kipling   
If you can keep your head when all about you 
Are losing theirs and blaming it on you; 
If you can trust yourself when all men doubt you, 
But make allowance for their doubting too; 
If you can wait and not be tired by waiting, 
Or, being lied about, don't deal in lies, 
Or, being hated, don't give way to hating, 
And yet don't look too good, nor talk too wise; 
If you can dream - and not make dreams your master;
If you can think - and not make thoughts your aim; 
If you can meet with triumph and disaster 
And treat those two impostors just the same; 
If you can bear to hear the truth you've spoken 
Twisted by knaves to make a trap for fools, 
Or watch the things you gave your life to broken, 
And stoop and build 'em up with wornout tools; 
If you can make one heap of all your winnings 
And risk it on one turn of pitch-and-toss, 
And lose, and start again at your beginnings 
And never breathe a word about your loss; 
If you can force your heart and nerve and sinew 
To serve your turn long after they are gone, 
And so hold on when there is nothing in you 
Except the Will which says to them: "Hold on"; 
If you can talk with crowds and keep your virtue, 
Or walk with kings - nor lose the common touch; 
If neither foes nor loving friends can hurt you; 
If all men count with you, but none too much; 
If you can fill the unforgiving minute 
With sixty seconds' worth of distance run - 
Yours is the Earth and everything that's in it, 
And - which is more - you'll be a Man, my son! 
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ABSTRACT 
During murine development, retinal ganglion cell (RGC) axons are presented with 
multiple navigational choices as they exit the eyes and follow a complex path to 
targets in the thalamus and superior colliculus of the brain. The optic chiasm is a 
major choice point, positioned at the ventral midline of the hypothalamus, where 
the majority of retinal axons cross to the contralateral side of the brain whilst only 
3% remain uncrossed and project ipsilaterally. Identifying the cellular and 
molecular processes involved in retinal axon divergence at the chiasm is an intense 
area of study and knockout mice have proved useful tools.  
  
Foxg1 is a winged helix transcription factor that is expressed in the nasal retina, 
nasal optic stalk and anterior ventral hypothalamus, which are all structures that 
retinal axons encounter as they project out of the RGC layer towards the chiasm. 
The coincidence between the expression pattern of Foxg1 and the route followed by 
retinal axons led to the hypothesis that Foxg1 plays a role in guiding retinal axons at 
the optic chiasm. Previous experiments in this laboratory lent support to this idea by 
revealing an increase in the number of ipsilateral projections in Foxg1
-/-
 mouse 
embryos from both nasal and temporal retina.  
Since Foxg1 is expressed in both the nasal retina and at the optic chiasm midline, 
the main hypotheses for this thesis are that Foxg1 influences retinal axon 
divergence by transcriptionally regulating the expression of cell surface molecules 
on (1) growth cones from the nasal retina or (2) guidance molecules on chiasm 
cells.  
In order to address these possibilities, the key aims of this thesis were (i) to 
investigate whether Foxg1 is primarily required in the nasal retina or at the chiasm 
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for retinal axon divergence, (ii) to determine whether the Foxg1 null retina and 
chiasm are patterned differently from those of wild types and (iii) to investigate the 






 chimeric co-cultures of retinal explants and chiasm cells were 
used to investigate the relative roles of the retina and chiasm in midline crossing. 
Axonal outgrowth was significantly reduced in co-cultures containing dorsonasal 
retina or chiasm cells from Foxg1 null embryos, suggesting that Foxg1 is normally 
required in both these tissues for nasal axons to cross the ventral midline.  
The dorsoventral and nasotemporal patterning of the retina was investigated to 
assess whether the ventral or temporal regions, from which ipsilateral RGCs 










were observed in both during the peak period of retinal axon divergence. 





 embryos, transcriptional activation of Foxg1 was most 
widespread in the dorsonasal retina and absent ventrotemporally. Foxg1
lacZ/lacZ
embryos showed increased Foxg1 activation in temporal regions but reduced 
activation in the dorsonasal retina, suggestive (but not conclusive proof) of 
disrupted nasotemporal patterning.  
A significant increase in the number of RGCs expressing the ipsilateral determinant 
Zic2 was observed in the nasal but not temporal retina of Foxg1
-/- 
embryos, 
suggesting that Foxg1 normally represses Zic2 expression in these RGCs. It has 
been previously demonstrated that the quantity of retinal cells expressing Zic2 and 
EphB1, through which Zic2 is thought to mediate its effects, is correlated with the 
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size of the ipsilateral projection. Therefore, Zic2 provides an explanation for the 
extra ipsilateral projections from nasal but not temporal retina.  
Finally, the expression patterns of molecules Nkx2.2, SSEA-1 and CD44 that are 
key markers of chiasm cells were examined using immunohistochemistry. The 
protein expression patterns were maintained in wild type and Foxg1
-/-
 embryos at 
the time when the ipsilateral projection is forming. Midline expression of ephrin-B2 
that repels ipsilateral axons was also unchanged.  
In summary, the co-cultures revealed a requirement for Foxg1 in the nasal retina 
and at the chiasm to allow axons from Foxg1-expressing RGCs to cross the ventral 
midline. In the absence of Foxg1, Zic2 expression increases in the nasal retina and
may explain the rise in ipsilateral projections. These data are consistent with a 
model in which Foxg1 normally represses Zic2 expression in the nasal retina, hence 
repressing the ipsilateral pathway in contralateral RGC axons.  
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CHAPTER 1: Introduction.  
1.1. An overview of axon guidance. 
In the developing mammalian brain, billions of nerve axons navigate over long 
distances to form connections with their targets and thereby establish neuronal circuits. 
Pathfinding axons are tipped with highly motile structures called growth cones that are 
constructed from actin filaments originating from a central microtubule core, with 
finger-like extensions called filopodia (Suter and Forscher, 1998). As growth cones 
sample the external environment, receptors on their surface bind diffusible or tethered 
molecules that act as guidance cues, in the extracellular matrix or on cell surfaces. 
Receptor-ligand binding triggers intracellular signaling cascades that alter the 
cytoskeletal architecture by rearranging actin or tubulin. The addition of cytoskeletal 
components in response to attractive guidance cues is thought to drive the growth cone 
forward, whereas disassembly of the cytoskeleton in response to chemorepulsive cues 
produces growth cone retraction. Asymmetric signaling on one side of the growth cone 
leads to axon turning towards or away from a guidance cue (Song et al., 1998; Song 
and Poo, 1999). Despite this basic knowledge, the precise mechanisms that underlie 
growth cone guidance are still not fully understood. 
Growth cones are guided by both contact-mediated and diffusible pathway and target-
derived cues that mediate contact attraction, contact repulsion, chemoattraction and 
chemorepulsion (Tessier-Lavigne and Goodman, 1996). Axon navigation usually 
occurs via several intermediate targets en route to an axon’s final destination, where 
growth cones sample guidance cues in the extracellular environment. It is remarkable 
how multiple axon populations from different regions of the brain manage to respond 
solely to appropriate cues and navigate accurately to their correct destinations. 
Targeting errors do occur but axons that are found in inappropriate locations are simply 
pruned by cell death postnatally (Provis and Penfold, 1988; Oppenheim, 1991).  
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1.2. Commissural axon tracts. 
Commissural tracts connect the left and right hemispheres of the brain and coordinate 
activity between them. The commissural tracts include the large tracts of the corpus 
callosum and anterior commissure (connecting the two cerebral hemispheres) and the 
hippocampal commissure (connecting the hippocampi), but also smaller commissures, 
including the optic chiasm, which relays visual information from the eyes to left and 
right visual brain targets in the thalamus and superior colliculi via retinal axons. The 
formation of these tracts is accurately regulated (1) cell-autonomously by transcription 
factors that regulate the expression of receptors on growth cones and signalling 
cascades and (2) cell-non-autonomously by the extracellular environment, involving 
pioneering axons and pathway-derived guidance cues that exist as diffusible gradients 
or as cues anchored to midline glial structures or other intermediate targets (reviewed in 
(Lindwall et al., 2007).  
1.2.1. Long-range guidance.  
It is well established that long-range diffusible guidance cues guide axons towards and 
across the brain midline. These include the ‘classic’ guidance molecules Netrins and 
Slits and their receptors: Deleted in colorectal cancer (DCC) and Roundabout (Robo) 
and also morphogens, such as Sonic hedgehog (Shh), Fibroblast growth factors (FGFs) 
and Wingless-type (Wnt) proteins that play a dual role in patterning tissues as well as 
guiding axons (Salie et al., 2005; Charron et al., 2003; Butler and Dodd, 2003; 
Lyuksyutova et al., 2003; Yoshikawa et al., 2003; Yoshikawa and Thomas, 2004; 
Augsburger et al., 1999). Gradients of guidance cues serve either to attract or repel 
axons. For example, at the vertebrate spinal cord and the Drosophila ventral nerve cord 
the long-range, diffusible chemoattractant netrin is secreted by the floor plate and 
attracts axons to the midline (Serafini et al., 1996; Serafini et al., 1994; Mitchell et al., 
1996). In contrast, the chemorepellent Slit prevents commissural axons from recrossing 
the midline and prevents ipsilateral axons from crossing at all via contact repulsion 
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following the binding of Slit to Robo receptors on these axons (Kidd et al., 1999; Kidd 
et al., 1998; Brose et al., 1999; Long et al., 2004; Kennedy et al., 1994; Placzek et al., 
1990; Tessier-Lavigne et al., 1988). Although netrin expression has not been identified 
directly at the optic chiasm, netrin-1-mediated attraction at the optic nerve head is 
thought to facilitate the exit of retinal axons from the eye to the optic stalk (Deiner et 
al., 1997).   
1.2.2. Short-range guidance.  
Not all axons are guided from a distance. Short-range guidance molecules, such as 
Ephrins and Eph receptors are expressed by cells and axons at the optic chiasm midline 
of the developing mouse forebrain (Marcus et al., 2000; Williams et al., 2003). Ephrins 
and Ephs mediate cell-cell contact repulsion, which play important roles in retinotectal 
mapping and are able to signal bidirectionally (Drescher et al., 1997; Braisted et al., 
1997; Hindges et al., 2002; Mann et al., 2002; Klein, 2004; Kullander and Klein, 2002; 
McLaughlin et al., 2003). Semaphorins (Semas) that interact with their transmembrane 
Neuropilin and Plexin receptors, require cell-cell contact, although some Semaphorins 
are soluble ligands (Pasterkamp and Kolodkin, 2003). Semaphorins mediate both 
chemorepulsion and chemoattraction and help position the anterior commissure (Falk et 
al., 2005; Gu et al., 2003). Also, laminin and fibronectin in the extracellular matrix 
were discovered as some of the earliest molecules that promote axon growth (Lander, 
1987).   
1.2.3. Attraction versus repulsion. 
There is growing evidence to support the hypothesis that growth cones make guidance 
decisions by measuring relative levels of attractive and repulsive molecules that they 
contact (Tessier-Lavigne and Goodman, 1996). Experimental manipulations of levels of 
guidance cues and receptors imply that an axon can alter its response to external cues 
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by changing the composition of guidance receptors present on the growth cone 
(Bashaw and Goodman, 1999; Lin and Goodman, 1994; Tessier-Lavigne and 
Goodman, 1996; Winberg et al., 1998). However, recent findings suggest that axon 
guidance is more complicated than the simple attraction and repulsion of axons to long- 
and short-range guidance molecules. It appears that axons can alter their response to 
guidance cues in a hierarchical manner depending on their position in the axon 
pathway. For example, commissural axons crossing the Xenopus spinal cord lose 
responsiveness to the chemoattractant Netrin-1 and gain responsiveness to the 
chemorepellent Slit only after crossing the midline when they start to express the Slit 
receptor Robo (Stein and Tessier-Lavigne, 2001). Slit is thought to silence netrin 
attraction by causing a direct interaction between Robo and DCC (the netrin receptor), 
enabling commissural axons to move on to their next target after reaching the attractive 
midline. Stein & Tessier-Lavigne’s (2001) findings have sparked a debate over whether 
the observed Slit-Robo interactions during axon guidance are primarily the 
consequence of inhibition of netrin attraction or simply axon repulsion or a 
combination of the two (Bhat, 2005; Garbe and Bashaw, 2007; Hiramoto and Hiromi, 
2006).  
1.2.4. Extracellular matrix molecules influence axon guidance. 
More complexity is thrown in by the heparan sulphates, chondroitin sulphates and their 
core glycoproteins. These highly diverse extracellular matrix molecules interact with 
axon guidance molecules and growth cones in various ways and the diversity of their 
carbohydrate chains appear to produce different axon guidance decisions even with the 
same guidance cue (Bulow and Hobert, 2004; Chung et al., 2001; Chung et al., 2000a; 
Chung et al., 2000b; Ichijo, 2004; McAdams and McLoon, 1995; Pratt et al., 2006). 
Bulow and Hobert (2004) proposed the term ‘heparan sulphate code’ to explain how 
heparan sulphate modifications of core proteins could be deployed in different brain 
regions along axonal pathways, resulting in the recruitment of specific groups of 
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guidance cues that influence axon navigation in key regions. This hypothesis arose 
from growing evidence for the use of heparan sulphate proteoglycans (HSPGs) as 
cofactors to recruit ligands to their receptors (Bernfield et al., 1999; Chung et al., 
2000a; Guimond and Turnbull, 1999; Perrimon and Bernfield, 2000). Only last year it 
was discovered that heparan sulphate, a cell surface residue on extracellular matrix 
proteoglycans, binds to the Slit protein and functions to enhance Slit-Robo binding, 
which is relatively weak on its own (Hussain et al., 2006). Therefore, the complex 
panoply of axon navigation decisions is determined by the combinatorial action of 
signaling molecules (Yu and Bargmann, 2001) in the context of a molecular code 
inscribed into the extracellular substrate that growth cones navigate through. 
Deciphering the diverse proteoglycan codes and precise downstream signaling events 
offers great scope for future experimentation.  
1.3. The visual system. 
The retinotectal pathway is a well-characterised and popular model for axon guidance. 
This pathway is particularly useful for this thesis as Foxg1 is expressed at various 
points along it. Retinal ganglion cells (RGCs) are projecting neurons found in the inner 
layer of the retina. These RGC axons carry visual information from the retinas, via the 
optic nerves and ventral midline of the brain, along the optic tracts that run 
dorsolaterally along the surface of the diencephalon to the left and right lateral 
geniculate nuclei in the thalamus and termination zones in the superior colliculi on both 
sides of the midbrain. RGC axons are presented with multiple navigational choices 
throughout their journey. A major choice point is the optic chiasm, positioned at the 
ventral surface of the hypothalamus, where retinal axons either cross to the contralateral 
side of the brain or remain uncrossed (ipsilateral). The optic chiasm itself provides cues 
for axons to cross or not (Mason and Sretavan, 1997). The simple, bilateral ‘choice’ of 
retinal axons at the optic chiasm means that any deviations from the norm are simple to 
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detect. The presence of an ipsilateral projection gives rise to binocular vision, enabling 
visual information from both eyes to be processed in the same region of the brain, 
which has advantages of improved depth perception. The trend in evolution has been 
from laterally-positioned eyes and complete RGC decussation at the optic chiasm 
(100% of retinal axons cross the midline) to frontally-placed eyes and partial 
decussation, in which a proportion of RGC axons project ipsilaterally, leading to the 
emergence of binocular vision that is exclusive to mammals and some predatory birds 
with forward-facing eyes (Jeffery, 2001). Therefore, observations in a mammal, such as 
the mouse, are more relevant to humans and other primates than observations in non-
mammalian species, despite humans possessing a larger ipsilateral projection (almost 
50%) than mice (~ 3% ipsilateral axons) due to their forward-facing eyes (Drager and 
Olsen, 1980; Fukuda et al., 1989; Polyak, 1957). Guidance molecules at the optic 
chiasm show strong evolutionary conservation between species, demonstrating the 
importance of this commissural tract and also the wide relevance of studies in a 
diversity of organisms from fruit flies and zebrafish to chicks and mice. The mouse was 
chosen for this thesis as it is the only animal with an uncrossed projection, lacking in 
birds and fish, for which appropriate mutants are available for experimental study. The 
ability to manipulate genes precisely and create gene knockouts, in which a gene is 
deleted, offers huge advantages for the study of normal gene function. 
1.4. Development of the mouse optic chiasm.
1.4.1. Early stages of optic chiasm development.  
At E9 in the mouse, Pax-2 is expressed in the ventral half of the optic stalk and the 
ventral midline of the forebrain, that will become the optic chiasm, is formed by 
neuroepithelial cells that express Shh (Echelard et al., 1993; Torres et al., 1996). At 
E11-E12, when the first RGC axons project towards the optic chiasm, Pax-2 expression 
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is present in both optic stalks and connecting midline neuroepithelium in a transverse 
line. Directly at the midline, Shh is absent (Torres et al., 1996) and this is thought to be 
the result of repression by Pax-2, limiting Shh expression to regions located caudal to 
decussating axons (Macdonald et al., 1997). In Pax-2 null mice, all axons project 
ipsilaterally and Shh expression is continuous across the midline, leading to the 
hypothesis that Pax-2 provides a permissive corridor through a Shh domain that may 
normally repel axons or inhibit their growth (Torres et al., 1996). However, the ability 
of retinal axons of zebrafish noi mutants (noi being highly homologous to Pax-2), to 
cross Shh-expressing cells puts this hypothesis in doubt and calls for detailed 
examination of axon growth at the Pax-2 null mouse chiasm.  
1.4.2. The main stages of retinal axon projections through the optic 
chiasm.  
The main stages of axon growth through the mouse optic chiasm are shown in Figure 1.
The eyes and ventral diencephalon region are shown as if the observer is looking down 
upon the dorsal surface of horizontal slices through the level of the optic chiasm. (The 
dorsal-ventral axis is perpendicular to the page). At around embryonic day 12 (E12) in 
the mouse, shortly after RGC genesis begins, pioneering retinal axons arising from 
dorsocentral RGCs project from both eyes and converge on the midline of the ventral 
diencephalon to form the optic chiasm (Colello and Guillery, 1990) (Figure 1A). Some 
of these early pioneers cross into the contralateral tract, whilst others remain ipsilateral, 
entering the optic tract directly without approaching the midline (Colello and Guillery, 
1990; Guillery et al., 1995; Marcus and Mason, 1995). These early ipsilateral 
projections are only transient and are eliminated later on during postnatal development 
(Insausti et al., 1984). E14 - E16 (Figure 1B) is the peak phase of RGC genesis and 
retinal axon growth through the optic chiasm and during this period the permanent 
ipsilateral projection develops (Colello & Guillery, 1990).  
The earliest retinal axons 
originate from RGCs in 
dorsocentral retina and 
project anterior to the 
boundary of SSEA-1/CD44 
neurons. Some project 
contralaterally (blue line), 
whilst others form a transient 
ipsilateral projection and 
enter the optic tract directly 
without approaching the 
midline (broken line). 
(A) Early projections at E12 - E13 
(B) Peak projections at E14 - E16 
(C) Late projections at E17 – P0 
The majority of RGCs project 
axons during this period. The 
permanent ipsilateral projection 
develops, arising from VT 
RGCs whose axons express 
EphB1 and are repelled upon 
contact with ephrin-B2 (grey 
box) found on midline radial glia 
at the chiasm. The most 
anterior tip of the SSEA-1/CD44 
neuronal array reaches into the 
midline chiasm region. Only 
contralateral axons cross it. 
During the late phase of RGC 
projections, all newly-
differentiated RGCs project 
contralaterally, even from the 
VT retina. No RGCs project 
ipsilaterally after ~ E18.5. 
Ephrin-B2 expression (dotted 
outline) is greatly diminished 
at the midline. 
Figure 1. The main stages of RGC axon projections at the 
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Contralateral RGC axons arise from the entire retina, whereas permanent ipsilateral 
RGC axons arise from a small region of the peripheral ventrotemporal (VT) retina, 
called the ‘ventrotemporal crescent’ (VTC). The adult pattern of decussation is 
established by E15 - E16 with a 97:3 ratio of contralateral to ipsilateral axons (Drager, 
1985; Drager and Olsen, 1980). At later stages (Figure 1C), from E17 to birth (at 
around E21), all RGC axons project contralaterally, including those from the VTC 
because ipsilateral RGC projections cease at E17.5 (Colello and Guillery, 1990; Drager, 
1985; Marcus et al., 1995; Marcus & Mason, 1995). 
1.5. Cells and molecules associated with axon divergence at the chiasm 
midline. 
1.5.1. Ephrin-B2 and midline radial glia. 
Glial structures play key roles in the formation of commissural tracts, particularly as 
sources of guidance cues, and the optic chiasm is no exception (Barresi et al., 2005; 
Lindwall et al., 2007; Silver, 1993; Steindler, 1993). All retinal axons appear to contact 
a midline specialization of radial glial cells prior to crossing the midline or remaining 
ipsilateral (Marcus et al., 1995). Figure 1 shows a diagram of the position of midline 
glia in relation to retinal axons in the developing optic chiasm. Midline glial cells 
express the axon guidance molecules Nr-CAM (Williams et al., 2006), Slit2 (Erskine et 
al., 2000) and Eph/ephrin subtype A and B receptors and ligands (Bertuzzi et al., 1999; 
Marcus et al., 2000). Ephrin-B2 is the only one of these molecules to date that has been 
shown to influence contralateral-ipsilateral axon divergence at the chiasm via the 
selective repulsion of VT RGC axons that express its receptor EphB1 (Nakagawa et al., 
2000; Williams et al., 2003). RGC axons from other regions of the retina (dorsonasal, 
dorsotemporal and ventronasal) do not express EphB1 and are not repelled by ephrin-
B2. Ephrin-B is absent from the ventral diencephalon of developing chick embryos 
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(Nakagawa et al., 2000), which lack a permanent ipsilateral projection, adding to 
evidence from Xenopus and mouse studies that ephrin-B2 is required for the uncrossed 
projection to form. Ephrin-B2 and EphB1 are also expressed in the human chiasm and 
temporal retina respectively (Lambot et al., 2005). Lambot et al. also showed that 
EphB1 expression occurs in the entire temporal half of the retina, mirroring the 
appearance of ipsilateral axons from all temporal RGCs and supporting the 50:50 
contralateral:ipsilateral ratio in humans, suggesting that the uncrossed projection forms 
in a similar way to mice. Interestingly, a number of other EphB receptors (EphB1, 
EphB2 and EphB3) are expressed in the retina and these also share the ability to bind to 
ephrin-B2 (Birgbauer et al., 2000; Braisted et al., 1997; Hindges et al., 2002; Mann et 
al., 2002; Williams et al., 2003). Therefore, it is still unclear why ephrin-B2 does not 
bind to these other receptors in addition to EphB1, although one explanation is that 
ephrin-B2 has a higher affinity for the EphB1 receptor compared to the others 
(Flanagan and Vanderhaeghen, 1998). Alternatively, binding of ephrin-B2 to EphB1 
may trigger ‘ipsilateral-specific’ downstream signaling events through specific EphB1 
interactions with adaptor proteins such as Grb7 (Han et al., 2002) or the local synthesis 
of EphB1 protein in VT retinal axons en route to the chiasm may ‘tag’ them for an 
ipsilateral fate.  
1.5.2. Chiasm neurons. 
Another important cellular specialization in the ventral diencephalon, posterior to the 
optic chiasm, is a population of early-differentiating neurons that expresses a variety of 
cell surface molecules, including stage-specific embryonic antigen-1 (SSEA-1), and the 
cell surface protein CD44 (Kruger et al., 1998; Marcus and Mason, 1995; Sretavan et 
al., 1994; Sretavan et al., 1995). SSEA-1 and other molecules expressed by overlapping 
but slightly variable subsets of these neurons, such as chondroitin sulphate 
proteoglycans (Chung et al., 2000a, 2000b), Slit1 and Robo2 (Erskine et al., 2000) 
inhibit the growth of all retinal axons equally and may normally prevent retinal axons 
31
deviating from their correct path rather than providing cues for axon divergence 
(Marcus et al., 2000). SSEA-1/CD44 neurons first appear at E12 in a ‘V’-shape and are 
believed to provide an anatomical template or scaffold, guiding the earliest axons 
anteriorly around their borders to create the characteristic ‘X’-shape of the chiasm 
(Erskine et al., 2000; Marcus and Mason, 1995; Mason and Sretavan, 1997; Runko and 
Kaprielian, 2002). At later stages, these neurons adopt a more elaborate conformation 
and borders of the SSEA-1/CD44 expression domain coincide with axon paths in the 
diencephalon (Lin et al., 2005). Recently, CD44 has been implicated in ipsilateral-
contralateral pathfinding (Lin and Chan, 2003; Lin et al., 2005).  
1.5.3. Slits, EphA and ephrin-As channel navigating axons.  
A number of other molecules are expressed at and around the optic chiasm, such as 
ephrin-As expressed ventral and posterior to the chiasm (Marcus et al., 2000; Zhang et 
al., 1996), Slit1, expressed by a subset of SSEA-1/CD44 neurons and Slit2, expressed 
by midline radial glia (Erskine et al., 2000). Although blocking ephrin-A and EphA-
binding reduced the inhibition of retinal axons to chiasm reaggregates in vitro, there 
was no differential effect on the growth of contralateral and ipsilateral axons (Marcus et 
al., 2000). Although the authors concluded that ephrin-A and EphA interactions are 
unlikely to control retinal axon divergence at the optic chiasm in vivo, this cannot be 
excluded entirely because divergence may require additional interactions or cues that 
are present in vivo but absent from the in vitro culture system used. Marcus et al. (2000) 
also proposed that ephrin-A - EphA repulsive interactions may prevent axons from 
entering inappropriate tissues and contribute to position-dependent sorting of retinal 





 double knockout mice, retinal axons form an ectopic chiasm anterior to 
the normal chiasm (Plump et al., 2002). These aberrantly-projecting axons originated 
from the entire retina and coupled with the observation of a normal ipsilateral 




 mice, it appears unlikely that Slit1 and Slit2 are
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important for retinal axon divergence, although a subtle role cannot be excluded. 
Rather, it appears that Slits are required to control the position at which retinal axons 
decussate in the ventral diencephalon and prevent axons from straying from their path 
(Thompson et al., 2006b; Thompson et al., 2006a).  
1.6. Molecules controlling ipsilateral-contralateral divergence at the 
chiasm. 
It is becoming increasingly evident from in vivo and in vitro experiments that the 
control of ipsilateral-contralateral pathfinding at the optic chiasm involves multiple 
attractive or repulsive factors that act sequentially or in concert in the eye, optic stalk, 
chiasm and possibly other regions along the retinofugal pathway (Bertuzzi et al., 1999; 
Chung et al., 2000b; Deiner et al., 1997; Deiner and Sretavan, 1999; Jeffery, 2001; 
Marcus et al., 1995; Marcus et al., 1999; Sretavan and Kruger, 1998; Sretavan and 
Reichardt, 1993; Wang et al., 1995; Wilson et al., 1997; Wizenmann et al., 1993; Zhang 
et al., 2000). In vitro work has shown that retinal axons are guided by both contact-
mediated (Sretavan and Reichardt, 1993; Wang et al., 1995; Wizenmann et al., 1993; 
(Godement et al., 1994) and diffusible (Wang et al., 1996) cues and that the chiasm is 
generally inhibitory to axon growth. In the optic chiasm region alone, the midline 
location where contralateral and ipsilateral axons diverge coincides with an area in 
which several regulatory gene expression domains overlap (Marcus et al., 1999). The 
expression patterns of regulatory genes, such as Vax1, Vax2 and Pax2 that are 
expressed very early in development suggests that they are more likely to be involved 
in morphogenesis and regional patterning of the eye and ventral hypothalamus and so 
affect processes upstream of retinal axon divergence rather than in contralateral-
ipsilateral divergence processes directly (Torres et al., 1996; Bertuzzi et al., 1999; 
Marcus et al., 1999). However, this does not mean that such an involvement does not 
occur.  
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Table 1 provides a summary of a few of the key molecules that are known to influence 
the contralateral-ipsilateral ratio in mice. This list is not intended to be exhaustive but 
rather provides a sample of notable findings in the literature. Figure 2 shows the 
contralateral-ipsilateral axon pathfinding defects at the chiasm in knockouts for a few 
of these molecules that are expressed in the retina. For each molecule a cartoon of the 
eye shows the location of RGCs that express that particular molecule. If the molecule is 
expressed by ipsilateral RGCs, these are shown in red. Contralateral RGCs are shown 
in blue. Foxd1 is the only molecule shown that is expressed both by contralateral RGCs 
more centrally and ipsilateral RGCs in peripheral VT regions (Herrera et al., 2004). 
Projection defects are shown for the mice in which the gene encoding the molecule has 
been knocked out. In the case of Zic2
kd/kd
 mice, Zic2 expression levels were reduced 
substantially to 20% of the wild type level in a gene ‘knockdown’ (Nagai et al., 2000).  
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Table 1. Molecules that affect the ipsilateral projection. 
Molecule Axon guidance phenotype  
Zic2  
Zinc-finger transcription factor 
expressed by ipsilateral RGCs in  
VTC. 
Expressed around optic chiasm. 
Reduced ipsilateral projection in Zic2
kd/kd
(abnormal chiasm) and Zic2
kd/+ 
mice (normal 
chiasm) (Herrera et al., 2003). 
EphB1  
Receptor tyrosine kinase expressed  
by ipsilateral RGCs in VTC  
& the majority co-label with Zic2.  
Reduced ipsilateral projection in EphB1 null  
mice (Williams et al., 2003).  
Ephrin-B2  
Expressed in midline radial glia at  
The optic chiasm midline.  
Expressed in dorsal (high) to ventral 
(low) gradient in retina. 
Blocking ephrin-B2 function in vitro: VT  
RGC axons experience less repulsion by 
dissociated chiasm cells (ie) reduction in 
ipsilateral projection (Williams et al., 2003).  
  
Foxd1 (BF-2) Foxd1 null mice: Increased ipsilateral  
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Forkhead box transcription factor 
expressed in the entire VT quadrant  
of the retina (not just the VTC).   
Expressed in posterior optic chiasm.  
projection in majority of embryos. Stalling  
and misrouting guidance defects also  
observed. Disrupted chiasm shape  
(Herrera et al., 2004). 
Islet-2  
LIM-homeodomain transcription  
factor expressed by ~ 40%  
contralateral RGCs. 
Islet-2 null mice: Increased ipsilateral  
projection from more ipsilateral RGCs  
confined to VTC (Pak et al., 2004).  
Nr-CAM  
Cell adhesion molecule expressed  
solely by contralateral RGCs. 
Nr-CAM null mice: Increased ipsilateral 
projection from more ipsilateral RGCs in VT 
retina at late stages only (E18.5).  
(Williams et al., 2006). 
Vax1  
Homeodomain transcription factor 
expressed in the optic stalk and  
ventral hypothalamic midline. 
Vax1 null mice: No chiasm. Axons stall and  
form whorls in the hypothalamus  
(Bertuzzi et al., 1999).  
Vax2  
Homeodomain transcription factor 
expressed in the ventral retina.  
Vax2 null mice: Variable results in two  
different papers despite deleting the same  
portion of the Vax2 gene on the same genetic 
background. (1) Greatly reduced ipsilateral 
projection (Barbieri et al., 2002).  
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(2) Normal or abnormally large ipsilateral 
projection (Mui et al., 2002).  
Pax-2  
Expressed by optic stalk and midline 
neuroepithelium from E11.  
Increased ipsilateral projection in Pax-2 null  
mice (Torres et al., 1996).  
Note: Pax2 overexpression in neural tube of  
chick embryos (Thanos et al., 2004) and  
zebrafish noi mutants (Macdonald et al., 1997) 
caused a variety of chiasm abnormalities: 
increased ipsilateral routing, axon stalling, 
disturbances in axon crossing.  
Brn3b 
POU-domain transcription factor 
expressed postmitotically in RGCs.  
Brn3b null mice: Increased proportion of 
ipsilateral projections.  
CD44  
Cell surface carbohydrate moiety 
expressed by early-differentiating 
neurons in the ventral diencephalon. 
In vitro brain slice culture: Reduced ipsilateral 
projection at E15 only (anti-CD44 antibodies 
applied at E15).  
Reduced contralateral projection at E13 only  
(Lin et al., 2005). 
Chondroitin sulphate  
proteoglycans   
In vitro brain slice culture: Absent ipsilateral 
projection at E14 and reduced ipsilateral 
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Expressed by early-differentiating 
neurons in the ventral diencephalon. 
projection at E15 following enzymatic  
removal of chondroitin sulphate (Chung et al., 
2000b).  
In vitro, chondroitin sulphate inhibits axons  
from VT retinal explants only (Cheung et al., 
2005). 
Shh  
Expressed by RGCs from E12 and in 
the ventral diencephalon anterior and 
posterior to axons.  
Inhibition of chick retinal axon outgrowth 
(Trousse et al., 2001). 
Anti-Shh antibody treatment in E13 brain slice 
cultures: fewer contralateral retinal axons. At 
E15: increased ipsilateral projection (Hao et al., 
2006).  
Tyrosinase  
Key enzyme in melanin synthesis 
pathway. 
Mutated in albino mammals.  
Albino mice: reduced ipsilateral projection  
from fewer, more peripheral VT RGCs. A  
greater proportion of RGCs in VTC project 
contralaterally (Marcus et al., 1996b).  
Non-mammalian albinos (frogs) have normal 





















































Figure 2. Molecules affecting the ipsilateral projection
Null phenotype*Molecule
Zic2kd/kd









1.6.1. Zic2 and EphB1 in the ventrotemporal crescent. 
The ‘ventrotemporal crescent’ (VTC) is the peripheral VT region of the retina from 
which ipsilateral RGCs and their axons arise. In the past decade, the transcription factor 
Zic2 was identified by in vivo and in vitro studies as an ipsilateral determinant that is 
expressed by VT RGCs that project ipsilaterally at the chiasm (Herrera et al., 2003). 
Zic2 is thought to mediate its effects via the VT-restricted expression of EphB1 that is 
repelled by ephrin-B2-expressing midline radial glia at the chiasm (Herrera et al., 2003; 
Williams et al., 2003). Although Zic2 is also expressed around the optic chiasm, the 
addition or removal of Zic2 from RGCs in vitro provided strong evidence that it 
influences the ipsilateral projection autonomously from within RGCs (Herrera et al., 
2003).   
1.6.2. Molecules associated with contralateral projections. 
The cell adhesion molecule Nr-CAM, is expressed by RGCs that project contralaterally 
and its retinal expression mirrors the spatiotemporal changes in the origins of 
contralateral axons that occur throughout all stages of chiasm development. For 
instance, from E14 - E16, Nr-CAM is found in the entire retina apart from the VT Zic2-
expressing region from E14 – 16 (Williams et al., 2006) but at later stages when all new 
RGCs project contralaterally, Nr-CAM is expressed in the entire retina including the 
VTC. Interestingly, Nr-CAM null mice display an increased ipsilateral projection 
specifically from more ipsilateral RGCs in the VT retina at E18.5 but not at earlier 
embryonic ages (Williams et al., 2006). Combined with in vitro findings that Nr-CAM 
mediates contralateral behaviour from within RGCs, the authors concluded that Nr-
CAM promotes the crossing of contralateral RGC axons from the VTC only at late 
stages in chiasm formation. However, the functions of Nr-CAM protein in retinal axons 
and at the optic chiasm, where it is expressed in a high anterior to low posterior 
gradient, remain to be elucidated.  
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Another gene associated with the crossing of axons is the LIM-homeodomain 
transcription factor Islet-2 (Pak et al., 2004). Islet-2 (Isl2) is expressed by only a subset 
of contralateral RGCs with reduced expression in the VTC of the retina (Pak et al., 
2004). In the VTC, Isl2-expressing RGCs are thought to suppress Zic2 and EphB1 
expression, allowing them to project contralaterally.  
Considering molecules at the chiasm, anti-CD44 and anti-Shh antibodies produced 
fewer contralateral retinal axons at the chiasm midline in slice cultures of the E13 brain 
(Lin et al., 2005; Hao et al., 2006), implying that CD44 and Shh normally promote the 
crossing of early axons. Interestingly, the same anti-Shh antibody treatment had no 
effect at E14 but at E15 the number of ipsilateral axons increased (Hao et al., 2006). 
The behaviour of E15 retinal axons to the removal of CD44 also changed but showed a 
reduction in the ipsilateral projection (Lin et al., 2005). These results suggest that CD44 
and Shh have different effects on retinal axons depending on the developmental age. 
Interestingly, a previous study reported a general growth-inhibitory influence for Shh 
on chick retinal axons (Trousse et al., 2001) and the differences between these results 
and those of Hao et al. (2006) could be attributed to different in vitro experimental 
conditions. In support of this, the influence of Shh on retinal axons depends on its 
precise molecular interactions. For instance, Shh secreted from the floor plate acts as a 
chemoattractant for commissural spinal cord axons in the presence of Netrin-1 (Charron 
et al., 2003).  
1.6.3. Genetic control of axon guidance.  
Although recent studies have made substantial progress in identifying the molecules 
directing retinal axons at the optic chiasm, the genes responsible for regulating the 
expression of receptors on contralateral and ipsilateral axons and for determining how 
retinal axons interact and respond to these guidance cues is less well understood. Over 
the past decade, it has emerged that the distribution of axon guidance molecules and 
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hence axon paths correlate with domains of regulatory gene expression in zebrafish 
(Macdonald et al., 1994) and also in the mouse (Mastick et al., 1997; Tole and 
Patterson, 1995). These expression boundaries outline areas that are inhibitory to axons 
with the consequence that axons are funneled along appropriate routes that are 
permissive to growth.  
Transcription factors, such as Foxg1, Foxd1, Zic2 and Isl2 exert their effects by 
activating or repressing downstream genes, which may in turn influence growth cone 
navigation cell-autonomously or cell-non-autonomously by regulating the expression of 
cell surface or diffusible molecules that act as pathway-derived guidance cues. It 
follows that the misexpression of certain regulatory genes (some examples are shown in 
Table 1) can lead to axon misrouting and this premise is supported by both in vitro and 
in vivo experiments (Herrera et al., 2004; Lin et al., 2005; Marcus et al., 1995; Pratt et 
al., 2002; Pratt et al., 2004; Sretavan et al., 1994). Recently, fascinating developments 
have revealed that transcription factors, such as Engrailed-2, Pax6 and Foxg1, multitask 
in their regulation of tissue morphogenesis in the developing embryonic brain as well as 
axon guidance (Brunet et al., 2005; Pratt et al., 2002; Pratt et al., 2004; Pratt et al., 
2000). 
This thesis will explore the influence of the forkhead box transcription factor Foxg1 on 
retinal axon divergence at the optic chiasm based on previous observations in this 
laboratory of axon guidance defects in the retinotectal and thalamocortical tracts (Pratt 
et al., 2002, 2004). 
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1.7. Foxg1 (formerly known as Brain Factor-1 [BF-1]) is a forkhead box 
transcription factor. 
1.7.1. Overview of forkhead genes.  
The fork head gene was first discovered in Drosophila (Weigel et al., 1989) and was 
found to encode a ‘forkhead box’ DNA binding domain that consists of 110 amino 
acids (Weigel and Jackle, 1990). Over the past two decades, forkhead genes have been 
identified across a wide range of phyla, forming a family of Forkhead box (Fox) 
transcription factors, whose members share the evolutionarily conserved Fox DNA 
binding domain (Carlsson and Mahlapuu, 2002). The forkhead transcription factors are 
also known as ‘winged helix’ transcription factors due to the butterfly-like structure of 
the loops (or ‘wings’) connecting the beta strands flanking one of the three alpha 
helices (Clark et al., 1993). The Fox DNA binding domain is highly conserved across 
species from Drosophila to mammals and chromosomal and phylogenetic analyses are 
suggestive of inter- and intra-chromosomal duplications (Lehmann et al., 2000; 
Lehmann et al., 2003). The Fox DNA binding domain binds specific DNA sequences, 
suggestive of a role for Fox proteins in transcriptional regulation (reviewed in Carlsson 
and Mahlapuu, 2002). Fox genes are expressed in a tightly regulated manner during 
development where they are involved in the formation of many different organs 
(Carlsson and Mahlapuu, 2002).  
Foxg1 belongs to the Fox gene family and was found by its homology to the vertebrate 
FoxA subfamily (formerly known as hepatocyte nuclear factors (HNF3)) (Tao and Lai, 
1992). There is strong in vitro evidence to show that Foxg1 acts as a transcriptional 
repressor by forming a complex with the Groucho transcriptional corepressors TLE and 
Hes that lack DNA-binding ability by themselves and also histone deacetylases to 
regulate expression of cell cycle inhibitors of the Cip/Kip family (Castella et al., 2000; 
Hardcastle and Papalopulu, 2000; Yao et al., 2001).
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1.7.2. Expression of Foxg1 in the developing brain.
In vertebrates from Xenopus to humans, Foxg1 displays a highly conserved pattern of 
expression in the anterior central nervous system (CNS) (Bourguignon et al., 1998; 
Murphy et al., 1994). Foxg1 is first expressed at the 1-3 somite stage in developing 
mouse embryos in the anterior neural ridge (ANR) located in the anterior non-neural 
ectoderm (Dou et al., 1999). Between somite stages 5 - 8, Foxg1 expression spreads 
from the anterior neural plate rostrally to areas that eventually form the telencephalon, 
its derivatives and anterior eye structures (Dou et al., 1999; Shimamura et al., 1995). 
Foxg1 expression is mainly restricted to anterior regions of the mouse forebrain: in the 
telencephalic neuroepithelial progenitors (Tao & Lai 1992), the nasal portion of the 
retina and optic stalk, the anterior hypothalamus and superior colliculus (Hatini et al., 
1994; Xuan et al., 1995).  
1.7.3. Foxg1 null embryos exhibit forebrain defects.  
Foxg1 is required for normal development of the forebrain and eyes, since the 
morphology of these structures is affected in Foxg1
-/-
 embryos (Hanashima et al., 2004; 
Hanashima et al., 2002; Hatini et al., 1994; Huh et al., 1999; Xuan et al., 1995). The 
olfactory bulbs, nasal placodes and resulting nasal epithelium also fail to grow 
properly, whereas the otic vesicle, pharyngeal pouches and Rathke’s pouch and their 
derivatives (inner ear, anterior foregut and the pituitary) appear unchanged from the 
wild type (Xuan et al., 1995).  
One of the most noticeable abnormalities in Foxg1 null mice is severe hypoplasia of the 
cerebral hemispheres (Dou et al, 1999). This hypoplasia appears to be caused by 
reduced proliferation and premature differentiation of telencephalic neuroepithelial 
cells between E10 and E18, reducing the size of the neural progenitor precursor pool 
(Hanashima et al., 2002; Martynoga et al., 2005; Takahashi et al., 1993; Xuan et al., 
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1995). Recent in vitro and in vivo evidence has revealed that Foxg1 regulates cell cycle 
progression via transcriptional repression of the cell cycle inhibitor p21Cip1 in 
telencephalic neuroepithelial cells leading to inhibition of TGF-beta-mediated 
cytostasis (Dou et al., 2000; Seoane, 2004). Therefore, Foxg1 normally prevents 
premature growth arrest in telencephalic progenitor cells. Not surprisingly, deregulation 
of Foxg1 has been associated with tumour growth. For example, the chick homologue 
of Foxg1, qin, was discovered as an oncogene (Li et al., 1997), and recently an increase 
in FOXG1 copy number was linked to medulloblastoma brain tumours in humans 
(Adesina et al., 2007).  
In addition to cerebral hemisphere hypoplasia, the ventral telencephalon of Foxg1 null 
embryos is never specified (Dou et al., 1999), signified by the absence of ventral 
telencephalic markers Nkx2.1, Mash1 and Olig2 and expression of the dorsally-
restricted telencephalic marker Pax6 in the entire mutant telencephalon from very early 
stages in development (Martynoga et al., 2005). Although, it was previously proposed 
that the inability of Foxg1 mutants to specify ventral telencephalic tissue was due to 
loss of Shh from the ventral telencephalon (Huh et al., 1999), recent in vivo work in this 
laboratory suggests that Foxg1 is required cell autonomously for the specification of the 
ventral telencephalon (Martynoga, unpublished).  
1.7.4. Morphogenesis of the Foxg1-/- eye is affected. 
Foxg1 and Foxd1 (formerly BF-2) are among the first factors to be expressed in the 
nasal (Foxg1) and temporal (Foxd1) neuroretina and they also define the anterior and
posterior chiasm region (Hatini et al., 1994; Yuasa et al., 1996). Consequently, Foxd1
and Foxg1 are thought to be responsible for establishing the nasal-temporal (or 
anterior-posterior) axis in the retina (Figure 3). Supportive evidence comes from the 
misexpression of Foxg1 in the temporal retina, which induces ephrin-A2/A5 expression 









Figure 3. Foxg1 and Foxd1 expression 
in the retina and chiasm
A schematic diagram looking down on a horizontal 
slice of the brain at the level of the optic chiasm. 
The mutually exclusive expression patterns of 
Foxg1 (blue) and Foxd1 (yellow) in the retina and 
chiasm region are marked. Contralateral RGC 
axons (blue lines) and ipsilateral RGC axons (red 
lines) are shown in relation to these expression 
domains. Foxg1 is expressed in the nasal retina and 
optic stalk and the anterior optic chiasm region, 
including the midline where axons diverge. Foxd1 is 
expressed in the temporal retina and optic stalk and 
it is absent from the midline. From E14.5, Foxd1
expression is more limited to the VT retinal quadrant 




Furthermore, reversing the normal expression domains of Foxd1 and Foxg1 across the 
nasotemporal axis of the chick optic vesicle produces a disturbance in the retinotectal 
projection (Yuasa et al., 1996).  
In addition to a putative role in retinal patterning, Foxg1 is also required for the normal 
morphogenesis of the eye (Hatini et al., 1994; Xuan et al., 1995; Huh et al., 1999). In 
Foxg1 null embryos, the initial evagination of the optic vesicle occurs normally and eye 
defects first appear at E10.5 (Huh et al., 1999). Foxg1
-/-
 embryos display abnormally-
shaped eyes with a medially-elongated retina and retinal pigment epithelium (RPE), an 
abnormally small, misshapen lens and no optic stalks, such that the mutant retina 
contacts the ventral hypothalamus directly (Xuan et al., 1995; Huh et al., 1999). The 
elongated retina folds abnormally and this is most obvious in nasal regions (Xuan et al., 
1995). The choroid fissure fails to close forming a ventral coloboma and is associated 
with an expansion of the optic vesicle proximally and the RPE failing to completely 
surround the optic cup in ventral and medial regions (Huh et al., 1999). The coloboma 
forms a channel that varies in width during development and between embryos, leaving 
the ventral optic cup open (Huh et al., 1999). Foxg1
-/-
 embryos lack optic stalks and this 
is associated with reduced Pax2 expression and its restriction to the medial optic 
neuroepithelium and also the expansion of markers of the neural retina as well as the 
transcription factor Pax6. These all suggest that the absence of Foxg1 favours the 
specification of a retinal fate rather than an optic stalk fate. These eye defects may be 
partly due to the absence of a ventral telencephalic supply of Shh in Foxg1 null 
embryos (Huh et al., 1999). However, Shh ventral midline expression, which mediates 
proximodistal and dorsoventral eye patterning via regulation of Pax and Vax expression 
(Ekker et al., 1995; Lupo et al., 2005; Macdonald et al., 1995) is maintained in the 
absence of Foxg1 in vivo (Huh et al., 1999).  
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1.7.5. Foxg1-/- embryos display an increased ipsilateral projection. 
The expression of Foxg1 in the source (RGCs), intermediate choice point (optic chiasm 
midline) and target (superior colliculi) cells of retinal axons in the retinotectal tract 
makes this transcription factor an ideal candidate for mediating axon guidance in the 
developing visual system. Recent work in this laboratory aimed to test whether Foxg1
plays a role in axon guidance during mouse development. Mice in which the Foxg1 
coding sequences were replaced with either cre recombinase (Hebert and McConnell, 
2000) or LacZ (Xuan et al., 1995) were used for anterograde tracing of retinal axons 
using the fluorescent dye dioctadecyltetramethylindocarbocyanine perchlorate (DiI). 
Surprisingly, despite abnormal development of the telencephalon and eyes of Foxg1
-/-
embryos, RGC axons were able to project from both eyes, cross at the optic chiasm, 
and reach thalamic targets as in wild type mice. However, a small proportion of retinal 
axons were misrouted from the optic tracts into the telencephalon, from which they are 
normally excluded (Pratt et al, 2002). Further investigation revealed that retinal axons 
from Foxg1 null mice show a substantial increase in ipsilaterally projecting axons 
arising from both nasal and temporal RGCs (see Figure 4) (Pratt et al., 2004). The 
presence of a chiasm in Foxg1 mutants suggests that the cause of the RGC pathfinding 
defect is more subtle than a complete loss of the crossed or uncrossed tract as 
previously described in Pax2 and Vax2 null mutants (Torres et al., 1996; Barbieri et al., 
2002) or agenesis of the chiasm (Williams et al., 1994). Despite abnormal development 
of the eyes and forebrain, Foxg1
-/-
 embryos exhibit a specific axon guidance defect, 
offering a tractable system with which to dissect the molecular mechanisms involved in 
the sorting of contralateral-ipsilateral retinal axons at the chiasm.  
RGC axon navigation in wild-type and Foxg1-/- embryos visualised by anterograde
tract tracing at (A-E) E13.5 and (F-L) E15.5. For each age progressively more 
caudal sections of an individual embryo show injections of DiI (red asterisks) in (A, 
F) wild type retina and (D, I) Foxg1-/- retina, (B, G, D, I) labelling of optic nerve (on) 
and optic chiasm (oc) and (C, H, E, J) labelling of optic tracts (ot). (C, H) In the wild-
type optic tracts, contralateral labelling is stronger than the ipsilateral labelling. (E, J) 
In the Foxg1-/- optic tracts, ipsilateral labelling appears stronger. (K, L) Double 
labelling experiments in which DiI was injected into one eye and DiA into the other 
eye of (K) an E15.5 wild type embryo and (L) an E15.5 Foxg1-/- embryo (ventral 
midline is marked by broken white line). (K’, K’’) Horizontal sections of the wild-type 
optic tracts, growing over the diencephalon, from the same embryo as in K showing 
that each optic tract is predominantly labelled with dye from the contralateral eye 
although some ipsilateral label is also detectable (appears yellow where dyes 
overlap). (L’, L’’) Horizontal sections of the Foxg1-/- optic tracts from the same 
embryo as in L showing abnormally high levels of label from the ipsilateral eye. 










Figure from Pratt et al., 2004
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Figure 4. Foxg1 null embryos display an 
increased ipsilateral projection 
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1.8. AIMS 
Foxg1 is expressed by many structures that projecting retinal axons encounter as they 
make their way to the optic chiasm, making it possible for Foxg1 to control growth 
cone navigation directly or indirectly, at any one or a combination of locations. 
Therefore, there are two important questions that this thesis aimed to address: (1) at 
which location(s) along the retinotectal pathway is Foxg1 required and (2) what type of 
mechanism is responsible for increasing the ipsilateral projection in Foxg1 null 
embryos?  
There are two main hypotheses regarding the location at which Foxg1 is primarily 
required for retinal axon guidance at the chiasm: -
(1) Foxg1 expression in the retina is required for the correct navigation of RGC axons 
at the optic chiasm by determining their response to cells and molecules encountered 
along their route and at the chiasm midline.  
(2) Foxg1-expressing cells at the optic chiasm may influence the ipsilateral-
contralateral ratio of RGC axons by regulating the expression of axon guidance cues 
around the midline or providing appropriate contacts between growth cones and 
surrounding cells.  
In order to distinguish between these two hypotheses, in vitro co-cultures consisting of 
wild type ↔ Foxg1
-/-
 dorsonasal (source of contralateral axons) or ventrotemporal 
(source of ipsilateral axons) retinal explants and optic chiasm cells were used to 
identify whether Foxg1 is primarily required in cells of the retina or chiasm for retinal 
axon divergence (Chapter 3). 
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Based on the co-culture findings, a candidate approach was then used to generate 
testable hypotheses about putative Foxg1 downstream effectors in order to elucidate the 
mechanism(s) by which Foxg1 influences the size of the ipsilateral projection. The 
expression patterns of regulatory genes and molecules known or suspected to affect 
axon guidance from within the eye (Chapters 4 and 5) and at the optic chiasm (Chapter 
6) were investigated.  
Since the position of progenitor cells in the developing retina determines whether they 
will differentiate into nasal, temporal, dorsal or ventral neurons and hence influence 
their axonal paths and final termination zones in the tectum (Dutting and Meyer, 1995; 
Dutting and Thanos, 1995), molecules involved in patterning the retina along the 
nasotemporal and dorsoventral axes were examined in Foxg1
-/-
 and wild type embryos 
(Chapter 5). 
Finally the expression pattern of Foxg1 protein was investigated using 
immunohistochemistry to examine whether its location mirrored Foxg1 mRNA 
expression and whether it is found in axons (Chapter 7).  
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CHAPTER 2: Materials and Methods 
More detailed materials and methods are included in the ‘Methods’ section for each 
individual Chapter.  
2.1. Animals and Foxg1 alleles. 
All mice were housed and cared for under Home Office regulations. Foxg1
heterozygous mice (Foxg1
+/–
) are viable and were maintained by breeding pairs 
consisting of one wild type and one Foxg1
+/–
 mouse.  





) allele in which coding sequences are replaced by a lacZ 





) allele in which coding sequences are replaced by a Cre recombinase cassette 




are predicted null alleles (Xuan 
et al., 1995; Hebert and McConnell, 2000). For lineage tracing, we used 
Gtrosa26tm1Sho (R26RS) reporter mice (Mao et al., 1999). Cre-mediated 
recombination in Foxg1
Cre
;R26RS embryos irreversibly activates lacZ expression from 
the ROSA26 locus (Mao et al., 1999; Hebert and McConnell, 2000). Lineage tracing 
experiments used the Foxg1
Cre
allele on an albino Swiss Webster background (as 





alleles on a mixed pigmented CBA/C57Bl6/Swiss Webster background. 
Foxg1 homozygous mutants (Foxg1
Cre/Cre
) and compound heterozygotes (Foxg1
Cre/lacZ
) 
were identified by their hypoplastic telencephalon and distorted eyes. Heterozygous 
embryos (i.e. Foxg1
+/–
) were identified by PCR genotyping, they were 
indistinguishable morphologically from wild type (Xuan et al., 1995; Huh et al., 1999) 
and we detected no RGC axon projection defects at the optic chiasm. 
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2.1.1. Mouse Genomic DNA Extraction. 
1.Mouse tail tips (approx 0.5cm long) or ear clips (1 to 4 clips) or embryo hind quarters 
(1) digested overnight in 500µl tail tip lysis buffer (TTLB) containing 100µg/ml 
Proteinase K (Sigma). 
2. Mix with 500µl PCIA (phenol: chloroform: isoamyl alcohol 50:49:1) for 20 minutes 
and centrifuge at 13K for 5 minutes.  Remove the upper aqueous layer to a fresh tube 
(only recover 100 µl to 200 µl if interface viscous).  
3.Add 1/10 volumes of sodium acetate pH5.5 and 2 volumes of 96% ethanol to the 
recovered aqueous portion. Mix until DNA strands visible. Spin 13K for 5 minutes and 
remove supernatant. 
4.Wash pellet with 500µl 70% ethanol. Spin 13K for 1 minute and remove supernatant. 
Dry pellet for about 30 minutes at 37
o
C. 
5.Dissolve in 100µl ddH20 with shaking overnight at 37
o
C. 
6.Use 1µl of DNA for subsequent PCR reactions.  
Tail tip lysis buffer (TTLB) 
200mM Tris pH8, 200mM NaCl, 5mM EDTA, 0.2% SDS 
(Make up without SDS, autoclave, then add SDS) 
2.1.2. Polymerase Chain Reaction (PCR) genotyping of Foxg1 alleles. 
  Allele    Forward 5’ Primer     Reverse 3’ Primer Product  
Size (bp) 
  Foxg1 5’-CTG ACG CTC AAT  
GGC ATC TA-3’ 
5’-TTT GAG TCA ACA  
CGG AGC TG-3’ 
   438 
 Foxg1lacZ 5’-TTG AAC TGC CTG 
AAC TAC CG-3’
5’-CCT GAC TGG CGG 
TTA AAT TG-3’
   250 
 Foxg1Cre 5’-CAT TTG GGC CAG 
CTA AAC AT-3’
5’-ATT CTC CCA CCG 
TCA GTAC G-3’
   307
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For all primers, cycling conditions were as follows: - 
96°C for 2 minutes  
[96°C for 30 seconds, 58.5°C for 30 seconds and 72°C for 30 seconds] for 35 cycles. 
2.1.3. PCR Reaction Mix. 
The following reaction mix was used for detection of all Foxg1 alleles (see above). 
Prepare 19µl mastermix per sample and prepare enough for n+1 samples. 
2µl 10X Reaction Buffer (including 15mM MgCl2) 
1µl 5’ Primer (10µM) 
1µl 3’ Primer (10µM) 
0.4µl dNTP mix (Promega) 
1µl DNA  
0.2µl Taq Polymerase (1 unit) 
14.4µl ddH20 
2.1.4. Agarose Gel Electrophoresis.  
1) Prepare an agarose (Sigma) solution 
1.5% agarose (for DNA fragments <600bp): 75g agarose in 50ml 1X TBE 
2) Microwave on full power for 3 minutes, replacing evaporation losses with ddH20 
3) Add 1µl ethidium bromide (Fisher Scientific) at 10µg/ml, mix gently 
4) Pour into a gel casting tray, immediately insert comb 
5) Allow to set for 30 minutes 
6) Prepare sample DNA by adding 2µl 10X loading buffer per 20µl PCR reaction 
7) Load 10µl sample per well 
8) Load 10µl (0.5µg) of DNA molecular weight marker XIV (Roche) in one well  
9) Run gels at 80V for ~ 30 minutes, or until bands have resolved 
10) Visualise by exposure to UV light 
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Molecular weight ladders: - 
DNA molecular weight marker: for fragments <600bp 
Working dilutions: 
5µl DNA molecular weight marker 
6µl 10X gel loading buffer 
49µl ddH20 
2.2. Histology. 
2.2.1. Fixation of Brain Tissue. 
Following decapitation, embryonic heads were submerged in a solution of 4% 
paraformaldehyde in 1XPBS for 2 - 16 hours at 4°C with agitation. The heads were 
then washed with 1XPBS and either (1) dehydrated through a series of increasingly-
concentrated ethanol solutions prior to embedding in paraffin wax, carried out using an 
automated tissue processor (Tissue-Tek VIP, Sakura) or (2) in the case of frozen 
sections, heads were placed in a 30% sucrose:PBS solution for cryoprotection and left 
overnight at 4°C with agitation until the heads sank. Heads were placed in OCT 
(Lamb), positioned in the horizontal, coronal or sagittal plane, frozen on dry ice and 
then stored at -80°C. 
2.2.2. Microtome Sectioning of Wax Sections.  
Wax-embedded heads were cut into 10µm-thick sections on a microtome (Reichert-
Jung 2050) and sections floated onto poly-l-lysine (Sigma) slides. Sections were left to 
dry at  37°C for at least one hour prior to immunohistochemistry or haematoxylin and 
eosin staining.  
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2.2.3. Cryostat Sectioning.  
Heads for cryostat sectioning were removed from storage at -80°C and equilibriated at -
20°C to -26°C for one hour in the cryostat. 10µm-thick sections were cut on the 
cryostat and collected onto Superfrost Plus (BDH) slides. All sections were air-dried 
prior to storage at -80°C with a dessicant until use. Prior to immunohistochemistry, 
slides were thawed thoroughly at room temperature in their slide box.   
2.3. Immunohistochemistry.  
See individual chapters for detailed protocols for different antibodies.  
2.3.1. Chromogenic endpoint.
A chromogenic endpoint was generally applied to wax sections. Sections were 
dewaxed in xylene and rehydrated through a series of solutions of descending ethanol 
concentration to water. Endogenous peroxidise activity was eliminated through 
incubation in dilute hydrogen peroxide solution. DNA was denatured and antigens 
unmasked by heat treatment in 10mM sodium citrate (pH6) in a microwave oven. 
Evaporation losses were replaced and slides cooled for at least 45 minutes prior to 
washing in 1XPBS. Blocking solutions varied according to the primary antibody used 
but generally contained 5 - 10% goat serum (NGS) in PBS with 0.1% Triton-X-100 
(Sigma). Following incubation with the primary antibody, slides were washed 3X with 
1XPBS followed by incubation with species-specific HRP-conjugated secondary 
antibodies for 1 hour at room temperature using a Envision
+
 Kit (Dako). Following 
several washes in 1XPBS, antibody staining was revealed using 3,3’-diaminobenzidine 
(DAB), which produces a brown precipitate. Slides were dehydrated through increasing 
concentrations of ethanol, cleared in two changes of xylene and then mounted under 
coverslips in DPX (BDH). 
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2.3.2. Fluorescent endpoint.
Immunofluorescence was performed as for those slides reacted with DAB except that 
dewaxing and rehydration steps did not need to be performed. Following incubation 
with the primary antibody, species-specific secondary antibodies conjugated to 
fluorescent molecules were used at 1:200 dilution: goat anti-mouse or goat anti-rabbit 
Alexafluor-488 or Alexafluor-568 (Molecular Probes). For double 
immunohistochemistry to detect two different primary antibodies, primary antibodies 
from two different species were chosen to avoid cross-reactivity and incubated 
together. This was followed by detection using Alexafluor-488 and -568 secondary 
antibodies. Nuclei were counterstained using the DNA dye TO-PRO-3 iodide 
(Molecular Probes) at 1:100 dilution in water. Sections were mounted under coverslips 
using Mowiol (see below) to prevent fading of fluorescence. 
2.4. Preparation of Mowiol Mounting Medium.  
This mountant solidifies once used and allows direct mounting of the coverslips onto 
glass slides. Once mounted, the coverslips can be viewed with immersion lenses as the 
coverslips will not move. The coverslips are also removeable by gently sliding off the 
side of the slide, using tweezers. The Mowiol can be removed by immersing the 
coverslips in ddH20 for a few minutes.
1. Add 2.4g Mowiol (Calbiochem Cat no 475904) to  
6g of Glycerol (Glycerol density =1.26g/ml – for 6g = 6/1.26 = 4.76mls) 
(in a 50ml conical flask). 
2. Stir with a pipette to mix. 
3. Add 12ml dH20 and leave stirring for several hours or overnight at room 
temperature. 
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4. Add 12ml 0.2M Tris (pH8.5)  
(1M Tris = 121.14 g/l, 100nM = 12.114g/l 
200nM = 24.228g/l or 2.423g/100ml) 
and heat to 50°C for 1 – 2 hr or until Mowiol is completely dissolved. 
Vortex occasionally.  
5. Centrifuge at 2000rpm for 15 minutes.  
6. Add 1,4-diazobicyclooctane (DABCO) Sigma(Antifade) to 2.5% (=0.72g) 
Aliquot and store at -20°C. 
7. Centrifuge before use to pull down any bubbles. 
2.5. Microscopy. 
2.5.1. Light Microscopy. 
Slides were photographed using a Leica DMLB upright compound microscope 
connected to a Leica DSC480 digital camera, using Leica IM50 image management 
software.  
2.5.2. Confocal Microscopy. 
Fluorescent staining was viewed using a Leica DMRE compound microscope, part of a 
Leica TCS NT confocal system using ‘Leica Lite’ software. To view the co-cultures in 
3D, a Zeiss Axiovert confocal microscope was used and viewed using the ‘LSM Image 
Browser’. Alexafluor-488 staining was collected in the FITC (green) channel, 
Alexafluor-568 in the TRITC (red) channel and TO-PRO-3 in the Cy3 (far-red, pseudo-
coloured blue) channel.  
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2.5.3. Image Analysis.  
Some images were re-sized or cropped with Adobe Photoshop 7 software. When the 
brightness or contrast or images was adjusted to enhance detail, the changes were 
applied globally to the whole image. 
2.6. Statistical Analysis. 
Sigmastat (Systat Software Inc.) and Excel (Microsoft) were used for data analysis.  
2.7. Staining for Bacterial LacZ (β-galactosidase). 
2.7.1. Reagents.  
LacZ Fixative (volumes for making 20ml)
4% paraformaldehyde in PBS  20ml 
0.02% NP40     40µl of 10% stock 
0.01% sodium deoxycholate  20µl of 10% stock 
5mM EGTA    200µl of 0.5M stock 
2mM MgCl2     40µl of 1M stock 
LacZ Wash (volumes for 100ml)
PBS      100ml 
2mM MgCl2     200µl of 1M stock 
0.02% NP40     200µl of 10% stock 
0.01% sodium deoxycholate  100µl of 10% stock 
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LacZ staining buffer (volumes for 10 ml)
PBS      10ml 
2mM MgCl2     20µl of 1M stock 
0.02% NP40     20µl of 10% stock 
0.01% sodium deoxycholate  10µl of 10% stock 
5mM Potassium ferricyanide 100µl of 0.5M stock 
5mM Potassium ferrocyanide 100µl of 0.5M stock 
1mg/ml X-gal 250µl of 40mg/ml stock in dimethylformamide (DMF)  
(kept in freezer). 
LacZ stop solution (20mM EDTA in PBS)
20ml PBS + 800µl 0.5M EDTA 
LacZ post-fix (2% Glutaraldehyde in PBS). 
20ml PBS + 800µl 50% Glutaraldehyde. 
2.7.2. Protocol. 
All steps performed using a 20ml volume, except staining, which was performed in a 
5ml volume. 
1. Dissect embryos in ice cold PBS. 
2. Fix with shaking at 4°C for 1 hour in LacZ Fixative 
3. Wash 3 x 20 minutes (minimum) at room temperature shaking in LacZ Wash. 
4. Stain in X-Gal at 37°C with shaking 1 hr to overnight (or longer) in the dark. 
5. Wash in LacZ Stop Solution. 
6. Postfix in LacZ postfix solution. 
7. If cutting sections transfer to 50% ethanol and proceed with wax embedding [X-gal 






embryonic heads were dissected and fixed for 1 
hour at 4°C in 4% paraformaldehyde, 0.02% NP40, 0.01% sodium deoxycholate, 5 
mM EGTA, 2mM MgCl2 in phosphate buffered saline (PBS). In some cases, heads 
were equilibrated in 30% sucrose/PBS and sectioned (10 mm) on a cryostat. Tissues 
were rinsed several times in wash buffer (2 mM MgCl2, 0.02% NP40, 0.01% sodium 
deoxycholate in PBS), transferred to staining solution (wash buffer supplemented with 
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 1 mg/ml X-gal), and 
stained overnight (cryostat sections on slides) or for 2 days with agitation 
(wholemounts) at 37°C in darkness. Staining was stopped with 20 mM EDTA in PBS. 
Some wholemounts were sectioned with a vibratome (200 µm) or processed to wax, 
sectioned (10 µm) and mounted. Cryostat sections were counterstained with Nuclear 
Fast Red (Fisher). 
2.8. Primary Cell Culture. 
2.8.1. Dissociation of chiasm cells.
Papain dissociation system kit (Worthington Biochemical Corporation, #LK003160). 
2.8.2. Collagen mixture for co-cultures.
Prepared by mixing the following reagents together on ice under sterile conditions. 
This mixture was made up fresh for each culture experiment.   
180µl rat tail collagen type 1 (BD Biosciences, #354236) 
180µl bovine collagen type 1 (BD Biosciences, #354231)  
40µl 10X DMEM (Sigma, #D7777) - reconstitute powder using sterile ddH20 and 
filter.  
~ 10µl 0.8M sodium bicarbonate or enough to turn the mixture a pale pink colour 
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2.8.3. Earle’s balanced salt solution (‘EBSS’).
Prepared by mixing the following reagents together under sterile conditions and stored 
for not more than two weeks at 4°C until use.  
100 ml Earle’s balanced salt solution 10X (Sigma, #E-7510) 
0.22 g Na2HCO3 (Sigma, #S5761), final concentration 22 mg/ml 
0.065 g glucose (Sigma, #G-7021), final concentration 6.5 mg/ml 
900 ml double deionised water. 
EBSS was oxygenated by bubbling with 95% O2 and chilled on ice prior to use.  
2.8.4. Serum-free culture medium.
Prepared by mixing the following reagents together under sterile conditions and stored 
for not more than two weeks at 4°C until use. Medium was warmed and equilibriated in 
a 37°C humidified incubator containing 5% CO2 for at least one hour prior to use.  
100 ml F12, Hams (Sigma, #N4888) 
100 ml Dulbecco’s modified Eagles’ medium (DMEM) (Sigma, #D5671) 
1 mg insulin (Sigma, #I6634), final concentration 5µg/ml 
2 mg apo-transferrin (Sigma, #T1147), final concentration 10µg/ml 
3 ml HEPES buffer (Sigma, #H0887) 
0.24 g Na2HCO3 (Sigma, #S5761), final concentration 0.12mg/ml 
3 ml antibiotics stock: 100 mg gentamycin (Sigma, #G1264) and 200 mg kanamycin 
(Sigma, #K1377) added to 20 ml sterile double deionised water, filter-sterilised and 
stored at -20°C. 
2 ml putrescene stock: 100 µM stock, 161.1mg/100ml in sterile double deionised water, 
filter-sterilised and stored at -70°C (Sigma, #P5780), final concentration 16.11µg/ml 
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20µl progesterone stock: 20 µM stock, 6.29mg/100ml ethanol stored at -70°C (Sigma, 
#P8783), final concentration 6.29ng/ml 
20µl Na2SeO3 stock: 30 µM stock, 5.2mg/100ml in sterile double deionised water, 
filter-sterilised and stored at -70°C (Sigma, #S5261), final concentration 5.2ng/ml 
2 ml L-glutamine stock: 0.2M stock, 6.344g/100ml in sterile double deionised water, 
filter-sterilised and stored at -70°C (Sigma, #G2128), final concentration 25µg/ml. 
2.8.5. Serum-free culture medium with methylcellulose.
5g of methylcellulose (Sigma, #M7027) was autoclaved and stirred in a 100 ml sterile 
bottle. 95 ml of DMEM/F12 was added to form a 5% solution and stirred over 3 days at 
4°C.  
1ml of methylcellulose was added to 9ml of serum-free culture medium for a final 
concentration of 0.5%.  
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CHAPTER 3: Foxg1 chimeric co-cultures of retina and 
chiasm show that Foxg1 is required both within 
dorsonasal retina and at the optic chiasm for the 
growth of nasal retinal axons over chiasm cells in vitro. 
3.1. ABSTRACT 
The chimeric co-culture experiment is a powerful tool with which to reveal the location 
where Foxg1 is primarily required to mediate the contralateral versus ipsilateral routing 
of retinal axons at the chiasm midline. The expression pattern of Foxg1 in the nasal 
retina and anterior chiasm raises the possibility that Foxg1 influences the guidance of 
retinal axons from their origins in the RGC layer of the retina or at the point where they 
diverge ipsilaterally or contralaterally at the chiasm midline. The increase in ipsilateral 
projections from Foxg1
-/-
 nasal retina could be the result of an autonomous requirement 
for Foxg1 in nasal RGCs or a non-autonomous requirement outwith RGCs at the 
chiasm. Since the majority of the temporal retina normally does not express Foxg1, the 
increase in ipsilateral projections from Foxg1
-/-
 temporal RGCs could either be the 
result of a non-autonomous requirement for Foxg1 in temporal retina or at the chiasm. 
To deduce whether the axon guidance defect in Foxg1 null embryos is principally due 
to a defect in the retina or the chiasm, DN and VT retinal explants were cultured with 
dissociated chiasm cells from E14.5 mouse embryos. Co-cultures were prepared 





) embryos, which were used interchangeably and so collectively 
denoted as ‘Foxg1
+/±
’ embryos. These co-cultures reproduced previous findings that 
the growth of ventrotemporal axons in vitro is reduced by chiasm cells to a greater 
extent than axons from other regions of the retina, reflecting their avoidance of the 




 retina ↔ Foxg1
-/- 
chiasm co-cultures was significantly lower compared to 
outgrowth from DN Foxg1
+/±
 retina ↔ Foxg1
+/±
 chiasm co-cultures, reflecting the 
increased avoidance of the chiasm by nasal axons observed in Foxg1
-/- 
embryos (Pratt 





compared to VT Foxg1
+/±
 retina ↔ Foxg1
+/±
 chiasm co-cultures, although this was not 
significant. The successful in vitro recapitulation of the in vivo behaviour of VT 
(uncrossed) and DN (crossed) axons co-cultured with chiasm were then used as 





co-cultures. These revealed that Foxg1 is required both within the nasal retina 
and in chiasm cells for the guidance of nasal RGC axons. Axon outgrowth did not vary 
significantly among the various VT co-cultures, suggesting that Foxg1 is not required 
by the temporal retina or at the chiasm for the guidance of VT axons. However, in 
order to confirm this, many more VT co-cultures would be needed due to the small 
amount of axon outgrowth produced by VT retina and the related difficulties in 
detecting small changes in axon outgrowth. Alternatively, VT retinal axons might 
normally be influenced by Foxg1 expression in other tissues. 
3.2. INTRODUCTION 
Over the past decade, a number of molecules and regulatory genes have been identified 
in the eye, optic stalk and chiasm to play roles in controlling the ipsilateral or 
contralateral routing of retinal axons at the optic chiasm (Bertuzzi et al., 1999; Chung 
et al., 2000a; Chung et al., 2000b; Deiner & Sretavan, 1999; Herrera et al., 2004; 
Herrera et al., 2003; Jeffery 2001; Marcus et al., 1995; Marcus & Mason 1995; Marcus 
et al., 1999; Pak et al., 2004; Pratt et al., 2004; Sretavan et al., 1994; Sretavan et al., 
1995; Sretavan & Reichardt, 1993; Sretavan & Kruger, 1998; Wang et al., 1995; Wang 
et al., 1996; Williams et al., 2006; Williams et al., 2003; Wizenmann et al., 1993; 
Zhang et al., 2000).  
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Foxg1 has been shown to affect the proportion of axons projecting ipsilaterally since in 
Foxg1 null embryos there is an 8-fold increase in the ipsilateral projection (Pratt et al., 
2004). During the peak period from E13 - E16 when RGCs project axons towards the 
chiasm, Foxg1 is expressed by RGCs and tissues that retinal axons encounter as they 
navigate from their origins in the RGC layer of the retina, through the optic stalk and to 
the optic chiasm midline. The lens, retinal pigment epithelium, nasal retina, nasal optic 
stalk and anterior chiasm all express Foxg1. Therefore, Foxg1 may control growth cone 
navigation at the ventral midline directly or indirectly, at any one or a combination of 
locations.  
3.2.1. Hypotheses 
This chapter aims to test the hypothesis that Foxg1 is required in the retina or at the 
chiasm or both for the guidance of retinal axons. Foxg1 expression is more widespread 
in the nasal retina compared to temporal retina (Hatini et al., 1994; Huh et al., 1999; 
Pratt et al., 2004; Chapter 5, this thesis). Therefore, Foxg1 might direct the navigation 
of nasal axons autonomously from Foxg1-expressing nasal RGCs, determining the 
response of their growth cones to cells and molecules encountered along the route. 
However, Foxg1
-/-
 embryos exhibit an increase in ipsilateral projections from both 
temporal and nasal RGCs (Pratt et al., 2004). This raises the possibility that Foxg1
affects the guidance of temporal retinal axons non-autonomously from temporal RGCs 
that do not express Foxg1. In other words, Foxg1 could exert its non-autonomous 
effects from within the temporal retina. An alternative hypothesis that would explain 
the increased ipsilateral projection from temporal retina and also nasal retina is that 
Foxg1-expressing cells around the optic chiasm influence the proportion of RGC axons 
projecting contralaterally or ipsilaterally, by providing an appropriate cellular and/or 
molecular environment around the midline.  
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3.2.2. Foxg1 chimeras. 
3.2.2.1. In vivo. 
One method of determining whether Foxg1 is required in the retina or at the chiasm to 
mediate the contralateral-ipsilateral projection of retinal axons would be to create 
Foxg1 chimeric embryos consisting of wild type and Foxg1
-/-
 cells. DiI labeling could 
then be used to label the paths taken by retinal axons at the chiasm and to backlabel 
axons to their origins in the retina. By examining whether Foxg1
-/-
 RGCs in the nasal or 
temporal retina produce axons that cross the optic chiasm or remain ipsilateral and also 
by studying the behaviour of axons when confronted with chiasms consisting of mostly 
wild type or mostly Foxg1
-/-
 cells, inferences could be drawn about the primary site of 
action of Foxg1 and whether its effects are autonomous or non-autonomous. For 
example, if the defect lies in the Foxg1
-/-
 chiasm, both wild type and Foxg1
-/-
 retinal 
axons would be expected to project ipsilaterally in greater numbers than normal. In 




 retinal axons would be 
expected to project ipsilaterally in greater numbers, whereas wild type axons would 
not. Axons originating from the nasal and temporal retina might show differences in 
the proportion of ipsilateral axons that are misrouted depending on whether the absence 
of Foxg1 affects the guidance of axons from the entire retina or solely those axons from 
Foxg1-expressing RGCs. However, this in vivo approach is time-consuming and 
analysis could be complicated depending on the percentage contribution of Foxg1
-/-
cells in the retina or chiasm.  
3.2.2.2. In vitro Foxg1 chimeric co-cultures of retina and chiasm. 
Instead of producing chimeras in vivo, an alternative approach was utilized using in 








embryos were used to provide Foxg1-expressing ‘control’ tissue because 
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Foxg1 heterozygous brains are morphologically indistinguishable from wild type brains 




embryos were used to provide tissue for culture, the notation ‘Foxg1
+/±
’ was used. 
Previous co-culture experiments have shown that the growth of axons from VT retinal 
explants is reduced to a greater extent than axons from the rest of the retina in the 
presence of dissociated chiasm cells (Herrera et al., 2004; Herrera et al., 2003; Marcus 
et al., 1995; Marcus and Mason, 1995; Marcus et al., 1996b; Wang et al., 1995). This 
has been interpreted as the in vitro equivalent of the in vivo avoidance of the chiasm by 
ipsilateral VT axons. In other words, axon outgrowth is a ‘read-out’ of crossing 
behaviour along a scale of low outgrowth, typical of VT ipsilateral axons, to high 
outgrowth, typical of contralateral axons from non-VT retina (see Figure 1). In order to 
decide whether axons from chimeric co-cultures behave like contralateral or ipsilateral 






 retina and chiasm that were used for calibration purposes. For 
example, a chimeric co-culture that produces high axon outgrowth similar to DN 
control co-cultures suggests that the axons behave like contralateral axons in vitro. In 
contrast, axons from chimeric co-cultures that grow as poorly as those in VT control 





 co-cultures using DN and VT retina were prepared to test the hypothesis that 
they produce less axon outgrowth than DN and VT control co-cultures, reflecting the 
increased avoidance of the chiasm by nasal and temporal Foxg1
-/-
 axons in vivo, shown 
by Pratt et al. (2004).  
                                                
1
For simplicity, the terms ‘DN control co-cultures’ or ‘VT control co-cultures’ are used in this chapter 
to refer to Foxg1+/± ↔ Foxg1+/± co-cultures using either DN or VT retina.  
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Figure 1. Co-cultures of retina and chiasm in vitro recapitulate in 
vivo axon projections at the optic chiasm.  
(A, B) Schematic diagrams of the eyes, optic chiasm (midline depicted as a 
dotted line) and contralateral (blue lines) or ipsilateral (red lines) retinal axons 
as viewed from above. The paths of (A) contralateral-projecting RGC axons 
and (B) ipsilateral-projecting RGC axons in vivo are depicted. (C) A cartoon 
of a DN retinal explant (circle), cultured with chiasm cells (unfilled circles) 
showing contralateral RGCs that project numerous axons (green lines). This 
reflects the crossing of the chiasm midline by contralateral axons in vivo. (D) 
A cartoon of a VT retinal explant cultured with chiasm cells, showing only a 
single axon. This reflects the repulsion of ipsilateral axons from the chiasm 
midline in vivo.  
DN retinal explants produce high 
axon outgrowth in the presence of 
chiasm cells in vitro reflecting the 
contralateral path followed by their 
axons at the chiasm midline
in vivo.
VT retinal explants produce low 
axon outgrowth in the presence of 
chiasm cells in vitro reflecting the 
ipsilateral path followed by their 


















Abbreviations: A, anterior; P, posterior; N, nasal; T, temporal; 
DN, dorsonasal; VT, ventrotemporal; r = retina, oc = optic 




          chiasm cell 









All experiments were carried out using Foxg1
LacZ
 (CBA) mated with Foxg1
cre
(Swiss 
Stanford mice). Noon on the same day a plug was found was considered E0.5. Pregnant 
mothers were terminally anaesthetized in halothane 14 days after a plug was found and 




 embryos were 
used to provide Foxg1-expressing tissue as their axon tracts and brain morphology are 
indistinguishable. They are both labeled ‘control’ or ‘Foxg1
+/±
’ in the Figures. Retina 
and chiasm co-cultures were prepared using embryos from the same litter to minimize 
variability between different co-culture combinations due to slight age differences. 
Only embryos with pigmented retinas were used for the dissections to facilitate 
dissection of the retina from the retinal pigment epithelium (RPE) and to eliminate 
possible variation in axon divergence caused by lack of pigmentation in albino 
embryos (Marcus et al., 1996b). 
3.3.2. Retinal explants. 
Co-cultures were prepared using a method similar to Wang et al. (1995). The co-culture 
method is outlined in Figure 2. Foxg1
-/-
 embryos were identified phenotypically by 









 embryos were decapitated in ice-cold oxygenated EBSS and 
retinas dissected free from the RPE, lens, vitreous and blood vessels in a sterile 
laminar-flow hood after making an orientating cut in the ventral pole. Equal-sized 
explants from peripheral dorsonasal or ventrotemporal retina were dissected in ice-cold 
EBSS. A 1:1 mixture of bovine dermis and rat tail collagen was prepared on ice by 
mixing 9 parts collagen to 1 part 10×DMEM/F12 medium. Bicarbonate was added to 
turn the collagen a pale pink/orange color. 10 - 20µl of collagen was pipetted and  
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Figure 2. Retina-chiasm co-culture method.  




co-cultures of retina and chiasm. Retinas are depicted as circles and optic 
chiasms as rectangles. Foxg1
-/-
 tissue is black and control Foxg1
+/±





 co-cultures are shown. These combinations were 
prepared for DN and VT explants separately. (B) Dissection of DN and VT 
retinal explants. The eye is depicted as a circle with D-V and N-T axes. (1) A 
ventral orientating cut (red dashed line) was made slightly nasal to the D-V 
axis. (2) DN (blue) and VT retina (white) from the peripheral third of the 
retinal radius was dissected. (3) These retinal explants were further cut into 
roughly equal 200 - 400µm wide pieces. (4) Finally these retinal explants were 
positioned far apart from one another on a thin layer of collagen (shown in 








1. Ventronasal orientating cut
3. Retina cut into 200 - 400um
wide pieces
2. Dissection of DN & VT
peripheral retina
Dissection of DN and VT retinal explants
4. Explants positioned on thin layer of
collagen gel








into DN & VT
explants
A
4. Mix and match in collagen
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spread evenly onto circular glass coverslips pre-treated with poly-l-lysine (100 µg/ml) 
overnight at 4°C in Nunc four-well dishes. After allowing the collagen to set for 20 
minutes in a 37ºC incubator (95% O2: 5% CO2), the retinal explants were placed on top 
of the collagen layer in a 20µl droplet of serum-free culture medium containing 0.5% 
methylcellulose to aid adhesion. The explants were placed in the 37ºC incubator where 
they were left for 2 hours to adhere to the collagen gel prior to adding chiasm cells.  





 optic chiasms were dissected and dissociated 




 optic chiasms were kept separate and 
care was taken to rinse dissecting instruments between dissections to avoid cross-
contamination with cells or cellular substances that might influence the results. 
Dissociated chiasm cells were resuspended in a 1:1 mixture of rat-tail and bovine 
collagen to a density of 500 cells per mm
2 
before adding to the retinal explants in a 5µl 
volume. The co-cultures were placed in a 37ºC incubator (95% O2: 5% CO2). After 2 
hours, fresh serum-free culture medium without methylcellulose was added to the 
cultures, which were then replaced in the 37ºC incubator and left for 48 hours.  
Retinal explants and dissociated chiasm cells were cultured in all eight possible 
combinations shown in Table 2 below.  
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Retina Chiasm Retina Chiasm 
DN Foxg1+/± Foxg1+/± DN Foxg1-/- Foxg1+/±
VT Foxg1+/± Foxg1+/± VT Foxg1-/- Foxg1+/±
DN Foxg1-/- Foxg1-/- DN Foxg1+/± Foxg1-/-
VT Foxg1-/- Foxg1-/- VT Foxg1+/± Foxg1-/-
3.3.4. Neurofilament and Brn3a immunohistochemistry. 
After 48 hours, the co-cultures were fixed using 4% paraformaldehyde in 1X PBS for 
40 minutes at 4°C. The fixed cultures were washed on a shaker at 4°C with five 
changes of 1X PBS, each wash lasting 15 minutes except the last wash that was 
overnight. The following incubations or washes were all done on a shaker. The co-
cultures were blocked in 10% goat serum, 0.2% PBSTx-100 for 90 minutes at room 
temperature. A mixture of primary antibodies: rabbit neurofilament (Biomol 
International) used at 1:200 and mouse Brn3a (Chemicon International) used at 1:300 
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diluted in the blocking solution was prepared. 250 µl of the primary antibody mixture 
was pipetted into each well and incubated overnight at 4°C. The primary antibody 
mixture was removed and cultures were washed six times with 0.1% PBSTx-100 at 
room temperature, each wash lasting 45 minutes. Secondary antibodies goat anti-mouse 
Alexa Fluor 546 and goat-anti-rabbit Alexa Fluor 488 were diluted in blocking solution 
to a final concentration of 1 in 500 each and 0.5 ml was pipetted into each well and 
incubated overnight at 4°C. The secondary antibody mixture was removed and cultures 
washed five times with 0.1% PBSTx-100 at room temperature. 0.5 ml of TO-PRO-3 
diluted 1 in 2000 in blocking solution was added to each well for 1 hour at room 
temperature. The cultures were washed twice with 1xPBS and then covered with 9:1 
glycerol: PBS before imaging.  
3.3.5. Confocal microscopy. 
Images of the cultures were obtained using a Zeiss inverted confocal microscope. 
Optical sections 4µm apart were scanned through each retinal explant in the red, blue 
and green channels allowing a 3D image to be reconstructed in the LSM Image 
browser.  
3.3.6. Computer analysis 
3.3.6.1. % axon coverage and fascicle width at varying distances from the 
retinal explant using Image J.  
For each co-culture, only the green channel image was used to prevent the blue chiasm 
cells from being detected as a ‘peak’ (neurite) and interfering with the histogram 
analysis. The image was converted to black (background) and white (axons) for ease of 
measurement. ‘Process’/Noise/Despeckle was built into the macro to remove some of 
the background ‘speckle’ effect that comes from chiasm cells picking up the green 
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secondary antibody. Macros were written to measure the width of each axon or fascicle 
at four set pixel distances perpendicularly outwards from the retinal explant surface: 25 
pixels (23µm), 50 pixels (45µm), 75 pixels (68µm) and 100 pixels (91µm). To provide 
a measure of the degree of axon outgrowth, the width of each axon fascicle at each of 
the four distances from the explant was measured for each co-culture (see Figure 3). At 
each of the four distances from the explant, the widths of all the fascicles were summed 
to give a measure of the axon coverage at that distance. A large explant will have a 
greater surface area from which to extend axons and will tend to have a larger area 
covered by axons compared to a smaller explant of the same co-culture combination. 
The confounding factor of explant size was accounted for by expressing the total of all 
fascicle widths as a percentage of the length of the measuring line (i.e. percentage of 
the measuring line crossed or covered by axons).  
Both computerized and manual methods were used to measure % axon coverage and 
the widths of fascicles or axons. The computerized method used the histogram of pixel 
intensity against distance along the measuring line provided by Image J. The width of 
each peak was measured along a horizontal line above the level of ‘noise’. Since each 
peak represents a fascicle, the width of each peak represents the width of each fascicle. 
The height of each peak is the pixel intensity, which provides a measure of the number 
of axons making up that fascicle. A tall peak represents a high pixel intensity, which 
indicates that more axons are present in that fascicle.  
To ensure that the peaks were ‘real’ rather than areas where there was high background 
staining from the secondary antibody, neurofilament-staining from chiasm cells or 
artifacts caused when acquiring the image, the histogram was compared to the original 
image and checked for correspondence. In the case of cultures with numerous axons or 
fascicles where an accurate visual comparison was impossible, individual fascicle 
widths were measured manually from the image. The computerized and manual 
methods were compared using one co-culture from each co-culture combination.  
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Figure 3. Measuring % axon coverage using Image J. 
(A) Starting image. (B) Conversion of the green channel to black and white. 
For both manual and computerized counts, the explant border was traced 
using the segmented line tool (blue polygon). Four macros were written 
specifying that each point on the polygon should be expanded by 25, 50, 75 or 
100 pixels. Each of these macros produced polygons radiating outwards from 
the explant border by 25, 50, 75 or 100 pixels. The 50 and 100 pixel polygons 
are shown in yellow. (C) For each of these distances, every time a neurite or 
fascicle crossed the yellow polygon, its width was measured (white line). (D) 
If a neurite did not grow outwards perpendicular to the explant border, the 
neurite width was measured manually where the polygon first touched the 
neurite (white line). Measurements were consistently done in the anti-
clockwise direction. (E, F) Histograms produced by the computerized method. 
The x-axis represents the distance along the measuring polygon and the y-axis 
is the 'gray intensity' or white pixel intensity. Each peak is one axon or axon 
fascicle. The horizontal dotted line was positioned above the 'noise' or level of 
background staining, which was different for each explant. (F) Enlargement of 
rectangle shown in (E) with blue arrows showing widths of peaks (= fascicle 
width) measured. (G) Calculation for % axon coverage. ‘Circumference of 
measuring polygon’ was obtained from the maximum value of the x-axis on 
the histogram. Scale bars (A, B) = 100µm, (C, D) = 400µm. 
% axon coverage =  Sum of all neurite fascicle widths x 100 
Circumference of measuring polygon









Figure 3. Measuring % axon coverage 
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Both methods gave almost identical results for cultures with low background but 
variable results for high background images. Therefore, manual analysis was used in 
the latter cultures, constituting approximately two-thirds of cases. This enabled ‘false’ 
peaks resulting from background staining to be identified and excluded from the final 
analysis.  
3.3.6.2. Axon/fascicle length. 
To obtain a quantitative measure of neurite extension, the five longest neurites or 
fascicles were traced and their length measured using the overlay tool in the LSM 
Image browser. If fewer than 5 neurites were present, all of them were measured and 
used in the resulting analysis. For each explant, the mean of the 5 longest neurites for 
each culture was calculated and these means were used to produce a graph for each co-
culture combination.  
3.3.6.3. Chiasm density. 
In order to show that all the co-cultures were plated with a similar density of optic 
chiasm cells, three 200µm by 100µm rectangles were drawn outwards from the retinal 
explant, with the 200µm edge perpendicular to the explant border. The placing of these 
rectangles was the same for each explant regardless of differences in size or shape. 
From the vertical line bisecting the explant, the first rectangle was placed 45 degrees 
diagonally to the right, the second rectangle at 180 degrees and the third 45 degrees 
diagonally to the left. The number of blue TOPRO3-positive chiasm cells was counted 
within these three measuring boxes and the average chiasm density calculated. 
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3.3.7. Statistical analysis. 
SigmaStat was used to conduct ANOVAs on all DN and VT co-cultures as well as DN 
or VT co-culture combinations only. If a p-value of less than 0.05 was returned by 
ANOVA, multiple pairwise comparisons were conducted using the Tukey test, t-test or 
Dunn’s test. For neurite length, p-values were calculated using the Tukey test on pools 
of mean longest neurite length for each explant, rather than pools of individual neurite 
lengths from all explants measured for each co-culture combination. The latter would 
break the assumption of independence of data points, since neurite lengths from the 
same explant are related or non-independent.  
3.4. RESULTS 
3.4.1. % axon coverage and longest neurite length did not vary between 
Foxg1-expressing and Foxg1-/- retina cultured in the absence of chiasm 
cells.  
In order to eliminate the possibility that differences in axon outgrowth and length 
between the various retina-chiasm co-cultures could be caused by variability in the 





 retina, retinal explants were cultured under identical conditions to those used 
for co-cultures, except that chiasm cells were not added. Figure 4 shows typical 




 explants from DN and VT retina. Fluorescent 
double immunohistochemistry reveals protein expression of the axon marker 
neurofilament (green) and the POU-homeodomain transcription factor Brn3a (red), 
expressed by postmitotic RGCs. Neurites were produced from all retinal explants. 
However, neurites from VT control explants appeared less fasciculated compared to the 
others. Neurite outgrowth was quantified for all retinal explants by measuring % axon 
coverage and the mean length of the five longest neurites for each culture.
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Figure 4. Foxg1-/- retinal explants are capable of producing neurite 
outgrowth resembling that from Foxg1-expressing retina when 





 explants from DN and VT retina 
cultured in collagen without chiasm cells. (A, E, F) DN control, (B, G, H) VT 
control, (C, I, J) DN Foxg1
-/-
 and (D, K, L) VT Foxg1
-/-
 retinal explants. (A - 
D) Neurofilament immunohistochemistry revealed neurite outgrowth from all 
explants. (B) VT control retina projected the most neurites, which were less 
fasciculated compared to those from the other explants. (A) DN control retina 
projected the fewest neurites. (E - L) Brn3a immunohistochemistry for the 
retinal explants shown in A - D marked the nuclei of postmitotic RGCs (red), 
showing that they were present in all retinal explants. (F, H, J, L) High 
magnifications of Brn3a images E, G, I & K. Abbreviations: DN is dorsonasal 

























































 retinal explants at 





 explants from either DN or VT retina separately, to 
control for differences in axon outgrowth between these two retinal quadrants and to 
test for possible effects of the presence or absence of Foxg1 on the behaviour of retinal 




 retinal explants within 
DN or VT retina separately, rather than comparisons between the two retinal quadrants, 





 DN retinal explants at 23, 45, 68 and 91µm distances from the 
explants did not vary significantly (Figure 5C). Therefore, any differences observed in 
the DN co-culture experiments can be attributed to particular co-culture combinations 






In contrast, t-tests comparing axon coverage between VT retinal explants revealed that 
Foxg1
-/-
 retina had a significantly lower % axon coverage compared to Foxg1
+/±
 retina 
at 23µm (p = 0.045) but not at any of the other distances. Since this difference is just 
below the critical p-value of 0.05 and occurred only at 23µm from the explant, it is 
unlikely that the difference in % axon coverage was large enough to obscure major 
differences between the various VT retina-chiasm co-culture combinations.  





 explants for either DN retina or VT retina 





 explants from VT retina exhibited significantly higher mean % axon coverage 
compared to DN Foxg1
+/±
 explants at 45µm. This indicates that VT retina is capable of 
high axon outgrowth in the absence of chiasm cells and also shows that the outgrowth 
of axons from VT Foxg1
+/±
 and VT Foxg1
-/-
 retina is more prolific compared to DN 
retina. 
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Figure 5. Axon coverage and mean longest neurite length did not 
vary between dorsonasal control and Foxg1-/- explants cultured in 
the absence of chiasm cells.  





explants from DN and VT retina at distances of (A) 23µm and (B) 45µm from 
the retinal explant and (E) mean longest neurite length. (C) Table showing t-
test results of % axon coverage when comparing DN or VT explants only. (D) 
Table showing % axon coverage results for the Tukey multiple pairwise 
comparisons test when comparing all DN and VT explants. (C, D) Statistically 
significant differences are highlighted in yellow. (A, B, D) Significant 
differences in % axon coverage were found when comparing mean values 
across all DN and VT explants. (A, B) VT control explants had a greater mean 
% axon coverage compared to DN control explants at both 23µm and 45µm. 
VT Foxg1
-/-
explants had a greater mean % axon coverage compared to DN 
Foxg1
-/-
explants at 45µm but not at 23µm. (C) Comparisons of DN control 
versus DN Foxg1
-/-
explants only did not reveal any significant differences by 
t-test at either 23µm or 45µm. Comparing VT control versus VT Foxg1
-/-
explants only revealed a significantly greater mean % axon coverage for wild 
type versus Foxg1
-/-
VT explants at 23µm (p = 0.045) but not at 45µm (p = 
0.593). (D) Comparisons across all explants failed to show significant 
differences between DN control and Foxg1
-/-
explants or between VT control 
and Foxg1
-/-
explants (highlighted in pink). (E) Mean neurite length did not 
differ among retinal explants (ANOVA, p = 0.184). (F) Table showing non-
significant t-test results for mean neurite length.  





tissue, -/- is Foxg1
-/-
tissue, N.S is not significant, error 
bars indicate standard error of the mean, n's are indicated in parentheses, * p < 
0.05, ** p < 0.005. 
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DN+/±     DN-/-      VT+/±      VT-/-
Comparison 23um p-value 45um p-value
DN +/± vs DN -/- 0.055 0.252
VT +/± vs VT -/- 0.045 0.593
T-test for DN or VT retinal explants only 
Retinal explant 23um p-value 45um p-value
DN +/± vs DN -/- 0.084 0.666
VT +/± vs VT -/- 0.197 0.921
DN +/± vs VT +/± < 0.001 0.027
DN +/± vs VT -/- 0.003 0.006
DN -/- vs VT +/± 0.01 0.152
DN -/- vs VT -/- 0.257 0.037
Tukey test comparing all retinal explants





DN +/± vs DN -/- 0.235
VT +/± vs VT -/- 0.544
T-test for DN or VT retinal explants only
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 explants from DN and VT retina grown without chiasm. A one-way ANOVA 
failed to reveal any significant differences in mean longest neurite length among the 
various explants. T-tests comparing DN retinal explants and VT retinal explants 





 retinal explants do not differ in their extension capabilities in collagen alone 
(Figure 5F).  
3.4.2. Non-chimeric control ↔ control co-cultures prepared from DN 
retina produced more extensive neurite outgrowth compared to DN 
Foxg1-/- ↔ Foxg1-/- co-cultures. 
Figure 6 shows typical confocal images of co-cultures prepared using retina and chiasm 









) displayed the most prolific neurite outgrowth in terms of length 





 co-cultures (Fig. 6C). 




 co-cultures all displayed low 
neurite outgrowth with short neurites (Fig. 6B & D). Neurites from all co-culture 
combinations contacted chiasm cells (white arrows outside explants in Fig. 6A, B, C, 
D). Neurites were observed to wrap themselves around all retinal explants but this was 
less prominent in DN control co-cultures. The green colour of the explant seen in 
Figure 6A was produced by many neurites growing outwards from the retina rather 
than wrapping around its surface. Brn3a-expressing RGCs were present and healthy in 
all retinal explants (Figures 6E – L). This was an important control, as explants with 
very few or apoptotic RGCs would produce fewer neurites. Excluding cultures with 









 co-cultures was due to the presence or  
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Figure 6. Non-chimeric co-cultures: E14.5 dorsonasal control co-
cultures displayed the most prolific outgrowth in terms of neurite 
length and number.  
(A - D) Immunohistochemistry for the axonal marker neurofilament (green) 
and the RGC marker Brn3a (red) of retinal explants co-cultured with 
dissociated chiasm cells in collagen gel for 48 hours. The nuclear counterstain 
TO-PRO-3 (blue) reveals cells in the retinal explant and dissociated chiasm 
cells in the surrounding collagen gel. Note that image (A) is half the scale of 
the other images. Neurites contacted chiasm cells in all cultures (white 
arrows). (A) Control DN retina showed prolific neurite outgrowth into the 
surrounding Foxg1-expressing chiasm cells (blue cells outside the retinal 
border). (B) VT control co-cultures produced only a few short fasciculated 
neurites that extended into the surrounding chiasm cells. Many neurites 
wrapped themselves around the retinal explant (white arrow heads). (C, D) 




 co-cultures displayed limited neurite 
outgrowth and neurites wrapped themselves around the explant. (D) An 





 co-cultures. (E - L) Brn3a immunohistochemistry for co-
cultures A - D showed that RGCs were present in all explants. (E, F) DN 
control retina, (G, H) VT control retina, (I, J) DN Foxg1
-/-
 retina and (K, L) 
VT Foxg1
-/-





tissue, DN is dorsonasal retina, VT is 
ventrotemporal retina, NF is neurofilament. Scale bars: A = 200µm, B - E, G, 








































absence of Foxg1 rather than differences in the numbers of viable RGCs within the 
retinal explant.  
3.4.3. Chimeric co-cultures of Foxg1+/± ↔ Foxg1-/- retina and chiasm. 




 was that DN Foxg1
-/-
retinal explants cultured with Foxg1
+/±
 chiasm displayed the greatest neurite outgrowth 
compared to all other chimeric co-culture combinations. Figure 7 shows typical 
examples of all four possible chimeric co-culture combinations. DN Foxg1
-/-
 retinal 
explants cultured with Foxg1
+/±
 chiasm produced many long neurites that contacted 
chiasm cells frequently (Figure 7A). Conversely, neurites from all the other chimeric 
co-cultures were shorter and less numerous (Figures 7B – D). Neurites were observed 
to contact chiasm cells in all co-cultures (white arrows). Figures 7E – L show typical 
confocal images of retinal explants labeled using a Brn3a antibody, showing the 
presence of healthy RGCs in all co-cultures.  
3.4.4. % axon coverage at varying distances from the retinal explant 
revealed differences among DN but not VT co-cultures.
Figure 8 shows mean % axon coverage at a distance of 23µm from the retinal explant 
for all DN (Fig. 8A) and all VT (Fig. 8B) co-culture combinations. % axon coverage 
differed significantly among all 8 co-culture combinations. The mean % axon coverage 
for DN control co-cultures (DN Foxg1
+/±
 retina ↔ Foxg1
+/±
 chiasm) was statistically 





 co-cultures had the lowest mean % axon coverage and there was no difference 
between DN and VT co-cultures. Analysing DN and VT co-cultures separately by 
ANOVA revealed significant differences among DN co-cultures only. Figure 8B shows 
that mean % axon coverage for all VT co-cultures was generally less than 3% (+/- 
standard error) and lower than all DN co-culture combinations.  
90
Figure 7. Chimeric co-cultures: E14.5 Dorsonasal Foxg1-/- retinal 
explants co-cultured with Foxg1-expressing chiasm displayed 
more neurite outgrowth compared to all other chimeric co-
cultures.  
(A - D) Immunohistochemistry for the axonal marker neurofilament (green) 
and the RGC marker Brn3a (red) in Foxg1
-/-
↔ control co-cultures. The 
nuclear counterstain TO-PRO-3 (blue) reveals cells in the retinal explant and 
dissociated chiasm cells in the surrounding collagen gel. Note that image (A) 
is half the scale of the other images. (A) DN Foxg1
-/-
 retina cultured with 
control chiasm: many neurites extended for long distances into the 
surrounding chiasm cells from all sides of the explant. In cultures of (B) VT 
Foxg1
-/-
 retina with control chiasm, (C) DN control retina with Foxg1
-/-
chiasm and (D) VT control retina with Foxg1
-/-
 chiasm, neurites were shorter 
and fewer in number compared to (A). Neurites contacted chiasm cells in all 
co-culture combinations (white arrows). (E - L) Brn3a immunohistochemistry 
of retinal explants in co-cultures A - D showed that RGCs were present in all 
explants. (E, F) DN Foxg1
-/-
, (G, H) VT Foxg1
-/-
, (I, J) DN control and (K, L) 
VT control retinal explants. (I - L) Magnifications of images E - H. 




tissue, -/- is Foxg1
-/-
 tissue, DN 
is dorsonasal retina, VT is ventrotemporal retina, NF is neurofilament. Scale 






































Figure 8. % axon coverage differed among dorsonasal but not 
among ventrotemporal co-cultures at a distance of 23µm from the 
retinal explant.  
% axon coverage for (A) DN and (B) VT co-cultures 23µm from the retinal 
explant. (A) % axon coverage differed significantly among the four DN co-
culture combinations (ANOVA, p < 0.001). The mean % axon coverage for 
DN control co-cultures (first bar) was statistically higher (p < 0.001) 
compared to all other DN combinations. Cultures of DN Foxg1
-/-
 retina with 





 co-cultures (fourth bar, p = 0.007). (B) % axon 
coverage did not differ among the four VT co-culture combinations (ANOVA 
p = 0.293). (C) Table showing multiple pairwise comparisons among DN co-
cultures only using the Tukey test. P = 0.05 is the critical value below which 
differences between means were considered statistically significant. (D) Table 
comparing all DN and VT co-culture combinations using the Tukey test. In 
(C) and (D), significant p-values were found for the same co-culture 
combinations and are highlighted in yellow. Abbreviations: DN is dorsonasal 




tissue, -/- is 
Foxg1
-/-
 tissue, oc is optic chiasm, error bars indicate standard error of the 
mean, n's are indicated in parentheses, ** p < 0.001, * p = 0.007. 
         DN Retina             VT







































+/± DN-/-  DN+/± DN-/-
Foxg1+/± Foxg1-/-        Chiasm
+/±   VT-/-  VT+/±   VT-/-   Retina
Foxg1+/± Foxg1-/-     Chiasm
**
(4) (6) (6) (5) (6) (6) (4) (5)
  *
A B
ANOVA (VT) P = 0.293
D
C
Co-culture combination p-value 
DN +/±, +/± oc vs DN -/-, +/± oc < 0.001
DN +/±, +/± oc vs DN +/±, -/- oc < 0.001
DN +/±, +/± oc vs DN -/-, -/- oc < 0.001
DN -/-, +/± oc vs DN -/-, -/- oc 0.007
DN -/-, +/± oc vs DN +/±, -/- oc 0.114
DN +/±, -/- oc vs DN -/-, -/- oc 0.464
Tukey test for DN co-cultures only 
Co-culture combination p-value 
DN +/±, +/± oc vs all other combinations < 0.001
DN -/-, +/± oc vs VT +/±, -/- oc < 0.001
DN -/-, +/± oc vs VT +/±, +/± oc < 0.001
DN -/-, +/± oc vs VT -/-, +/± oc 0.01
DN -/-, +/± oc vs DN -/-, -/- oc 0.006
DN -/-, +/± oc vs VT -/-, -/- oc < 0.001
DN -/-, +/± oc vs DN +/±, -/- oc 0.192
VT -/-, -/- oc vs DN +/±, -/- oc 0.106
Tukey test for all DN & VT co-cultures 
ANOVA (DN & VT) P < 0.001
% axon coverage for retina-chiasm co-cultures at a 
distance of 23um from the retinal explant
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Multiple pairwise comparisons among the four DN retina-chiasm combinations 
produced the same results as for comparisons among all DN and VT co-cultures 
(Figures 8C, D).  
The % axon coverage means for chimeric co-cultures DN Foxg1
+/±
 retina ↔ Foxg1
-/-
chiasm and DN Foxg1
-/-
 retina ↔ Foxg1
+/±
 chiasm were not significantly different 
from one another. However, they were significantly lower than non-chimeric DN 
control co-cultures, demonstrating that Foxg1-expression in the retina and chiasm was 










 co-cultures, suggesting that Foxg1 expression in the 
chiasm can partially rescue neurite outgrowth from Foxg1 null retina. Interestingly, 
although axon coverage for co-cultures of DN Foxg1
+/±
 retina ↔ Foxg1
-/-
 chiasm was 




 co-cultures, this difference was not 
statistically significant. 
In summary, the % axon coverage for co-cultures of DN retinal explants with chiasm 
followed the order:- 
Foxg1+/± retina ↔ Foxg1+/± chiasm > Foxg1-/- retina ↔ Foxg1+/± chiasm > 
Foxg1-/- retina ↔ Foxg1-/- chiasm 
Figure 9 shows mean % axon coverage at a distance of 45µm from the retinal explant 
for each of the different co-culture combinations. As for 23µm, % axon coverage 
differed significantly among all 8 co-culture combinations and also among all DN co-
culture combinations, whereas VT co-cultures (Fig. 9B) failed to reveal any 
differences. Multiple pairwise comparisons produced the same results as for 23µm 
from the explant (Figures 9C, D).  
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Figure 9. % axon coverage differed among dorsonasal but not 
among ventrotemporal co-cultures at a distance of 45µm from the 
retinal explant.  
% axon coverage for (A) DN and (B) VT co-cultures 45µm from the retinal 
explant. (A) The % axon coverage differed significantly among the four DN 
co-culture combinations (ANOVA, p < 0.001). The mean % axon coverage 
for DN control co-cultures (first bar) was statistically higher (p < 0.001) 
compared to all other DN combinations. Cultures of DN Foxg1
-/-
 retina with 





 co-cultures (fourth bar, p = 0.033). (B) % axon 
coverage did not differ among the four VT co-culture combinations (ANOVA, 
p = 0.345). (C) Table showing multiple pairwise comparisons among DN co-
cultures only using the Tukey test. P = 0.05 is the critical value below which 
differences between means are considered statistically significant. (D) Table 
comparing all DN and VT co-culture combinations using the Tukey test. In 
(C) and (D), significant p-values were found for the same co-culture 
combinations and are highlighted in yellow. Abbreviations: DN is dorsonasal 




tissue, -/- is 
Foxg1
-/-
 tissue, oc is optic chiasm, error bars indicate standard error of the 







































         DN Retina               VT+/±   VT-/-   VT+/±  VT-/-    Retina




+/± DN-/-  DN+/± DN-/-
Foxg1+/± Foxg1-/-      Chiasm
B
(4) (4)(6) (6) (6) (6)(5) (5)
*
ANOVA (DN) P < 0.001 ANOVA (VT) P = 0.345
C
Co-culture combination p-value 
DN +/±, +/± oc vs DN -/-, +/± oc < 0.001
DN +/±, +/± oc vs DN +/±, -/- oc < 0.001
DN +/±, +/± oc vs DN -/-, -/- oc < 0.001
DN -/-, +/± oc vs DN -/-, -/- oc 0.033
DN -/-, +/± oc vs DN +/±, -/- oc 0.06
DN +/±, -/- oc vs DN -/-, -/- oc 0.972
Tukey test for DN co-cultures only 
ANOVA (DN & VT) P < 0.001
D
Co-culture combination p-value 
DN +/±, +/± oc vs all other combinations < 0.001
DN -/-, +/± oc vs VT +/±, -/- oc 0.002
DN -/-, +/± oc vs VT +/±, +/± oc < 0.001
DN -/-, +/± oc vs VT -/-, +/± oc 0.013
DN -/-, +/± oc vs DN -/-, -/- oc 0.031
DN -/-, +/± oc vs VT -/-, -/- oc < 0.001
DN -/-, +/± oc vs DN +/±, -/- oc 0.086
VT -/-, -/- oc vs DN +/±, -/- oc 0.867
Tukey test for all DN & VT co-cultures 
% axon coverage for retina-chiasm co-cultures at a 
distance of 45um from the retinal explant
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At 23µm and 45µm distances, even though DN Foxg1
-/-
 retina cultured with Foxg1
+/±
chiasm produced greater axon coverages than DN Foxg1
+/±
 retina cultured with Foxg1
-
/-
 chiasm, the difference in means was not statistically significant, although at 45µm 
this comparison produced a smaller p-value. Statistical analyses of % axon coverage at 
68µm from the explant produced the same results as those found closer to the explant 









 co-cultures disappeared.  
Moving further away from the explant to a distance of 91µm, the data did not follow a 
normal distribution (data not shown). Multiple pairwise comparisons revealed that the 
mean % axon coverage for DN control co-cultures was significantly higher compared 




 co-cultures. However, all other 
differences in axon coverage that were present closer to the explant disappeared. One 
possible explanation is that very few axons remain at this distance, particularly for co-
cultures with less axon outgrowth. Therefore, it becomes more difficult to accurately 
compare axon coverage between different co-cultures as the distance from the explant 
increases because axon length becomes a confounding factor. As a consequence, 
inferences were drawn from axon coverage measures obtained at the two distances 
closest to the explant (23µm and 45µm), which gave identical results.  
Figure 10A shows % axon coverage for all DN co-culture combinations at increasing 
distances from the explant. All cultures showed a reduction in % coverage as the 
measuring distance increased from 23µm to 91µm. DN control co-cultures (blue 
diamonds on highest line) had the highest axon coverage over all distances measured 
and showed the steepest decline between 23µm and 45µm. Figure 10B is a summary 
graph for all 8 co-culture combinations at each of the four distances measured from the 
explant. VT co-cultures displayed the lowest % axon coverage means and at all 
distances from the explant one-way ANOVAs failed to reveal any significant 
differences in % axon coverage among the VT co-cultures. 
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Figure 10. % axon coverage for all co-cultures declined with 
increasing distance from the retinal explant. 
(A) Graph showing % axon coverage for all dorsonasal retina-chiasm co-
cultures at distances of 23, 45, 68 and 91µm from the retinal explant. All DN 
co-cultures showed an inverse relationship between axon coverage and 
distance from the explant. DN control co-cultures had significantly greater % 
axon coverages at all distances. The slopes of the lines are shallower for 
Foxg1
-/-




 co-cultures reflecting the low 
number of neurites in these co-cultures.  
(B) Summary graph of % axon coverage at varying distances from the retinal 
explant for all co-cultures. For each of the co-culture combinations, mean % 
axon coverage was highest closest to the explant and declined gradually as the 
distance from the explant increased. DN control co-cultures (first bar) had the 
highest mean % axon coverage overall. % axon coverage declined when 
Foxg1 was absent from the DN retina (second bar) and was reduced further 
still when Foxg1 was absent from the chiasm in the presence of Foxg1-




 co-cultures had the 
lowest mean % axon coverage out of all four DN combinations. All the VT 
co-cultures had low % axon coverage and none of them differed statistically 
from one another. Abbreviations: DN is dorsonasal retina, VT is 




tissue, -/- is Foxg1
-/-
 tissue, 

























































23 45 68 91






















+/± r, +/± oc
-/- r, +/± oc
+/± r, -/- oc
-/- r, -/- oc




3.4.5. The longest axons produced by dorsonasal Foxg1-/- retina cultured 
in the presence of Foxg1+/± chiasm were comparable in length to those 
from dorsonasal control co-cultures. 
Figure 11 shows the mean length of the five longest neurites for DN and VT co-
cultures. All 8 co-culture combinations had significantly different longest neurite 
lengths. The mean length of the five longest neurites was significantly greater for DN 
control co-cultures (Fig. 11A, 1
st
 bar) compared to all other co-culture combinations
apart from cultures of DN Foxg1
-/-
 retina ↔ Foxg1
+/±
 chiasm (Fig. 11A, 2
nd
 bar), where 
there was no statistical difference (Figures 11A, D). In other words, removing Foxg1
from the DN retina in the presence of Foxg1-expressing chiasm did not alter the 
maximum length to which neurites can extend compared to DN control co-cultures.  
Comparisons among VT co-cultures failed to reveal any significant differences (Figure 
11B). Statistical comparisons among DN co-cultures only (Fig. 11C) produced the 
same results as comparisons for all co-culture combinations (Fig. 11D), with one 
exception (asterisks in Figures 11C, D). Mean longest neurite lengths in cultures of DN 
Foxg1
+/±
 retina with Foxg1
-/-





cultures but were significantly shorter compared to those produced by DN control co-









However, this difference was only significant in statistical comparisons that 
encompassed all co-cultures but not significant in comparisons of DN co-cultures only, 
although the p-value of 0.057 is close to the critical value of p = 0.05. Therefore, the 
order of mean length for the 5 longest neurites from longest to shortest is: - 
1. DN Foxg1+/± retina ↔ Foxg1+/± chiasm = DN Foxg1-/- retina ↔ Foxg1+/±
chiasm  
2. DN Foxg1+/± retina ↔ Foxg1-/- chiasm = DN Foxg1-/- retina ↔ Foxg1-/-
chiasm 
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Figure 11. Dorsonasal Foxg1-/- retina cultured with Foxg1-
expressing chiasm produced similar longest neurite lengths to 
DN control co-cultures.  
Graphs showing mean lengths of the five longest neurites for (A) DN and (B) 
VT co-cultures. (B) Table comparing all DN co-cultures using the Tukey test, 
where p < 0.05 indicates a statistically significant result. (C) Table comparing 
all DN and VT co-culture combinations using the Tukey test. (B, C) 
Statistically significant results are highlighted in yellow. (A, B) Longest 
neurite means differed significantly among the four DN co-culture 
combinations (ANOVA, p = 0.004). The mean longest neurite length for DN 
control co-cultures (first bar) was significantly greater compared to all other 
DN combinations (p ≤ 0.016), apart from DN Foxg1
-/-
 retina cultured with 
control chiasm (second bar). (B, C) The longest neurites from cultures of DN 
Foxg1
-/-
 retina with control chiasm did not differ significantly in length from 
those of DN control co-cultures (row highlighted in pink). (B) Longest neurite 
means did not differ among the four VT co-culture combinations (ANOVA, p 
= 0.285). (C) The mean lengths of the longest neurites for DN control co-
cultures and cultures of DN Foxg1
-/-
 retina with control chiasm were 
significantly greater compared to all VT combinations (p ≤ 0.006). Cultures of 
DN Foxg1
-/-
 retina with control chiasm had significantly higher mean longest 




 co-cultures (p = 0.028*). 
However, when comparisons were made solely between DN co-cultures (B), 
this difference disappeared but remained close to the critical p-value of 0.05 
(p = 0.057*). The bracketed asterisk in (A) indicates this comparison. 
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(6) (6) (6) (5)
DN+/± DN-/- DN+/± DN-/- Retina VT+/± VT-/- VT+/± VT-/- Retina
Foxg1+/± Foxg1-/- Chiasm Foxg1+/± Foxg1-/- Chiasm
ANOVA P = 0.285ANOVA P = 0.004
A B
C
D ANOVA (all) P < 0.001
Co-culture combination p-value
DN +/±, +/± oc vs DN -/-, -/- oc 0.007
DN +/±, +/± oc vs DN +/±, -/- oc 0.016
DN +/±, +/± oc vs DN -/-, +/± oc 0.577
DN -/-, +/± oc vs DN -/-, -/- oc 0.057*
DN -/-, +/± oc vs DN +/±, -/- oc 0.127
Tukey test for DN co-cultures only
Co-culture combination p-value
DN +/±, +/± oc vs DN -/-, -/- oc < 0.001
DN +/±, +/± oc vs DN +/±, -/- oc 0.003
DN +/±, +/± oc vs DN -/-, +/± oc 0.736
DN +/±, +/± oc vs all other VT co-cultures < 0.001
DN -/-, +/± oc vs DN +/±, -/- oc 0.098
DN -/-, +/± oc vs DN -/-, -/- oc 0.028*
DN -/-, +/± oc vs VT +/±, +/± oc 0.006
DN -/-, +/± oc vs VT -/-, +/± oc < 0.001
DN -/-, +/± oc vs VT +/±, -/- oc < 0.001
DN -/-, +/± oc vs VT -/-, -/- oc < 0.001
DN +/±, -/- oc vs VT -/-, -/- oc 0.254
Tukey test for all DN & VT co-cultures
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These results show that removing Foxg1 from chiasm cells reduces the maximum 
length of DN Foxg1-expressing neurites. Also, the presence of Foxg1 at the chiasm can 
fully rescue the extension of DN Foxg1
-/-
 axons such that the longest neurites reach 
lengths equivalent to those found in DN Foxg1-expressing control co-cultures.  
Figure 12A shows mean longest neurite lengths of retinal explants only alongside non-
chimeric Foxg1
+/±
 retina ↔ Foxg1
+/±
 chiasm and Foxg1
-/-
 retina ↔ Foxg1
-/-
 chiasm co-
cultures. Figure 12B shows the results of t-tests between retinal explants and their 
corresponding retina-chiasm co-culture, showing that DN Foxg1
-/- 
(p = 0.014), VT 
control or ‘Foxg1
+/±
’ (p = 0.005) and VT Foxg1
-/-
 (p = 0.016) explants all produced 
shorter neurites in the presence of chiasm cells. Interestingly, the lengths of the longest 
neurites produced by DN Foxg1
+/±
 explants cultured alone were significantly shorter
compared to those produced in combination with Foxg1
+/±
 chiasm (p = 0.021). This 
indicates that DN Foxg1-expressing retinal neurites extend over greater distances when 
grown on a Foxg1
+/±
 chiasm cell substrate. 
3.4.6. Chiasm density. 
The mean chiasm density did not vary significantly between different co-culture 
combinations (Figure 13). Therefore, any differences in axon outgrowth cannot be 
attributed to greater or lower densities of chiasm cells.  
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Figure 12. With the exception of dorsonasal control retina, chiasm 
cells reduced mean longest neurite lengths from DN and VT 
retinal explants. (A) A graph showing means for the length of the 5 longest 
neurites for retinal explants grown in the absence of chiasm cells in collagen 
alongside equivalent retina-chiasm co-cultures. (B) Tables of t-tests between 
adjacent pairs showed a significant reduction in mean longest neurite length 
when DN Foxg1
-/-
 , VT control and VT Foxg1
-/-
retinal explants were grown 
in combination with chiasm cells of the same genotype. However, DN control 
explants produced significantly longer neurites when grown in the presence of 
wild type chiasm cells (p = 0.021). Abbreviations: DN is dorsonasal retina, 




tissue, -/- is 
Foxg1
-/-
tissue, error bars indicate standard error of the mean. 
Comparison p-value 
DN control vs DN control co-culture 0.021
DN Foxg1-/- vs DN Foxg1-/- co-culture 0.014
VT control vs VT control co-culture 0.005
T-test 
Comparison p-value 
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Figure 13. Chiasm cell density is the same across all co-cultures
analysed.
The chiasm cell density for each co-culture combination does not differ
(p = 0.653).




The chimeric co-culture experiment revealed that Foxg1 is required both in the DN 
retina and in chiasm cells to mediate retinal axon laterality at the chiasm. The in vitro
system was validated by preparing control co-cultures of Foxg1-expressing retina and 
chiasm. The axon outgrowth observed reproduced previous findings that in the 
presence of chiasm cells, VT axons are shorter and fewer in number compared to axons 
from DN retina (Herrera et al., 2004; Herrera et al., 2003; Marcus et al., 1995; Marcus 
and Mason, 1995; Marcus et al., 1996b; Wang et al., 1995). This reflects the avoidance 
of the chiasm region and subsequent ipsilateral path taken by VT retinal axons 
compared to the contralateral path across the chiasm midline followed by DN axons in 




VT and DN co-cultures was then 
used to define end-points on a scale from low outgrowth typical of ipsilateral axons to 
high outgrowth typical of contralateral axons. By comparing axon coverage (a measure 





chimeric co-cultures, conclusions could be made about the relative importance 
of Foxg1 in the retina or the chiasm in producing contralateral axonal behaviour.  
3.5.1. The behaviour of retinal axons from Foxg1-/-  Foxg1-/- co-cultures 
reflects the increased avoidance of the chiasm by nasal and temporal 
Foxg1-/- axons in vivo. 














 co-cultures producing means between these two extremes. VT co-





displaying lower axon coverage and shorter neurites compared to non-chimeric VT 
control co-cultures, although the difference was not statistically significant unlike for 
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 co-cultures relative to non-chimeric control Foxg1-expressing co-
cultures is reminiscent of the greater ipsilateral routing of Foxg1
-/-
 nasal and temporal 




co-cultures failed to reflect the temporal bias in the source of ipsilateral projections in 
Foxg1
-/-
 embryos, as in wild type embryos (Pratt et al., 2004). Nevertheless, there were 





 co-cultures prepared using VT retina compared to those using DN 





provide accurate in vitro representations of the increased tendency of axons from the 
entire retina to project ipsilaterally at the chiasm. 
3.5.2. Foxg1 expression in the DN retina and chiasm is required for 
normal outgrowth of DN axons. 
Overall, analyses of % axon coverage and longest neurite lengths produced similar 
trends and together showed that Foxg1 is required in DN retina and in chiasm cells for 
high axon outgrowth from DN retina in vitro. Absence of Foxg1 from DN retina 
significantly reduced axon coverage relative to non-chimeric DN control co-cultures, 
regardless of whether Foxg1 was present at the chiasm suggesting an autonomous 
requirement for Foxg1 in DN retina. However, Foxg1 also acts non-autonomously 




chiasm co-cultures, axon 
coverage from DN Foxg1
-/-





co-cultures. This requirement for Foxg1 at the chiasm was strongly 
corroborated by observations that Foxg1-expressing chiasm can fully rescue maximum 
neurite lengths to non-chimeric control co-culture levels. In contrast, Foxg1-expressing 




 chiasm co-cultures) could not increase neurite 




 co-cultures.  
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In summary, the neurite length and axon coverage analyses showed the following: - 
DN Foxg1+/± retina  Foxg1+/± chiasm  DN Foxg1-/- retina  Foxg1+/± chiasm  
DN Foxg1-/- retina  Foxg1+/± chiasm > DN Foxg1-/- retina  Foxg1-/- chiasm  
DN Foxg1+/± retina  Foxg1-/- chiasm = DN Foxg1-/- retina  Foxg1-/- chiasm 
Although this evidence shows that loss of Foxg1 in the chiasm is sufficient to account 
for the drop in axon outgrowth and shorter neurites, the axon coverage findings show a 
clear role for Foxg1 in the DN retina. 
The fact that Foxg1-expressing chiasm fully rescued maximum neurite length but only 
partly rescued % axon coverage relative to non-chimeric DN control co-cultures may 
represent a real difference in the roles of Foxg1 in mediating axon extension versus 
axon coverage. Alternatively, it could be a consequence of how the co-cultures were 
analysed. For a given co-culture, measurements of the five longest neurites only 
represented a small subpopulation of the total number of neurites in the whole co-
culture. In contrast, % axon coverage encompassed all neurites and thus represented 
axon outgrowth from the whole culture. Moreover, there was considerable variability in 
longest neurite length between different explants within the same co-culture 




 chiasm co-cultures and all 
the VT co-culture combinations. Even when the mean neurite length was short, 
anomalously long neurites were often found. One explanation is that despite the 
repulsive environment presented to the retinal neurites by chiasm cells in culture, a 
couple of neurites can extend in a highly fasciculated manner over long distances by 
avoiding contact with chiasm cells. Despite these caveats, analyses of neurite length, 
combined with axon coverage data, are useful in determining the site of action of 
Foxg1.  
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3.5.3. Foxg1 expression does not affect the outgrowth of VT retinal axons 
co-cultured with chiasm. 
Axon coverage and longest neurite length did not differ among VT co-cultures. Taken 
at face value, these non-significant comparisons suggest that Foxg1 does not play any 
role in the VT retina or at the chiasm in guiding VT RGC axons contralaterally or 
ipsilaterally. However, this is inconsistent with the DiI backlabeling observations of an 
increased ipsilateral projection from nasal and temporal retina in Foxg1
-/-
 embryos 
(Pratt et al., 2004). A possible explanation for this inconsistency is that the co-culture 





 chiasm cells. This is plausible as the paucity of axons produced 
when VT retina is cultured with chiasm cells may make it hard to distinguish further 
reductions in axon coverage. For example, comparing co-cultures with three or four 
axons to those that show a reduction of one or two axons may not produce a 
statistically significant difference. It is possible that increasing the number of replicates 
for each VT co-culture combination may improve the power of the statistical test, 
enabling small changes to be detected. In order to distinguish between lack of 
sensitivity and a true result, more sensitive analyses of axon growth in VT co-cultures 
could be attempted, such as time-lapse video microscopy, growth cone turning assays 




 chiasm (Sretavan and Reichardt, 
1993; Walter et al., 1987; Zheng et al., 1996).  
Another possible reason that could lead to differential effects of Foxg1 among the VT 
co-cultures being obscured is the presence of contralateral RGCs in the VT retinal 
explants. Although ipsilateral RGCs are concentrated in the VT crescent (VTC) that 
occupies approximately 20% of the entire retina, roughly 25% of RGCs in the VTC 
project ipsilaterally (Jeffery et al., 1981). Therefore, it was unavoidable that the VT 
retinal explants used for the co-cultures contained some contralateral RGCs. In order to 
eliminate ‘contaminating’ contralateral RGCs and provide a pure population of 
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ipsilateral RGCs for culture, a technique called immunopanning could be used (Butowt 
et al., 2000). This method has been used to isolate a pure population of chick RGCs for 
culture using monoclonal antibodies raised against Thy1 expressed exclusively by 
RGCs. It is conceivable that the same could be done using a marker of ipsilateral 
RGCs, such as the EphB1 receptor (Williams et al., 2003). However, this technique 
would dissociate RGCs into single cells and produce less retinal tissue. Therefore, 
changes to the in vitro co-culture method would have to be made.   
3.5.4. Foxg1-/- retinal explants cultured without chiasm were not impaired 
in their ability to produce axons relative to Foxg1-expressing explants. 
To exclude the possibility that intrinsic differences exist in the outgrowth or extension 
of neurites from Foxg1-expressing and Foxg1
-/-
 retina that might explain the co-culture 
results observed, cultures of DN and VT retinal explants were prepared without chiasm 





 retinal explants and between VT Foxg1
+/±
 and VT Foxg1
-/-
 explants failed 
to reveal significant differences, apart from a small difference in axon coverage 
between VT Foxg1
+/±
 and VT Foxg1
-/-
 explants observed at 23µm from the explant. 
However, this was not replicated at any other distance, nor was it seen in analyses of 
neurite extension. Consequently, any effect this might have had on axon coverage in 
the VT retina-chiasm co-cultures is considered negligible.  
% coverage of axons from VT retina was greater compared to that from DN retina 
when cultured without chiasm cells. These data agree with a similar culture system in 
which VT wild type retina cultured alone in collagen produced significantly longer and 
more numerous axons than the other retinal quadrants (Wang et al., 1996). This is the 
opposite trend to that shown in the retina-chiasm co-cultures, where explants from non-
chimeric DN control co-cultures produced significantly greater axon coverage 
112
compared to all VT co-cultures. This indicates that Foxg1-expressing chiasm actually 
promotes the growth of contralateral (DN) axons and that the high axon coverage 




chiasm co-cultures was not simply the 
result of differences in axon outgrowth between DN and VT retina. Rather this reflects 
previous findings that contralateral and ipsilateral retinal axons respond differently to 
chiasm cells and their diffusible molecules, with ipsilateral axons growing less well in 
their presence (Wang et al., 1995, Wang et al., 1996, Marcus et al., 1996b, Williams et 
al., 2006; Wizenmann et al., 1993). In conclusion, any variation in axon outgrowth or 
longest neurite lengths observed in the co-culture experiments could be completely 
attributed to the presence or absence of Foxg1 for a particular combination of retina 
and chiasm. 
3.5.5. DN retinal axons grow better in the presence of chiasm cells than in 
their absence whereas VT axons grow more poorly. 
In the co-culture experiment described here, chiasm cells have a positive effect on axon 
outgrowth from DN retina but a negative effect on VT axon outgrowth relative to 
explants grown alone. The growth-promoting effect of chiasm on DN retinal axons is 
consistent with the co-culture results of Chan et al. (2002) in which DN but not VT 
neurites invaded neighbouring chiasm explants. Together, these results suggest that 
chiasm tissue not only provides inhibitory cues that reduce overall neurite outgrowth 
from VT but not DN retina but also contact-dependent attractive cues to axons from 
DN retina. It is possible that chiasm cells secrete a diffusible chemoattractant, such as 
netrin, that helps guide navigating retinal axons from the retina towards the ventral 
midline in order for them to contact midline radial glia. However, this remains 
hypothetical as no diffusible chemoattractants have been found at the chiasm. Although 
the diffusible protein netrin plays an important role in the navigation of commissural 
axons at the midline of the Drosophila ventral nerve cord and at the floor plate of the 
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vertebrate spinal cord (Kaprielian et al., 2001; Mitchell et al., 1996; Serafini et al., 
1996; Shirasaki et al., 1996), netrins are not expressed at the chiasm midline in mice 
(Deiner et al., 1999). However, netrin-1 is present in the optic nerves and in ventral-
lateral hypothalamic regions (Deiner & Sretavan, 1999). Therefore, it is conceivable 
that netrin-1 in these regions may interact with its receptor DCC and its repulsive 
receptor UNC-5, expressed on retinal axons to influence their navigation course 
(Anderson and Holt, 2002; Shewan et al., 2002).  
More is known about molecules involved in contact-dependent attraction surrounding 
the chiasm. Cells of the ventral diencephalon are known to express surface molecules 
involved in cell-cell adhesion and axon extension, such as the L1 family of cell 
adhesion molecules expressed by RGCs and their axons (Lustig et al., 2001; Sretavan 
et al., 1994). One L1 family member is Nr-CAM that is expressed at the chiasm and 
also exclusively by contralateral RGCs and their axons and has been shown to promote 
contralateral behaviour in vitro and in vivo (Williams et al., 2006). However, Nr-CAM 
at the chiasm itself is unlikely to promote the growth of contralateral axons because 
wild type and Nr-CAM
-/-
 chiasm reduced outgrowth of both DT (crossed) and VT 
(uncrossed) axons equally in retina-chiasm co-cultures and the same co-cultures 
showed that Nr-CAM acts primarily in the retina. Also, in vivo experiments using Nr-
CAM null mice showed that Nr-CAM influences the guidance of late-born VT RGCs 
and is, therefore, an unlikely candidate for increasing ipsilateral projections in Foxg1
-/-
embryos. Chiasm cells express heparan sulphate, a sugar moiety on the transmembrane 
glycoprotein CD44 that promotes axon growth by sequestering heparin binding growth 
factors. CD44 itself has been reported to promote the growth of contralateral axons at 
the chiasm midline (Lin and Chan, 2003), although there is contradictory evidence that 
CD44 reduces neurite outgrowth from mouse retina (Sretavan et al., 1994). In 
summary, although there are a couple of molecules that appear to promote the growth 
of contralateral axons, it is unclear whether any of these are responsible for producing 
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the increased outgrowth of DN axons over chiasm cells observed in the co-cultures 
presented here.  
3.5.6. Lack of Foxg1 in vitro produced axon outgrowth that resembled 
that of ipsilateral axons suggesting altered expression of ipsilateral 
determinants in the DN retina and at the chiasm. 
In DN co-cultures lacking Foxg1 in the DN retina or at the chiasm or both, % axon 
coverage was reduced, resembling that produced by VT axons from control co-cultures. 
The requirement for Foxg1 in the retina and chiasm for contralateral axon outgrowth 
implies that changes occur in both of these tissues in Foxg1
-/-
 embryos to increase 
ipsilateral behaviour by axons. In the DN retina, it is likely that expression of an 
ipsilateral determinant increases or alternatively a contralateral determinant could 
decrease. Similarly at the chiasm, the increased avoidance of the chiasm by Foxg1
-/-
retinal axons suggests an increase in a repulsive guidance cue or a reduction in an 
attractive cue.  
The majority of research directed at understanding the role of the chiasm in 
contralateral-ipsilateral axon pathfinding has centred on repulsive or inhibitory factors 
rather than attractive cues. The reason for this is that during the peak period of retinal 
axon divergence in the mouse from E14 – E16, the chiasm is generally inhibitory. 
Molecules that are inhibitory to retinal axon growth in the chiasm region or ventral 
diencephalon include ephrin-B2 (Nakagawa et al., 2000; Williams et al., 2003), 
chondroitin sulphate proteoglycans (Tuttle et al., 1998); Chung et al., 2000a, 2000b), 
CD44 (Sretavan et al., 1994; Sretavan et al., 1995), SSEA-1 (Marcus and Mason, 1995; 
Sretavan et al., 1994) and slits (Thompson et al., 2006a, 2006b; Plump et al., 2002; 
Erskine et al., 2000; (Niclou et al., 2000; Ringstedt et al., 2000). However, the majority 
of these molecules have been shown to reduce axon growth from all retinal regions, 
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rather than VT axons selectively, supporting findings of the production of one or more 
diffusible repulsive cue(s) that affect all retinal loci equally (Chan et al., 2002; Wang et 
al., 1996). The effect of a diffusible cue on the different retinal explants could not be 
addressed in the co-cultures presented in this Chapter because it would involve keeping 
the chiasm intact and/or preventing it from contacting the retina. However, it is 
unlikely that this diffusible cue is responsible for changing the proportion of 
contralateral versus ipsilateral axons in Foxg1
-/-
 embryos since it has been found to 
reduce axon outgrowth from wild type DN and VT retina equally (Chan et al., 2002; 
Wang et al., 1995).  
In the past few years, a number of candidates have been identified that potentially 
influence ipsilateral-contralateral pathfinding (Herrera et al., 2003; Herrera et al., 2004; 
Pak et al., 2004; Williams et al., 2003; Williams et al., 2006). Previous studies have 
shown that contacts between retinal axons and cells or membranes from the chiasm 
region are crucial for suppressing the growth of ipsilateral but not contralateral axons 
(Chung et al., 2000a, 2000b; Wang et al., 1995; Wizenmann et al., 1993). Specifically, 
all axons contact a radial glial ‘palisade’ at the chiasm midline before either projecting 
ipsilaterally or contralaterally (Marcus & Mason 1995; Marcus et al., 1995). These 
midline radial glial cells express the evolutionarily-conserved molecule ephrin-B2, 
which is known to be responsible for the selective repulsion of EphB1- bearing 
ipsilateral axons in the amphibian Xenopus and mice (Nakagawa et al., 2000; Williams 
et al., 2003). Since contralateral axons do not express EphB1, they are not repelled 
when they contact their ligand ephrin-B2 at the chiasm midline. Therefore, it will be 
crucial to examine both ephrin-B2 at the chiasm and EphB1 expression in the retina of 
Foxg1
-/-
 embryos. Another ipsilateral determinant is a zinc finger transcription factor 
involved in early neural patterning called Zic2 that is expressed in VT retina 
cotemporaneously and in the same RGCs as EphB1 (Williams et al., 2003). Zic2 has 
been shown to control the ipsilateral routing of RGCs both in vitro and in vivo (Herrera 




 embryos from the retina. In terms of contralateral determinants, 
Islet 2 (Isl2) expression is confined to RGCs that project contralaterally, although it is 
not expressed by all contralateral RGCs (Pak et al., 2004). Isl2 null mice show an 
increased ipsilateral projection from a greater number of Zic2-expressing RGCs in the 
VTC. Therefore, Isl2 is another candidate molecule whose expression may be altered in 
the Foxg1
-/-
 retina.  
3.5.7. Extra-retinal tissues that express Foxg1 may influence retinal axon 
guidance. 
Although the co-cultures show a requirement for Foxg1 in DN retina, they do not prove 
whether this is RGC-autonomous. It is possible that during eye development, Foxg1-
expressing tissues, such as the lens and retinal pigment epithelium, influence the 
expression of genes in the retina that control its development (Dou et al., 1999). In the 
absence of Foxg1, retinal patterning may be disrupted through altered expression of 
patterning molecules or morphogens producing a retina that is more ipsilateral in 
character. Hence nasal RGCs that would normally project contralaterally would be 
respecified to project ipsilaterally. In this model, Foxg1 is not required autonomously 
within nasal RGCs themselves but is required autonomously by the nasal retina. In the 
co-cultures, the retina had been dissected free from the RPE and lens. Therefore, 
throughout the in vitro 48-hour culture period, these extra-retinal tissues could not have 
influenced axon guidance directly. However, development of the retina occurs before 
the first axons leave the RGC layer and before E14.5, the age of the embryos used for 
the co-cultures. Therefore, extra-retinal tissues could have already patterned the retina 
in control and Foxg1
-/-
 embryos, influencing the behaviour of retinal axons in culture. 
Since the co-cultures are not able to discriminate between an RGC- versus nasal retina- 
autonomous requirement, this hypothesis cannot be excluded. 
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3.5.8. Analyses of axon fasciculation, volume and surface area suffered 
from limitations and were not as representative as axon coverage. 
For each co-culture, the widths of all axon fascicles were measured and the means 
calculated to provide a measure of axon fasciculation. Similarly the volume and surface 
area of axons extending into the surrounding chiasm cells were measured using the 
computer software Volocity. However, none of these analyses produced statistically 
significant results. This was surprising as it was hypothesized that chiasm cells would 
elicit greater fasciculation from VT (uncrossed) axons than from DN (crossed) axons 
due to greater inhibition of axon outgrowth by chiasm cells. VT axons might attempt to 
minimize the surface area of the axon in contact with optic chiasm cells or their 
secreted products whilst DN axons should show less fasciculation and greater surface 
areas and volumes because they are not as inhibited by chiasm cells.  
Axon fasciculation analysis actually produced results opposite to those predicted. DN 





 co-cultures had the narrowest fascicles (instead of the widest). A 
possible explanation could be the confounding influence of axon number. The more 
axons there are, the greater the probability that they will meet, bundle together and 
form fascicles as observed in DN control co-cultures. The fewer axons there are, the 
less likely they will be to fasciculate as they emerge from fewer locations along the 
explant surface, reducing the probability of one axon contacting another. Equally there 
are problems with measuring neurite volumes and surface area because they are 
confounded by the degree of fasciculation. For these reasons coupled with large 
variation between cultures of the same combination, fascicle width, axon volume and 
axon surface area were not considered reliable ways of analyzing axon outgrowth.  
Examination of 3D reconstructions of the co-culture confocal images revealed that 
contacts between axons and chiasm cells were observed in all co-culture combinations. 
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However, it was unclear whether there was a reduction in the frequency of axon-
chiasm contacts in cultures with less axon outgrowth, since contact frequency is 
expected to increase proportionally with increasing numbers of axons. This could be 
examined further using time-lapse video microscopy to observe the behaviour of 
growth cones in the proximity of chiasm cells.  
The co-culture system used here does not attempt to fully recreate the complex 
environment found in vivo where there are many more factors, including the 
extracellular matrix and other tissues or diffusible molecules that almost certainly 
affect axon guidance. However, it reflects the observations seen by DiI tracing in wild 
type and Foxg1
-/-
embryos and more importantly it confirms previous findings using 
similar co-culture methods. The scope for manipulating the simple co-culture system, 
for example by adding molecules or blocking guidance cues or receptors present in the 
chiasm or retina, is immense. The unambiguous axon outgrowth phenotype of DN and 
VT retina co-cultured with chiasm means that any abnormalities are simple to identify 
and analyse, making this experiment a powerful tool for studying retinal axons at the 
chiasm.   
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CHAPTER 4: The number of cells expressing the 





Previous studies have identified the zinc finger transcription factor Zic2 as an 
ipsilateral determinant that is expressed by postmitotic RGCs in the peripheral 
ventrotemporal (VT) retina. The aim of this chapter was to test the hypothesis that 
numbers of Zic2-expressing cells increase to match the unusually large ipsilateral 




nasal retina displayed 
an increase in the numbers of cells expressing Zic2 relative to the wild type but there 
was either no change or a slight decrease in the temporal retina. In wild type retinas, 
clusters of Zic2-expressing cells were mostly seen in VT retina and never in the nasal 
retina where Foxg1 is normally expressed. This suggests that Foxg1 represses Zic2 in 
the nasal retina, thereby inhibiting ipsilateral projections in this region. In the nasal 
retina of Foxg1 null embryos, it is hypothesized that the repression on Zic2 by Foxg1 is 
relieved. This results in increased Zic2 expression and ipsilaterally-projecting axons, 
most likely through induction of EphB1 receptors by Zic2, which are repelled by 
ephrin-B2 at the optic chiasm. Gain- and loss-of-function experiments would confirm 
whether Foxg1 can repress Zic2 in vitro and whether Foxd1 is involved in this process. 
Furthermore, studies of EphB1 expression in the Foxg1
-/- 
retina would reveal whether 
its expression increases concomitantly with Zic2 in the nasal retina, bolstering evidence 
for EphB1’s involvement in the ipsilateral program. In the Foxg1
-/-
 eye, changes in 
Zic2 expression are biased towards the nasal retina compared with more subtle 
alterations in the temporal retina. This is compatible with a theory in which Foxg1 
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normally regulates Zic2 expression in nasal RGCs themselves, although a non-
autonomous effect in temporal RGCs remains a possibility. 
4.2. INTRODUCTION 
4.2.1. An overview of the developmental roles of the Zic gene family. 
Zic2 is a member of the Zic family of zinc-finger (ZF) proteins encoded by the Zic 
genes that are vertebrate homologues of the Drosophila odd-paired (opa) pair-rule gene 
(Aruga et al., 1996). The Zic or ‘zinc finger protein of the cerebellum’ genes were first 
discovered in the mouse cerebellum as a family of structurally-related genes that 
exhibited highly restricted patterns of expression (Aruga et al., 1996; Aruga et al., 
1994). Five homologous Zic genes play evolutionarily conserved roles in human, 
mouse, frog, fish and ascidian development, including left-right axis formation, 
myogenesis, skeletal patterning and neurogenesis as well as a multitude of important 
functions in neural development (Aruga, 2004). These functions can be split into five 
main categories: cell fate determination in the ectoderm, neurulation, forebrain 
development, cerebellar patterning and retinal axon guidance.  
Vertebrate Zic1, Zic2 and Zic3 are closely related forming a subgroup in phylogenic 
trees of the Zic gene family (Aruga et al., 1996). They are known as ‘pre-patterning’ 
genes as they are expressed before the earliest events in the development of the CNS. 
Zic1 - 3 proteins have highly similar amino acid sequences with partly overlapping 
expression patterns along the dorsal spinal cord and midbrain (Elms et al., 2004; Nagai 
et al., 1997). At later embryonic stages, Zic1 - 3 are expressed in structures derived 
from the dorsal neural tube, notably the dorsal and ventral diencephalons and 
cerebellum (Inoue et al., 2004; Nagai et al., 1997). The restriction of Zic1, 2 and 3 to 
the dorsal part of the neural tube and its derivatives is due to the opposing actions of 
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BMP and Shh during neural tube development (Aruga et al., 2002). In the developing 
neural tube, Shh inhibits Zic gene expression ventrally, whereas dorsally, BMP4 and 
BMP7 act as positive regulators, demonstrated by overexpression studies in the chick 
spinal cord and in zebrafish (Aruga et al., 2002; Rohr et al., 1999).  
Despite extensive knowledge of the various roles of Zic genes in development, their 
transcriptional targets and the signaling pathways through which Zic gene products 
exert their effects remain unknown. Nevertheless, some clues are emerging. Zic 
proteins play diverse roles during neural development, enhancing differentiation into 
neuroectoderm early in development but inhibiting neuronal differentiation later 
(Aruga et al., 2002). Inhibiting neuronal differentiation requires Notch signaling, which 
controls myriad developmental processes. This may in turn explain the numerous 
functions that Zic gene products play during development (Artavanis-Tsakonas et al., 
1999; Kintner, 2002).  
4.2.2. Zic transcription factors are possible modulators of hedgehog 
signaling. 
Several lines of evidence suggest that Zic proteins have the potential to modulate 
hedgehog signaling. The zinc-finger domains of Zic and Gli transcription factors are 
highly homologous and recently it was shown that Zic proteins are capable of binding 
to specific Gli target DNA sequences in vitro, albeit with lower affinity than Gli 
proteins, suggesting possible interactions in vivo (Mizugishi et al., 2001). Moreover, 
recent findings elucidated that the ZF domains of Zic and Gli proteins can interact with 
one another, enhancing the nuclear localization of Gli and suggesting a role for Zic 
proteins as Gli cofactors (Koyabu et al., 2001). In this way, transcriptional regulation 
by Zic proteins may not always result from conventional sequence-specific binding. 
Although a Zic-Gli interaction has not been conclusively demonstrated in neural tissue, 
there is accumulating evidence for both opposing and cooperative interactions between 
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these two proteins through gain-of-function and loss-of-function analyses (Aruga et al., 
1999; Brewster et al., 1998).  
Further indications of a link between hedgehog signaling and Zic2 come from studies 
of mice with reduced Zic2 expression (Nagai et al., 2000). These Zic2
kd/kd
 (Zic2 
knockdown) mice possess a mutated Zic2 allele (Zic2
kd
) whose expression is 21% of 
the wild type allele (Nagai et al., 2000). Zic2
kd/kd
 mice experience a neurulation delay 
and subsequent neural tube closure defects resulting in spina bifida and a forebrain 
abnormality called holoprosencephaly (HPE) (Brown et al., 2001; Brown et al., 1998; 
Nagai et al., 2000) HPE is also a characteristic of Shh null mice (Chiang et al., 1996). 
HPE results from disrupted left-right forebrain patterning and produces phenotypes that 
range from severe cases in which there is a single ventricle or milder forms in which 
midline structures are malformed to varying degrees. Heterozygous loss-of-function 
mutations in ZIC2 are thought to be responsible for 3 – 4% of HPE cases in humans 
(Brown et al., 1998, 2001), although other genes, including SHH (Belloni et al., 1996; 
Roessler et al., 1996), SIX3 (Wallis et al., 1999) and TGIF (Gripp et al., 2000) also 
cause this forebrain phenotype. The convergent HPE phenotype of Zic2 and Shh null 
mice suggests that Shh and Zic2 act in the same signaling pathway or that Shh 
regulates Zic2. Several observations are consistent with the idea that Shh inhibits or 
restricts Zic2 expression ventrally in the neural tube. For example, the Zic2-expressing 
region shifts ventrally in the spinal cord of Shh null mice (Brown et al., 2003) and also 
in mice with degeneration of the notochord, a structure that normally expresses Shh 
which then sets up ventral identity in the neural tubes (Nagai et al., 1997). 
Despite the shared HPE phenotype, there are several differences between Shh and Zic2
mutants. For instance, Shh mutants display facial deformities, such as cyclopia and 
midline clefts whereas Zic2
kd/kd
 mice and ZIC2-deficient do not (Chiang et al., 1996; 
Roessler et al., 1996). Also, exencephaly and anencephaly occur in several Zic2
kd/kd
mice (Nagai et al., 2000) but these brain malformations are never observed in Shh
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mutants. Therefore, further investigation is required to reveal the exact relationship 
between Zic2 and Shh specifically in forebrain development.  
4.2.3. Zic2 determines the uncrossed retinal axon pathway. 
In mouse embryos, Zic2 appears in the developing eye from E9.5 when it is expressed 
along with Zic1 and Zic3 in the optic vesicle and optic stalk. From E10.5, Zic2 is 
expressed in the proliferating ciliary marginal zone (CMZ) by retinal precursors (Nagai 
et al., 1997). Zic2 is expressed in ventrotemporal postmitotic RGCs from E14 - E17, 
the time-frame during which the permanent ipsilateral projection forms (Herrera et al., 
2003). Since the ventrotemporal retina is the part of the retina that gives rise to 
ipsilateral retinal axons, Zic2 expression coincides spatially and temporally with the 
ipsilateral projection.  
Simply observing a correlation between Zic2 expression and the appearance of 
ipsilateral retinal axons does not prove that Zic2 expression in VT RGCs is responsible 
for determining an uncrossed path at the chiasm. However, in the past few years, 
several lines of evidence have strongly implicated Zic2 as an ipsilateral determinant. 





), which reduces Zic2 expression to 20% of the wild type level, 
display a severely reduced ipsilateral projection. However, Zic2
kd/kd
 mice show 
morphological abnormalities of the ventral diencephalon and abnormal ephrin-B2 
expression, so it is unclear whether the abnormal chiasm or lack of retinal Zic2 
produced the guidance defect. In contrast, Zic2
kd/+
 embryos, which have intermediate 
Zic2 expression levels between Zic2
kd/kd
 and wild type embryos, have a chiasm that is 
normal anatomically and molecularly, yet still possess a reduced ipsilateral projection. 
Herrera et al. (2003) suggested that a reduction in Zic2 in the retina was probably the 
most likely explanation for this. The number of Zic2-positive cells is proportional to 
the degree of binocularity in different species (Herrera et al., 2003). For example, in the 
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stages when axons reach the chiasm (Thanos and Mey, 2001). Albino mice display a 
smaller ipsilateral projection compared to pigmented mice (Marcus & Mason, 1995) 
and this is reflected by a corresponding reduction in the number of Zic2-positive cells 
in the albino retina (Herrera et al., 2003). In addition in Xenopus, the subpopulation of 
VT RGCs that project ipsilaterally at metamorphosis expresses Zic2 mRNA (Herrera et 
al., 2003). Herrera et al. also showed that Zic2 is only expressed by uncrossed RGCs 
using dextran backlabeling from one optic tract combined with Zic2 
immunohistochemistry at E16.5. Moreover, loss- and gain-of function in vitro
experiments by the same authors further supported a role for Zic2 as an ipsilateral 
determinant acting primarily in the retina.  
4.2.4. Hypotheses. 
Given that Zic2 is expressed by VT ipsilateral RGCs and Foxg1 null embryos display 
an increase in the numbers of ipsilateral RGCs, it is possible that there are greater 
numbers of Zic2-positive RGCs in Foxg1
-/-
 retinas compared to those of wild types. 
Zic2 is also expressed in the developing ventral diencephalon from which the optic 
chiasm forms (Brown et al., 2003). Although all the evidence to date suggests that Zic2 
expression in the retina primarily controls the size of the ipsilateral projection, it cannot 
be excluded that Zic2 expression at the optic chiasm also plays a role in retinal axon 
guidance. In this chapter, Zic2 expression was explored in the retina and optic chiasm 
of Foxg1 null embryos using a Zic2-specific antibody and compared to age-matched 
wild type embryos to test the following hypotheses: -  
Hypothesis 1: Numbers of Zic2-expressing cells increase in the Foxg1
-/- 
retina in 
proportion to the increased ipsilateral projection.  






All experiments were carried out using embryos from Foxg1
LacZ
 (CBA) matings. Noon 
on the day the plug was found was considered E0.5. Embryos for Zic2 & Brn3a double 
fluorescence immunohistochemistry: pregnant females were sacrificed 13, 14, 15 and 
16 days after the plug date. E13.5 – E16.5 embryos were fixed in 4% PFA in PBS for 2 
hours, cryoprotected by immersion in 30% sucrose in PBS overnight, embedded in 
OCT compound, frozen on dry ice and stored at -80°C prior to sectioning on a Leica 
cryostat. Embryos for Brn3a immunohistochemistry on wax sections: pregnant females 
were sacrificed 14 or 16 days after the plug date giving E14.5 or E16.5 embryos. The 
decapitated heads were fixed in 4% PFA in PBS overnight, rinsed in 1XPBS and 
immersed in 50% ethanol prior to wax processing. After processing, heads were 
embedded horizontally in wax and sectioned into serial 10µm-thick sections on a 
microtome. Sections were mounted onto poly-l-lysine slides and dried overnight at 
37ºC prior to Brn3a immunohistochemistry.  
4.3.2. PCR genotyping. 
Heterozygous embryos (Foxg1
+/–
) were indistinguishable morphologically from wild 
type embryos (Xuan et al., 1995; Huh et al., 1999) and identified by PCR using specific 
primers that detected the Foxg1
lacZ
allele: LacZ F2 5’-TTG AAC TGC CTG AAC TAC 
CG-3’ and LacZ R2 5’-CCT GAC TGG CGG TTA AAT TG-3’. Only wild type 
embryos were used for quantitation purposes even though there appeared to be no 
difference in Zic2 or Brn3a expression between Foxg1
+/–
 and wild type embryos. Wild 
type (Foxg1
+/+
) embryos were identified by the absence of a PCR product using the 
Foxg1
lacZ
allele-specific primers and used in all experiments. PCR cycling conditions 
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were 96°C for 2 minutes followed by [96°C for 30 seconds, 58.5°C for 30 seconds and 
72°C for 30 seconds] for 35 cycles.  
4.3.3. Zic2 DAB immunohistochemistry. 
Zic2 immunohistochemistry was performed on 10µm-thick serially-collected cryostat 
sections cut horizontally through the eyes of E13.5 – E16.5 embryos using a rabbit 
monoclonal Zic2 antibody kindly donated by Stephen Brown, Columbia University, 
New York, at a concentration of 1 in 8000. The protocol used was identical to that for 
Zic2 and Brn3a double immunohistochemistry except that DAB was used to reveal the 
Zic2 primary antibody using a rabbit DAKO-EnVision+ Kit (Dako K4010). Slides 
were dehydrated through an ascending alcohol series (70% - 100%), immersed in two 
changes of xylene for 15 minutes each and mounted in DPX.  
4.3.4. Brn3a DAB immunohistochemistry. 
Brn3a immunohistochemistry was performed on 10µm-thick serial wax sections cut on 
a microtome. Sections were dewaxed by immersion in xylene and rehydrated through a 
descending series of ethanols from 100% to 70% and finally double distilled water. 
Endogenous peroxidase activity was blocked using a 9:1 ratio of methanol:30% 
hydrogen peroxide for 5 minutes. Antigens were retrieved by microwaving at medium-
high in 10mM sodium citrate buffer pH5.5 in two 5 minute bursts replacing 
evaporation losses inbetween. Slides were rinsed 3 times in double distilled water and 
blocked for 1 hour at room temperature in 5% goat serum, 0.2% BSA, 0.1% TritonX-
100 in PBS. A primary mouse monoclonal antibody for Brn3a (1 in 150) was applied 
for 1 hour at room temperature. Slides were rinsed in 1xPBS and a mouse DAKO-
EnVision+ Kit was used to reveal the antibody staining using DAB. Following a 
sufficient DAB development time, slides were dehydrated through an ascending 
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alcohol series (70% - 100%), immersed in two changes of xylene for 15 minutes each 
and mounted in DPX.  
4.3.5. Zic2 & Brn3a double immunohistochemistry at E14.5. 
Zic2 and Brn3a double immunohistochemistry was carried out on 10µm-thick serially-
collected cryostat sections cut horizontally through the eyes of E14.5 mouse embryos. 
Slides were thawed thoroughly at room temperature prior to fixing in ice-cold acetone 
for 10 minutes. Slides were rinsed in 3 changes of 1xPBS for 5 minutes each and 
endogenous peroxidase activity was blocked using 0.1% hydrogen peroxide in 1xPBS 
for 5 minutes. Antigens were retrieved by microwaving twice in 10mM sodium citrate 
buffer pH5.5 for 5 minutes each on ‘medium’. Slides were rinsed in double distilled 
water and then blocked for 1 hour at room temperature in 5% goat serum, 0.2% BSA, 
0.1% TritonX-100 in PBS. Primary antibodies: a mixture of rabbit monoclonal Zic2 
antibody (1 in 8000) (Stephen Brown, Columbia University, New York) and mouse 
monoclonal Brn3a antibody (1 in 300) (Chemicon International) diluted in blocking 
solution was pipetted onto each section, covered in parafilm and left to incubate in a 
dark humidified chamber overnight at 4ºC and then for 30 minutes at room 
temperature. Slides were rinsed 3 times in 1xPBS for 5 minutes each. A mixture of 
secondary antibodies goat anti-rabbit IgG (H & L) AlexaFluor 488 and goat anti-mouse 
IgG (H & L) AlexaFluor 546 was applied to the sections at a concentration of 1 in 150 
each and incubated for 1 hour in a dark humidified chamber at room temperature. 
Slides were rinsed 3 times in 1xPBS and counter-stained using TO-PRO-3 (1 in 2000). 
Slides were rinsed several times in 1xPBS, followed by a double distilled water wash 
prior to mounting in mowiol (Calbiochem).  
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4.3.6. Imaging and quantification. 
Fluorescent images were obtained using a Leica confocal microscope. High power x40 
magnification images were obtained in the red (Brn3a), green (Zic2) and blue (TO-
PRO-3) channels. Montages were assembled and for each eye, the numbers of Zic2- 
and Brn3a-positive cells were counted in six evenly-spaced sections from most dorsal 
to most ventral. This was done by selecting the dorsal-most and ventral-most sections 
in which Brn3a-positive cells were visible. The intervening four sections were then 
chosen by dividing up the length between the dorsal- and ventral-most sections equally. 
Zic2 and Brn3a-expressing cells were counted in both wild type and Foxg1 null retinas 
and summed to obtain means. Nasal and temporal counts were kept separate. For Zic2 
DAB immunohistochemistry, images were obtained using a Leica microscope and 
Zic2-positive cells counted in six evenly-spaced sections from most dorsal to most 
ventral. Nasal and temporal counts were kept separate.  
4.3.7. Dextran backlabeling. 
CBA females were mated with CBA males to obtain wild type embryos. Embryos were 
taken at E14.5, decapitated and the heads removed into ice-cold oxygenated EBSS in a 
Sylgard-coated dish. Under a dissecting microscope the lower jaw was removed. The 
head was turned upside down and one optic tract exposed. The tract was cut using 
microscissors and EBSS was removed from the dish. Filter paper was used to dry the 
cut optic tract as thoroughly as possible before inserting a pinch of dextran-rhodamine 
3000 MW (Molecular Probes D3308) into the cut. The heads were placed into room-
temperature oxygenated EBSS. The solution was bubbled gently for 3 hours at room 
temperature after which the heads were transferred to fresh, cold oxygenated EBSS. 
The embryos were stored covered overnight at 4ºC. The next day, heads were 
transferred to 4%PFA and fixed for 24 hours. The PFA was removed and 1xPBS 
added. Ipsilateral and contralateral retinas were dissected after making a ventral 
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orientating cut and the pigmented epithelium removed. 3 additional cuts were made 
from the periphery of the retina and each retina was flattened with the neural retina 
facing upwards on the slide. Zic2 immunohistochemistry was then performed as for 
cryostat sections and revealed using the goat anti-rabbit IgG (H & L) AlexaFluor 488. 
Retinas were cover-slipped using mowiol.  
4.4. RESULTS 
4.4.1. Zic2 is ectopically expressed in the nasal retina of Foxg1-/- embryos 
throughout the period when RGC axons navigate the optic chiasm. 
Initially, Zic2 protein expression was investigated in the retinas of wild type and Foxg1
heterozygous embryos (collectively called ‘Foxg1
+/±
’ in Figure 1) and Foxg1 null 
embryos from E13.5 to E16.5. These embryonic ages were chosen because they 
correspond with the time when RGC axons navigate the optic chiasm. The Zic2 
antibody used in all immunohistochemistry experiments was identical to that used by 
Brown et al. (2003). DAB immunohistochemistry confirmed previous findings (Herrera 
et al., 2003) that Zic2 protein is found in the peripheral VT region of the neural retina 
from E14.5 in wild type and Foxg1 heterozygous embryos (Figure 1). The appearance 
of Zic2-expressing cells in the retina at E14.5 corresponds with the generation of the 
first permanent ipsilaterally-projecting RGCs from VT retina. Prior to this at E13.5, no 
clusters of Zic2-expressing cells were seen in the VT retina and Zic2-positive cells 
were mainly confined to the CMZ with some cells scattered throughout the retina 
(Figure 1A, B). At E15.5 and E16.5, the cluster of cells expressing Zic2 in peripheral 
VT retina became larger relative to the size of the retina, corresponding to more axons 
projecting ipsilaterally from this region (Figure 1I, M). In wild type and Foxg1
heterozygous retinas from E13.5 to E16.5, no clusters of Zic2 expression were visible 
in dorsal regions of the retina.  
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Figure 1. Zic2 is ectopically expressed in the nasal retina of 
Foxg1-/- embryos throughout the period when RGC axons project 
and persists in ventrotemporal retina. (A – S) Zic2 
immunohistochemistry revealed using DAB staining at E13.5 (A – D), E14.5 









 retinas. All sections are 10µm 
cryostat sections cut in the horizontal plane with nasal pointing upwards. Zic2 
is expressed in the ciliary marginal zone (CMZ) at all ages. Black dotted lines 
show the border between the CMZ and the neural retina and black arrows 
show the locations of Zic2-expressing cells. (A, B) In E13.5 Foxg1
+/±
 retinas, 
Zic2-positive cells are scattered in all retinal layers but large clusters of cells 
are not seen outside the CMZ. (C) In Foxg1
-/-
 ventral retina, strong Zic2 
expression is seen in the temporal retina adjacent to the CMZ. (D) In dorsal 
Foxg1
-/-
 retina, strong Zic2 expression is seen in cells of the nasal retina. (E, I, 
M) In E14.5 – E16.5 Foxg1
+/±
 ventral retinas, a cluster of Zic2-positive cells 
is visible in the inner ventrotemporal retinal layer adjacent to the CMZ. (F, J, 
N) In E14.5 – E16.5 Foxg1
+/±
 dorsal retinas, Zic2-expressing cells are found 
scattered in all retinal layers but there are no clusters of Zic2-expressing cells. 
(G, K) Ventral sections of E14.5 & E15.5 Foxg1
-/-
 retinas show a cluster of 
Zic2-positive cells in temporal retina only near the CMZ. (O) In ventral E16.5
Foxg1
-/-
 retinas, Zic2-expressing cells are scattered and less densely packed in 
temporal retina. Zic2-positive cells are also found in nasal retina (arrow-
head). (H, L, D) Dorsal sections of E14.5 – E16.5 Foxg1
-/-
 retinas show 
ectopic Zic2 expression in the nasal retina. (Q) High power magnification of 
the Foxg1
+/±
 temporal retina of (M) showing a cluster of Zic2-positive cells. 
(R, S, T) High power magnifications of Foxg1
-/-
 peripheral temporal retina in 
(O) and peripheral nasal and temporal retina in (P). Arrows point to regions of 
Zic2-expressing RGCs. (O) Scattered Zic2-expression (arrows point to a few 
Zic2-positive cells). (S) Cluster of Zic2-expressing cells in the nasal retina. 
(T) Clusters of Zic2-expressing cells are absent in temporal retina. 
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Figure 1. Developmental series of Zic2 expression 
in the retina from E13.5 - E16.5
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The most notable finding in Foxg1 null dorsal sections from E13.5 to E16.5 was a 
cluster of Zic2-positive cells in the nasal peripheral retina. Zic2-expressing clusters 
were never observed in the nasal half of wild type or Foxg1 heterozygous retinas, apart 
from small clusters of approximately a dozen or so Zic2-positive cells at E16.5 (Figure 
1M). In Foxg1
-/-
 retinas, this Zic2-expressing dorsonasal cluster became wider along 
the lateral-medial axis with increasing age, extending further into the extended retina 
(arrows in Figure 1P). In contrast to Foxg1-expressing retinas, Zic2 expression was 
observed one day earlier at E13.5 in temporal and nasal regions of Foxg1
-/-
 retinas in 
addition to the CMZ (Figure 1C, D). In ventral sections in E13.5 to E15.5 Foxg1
-/-
retinas, Zic2 expression was observed in peripheral VT retina adjacent to the strongly-
expressing CMZ as in Foxg1-expressing retinas. In E16.5 Foxg1
-/-
 retinas, Zic2 
expression was still present in the VT region but Zic2-expressing cells were more 
scattered laterally within the RGC layer in contrast to the tight clusters seen at earlier 
ages (arrows in Figures 1O, R). In addition, in ventral sections of E16.5 Foxg1
-/-
retinas, some Zic2-expressing cells were consistently observed in peripheral nasal 
retina (arrowhead in Figure 1O).  
4.4.2. Qualitative analysis of Zic2 and Brn3a double fluorescence 
immunohistochemistry. 
In order to investigate this Zic2-expressing cluster of cells in nasal Foxg1
-/-
 retina in 
greater detail and to quantify the numbers of Zic2-positive cells in retinas that express 
Foxg1 compared to Foxg1 null retinas, double immuhistochemistry for Zic2 and Brn3a, 
a marker of postmitotic RGCs, was performed on serial sections at E14.5. Although 
E14.5 is not the age of maximal Zic2 expression, which peaks around E15.5 to E16.5, 
the shape of the Foxg1
-/-
 eye is not as distorted by extensive folding at this age, 
facilitating identification of the nasal-temporal axis.  
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4.4.2.1. Zic2 expression in E14.5 wild type retinas.  
Ventral sections of wild type retinas showed a cluster of strongly Zic2-expressing cells 
in peripheral temporal retina adjacent to the Zic2-positive CMZ (Figures 2E, 2F, 5A - 
D). Temporally-located Zic2-expressing clusters of cells were also seen in the central 
retina around the level of the optic stalk (Figures 2C, 2D) and in sections just ventral to 
the optic stalk (Figures 4A - D). In all cases these clusters were located adjacent to the 
CMZ that expressed Zic2 consistent with previous reports (Nagai et al., 1997). In 
addition to the Zic2-positive clusters, scattered Zic2-expressing cells were found in the 
outer neuroblastic layer and more sparsely in the Brn3a-expressing RGC layer (Figures 
4A, 4B, 5A, 5B). Zic2-expressing clusters were absent from dorsal sections of the wild 
type retina (Figures 2A, 2B, 3A - F). However, scattered Zic2-positive cells were 
observed throughout all layers of the dorsal retina with stronger expression in the outer 
neuroblastic layer (Figures 3A, B). Brn3a-labelled cells were found in the inner RGC 
layer of the retina. The clusters of Zic2-positive cells were located peripheral to the 
Brn3a-expressing RGCs and the majority failed to co-label.  
4.4.2.2. Zic2 expression in E14.5 Foxg1-/- retinas. 
In Foxg1
-/-
 retinas, dorsal sections consistently showed a conspicuous cluster of Zic2-
expressing cells in peripheral nasal retina adjacent to the CMZ (Figures 6A, 6B, 8A, 
8E). In extremely dorsal sections, there was no obvious difference in the distribution of 
Zic2-positive cells, which were scattered sparsely among the nasal and temporal retina 
with strong expression in the CMZ (Figure 7A - F). The Zic2-expressing cluster of 
cells in nasal retina was also present in ventral sections of Foxg1
-/-
 retinas (Figures 6D 
& E, 9A & E, 10A, B, E, F). The nasal Zic2-expressing cluster extended medially 
towards the midline into the extended retina (Figures 9A & E, 10A & E).  
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Figure 2. Dorsal to ventral series of Zic2 expression through an 
E14.5 wild type retina. Zic2 (green) and Brn3a (red) fluorescence 
immunohistochemistry in 10µm-thick sections of E14.5 wild type eyes from 
dorsal (A) to ventral (F). All sections are cut in the horizontal plane. 
Schematic diagrams above each image represent the eye as a sphere and 
indicate the dorsal-ventral position of the plane of section. Zic2 expressing 
cells are found predominantly in the ventro-temporal part of the retina. (A, B) 
Dorsally, no clusters of Zic2-expressing cells are present outside the CMZ. (C 
- F) In dorso-central to ventral sections, a cluster of Zic2-expressing cells is 
present in the temporal retina adjacent to the Zic2-positive CMZ. In all 
sections the RGC layer and outer layers contain scattered Zic2-positive cells 
throughout the retina. Abbreviations: A is anterior, P is posterior, N is nasal, 
T is temporal, D is dorsal, V is ventral. Scale bars: all 200µm.  
Figure 2. Dorsal to ventral series of Zic2 expression in 



























































Figure 3. Cells expressing Zic2 are scattered sparsely throughout 
the dorsal retina of E14.5 wild type embryos. (A-F) Zic2 (green) and 
Brn3a (red) fluorescence immunohistochemistry in dorsal sections of E14.5 
wild type eyes. All sections are cut in the horizontal plane. Schematic 
diagrams above each image represent the eye as a sphere and indicate the 
dorsal-ventral position of the plane of section. (C, E) and (D, F) High power 
magnifications of temporal and nasal retina nearest the CMZ from (A) and 
(B). (A) Dorsal section showing strong Zic2 expression in the CMZ in nasal 
and temporal retina. The CMZ borders are delineated by a white line. (C, E) 
Zic2-expressing cells are scattered around the whole retina and only a few are 
present within the Brn3a-expressing domain (some examples are indicated by 
white arrows). (B) Section ventral to (A) showing strong Zic2 expression in 
the CMZ. (D, F) Only a few Zic2-positive cells are found in the Brn3a-
expressing RGC layer (white arrows). One double-labelled cell is visible in 
(D) (white arrow-head) but otherwise there is no double-labelling. 
Abbreviations: A is anterior, P is posterior, N is nasal, T is temporal, D is 
dorsal, V is ventral, CMZ is the ciliary marginal zone. Scale bars: A, B = 







Figure 3. Zic2 expression in dorsal sections of E14.5 














































Figure 4. Zic2 expression is concentrated in the ventrocentral 
retina adjacent to the CMZ in the wild type. (A – F) Zic2 and Brn3a 
fluorescence immunohistochemistry in ventrocentral sections of E14.5 wild 
type eyes. (A, B) Sections just ventral to the central retina, although B is 
slightly more ventral than A. (A, B) Zic2-expressing cells are present in the 
temporal retina adjacent to the CMZ that expresses Zic2. (C, D) High power 
magnifications of the Zic2-positive cells in temporal retinas shown in (A) and 
(B). Yellow double-labelled cells that express both Zic2 and Brn3a are visible 
(white arrows indicate some examples). However, the majority of Zic2-
positive cells do not express Brn3a. (E, F) High power magnifications of the 
nasal retinas of (A) and (B) showing only weak scattered Zic2 expression. 
Abbreviations: A is anterior, P is posterior, N is nasal, T is temporal, D is 
dorsal, V is ventral, CMZ is the ciliary marginal zone. Scale bars: A, B = 




Figure 4. Zic2 expression in ventrocentral E14.5 













































Figure 5. Zic2 is expressed in the ventrotemporal retina of E14.5 
wild type embryos. (A-F) Zic2 and Brn3a fluorescence 
immunohistochemistry in ventral sections of E14.5 wild type eyes. (A) 
Ventral section showing a cluster of Zic2-expressing cells in temporal retina 
(white arrow). (B) Section ventral to (A) showing strong Zic2 expression in 
temporal retinal cells but weaker, scattered Zic2-positive cells in nasal retina. 
(C, E) and (D, F) High power magnifications of (A) and (B) respectively 
showing that Zic2 expression is predominantly found in temporal retina where 
a few double-labelled cells are found (white arrows indicate some examples). 
(E, F) Zic2 is expressed more weakly in fewer cells in nasal retina. 
Abbreviations: A is anterior, P is posterior, N is nasal, T is temporal, D is 
dorsal, V is ventral, CMZ is the ciliary marginal zone. Scale bars: A, B = 
200µm, C - F = 100µm.  
Figure 5. Zic2 expression in the ventrotemporal retina of 














































Figure 6. Dorsal to ventral series of Zic2 expression through the 
retina of an E14.5 Foxg1-/- embryo. Zic2 is expressed in ventrotemporal 
retina and also ectopically in nasal retina in E14.5 Foxg1
-/-
 embryos. (A - F)
Zic2 and Brn3a fluorescence immunohistochemistry in E14.5 Foxg1
-/-
eyes 
from dorsal (A) to ventral (F). In dorsal (A – C) and some ventral sections (D, 
E), Zic2-expressing cells are present in the nasal retina adjacent to the Zic2-
positive CMZ and medially in the extended retina. (E, F) Ventrally, Zic2-
positive cells cluster next to the CMZ in temporal retina. The RGC layer and 
outer layers contain scattered Zic2-positive cells throughout the entire retina. 
In dorsal and ventral sections the CMZ expresses Zic2 strongly. 
Abbreviations: er = extended retina, A is anterior, P is posterior, N is nasal, T 
































































Figure 7. In extremely dorsal sections of E14.5 Foxg1-/- retina, 
Zic2 is expressed in cells scattered over the entire retina. Zic2 and 
Brn3a fluorescence immunohistochemistry in dorsal sections of E14.5 Foxg1
-
/-
 eyes. (A, B) Dorsally, Zic2 is expressed in the CMZ in peripheral nasal and 
temporal retina. (A) Dorsal section showing strong Zic2 expression in cells of 
the ciliary marginal zone. A white line indicates the boundary between the 
ciliary marginal zone and neural retina. Zic2 is expressed equally in nasal and 
temporal retina. Only a few Brn3a-positive cells are visible as the section is at 
the dorsal boundary of the RGC layer. (B) Section ventral to (A) showing 
RGCs expressing Zic2 and Brn3a equally in nasal and temporal retina. (C, E) 
and (D, F) High power magnifications of the temporal and nasal retina from 
(A) and (B) respectively. Abbreviations: A is anterior, P is posterior, N is 
nasal, T is temporal, D is dorsal, V is ventral, CMZ is the ciliary marginal 















































Figure 7. Zic2 expression in E14.5 Foxg1-/- dorsal retina 
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Figure 8. In dorsal sections of E14.5 Foxg1-/- retina, Zic2 protein is 
ectopically expressed in the nasal retina. (A - F) Zic2 and Brn3a 
fluorescence immunohistochemistry in dorsal sections of E14.5 Foxg1
-/-
 eyes. 
In all dorsal sections, Zic2 is expressed in the CMZ in peripheral nasal and 
temporal retina. (A, B) Dorsal sections showing a cluster of Zic2-expressing 
cells in nasal but not temporal retina. (B) is ventral to (A). (C, E) and (D, F) 
High power magnifications of the temporal and nasal retina from (A) and (B) 
showing ectopic Zic2 expression in nasal retina. Some double-labeled cells 
(yellow) are visible in (E) & (F). Some examples are indicated using white 
arrows. Abbreviations: er is the extended retina, A is anterior, P is posterior, 
N is nasal, T is temporal, D is dorsal, V is ventral, CMZ is the ciliary 
















































Figure 8. Zic2 expression in E14.5 Foxg1-/- dorsal retina 
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Figure 9. In ventral sections, Zic2 protein is ectopically expressed 
in the nasal retina of E14.5 Foxg1-/- embryos but is still present in 
temporal retina. (A - F) Zic2 and Brn3a fluorescence 
immunohistochemistry in ventral sections of E14.5 Foxg1
-/-
 eyes. In all 
ventral sections, Zic2 is expressed in the CMZ. (A) Ventral section showing 
Zic2 expression predominantly in nasal retina extending medially into the 
extended retina. (C, E) High power magnifications of the temporal and nasal 
retina from (A) showing that Zic2-positive cells are more numerous in the 
nasal retina. (B) Section ventral to (A) showing Zic2 in temporal retina. (D, F) 
High power magnifications of temporal and nasal retina from (B) showing 
that there are Zic2-positive cells in temporal and nasal retina.  Abbreviations: 
er = extended retina, N is nasal, T is temporal, D is dorsal, V is ventral. Scale 



















































Figure 10. In ventral sections, Zic2 is ectopically expressed in the 
nasal retina of E14.5 Foxg1-/- embryos but is still present in 
temporal retina. (A - F) Zic2 and Brn3a immunohistochemistry in ventral 
sections of E14.5 Foxg1
-/-
 eyes. In all ventral sections, Zic2 is expressed in 
the CMZ. (C, E) and (D, F) High power magnifications of the nasal and 
temporal retina nearest the CMZ in (A) and (B) respectively. (A) Section just 
ventral to the central retina. Zic2 is expressed in nasal retina including the 
extended retina. Expression is not as strong in temporal retina. (B) Section 
ventral to (A) showing the Foxg1
-/-
 optic stalk. (D, F) Zic2-expressing cells 
are present in temporal retina as in wild type embryos but also ectopically in 
nasal retina. (D) White arrow points to one of a few double-labelled cells. 
Abbreviations: er is the extended retina, os indicates the Foxg1
-/-
 correlate of 
the optic stalk, A is anterior, P is posterior, N is nasal, T is temporal, D is 





















































In extremely ventral sections, Foxg1
-/-
 retinas displayed a Zic2-positive cluster in 
peripheral VT retina adjacent to the CMZ as in wild type retinas (Figures 9B & D, 10B 
& D). In all Foxg1
-/-
 retinas examined, the CMZ expressed Zic2 as in the wild types. 
Scattered Zic2 expression was also visible throughout the rest of the retina, with 
stronger expression in the outer neuroblastic layer.  
4.4.3. The number of Zic2-expressing cells is increased in the Foxg1-/-
retina.
In order to quantify and compare the numbers of Zic2-positive cells in the wild type 
and Foxg1 null retinas shown in Figures 2 - 10, the retinas were divided into six 
equally-spaced sections from dorsal to ventral (Figure 11A) and the numbers of Zic2-
expressing cells counted and summed (Figure 11B). Numbers of Brn3a-expressing 
cells were counted in the same sections to provide a count of the numbers of RGCs. 
The nasal retina of Foxg1
-/-
 embryos had a significantly greater number of Zic2-
positive cells compared to wild type nasal retina (Figure 11B). However, there was no 
difference in the number of Zic2-expressing cells between Foxg1
-/-
 and wild type 
temporal retinas. In the wild type, the temporal retina had significantly more Zic2-
positive cells compared to the nasal retina as expected from previous studies. In order 
to control for differences in numbers of RGCs in each section that may have 
contributed to variation in the absolute Zic2 counts, the numbers of Zic2-positive cells 
were expressed as proportions of the numbers of Brn3a-expressing RGCs in each 
section. This produced the same trends as the absolute Zic2 counts, although the 
standard errors were reduced (Figure 11C). In Foxg1
-/-
 embryos, the number and 
proportion of Zic2-positive cells in the nasal retina was greater than in the temporal 
retina. However, a significant difference was only found when Zic2-expressing cells 
were expressed as proportions of Brn3a-positive RGCs (Figures 11C, E).  
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Figure 11. Zic2-expressing cells are more numerous in E14.5 
Foxg1-/- nasal retina compared to wild type retina. (A) Quantification 
method for fluorescence immunohistochemistry at E14.5. For each retina, 
numbers of Zic2- & Brn3a-positive cells were counted in 6 cryosections 
spaced at 80 – 100µm intervals through the retina from D (blue horizontal 
lines) to V (green horizontal lines). Counts for nasal and temporal retina were 
kept separate. Zic2 counts plotted in subsequent graphs are means for 4 
(Foxg1
+/+
) or 3 (Foxg1
-/-
) retinas from different embryos. (B) There are 
significantly more Zic2-positive cells in Foxg1
-/-
nasal retina compared to 
wild type nasal retina. In wild type embryos, the temporal retina contains 
significantly more Zic2-positive cells than nasal retina. (C) The number of 
Zic2-positive cells expressed as a proportion of RGCs (Brn3a-positive cells) 
is significantly greater in Foxg1
-/-
nasal retina compared to both Foxg1
-/-
temporal retina and wild type nasal retina. The proportion of Zic2-positive 
RGCs is significantly greater in Foxg1
-/-
nasal retina than Foxg1
-/-
temporal 
retina. Means are counts of Zic2-positive cells in evenly-spaced sections from 
dorsal to ventral retina expressed as a percentage of the number of Brn3a-
positive cells. (D, E, G) T-test comparisons for graphs (B, C, F). Statistically 
significant differences are highlighted in yellow. (F) The number of Zic2-
positive cells expressed as a proportion of RGCs for the four retinal 
quadrants. The proportions of Zic2-expressing cells are significantly greater 
in Foxg1
-/-
DN and VN retinal quadrants. Abbreviations: N is nasal, T is 
temporal, DN is dorsonasal, VN is ventronasal, DT is dorsotemporal, VT is 
ventrotemporal, Foxg1
+/+ 
is wild type retina, Foxg1
-/-
 is Foxg1 null retina, 
Zic2+ve indicates Zic2-expressing cells, Brn3a+ve indicates Brn3a-










































































































Figure 11. Quantification of Zic2-positive cells at E14.5 
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The same data was divided into the four retinal quadrants: dorsonasal, dorsotemporal, 
ventronasal and ventrotemporal in order to investigate whether the increase in Zic2-
labelled cells originated equally from the dorsal and ventral part of the nasal retina 
(Figure 11F). In Foxg1
-/-
 embryos, the DN and VN retinal quadrants showed a 
significant increase in the number of Zic2-positive cells relative to equivalent wild type 
quadrants showing that increased Zic2 expression occurs in both the dorsal and ventral 
parts of the nasal retina (Figure 11G). None of the other retinal quadrants showed 
differences in the number of Zic2-positive cells. In wild type embryos, VT retina 
possessed the greatest number of Zic2-positive cells confirming previous studies and 
consistent with the role of Zic2 as an ipsilateral determinant. There were fewer Zic2-
positive cells in the VT Foxg1
-/-
 retina compared to wild type VT retina but this 
difference was not statistically significant.  
4.4.4. Quantification of DAB immunohistochemistry. 
Numbers of Zic2-positive cells were counted in the same way at E16.5 (Figures 12C, 
D) and also at E14.5 (Figures 12A, B) using DAB immunohistochemistry. Zic2 counts 
are shown as absolute numbers of Zic2-positive cells in six sections through the retina. 
These data are not expressed as proportions since the numbers of Brn3a-expressing 
cells were not counted in the same eyes used for the Zic2 counts, which would have 
produced variation. At E14.5, there are significantly greater numbers of Zic2-positive 
cells in nasal Foxg1
-/-
 retina compared to nasal wild type retina (Figure 12A, E). In 
contrast, comparisons of the temporal retina revealed significantly fewer Zic2-
expressing cells in Foxg1
-/-
 embryos compared to wild types. Dividing the retina into 
quadrants revealed statistically significant differences in VN, DT and VT quadrants 
between wild type and Foxg1
-/-
 embryos (Figure 12B, F). In VN and DT quadrants, 
Foxg1
-/-
 retinas had greater numbers of Zic2-positive cells than equivalent wild type 
retinal quadrants, whereas comparisons of VT retina revealed fewer Zic2-expressing  
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Figure 12. Numbers of Zic2-expressing cells are greater in E14.5 
and E16.5 Foxg1-/- nasal retina compared to wild type retina.
Graphs show means of numbers of Zic2-positive cells in evenly spaced 
sections through E14.5 and E16.5 wild type and Foxg1
-/-
 retinas processed for 
Zic2 immunohistochemistry and revealed using DAB staining. The 
quantification method used was identical to that shown in Figure 11A. (B, D) 
Data in (A) and (D) shown divided into retinal quadrants. (A - D) Numbers of 
Zic2-positive cells in wild type and Foxg1
-/-
 retinas at E14.5 (A, B) and E16.5 
(C, D). Significant pairwise differences are marked with an asterisk. (A, C) At 
E14.5 and E16.5, the number of Zic2-positive cells is significantly greater in 
the nasal retina of Foxg1
-/-
 embryos compared to wild type embryos. (E, F) T-
tests between wild type and Foxg1
-/-
 retinas for nasal and temporal retina (E) 
or retinal quadrants (F). Significant differences are highlighted in yellow. 
Abbreviations: N is nasal, T is temporal, DN is dorsonasal, VN is ventronasal, 
DT is dorsotemporal, VT is ventrotemporal, Foxg1
+/+ 
is wild type retina, 
Foxg1
-/-
 is Foxg1 null retina, Zic2+ve indicates Zic2-expressing cells, error 
bars show SEM. 
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Figure 12. Numbers of cells expressing Zic2 in E14.5 & E16.5 















































































































cells in the Foxg1
-/-
 retina. Although DN Foxg1
-/-
 retinal quadrants had greater numbers 
of Zic2-positive cells than equivalent wild type retinal quadrants, the difference was 
not significant. However, the standard error is very large for the DN Foxg1
-/-
 Zic2 
mean, which could have contributed to the insignificant p-value. Although the temporal 
retina shows differences that are not seen in the double fluorescence counts, the trend 
for each of the retinal quadrants and the nasal retina is the same for both DAB and 
fluorescence.  
Quantification of Zic2 expression at E16.5 using DAB immunohistochemistry revealed 
the same results for the nasal retina at E14.5: significantly greater numbers of Zic2-
positive cells were present in nasal Foxg1
-/-
 retina compared to nasal wild type retina 
(Figure 12C). However, no difference was found between wild type and Foxg1
-/-
temporal retina. In Foxg1
-/-
 embryos, both DN and VN retinal quadrants had 
significantly greater numbers of Zic2-positive cells (Figure 12D). The DT Foxg1
-/-
retina also showed a significant increase in Zic2-expressing cells compared to DT wild 
type retina. No difference in the numbers of Zic2-expressing cells was found in the VT 
retina at this age. Regardless of slight differences between the retinal quadrants that 
mainly affected temporal retina, all the data presented here reveal an increase in Zic2-
expressing cells in the nasal retina of Foxg1 null embryos at E14.5 and E16.5.  
4.4.5. The number of RGCs does not differ between Foxg1-/- and wild type 
retina at E14.5 or E16.5. 
In order to eliminate the possibility that the increased number of Zic2-expressing cells 
in the Foxg1
-/-
 nasal retina was simply due to an increased number of RGCs, the 
numbers of postmitotic RGCs, identified using a Brn3a antibody, were counted in the 
same six sections through the retina used for quantifying Zic2 expression (Figure 13A, 
B).  
Numbers of Brn3a-positive RGCs in the retina of wild type and









































































































ANOVA P = 0.655
E14.5 E14.5
Figure 13. Numbers of Brn3a-expressing RGCs do not vary between 
wild type and Foxg1-/- retinas. All graphs show means of total numbers of Brn3a-
positive cells in six evenly-spaced sections through a wild type or Foxg1-/- retina at E14.5 
(A, B) and E16.5 (C, D). E14.5 counts are from Brn3a fluorescent immunohistochemistry 
and E16.5 counts are from DAB-revealed Brn3a immunohistochemistry. (E, F) T-test 
comparisons between Foxg1+/+ and Foxg1-/- retina at E16.5. (A, C, E) Numbers of Brn3a-
positive cells do not vary between Foxg1+/+ and Foxg1-/- nasal and temporal retina. (A, B) 
At E14.5, one-way ANOVAs returned non-significant p-values. (B, D) Data in (A) and (C) 
split into retinal quadrants. (E, F) At E16.5, t-tests failed to produce significant differences. 
Abbreviations: N is nasal, T is temporal, DN is dorsonasal, VN is ventronasal, DT is 
dorsotemporal, VT is ventrotemporal, Foxg1+/+ is wild type retina and Foxg1-/- is Foxg1
null retina.


































Although the Brn3a counts were more variable in Foxg1 null retinas, the numbers of 
Brn3a-labelled cells between E14.5 wild type and Foxg1
-/-
 retinas did not vary 
significantly. Similarly at E16.5, no significant differences were discovered between 
wild type and Foxg1
-/-
 retinas (Figure 13 C, D). Therefore, an increase in the numbers 
of RGCs cannot account for the difference in Zic2 expression between wild type and 
Foxg1
-/-
 nasal retinas. This is consistent with the finding that similar conclusions were 
drawn from the graphs showing Zic2-expressing cells as absolute counts or proportions 
(Figures 11B, C). Moreover, the numbers of Brn3a-positive cells did not differ between 
the nasal and temporal retina within either wild type or Foxg1 null embryos confirming 
that the nasal-temporal axis imposed for the counts was valid. 
4.4.6. Zic2 is expressed at the optic chiasm of wild type and Foxg1-/-
embryos. 
Zic2 is also expressed at the optic chiasm of E13.5 – E16.5 wild type and Foxg1
-/-
embryos throughout the period when RGC axons project (Figure 14). In wild type and 
Foxg1
-/-
 retinas, Zic2 expression was strongest in lateral regions around the optic recess 
with a decreasing gradient towards the midline. The distorted shape of the Foxg1
-/-
chiasm hindered a straightforward comparison with chiasms from wild type embryos in 
the absence of quantitation using a method such as qRT PCR or counts of Zic2-
expressing cells. Nevertheless, Chapter 6 of this thesis shows that many molecular and 
anatomical features of the chiasm region are preserved in Foxg1 null embryos. In 
support of this, the Zic2 expression pattern at the Foxg1
-/-
 chiasm shares certain 
features with that of wild type embryos, such as stronger lateral expression and a 
boundary between anterior Zic2-expressing and posterior Zic2-negative regions of the 
ventral hypothalamus. This anterior-posterior divide in Zic2 expression was examined 
further using Islet-1, which is expressed only in the most posterior chiasm regions, as 
well as in a few cells at the optic chiasm midline (Herrera et al., 2004).  
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Figure 14. Zic2 is expressed at the optic chiasm in wild type and 
Foxg1 null embryos throughout the period when RGC axons 
project. Zic2 immunohistochemistry on horizontal sections of E13.5 – E16.5 
optic chiasm revealed using DAB. All sections are taken at a similar dorsal-
ventral location through the optic chiasm. Anterior is down. Arrows mark the 
midline. (A – D) E13.5, (E, F) E14.5 and (G, H) E16.5. (A, C, E, G) Foxg1
+/+
chiasm. (B, D, F, H) Foxg1
-/- 
chiasm. (C, D) High power magnifications of 
(A) and (B) respectively. Abbreviations: er = extended retina. Scale bars: A, 


























The function of Islet-1 at the chiasm is unknown but it is useful for orientation 
purposes. In Foxg1
-/-
 embryos, the cortex is not present in this plane of section as it is 
much smaller (Figure 15A, B). Zic2 was not expressed in Islet-1-positive posterior 
chiasm regions in wild type embryos, indicated by the absence of Zic2 and Islet-1 
double-labeled cells. In Foxg1
-/-
 embryos, the Zic2-expressing region of the chiasm is 
located just posterior to where the extended retina attaches to the ventral hypothalamus. 
Islet-1 expression is absent from the Foxg1
-/-
 posterior chiasm region (Figure 15B, D). 
The Zic2-expressing region extends further dorsally in Foxg1 null embryos compared 
to the wild type but there is still a clear divide between the Zic2-positive anterior and 
Zic2-negative posterior region in the ventral chiasm as in the wild type. However, these 
results are based on a Foxg1
-/-
 n of 1 and so more replicates are required before 
conclusions can be drawn. Zic2 was also expressed in other brain regions, including the 
thalamus with strong expression in the zona limitans intrathalamica (zli) (Figure 15A, 
B).  
4.4.7. Zic2 is only found in ipsilaterally-projecting RGCs. 
In order to show that Zic2-expressing cells in the retina project ipsilaterally but not 
contralaterally, dextran was used to backlabel one optic tract followed by Zic2 
immunohistochemistry on the retina contralateral and ipsilateral to the dextran 
injection. This revealed that in wild type E14.5 embryos only ipsilateral RGCs are 
double-labeled and express Zic2, whereas contralateral RGCs are more numerous and 
Zic2-negative (compare Figures 16A and C). A similar result was found in an 
additional two dextran-backlabeled wild type embryos and the contralateral and 
ipsilateral eyes shown in Figure 16 are the clearest and most representative examples 
for this preliminary experiment.  
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Figure 15. Zic2 is expressed at the optic chiasm and thalamus in 
wild type and Foxg1-/- embryos at E14.5. (A – D) Zic2 (green) and 
Islet-1 (red) immunohistochemistry in 10µm-thick sagittal sections at the 
midline. (E) Schematic diagram of a sagittal section corresponding to (A – D). 
(A, C) wild type, (B, D)    Foxg1
-/-
. (A) In the wild type Zic2 is expressed at 
the optic chiasm but also in other parts of the brain including the thalamus. 
(C) High power magnification of (A) showing Zic2 expression dorsal to 
axons (white arrow) but anterior to Islet-1, which is expressed in posterior 
chiasm cells. (B) Foxg1
-/-
 section showing the extended retina joining the 
ventral hypothalamus. (D) High power magnification of (B) showing Zic2 
expression in the optic chiasm region (white arrow). Islet-1 is expressed in 
RGCs in the extended retina. Abbreviations: A = anterior, P = posterior, oc = 
optic chiasm, th = thalamus, ctx = cortex, r = retina, or = optic recess, zli = 
zona limitans intrathalamica. Scale bars: A, C, D = 200µm, B = 400µm.





































Figure 16. Zic2 is only found in ipsilateral RGCs in E14.5 wild type 
retina. (A - C) Zic2 immunohistochemistry in the ipsilateral and contralateral 
retina following dextran backlabeling from one optic tract in an E14.5 wild 
type embryo. (A) The retina ipsilateral to the dextran injection shows only a 
few backlabeled RGCs limited to the ventrotemporal retina. Some 
backlabeled RGCs are Zic2-positive and appear yellow (examples shown with 
black arrows). (B) The dorsonasal part of the ipsilateral eye is Zic2-negative 
and no backlabeled RGCs are visible. There are a few backlabeled RGCs in 
dorsonasal retina (white arrow). (C) The retina contralateral to the dextran 
injection shows many backlabeled RGCs spread over the entire retina but 
none express Zic2. (D) Diagram showing the site of dextran injection into the 
optic tract and areas of the retina where backlabeled RGCs (red) and Zic2-
expressing cells (green) and double-labeled cells (yellow) are found. Dorsal is 
up and anterior is pointing directly outwards perpendicular to the page. 
Abbreviations: D is dorsal, V is ventral, A is anterior, P is posterior, VN is 
ventronasal, VT is ventrotemporal, DN is dorsonasal, DT is dorsotemporal. 
Scale bars all 100µm.  
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4.5.1. Significantly greater numbers of Zic2-expressing cells are present 
in the nasal Foxg1-/- retina. 
Zic2 protein was found in the retinas of Foxg1-expressing and Foxg1 null embryos 
throughout the period when retinal axons make a binary decision to cross the chiasm 
midline or remain ipsilateral. In the retina of wild type and Foxg1 heterozygous 
embryos, Zic2 was expressed in a cluster of cells in the VT periphery of the retina, 
adjacent to the Zic2-expressing CMZ from E14.5 to E16.5, confirming previous 
findings (Herrera et al., 2003). Zic2-positive cells were also observed scattered 
throughout the remainder of the retina, including a sizeable number in the nasal retina 
but these were never found in clusters. Foxg1
-/-
 embryos displayed an ectopic Zic2-
expressing cluster in the nasal retina from E13.5 to E16.5. Although the VT Zic2 
cluster was preserved in the retina of Foxg1
-/-
 embryos, numbers of Zic2-expressing 
cells were greater in the nasal retina. Thus in the Foxg1
-/-
 retina, Zic2 counts follow a N 
> T trend, which is the reverse of the wild type T > N. Quantification of the numbers of 
Zic2-expressing cells at E14.5 and E16.5 revealed that the nasal retina of Foxg1
-/-
embryos has significantly more Zic2-positive cells compared to that of an age-matched 
wild type embryo. This result was reproducible regardless of whether Zic2 expression 
was revealed by fluorescence or DAB. It follows that increased expression of the 
ipsilateral determinant Zic2 appears to be a likely cause of the increased ipsilateral 
projection from the nasal retina of Foxg1 null embryos (see Figure 17).  
Figure 17. Proposed relationship between Zic2 expression 
and the ipsilateral projection in wild type and Foxg1-/-
embryos. (A) Wild type, (B) Foxg1-/- retina. (A) Only RGCs from 
the VT crescent in the VT retinal quadrant express Zic2 (green 
circles) and project ipsilaterally at the chiasm midline (dashed line). 
Foxg1 expression is indicated by blue stippling. (B) In Foxg1-/- retina, 
RGCs in the nasal hemiretina express Zic2 and their axons behave 
like those from VT retina by projecting ipsilaterally. RGCs in the VT 
crescent also express Zic2. Note: for simplicity, only a few projecting 
axons are illustrated.
Abbreviations: N, nasal; T, temporal; D, dorsal; V, ventral; P, 
posterior. 
Key: Blue lines represent contralaterally-projecting RGC axons, 
green lines represent ipsilaterally-projecting RGC axons. Grey 












When the numbers of Zic2-expressing cells were divided into the different retinal 
quadrants, fluorescence and DAB methods gave different results at E14.5. The 
fluorescence method revealed significantly greater numbers of Zic2-expressing cells 
per retina expressed as a proportion of the numbers of Brn3a-positive RGCs in dorsal 
and ventral locations within the Foxg1
-/- 
nasal retina. However, counts using DAB only 
revealed the same finding in VN retina. Although numbers of Zic2-positive cells were 
greater in Foxg1
-/- 
DN retina, the difference was not statistically significant from wild 
type DN retina. However, the variability in terms of the standard error in Foxg1
-/- 
Zic2 
counts was greatest for the DN quadrant compared to all other retinal quadrants for 
E14.5 fluorescence and DAB methods. This may be due to real variability in the DN 
quadrant of the Foxg1
-/- 
retina compared to other regions of the retina or alternatively 
the low ‘n’ numbers (n = 3). If the latter is true and since the data follow a similar trend 
for DN retina for fluorescence and DAB Zic2 counts, it is plausible that increasing the 
numbers of Foxg1
-/- 
retinas for Zic2 quantification using immunohistochemistry 
revealed by DAB may result in a significant difference in DN retina. At E16.5, 
significantly greater numbers of Zic2-positive cells were found in DN and VN Foxg1
-/- 
retina, agreeing with the E14.5 fluorescence data. 
Foxg1 is most widely expressed in the nasal half of the retina (Chapter 5, this thesis; 
Hatini et al., 1994; Huh et al., 1999; Pratt et al., 2004), which is the half of the retina 
that displays an increase in Zic2 expression in Foxg1 null embryos. These results lend 
support to the hypothesis put forward earlier in this Chapter that the numbers of Zic2-
expressing cells rise in proportion to the increased ipsilateral projection. However, an 
increase in Zic2 expression was only found in the nasal but not the temporal retina, 
from which many ipsilateral projections also arise in Foxg1
-/-
 eyes. Consequently, a 
different explanation must be invoked to explain the increase in temporal ipsilateral 
projections. In summary, these results are consistent with a model in which Foxg1 
normally suppresses Zic2 in the nasal retina. In Foxg1
-/-
 embryos, Foxg1 is absent from 
the nasal retina, relieving the repression on Zic2 and thereby allowing Zic2 expression 
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to increase. The theory that Foxg1 acts cell autonomously to regulate Zic2 expression 
in nasal RGCs themselves is compatible with the data presented here but not proved by 
it.  
4.5.2. Zic2 expression in the temporal retina. 
The same trend for greater numbers of Zic2-positive cells in DT Foxg1
-/-
 retina and 
fewer Zic2-positive cells in Foxg1
-/- 
VT retina relative to equivalent wild type retinal 
quadrants was found for the fluorescence and DAB counts at E14.5. However, 
comparisons of the temporal retina of Foxg1
-/-
 and wild type embryos revealed a 
significant difference with the DAB counts only. As mentioned previously for the nasal 
retina, it is impossible to tell whether the difference in statistical significance is due to 
intrinsic differences in the results obtained counting DAB- or fluorescently-labeled 
Zic2-positive cells or due to low ‘n’ numbers. One way to overcome this problem 
would be to increase the numbers of retinas analyzed using both fluorescence and DAB 
methods for revealing Zic2 expression. 
At E16.5, there was no difference in Zic2 expression between the temporal retinas of 
wild type and Foxg1
-/- 
embryos. Splitting up the temporal retina into dorsal and ventral 
regions revealed a significantly greater number of Zic2-positive cells in Foxg1
-/- 
DT 
retina compared to the wild type, mimicking the trend in E14.5 embryos. E16.5   
Foxg1
-/- 
embryos showed no change in Zic2 counts in the VT retina relative to wild 
types. Interestingly, this is the only part of the retina in which a change in Zic2 
expression was observed between E14.5 and E16.5. This suggests that there might be a 
developmental delay in the expression of Zic2 in the Foxg1
-/- 
VT retina, which is 
apparent at E14.5 but disappears by E16.5. It would be fascinating to investigate this 
hypothesis further by examining Zic2 expression at E13.5 (when Zic2 expression 
appears in the retina), E15.5 and later on after E16.5 to observe temporal fluctuations in 
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Zic2 numbers in the VT retina in greater detail. Additionally, it would be prudent to 
investigate the onset of expression of various retinal markers, including Brn3b that is 
expressed in the earliest postmitotic RGCs from E11.5 (Pan et al., 2005), Islet-1 that is 
expressed just after RGCs leave the cell cycle (Rachel et al., 2002) and also Foxd1, a 
forkhead box transcription factor whose expression is limited to the VT retina from 
E14.5 - E16.5 (Herrera et al., 2004). Interestingly, very low numbers of RGCs express 
Brn3a in the VTC, whereas Brn3b is expressed there to a greater extent (Quina et al., 
2005). This could also account for the general lack of co-labeling between Brn3a and 
Zic2 in wild type and Foxg1
-/- 
embryos. In all other regions of the retina, almost all 
RGCs expressing Brn3a also express Brn3b albeit at different levels. Brn3b was not 
used as an RGC marker in the experiments presented here because it is also expressed 
in RGCs in the neuroepithelial layer between E13.5 and E16.5, unlike Brn3a, which is 
expressed solely by RGCs in the ganglion cell layer (Pan et al., 2005). 
The Zic2 counts for the temporal retina in Foxg1 null eyes fail to explain the increased 
ipsilateral projections from the temporal half of the Foxg1
-/-
 retina because they either 
show no change or a slight decrease in Zic2 expression. The increased proportion of 
temporal ipsilaterally-projecting retinal axons may be caused by a non-autonomous 
effect of Foxg1, since Foxg1 is not normally expressed there. Alternatively, changes in 
the chiasm region or in other structures that temporal retinal axons encounter may 
result in their preference for an uncrossed trajectory. These results call for a more 
thorough study of possible non-autonomous effects of Foxg1 in the temporal retina and 
its resident RGCs.  
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4.5.3. The number of RGCs in E14.5 Foxg1-/- retina does not differ from 
the wild type at E14.5 or E16.5. 
A possible explanation for the increase in Zic2-expressing cells in the Foxg1
-/- 
retina is 
simply that there are more cells in the RGC layer relative to the wild type retina due to 
more extensive proliferation. Although the volume of the wild type and Foxg1 null 
retina does not differ significantly at E15.5 (Pratt et al., 2004), it was not known 
whether the number of RGCs differed. Counts of RGCs expressing the postmitotic 
marker Brn3a showed that Foxg1
-/- 
retinas have the same number of RGCs as age-
matched wild type retinas at E14.5 and E16.5. This was true for the nasal and temporal 
retina and also for the different retinal quadrants rendering the possibility of a 
proliferative defect in the eye unlikely. Therefore, it was valid for Zic2 DAB counts to 
be shown without correcting for the number of RGCs. Moreover, within wild type or 
Foxg1
-/- 
retinas, the numbers of Brn3a-positive cells did not differ between the nasal 
and temporal retina confirming that the nasal-temporal boundary imposed for the 
counts was valid. 
4.5.4. Zic2 is expressed exclusively by ipsilateral RGCs. 
The backlabeling experiment showed that only some ipsilateral RGCs express Zic2 and 
therefore, appear yellow or double-labeled. Contralateral dextran-backlabeled RGCs 
never co-labeled with Zic2, which concords with previous findings (Herrera et al., 
2003). This also agrees with the fluorescence Zic2 images in which Zic2-positive cells 
rarely co-labeled with Brn3a-positive RGCs and were generally positioned at a more 
peripheral location (Figures 2 - 10). Double-labeled cells were usually found in the VT 
retina at the most peripheral extent of the Brn3a-expression domain, as for the dextran-
backlabeled ipsilateral RGCs. Since RGCs are generated in a wave of differentiation 
from central to peripheral retina regulated by Brn3-a, -b and -c, this implies that Zic2-
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positive cells are immature RGCs that have not yet begun to express certain RGC 
markers such as Brn3a (Pan et al., 2005; Xiang et al., 1995). Previous studies have 
shown that Zic2 is co-expressed with Islet-1 (Herrera et al., 2003), which is expressed 
prior to Brn3a by postmitotic RGCs as they leave the cell cycle (Rachel et al., 2002).  
In the future, it will be interesting to repeat this experiment using Foxg1
-/- 
retinas to test 
the hypothesis that the increased ipsilateral projections in Foxg1 null embryos are the 
result of increased Zic2 expression in the nasal retina. In other words, do Zic2-positive 
cells in the nasal Foxg1
-/-
 retina follow an ipsilateral route rather than a contralateral 
one typical of Zic2-negative nasal retinal cells in the wild type? If this hypothesis is 
true, it is expected that Foxg1
-/-
 retinas will show an increase in the number of double-
labeled ipsilateral RGCs in the nasal retina relative to wild type retinas.  
The main drawback with the dextran backlabeling experiment is that Zic2 is initially 
expressed in RGCs that project ipsilaterally but is subsequently downregulated once 
their axons reach the optic chiasm (Herrera et al., 2003). Therefore, backlabeled 
ipsilateral RGCs may not appear to express Zic2 even though they may have done so in 
the past. In addition, backlabeled RGCs are more mature and are located nearer to the 
central retina than Zic2-positive cells, which differentiate later by virtue of their 
peripheral location. In other words, Zic2-positive cells may have extended axons that 
have not reached the chiasm yet, or alternatively, they may not have extended axons at 
all. In order to investigate this more thoroughly, lineage-tracing would be required to 
identify retinal cells that have expressed Zic2 at any time in their lineage. Zic2 lineage 
tracing could be done using two mouse lines: (1) mice in which the coding sequences 
of Zic2 have been replaced with a cre recombinase cassette and (2) mice carrying a 
ROSA βgeo 26 reporter allele, ‘R26R’ (Soriano, 1999).  The R26R reporter allele 
consists of a stop codon flanked by loxP sites that is situated upstream of a βgeo 
cassette containing the beta-galactosidase gene. Mice carrying the R26R reporter allele 
express LacZ (βgeo) ubiquitously only after recombination due to recognition of loxP
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sites and excision of the stop codon by cre recombinase. Therefore, when a Zic2-Cre 
heterozygous mouse is crossed with a ROSA26 reporter mouse, cre-mediated 
recombination occurs in tissues where Zic2 is active. This irreversibly activates beta-
galactosidase expression that is visualized by LacZ staining, revealing any cells and 
their descendants that have expressed Zic2 at any time during development. Combined 
with backlabeling, lineage tracing would reveal whether RGCs that have expressed 
Zic2 project ipsilaterally, even if they have subsequently downregulated this 
transcription factor.
4.5.5. Zic2 expression at the wild type and Foxg1-/- optic chiasm. 
The expression of Zic2 in the anterior chiasm region of wild type and Foxg1
-/- 
embryos 
from E13.5 to E16.5 shows that Zic2 is present at the time retinal axons are projecting. 
Due to morphological differences between the wild type and Foxg1
-/- 
ventral 
diencephalon, it is not possible to tell whether there are changes in Zic2 expression in 
the Foxg1 null chiasm using Zic2 immunohistochemistry alone. This would require 
quantifying Zic2 protein expression at the chiasm using Western blotting or 
quantification of mRNA using qRT PCR. Nevertheless, the results show that Zic2 
expression in the Foxg1
-/- 
chiasm shares many properties with the wild type, such as 
stronger expression in lateral and anterior chiasm regions. All the in vitro and in vivo
evidence to date suggests that Zic2 acts primarily in the retina to specify the ipsilateral 
routing of VT RGCs (Herrera et al., 2003, Pak et al., 2004, Williams et al., 2003, 
2004). However, the possibility that Zic2 expression at the chiasm influences retinal 
axon pathfinding cannot be excluded. 
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4.5.6. Zic2 may influence ipsilaterality via EphB1.
EphB1 is an ephrin-B receptor that co-localises with Zic2 in VT retina from E14 – E17 
when the permanent ipsilateral projection originates from VT retina (Pak et al., 2004). 
When EphB1-bearing VT retinal axons encounter ephrin-B2 at the optic chiasm, they 
are selectively repelled, whereas EphB1-negative retinal axons from other regions of 
the retina are not repelled (Williams et al., 2003). Although EphB1 has been implicated 
in mediating the behaviour of axons originating from Zic2-expressing RGCs, EphB1 is 
expressed prior to the onset of Zic2 expression from E12 – E13 in dorsocentral RGCs 
coinciding with the appearance of the first transient ipsilateral projections. This implies 
that EphB1 is regulated by transcription factors other than Zic2 at this early stage in the 
development of retinal projections (Williams et al., 2003). Nevertheless, evidence from 
EphB1 and Isl2 null mice supports a link between EphB1 and Zic2. EphB1 null mice 
display a marked reduction in the size of the ipsilateral projection, which resembles the 
phenotype of Zic2
kd/kd
 mice (Williams et al., 2003). This phenotype is thought to be due 
to deletion of EphB1 in the retina because chiasm molecules associated with the 
ipsilateral projection, such as ephrin-B2, are all normal in EphB1 null embryos. Also, 
in Isl2 null mice that display an increased ipsilateral projection from VT RGCs, both 
Zic2 and EphB1 are upregulated in VT retina suggesting that they are both involved in 
the ipsilateral pathway (Pak et al., 2004). Although all the evidence to date suggests 
that Zic2 might control EphB1 expression, it is equally possible that Zic2 specifies 
ipsilaterality independently of EphB1.  
If Zic2 mediates its effects through EphB1, EphB1 should be expressed in the same 
nasal RGCs where Zic2 is ectopically expressed in Foxg1 null embryos. The 
spatiotemporal pattern of EphB1 could be investigated using in situ hybridization and 
quantitatively by qRT PCR. Although, EphB1 antibodies exist, none have proved 
successful in immunohistochemistry in this or any other laboratory. 
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4.5.7. Hypotheses for the increase in Zic2 expression in nasal Foxg1-/-
retina. 
4.5.7.1. Foxg1 repression of Zic2.  
Before hypothesizing about the possible interactions between Foxg1 and Zic2, it is 
important to understand how Zic2 is repressed in a subset of RGCs in the VT retina. 
The LIM homeodomain transcription factor Islet-2 (Isl2) is expressed in a subset of 
RGCs across the entire retina (Pak et al., 2004). There are a few Isl2-expressing RGCs 
in the VTC but they do not express Zic2 or EphB1, which are expressed by other RGCs 
in this region. In Isl2 null mice the increased ipsilateral projections arise from a greater 
number of Zic2- and EphB1-positive RGCs in the VT retina, raising the possibility that 
Isl2 represses the ipsilateral genetic program via repression of Zic2 and EphB1 in the 
VT retina.  
At present, it is unclear how Zic2 expression is regulated in the rest of the retina. One 
hypothesis that is compatible with the data presented here is that Foxg1 normally 
represses Zic2 in the nasal retina, where Zic2 is only weakly expressed, which would 
then prevent the expression of EphB1 in this region and thus prevent nasal RGC axons 
from projecting ipsilaterally (Figure 18). Zic2 is strongly expressed by RGCs in the VT 
retina because Foxg1 is not expressed in this region and so cannot repress Zic2 (see 
Chapter 5). In Foxg1
-/-
 retina, the absence of Foxg1 in nasal retina may relieve 
repression on Zic2, allowing cells in the nasal retina to express Zic2. Foxg1 has been 
shown to act as a transcriptional repressor in vitro (Dou et al., 2000; Yao et al., 2001), 
although no direct targets relating to retinal axon guidance have been identified. There 
is evidence for repression of Zic2 by Foxg1 in the ventral hypothalamus of Foxd1
-/-
embryos where Foxg1 and Zic2 occupy mutually exclusive expression domains 
(Herrera et al., 2004). However, there are no reports of this occurring in the retina.  
Figure 18. Hypothetical model of transcriptional regulation 
of binocularity in RGCs. (A) Wild type retina. Foxg1-expressing 
RGCs project contralateral axons by repressing Zic2 in nasal retina this 
is hypothesised to diminish the expression of EphB1 receptors on
axons. These axons are not repelled by ephrin-B2 at the chiasm. Zic2-
expressing RGC axons in the VT retina project ipsilaterally. Zic2 
expression in RGCs is thought to activate the expression of EphB1 
receptors on axons that are repelled by ephrin-B2 at the chiasm. (B) In 
the wild type retina, Isl2 is thought to repress Zic2 in a subset of VT 
RGCs and thus repress the ipsilateral programme, leading to the 
production of contralaterally-projecting axons. Isl2 may generally 
repress the ipsilateral genetic programme in the rest of the retina, 
although the mechanism is unknown. (C) Foxg1 null retina. Removing 
Foxg1 relieves repression on Zic2, producing an increase in the number 
of Zic2-positive RGCs, which theoretically produces an increase in 
EphB1 receptors (vertical arrows), culminating in an increased 
ipsilateral projection. The VT retina still expresses Zic2, producing 
ipsilateral axons. 
Abbreviations: D, dorsal; V, ventral; N, nasal; T, temporal; ipsi, 
ipsilateral; contra, contralateral; green indicates components of the 








































In order to test whether Foxg1 is responsible for repressing Zic2, Foxg1 could be 
ectopically expressed in the VT retina, where it is normally absent, to see if Zic2 
expression disappears or is reduced. Similarly, a Foxg1 expression construct could be 
used to transfect Foxg1
-/-
 nasal retina, which ectopically expresses Zic2. If Foxg1 
represses Zic2, it is expected that Zic2 levels would be reduced or eliminated. Finally 
Foxg1 expression could be knocked down specifically in the nasal retina of wild type 
embryos to test whether Zic2 expression increases in the absence of Foxg1 as in the 
Foxg1
-/-
 retina. If this hypothesis is proved correct, elucidating the molecular 
mechanisms through which Foxg1 achieves this repression would then present the next 
challenge.  
4.5.7.2. Foxd1 is required for Zic2 expression. 
Another explanation for the increase in Zic2-positive cells in the nasal retina involves 
another Fox gene called Foxd1 (formerly known as ‘BF-2’). Foxd1 is expressed in the 
ventrotemporal retina (Herrera et al., 2004) and its expression domain overlaps with 
that of Zic2, although it occupies a larger area. Foxd1
LacZ/LacZ
 mice do not produce 
Foxd1 protein and expression of Zic2 and EphB1 is lost from the ventrotemporal retina 
entirely (Herrera et al., 2004). Although these Foxd1 null mice exhibit an increased 
ipsilateral projection, which appears counter-intuitive given that Zic2 is an ipsilateral 
determinant, an expansion of Slit2 in the ventral diencephalon was assumed to repel 
more axons away from the midline. Therefore, Foxd1 may be required for the 
expression of Zic2 in VT retina since its absence abolishes Zic2 expression in this 
region. In Foxg1 null embryos, Foxd1 expands into the nasal retina where Foxg1 is 
normally expressed (Huh et al., 1999). Therefore, if Zic2 requires Foxd1 for its 
expression, expansion of Foxd1 into Foxg1
-/-
 nasal retina may lead to Zic2 expression 
here, leading to an increase in the number of Zic2-expressing cells.  
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However, there is an alternative explanation for the loss of Zic2 in Foxd1 null embryos. 
In Foxd1
LacZ/LacZ
 mice, Foxg1 expression expands into the VT retina, occupying the 
Foxd1 domain (Herrera et al., 2004). Therefore, if Foxg1 normally represses Zic2 
expression, the absence of Zic2 in the VT retina of Foxd1 null mice may be a 
consequence of repression by Foxg1, rather than loss of Foxd1 in VT retina.  
Investigating whether Foxg1 represses Zic2 or whether Foxd1 is required for Zic2 
expression would require gain- and loss-of-function in vitro experiments. Levels of 
Foxd1 would have to be monitored in experiments that manipulate Foxg1 and vice-
versa since the expression domains of these two transcription factors expand whenever 
the other is absent (Huh et al., 1999; Herrera et al., 2004).  
In summary, the increase in Zic2-expressing RGCs in the nasal retina of Foxg1 null 
embryos provides a possible explanation for the increased number of ipsilaterally-
projecting RGC axons, although this remains to be proven experimentally. Foxg1 
normally represses Zic2 in the nasal retina, although it is unclear whether this 
repression is direct or indirect at present.  
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CHAPTER 5: Characterisation of the Foxg1
-/-
 eye.  
5.1. ABSTRACT  
The aim of this chapter was to test the hypothesis that the increased ipsilateral 
projection in Foxg1
-/-
 embryos might be caused by abnormal patterning of the Foxg1
-/-
retina leading to an expansion of ventral or temporal regions, which normally give rise 
to ipsilateral RGCs. The histology of the Foxg1
-/-
 retina was also examined revealing 
that, despite its medial extension, the retina develops normally, forming the inner and 
outer retinal layers and an optic nerve-like structure. To examine whether dorsal, 
ventral, temporal or nasal patterning of the retina was altered in Foxg1
-/-
 embryos, 
immunohistochemistry was used to detect EphB2 and ephrin-B2 proteins that are 
expressed in opposing dorsoventral (DV) gradients. The DV gradients of EphB2 and 
ephrin-B2 were maintained in the Foxg1
-/-
 retina throughout the period when RGC 
axons project, implying that retinal patterning along this axis is not drastically altered. 
Foxg1 itself was used as a nasal patterning marker in mice that contained one or two 
copies of a Foxg1lacZ reporter allele, which allowed recognition of sites of Foxg1
transcriptional activation. Foxg1
LacZ/+ 
embryos from E13.5 to E15.5 showed Foxg1
activation in dorsonasal (DN) and dorsotemporal (DT) retina, with expression 
becoming increasingly restricted to nasal regions in the ventral retina. The spatial 
pattern of Foxg1 activation in the Foxg1
LacZ/LacZ 
retina differed from that in Foxg1
LacZ/+ 
embryos. In the Foxg1LacZ/LacZ dorsal retina, Foxg1 activation was found in temporal 
regions that do not usually express Foxg1 in the wild type whilst Foxg1 activation was 
reduced in dorsonasal regions that normally express Foxg1. Ventrally, Foxg1 activation 
was biased towards the nasal retina. The Foxg1
LacZ/LacZ 
reporter mice and lineage tracing 
experiments indicated a slight increase in Foxg1 transcriptional activation in the Foxg1
null ventrotemporal (VT) retina compared to equivalent locations in the wild type 
retina. Although these findings are suggestive of abnormal nasotemporal (NT) retinal 
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patterning in the Foxg1 null eye, further expression studies of molecules expressed 
along the NT axis are required to corroborate this.  
5.2. INTRODUCTION 
5.2.1. Eye development. 
During neurulation, at approximately E9.5 in the mouse, optic vesicles evaginate from 
the forebrain and contact the overlying surface ectoderm, remaining attached to the 
diencephalon via the optic stalks. The optic vesicles then invaginate to form the optic 
cups. Determination of the eye fields is mediated by two members of the paired box 
(Pax) gene family: Pax6 and Pax2. In mice and zebrafish, the evolutionarily conserved 
transcription factor Pax6 is expressed throughout the optic vesicles in cells of the 
prospective retina, retinal pigment epithelium (RPE) and lens epithelium (Walther and 
Gruss, 1991). Loss-of-function mutations in Pax6 produce a Small eye phenotype in 
mice (Hill et al., 1991), with heterozygotes showing reduced Pax6 expression and 
microphthalmia, while homozygotes lack eyes, demonstrating the importance of Pax6
in eye development. Sonic hedgehog (Shh) secreted from the ventral midline specifies 
the optic stalk (future optic nerve) proximally by inducing expression of Pax2, which 
then represses Pax6 expression, limiting it to the optic cup that will form the neural 
retina and RPE (Macdonald et al., 1995; Walther and Gruss, 1991). Examination of the 
eyes of Pax6 null mice suggests that Pax6 is involved in the development of retinal 
polarity along dorso-ventral and nasal-temporal axes via Vax2 (ventral) and Tbx5 
(dorsal) and Foxg1 (nasal) and Foxd1 (temporal) (Baumer et al., 2002). Recently, Pax6 
overexpression experiments in chick revealed that Pax6 regulates FGF8 and BMP4 
expression to pattern the optic cup and also maintains a precise balance between these 
two signalling molecules for retinogenesis (Reza et al., 2007).  
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5.2.2. Hypothesis of altered retinal patterning in the Foxg1-/- eye. 
The eyes of Foxg1-/- embryos develop abnormally, suggesting that Foxg1 plays a key 
role in patterning the developing eye (Xuan et al., 1995; Huh et al., 1999; Mui et al., 
2002). Defects in the development of Foxg1
-/-
 eyes are first observed at E10.5 (Huh et 
al., 1999). Foxg1
-/-
 embryos lack a morphologically recognisable optic stalk and have 
abnormal ellipsoid-shaped eyes, with a medially-expanded retina, small lens and large 
ventral coloboma (failure of the choroid fissure to close) (Huh et al., 1999). The 
expanded optic vesicle connects directly with the brain due to the absence of an optic 
stalk. The RPE is also expanded medially. Pax6 retinal expression is expanded 
ventrally and medially in both anterior and posterior regions, whereas Pax2 that is 
normally restricted to the optic stalk and ventral pole of the optic cup is reduced to a 
few cells in the medial extent of the extended retina (Huh et al., 1999).  
Retinogenesis proceeds in a fixed chronological order: retinal ganglion cells and 
horizontal cells are the first to differentiate at around E11, followed by cone-
photoreceptors, amacrine cells, rod-photoreceptors, bipolar cells and finally Müller 
glia-cells (Drager, 1985; Young, 1985). Retinal progenitor cells are multipotent, 
meaning that they are able to generate any of the seven different retinal cell types up to 
the final cell division (Holt et al., 1988; Turner and Cepko, 1987; Wetts and Fraser, 
1988). Retinal patterning along the dorsoventral and nasotemporal axes precedes the 
onset of retinogenesis (Hatini et al., 1994) and cell differentiation in the murine retina 
occurs in a central to peripheral wave (Prada et al., 1991). Consequently, the position of 
retinal progenitor cells in the retina determines which transcription factors are 
expressed by differentiated retinal cells, which then go on to dictate the behaviour of 
RGC axons at the optic chiasm and their topographic mapping onto the superior 
colliculus (Barbieri et al., 2002; Koshiba-Takeuchi et al., 2000; Schulte and Cepko, 
2000; Schulte et al., 1999; Sperry, 1963; Yuasa et al., 1996).  
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Altered retinal patterning can lead to RGCs experiencing a different genetic and 
cellular environment culminating in aberrant projections. An increased ipsilateral 
projection could arise if there is an expansion in the absolute number of RGCs with 
molecular properties of ventral or temporal retina, since the VT quadrant gives rise to 
ipsilaterally-projecting RGCs (Colello and Guillery, 1990; Sretavan, 1990). This 
hypothesis appears more likely given the findings of Chapter 4 that showed an increase 
in the proportion of nasal RGCs expressing Zic2, which is primarily restricted to the 
VT retina (Herrera et al., 2003). Evidence against an increased number of VT RGCs 
without a corresponding reduction in RGC numbers in other parts of the retina comes 
from the finding that numbers of RGCs between the Foxg1
-/-
 dorsal and ventral retina 
do not vary and are not significantly different from those of the wild type (presented in 
Chapter 4 of this thesis). Moreover, the overall volume of the Foxg1
-/-
 eye is similar to 
that of an age-matched wild type eye (Pratt et al., 2004). However, these findings do 
not exclude the possibility of altered DV or NT patterning of the Foxg1
-/-
 eye. This 
leads to the hypothesis for this chapter that the Foxg1
-/-
 retina is more ventral or 
temporal in character, expanding the ipsilateral domain of the retina and 
reprogramming RGC axons from a contralateral to an ipsilateral fate in areas outside 
the VT crescent. This hypothesis could account for the rise in ipsilateral projections 
previously observed in the Foxg1
-/-
 nasal and temporal retina (Pratt et al., 2004).  
5.2.3. Nasotemporal polarity. 
NT retinal polarity develops before DV axial polarity. At the optic cup stage, the 
transcription factor Foxg1 is expressed in the nasal optic cup and stalk whereas Foxd1 
is expressed in the temporal optic cup and stalk (Figure 1) (Hatini et al., 1994). The 
expression domains of Foxg1 and Foxd1 are mutually exclusive and are separated by a 
gap (Hatini et al., 1994). Subsequently, the homeodomain transcription factors SOHo1 
and GH6 are expressed in nasal retina and both repress EphA3, restricting its 
expression to the temporal retina (Schulte & Cepko, 2000).  
























Adapted from McLaughlin et al., 2003
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Figure 1. Genetic regulation of retinal polarity 
The expression patterns of genes involved in establishing 
retinal patterning of the (A) NT and (B) DV axes are shown 
in a sequence from early development (left) to late 
development (right). Figure based on McLaughlin et al., 
2003. Abbreviations: A, anterior; D, dorsal; L, lateral; M, 
medial; P, posterior; V, ventral.
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Experiments in chick have shown that ectopic expression of CBF1 (chick homologue of 
Foxg1), SOHo1 or GH6 in temporal retina and ectopic expression of CBF2 (chick 
Foxd1 homologue) in nasal retina results in retinotectal mapping defects along the 
anterior-posterior axis (Yuasa et al., 1996). Therefore, Foxg1 and Foxd1 play crucial 
roles in guiding nasal and temporal axons to their appropriate anterior-posterior 
termination zones in the superior colliculus.  
The restricted expression of Foxg1 in the nasal retina enables its use as a nasal retinal 
marker. The mice used in this Chapter were Foxg1
lacZ
knock-in mice in which the 
coding sequences of Foxg1 were replaced by a lacZ cassette (Xuan et al., 1995). The 
Foxg1
lacZ
reporter allele reveals sites where Foxg1 is transcriptionally active via the 
production of lacZ protein, which turns X-galactosidase or ‘lacZ’ staining solution blue. 
Foxg1 transcriptional activation has been examined previously at E12.5 showing that 
the anterior-posterior patterning of the Foxg1
lacZ/LacZ
 optic vesicle resembles that of 
Foxg1
LacZ/+
 embryos, with lacZ staining confined to the anterior half of the optic vesicle 
as shown schematically in Figure 2 (Huh et al., 1999).  
In this Chapter, later embryonic ages were examined using the same Foxg1LacZ reporter 
mice to observe whether this anterior-posterior divide in lacZ staining was maintained. 
Foxg1
lacZ/+
 embryos possess only one copy of the Foxg1 allele but are indistinguishable 
from Foxg1
+/+
 embryos and have normal eyes as reported previously (Huh et al., 1999). 












Figure 2. Foxg1 activation in the Foxg1LacZ/LacZ eye 
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Figure 2. Foxg1 activation in the Foxg1lacZ/lacZ eye. 
A schematic diagram of sagittal sections through the optic 
cup extended retina of a Foxg1lacZ/lacZ eye at E12.5. The 
anterior and posterior lips of the invaginated optic vesicle 
fail to fuse normally to form the choroid fissure (cf). The 
blue shading indicates the anterior domain of the optic 
vesicle where Foxg1 has been deleted in the Foxg1 null 
retina. Abbreviations: A = anterior, D = dorsal, L = lateral, 
M = medial, P = posterior, V = ventral. Figure based on 
Huh et al., 1999. 
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5.2.4. Dorsoventral polarity. 
The results of chick gain-of-function analyses and mouse loss-of-function analyses 
suggest that dorsoventral (DV) patterning is complex. However, the following gene 
interactions are well characterized. DV polarity is initially set up by Shh, retinoic acid 
and BMPs (Chow and Lang, 2001; Peters, 2002). Ventroptin is expressed in ventral 
retina, whilst BMP4 is confined to dorsal retina. Both ventroptin and BMP4 are 
mutually repressive and regulate the spatial distribution of downstream target genes 
along the DV axis (Sakuta et al., 2001). Dorsally, BMP4 activates Tbx5 but represses 
Vax2. Tbx5 in turn activates transcription of ephrin-Bs but represses EphBs in the 
dorsal retina, whilst Vax2 activates EphBs but represses ephrin-Bs in the ventral retina 
(Schulte et al., 1999; Koshiba-Takeuchi, 2000). EphB2, EphB3 and EphB4 are 
expressed in a low-to-high gradient from dorsal to ventral (Birgbauer et al., 2000; 
Connor et al., 1998; Henkemeyer et al., 1996; Hindges et al., 2002; Holash and 
Pasquale, 1995). In contrast, ephrin-B1 and ephrin-B2 are expressed in a 
complementary high-to-low gradient from dorsal to ventral (Marcus et al., 1996; 
Birgbauer et al., 2000; Hindges et al., 2002).  
5.2.5. EphBs and ephrin-Bs are important mediators of axon guidance. 
The polarised expression of EphBs and ephrin-Bs is highly conserved across species 
from fish (Brennan et al., 1997), amphibians (Mann et al., 2002), birds (Connor et al., 
1998; Holash et al., 1997), mammals (Barbieri et al., 2002; Birgbauer et al., 2000, 
Marcus et al., 1996) and marsupials (Vidovic and Marotte, 2003; Vidovic et al., 1999). 
This evolutionary conservation fits with the discovery that Ephs and ephrins from both 
subclasses A and B play roles in retinotopic mapping from lower to higher vertebrates: 
subclass B members mediate latero-medial tectal mapping from DV retinal gradients 
(Braisted et al., 1997; Hindges et al., 2002; Mann et al., 2002; O'Leary and 
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McLaughlin, 2005) and subclass A members mediate antero-posterior topographic 
mapping from NT retinal gradients (Drescher et al., 1997; McLaughlin et al., 2003).  
In addition to their roles in retinotectal mapping, some subclass B Ephs and ephrins 
appear to mediate retinal axon guidance at the mouse optic chiasm (Williams et al., 
2003). Recently, it was shown that repulsion between EphB1 receptors expressed on 
VT retinal axons and ephrin-B2 at the optic chiasm midline produced ipsilateral 
projections in the mouse (Williams et al., 2003). Nevertheless the EphB1 - ephrin-B2 
interaction could not provide a global mechanism for all ipsilateral axons due to the 
presence of a few residual ipsilateral axons in EphB1 null mice. Williams et al. showed 
that EphB1 and EphB2 mRNAs are most strongly expressed in the peripheral VT retina 
where ipsilateral RGCs are located in the mouse and Xenopus. Murine EphB2 is 
expressed more widely in the ventral retina than VT-restricted EphB1 and so EphB2
was chosen as the ventral marker in this chapter. EphB2’s ligand ephrin-B2 is 
expressed at the chiasm in developing mouse and Xenopus embryos where it has been 
linked to the ipsilateral projection as mentioned earlier (Nakagawa et al., 2000; 
Williams et al., 2003). However, it is also expressed in a dorsoventral gradient that is 
strongest in the dorsal part of the retina. Due to their clear polarised DV expression 
gradients, EphB2 and ephrin-B2 were chosen to study DV patterning in this Chapter.   
5.3. METHODS 
5.3.1. Foxg1 alleles and genetic background. 
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 alleles on a mixed pigmented 
CBA/C57Bl6/Swiss Webster background. Foxg1 homozygous mutants (Foxg1
Cre/Cre
) 
and compound heterozygotes (Foxg1
Cre/lacZ
) were identified by their hypoplastic 
telencephalon and distorted eyes. Heterozygous embryos (i.e. Foxg1+/–) were identified 
by PCR genotyping: they were indistinguishable morphologically from wild type (Xuan 
et al., 1995; Huh et al., 1999) and no RGC axon projection defects were observed at the 
optic chiasm. 
Dissections: Pregnant females were terminally anaesthetized and embryos removed by 
caesarian section in ice-cold PBS. Embryos were taken at E13.5, E14.5, E15.5 and 
E16.5. 
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5.3.2. PCR genotyping Foxg1 alleles. 
Tails were removed from the embryos to obtain tissue for genotyping. The Foxg1LacZ
allele was detected with primers LacZ F2 5’-TTG AAC TGC CTG AAC TAC CG-3’ 
and LacZ R2 5’-CCT GAC TGG CGG TTA AAT TG-3’. The Foxg1
Cre
 allele was 
detected using primers NLSCreFor 5’-CAT TTG GGC CAG CTA AAC AT-3’ and 
NLSCreRev 5’-ATT CTC CCA CCG TCA GTA CG-3’. Cycling conditions: 96°C for 
2 minutes followed by [96°C for 30 seconds, 58.5°C for 30 seconds, and 72°C for 30 
seconds] for 35 cycles.  
5.3.3. H & E staining. 
Wax-embedded heads from E13.5 and E15.5 embryos were cut into 10µm-thick 
coronal sections, collected onto poly-l-lysine-coated slides and dried overnight in a 
37ºC incubator. Wax sections were dewaxed in two changes of xylene and then 
dehydrated through a series of alcohol solutions: 100%, 95%, 90%, 70% and finally 
distilled water. Haematoxylin and eosin (1% aqueous) solutions were filtered prior to 
use. Sections were immersed in the filtered Harris Hematoxylin for 2 minutes followed 
by a rinse in tap water until the water turned clear. Sections were immersed in eosin 
stain for 3 minutes, dipped in tap water, transferred to potassium aluminium sulphate 
for 2 minutes and then rinsed in tap water. Sections were dehydrated in a series of 
ascending alcohol solutions (70%, 90%, 95%, 100% x2), cleared in 2 changes of xylene 
and mounted using DPX.  





embryonic heads were dissected and fixed for 1 
hour at 4°C in 4% paraformaldehyde, 0.02% NP40, 0.01% sodium deoxycholate, 5mM 
EGTA, 2mM MgCl2 in phosphatebuffered saline (PBS). In some cases, heads were 
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equilibrated in 30% sucrose/PBS and sectioned (10µm) on a cryostat and collected onto 
Superfrost Plus slides. Tissues were rinsed several times in wash buffer (2 mM MgCl2, 
0.02% NP40, 0.01% sodium deoxycholate in PBS), transferred to staining solution 
(wash buffer supplemented with 5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide and 1 mg/ml X-gal), and stained overnight (cryostat sections on slides) or 
for 2 days with agitation (wholemounts) at 37°C in darkness. Staining was stopped with 
20 mM EDTA in PBS. Wholemounts were processed to wax, sectioned (10µm) using a 
microtome and mounted onto poly-l-lysine-coated slides. Cryostat sections were 
counterstained with Nuclear Fast Red. 
5.3.5. Immunohistochemistry.
EphB2 and ephrin-B2 immunohistochemistry was performed essentially as described 
by Batlle et al. (2002). E13.5 and E16.5 embryo heads were fixed in 4% 
paraformaldehyde in phosphate buffer high salt (PBHS) (0.04M phosphate, 0.03M 
NaCl, pH7.0) at 4
o
C with shaking overnight and processed to wax. 10µm sections were 
cut and floated onto polylysine coated glass slides. After rehydration, endogenous 
peroxidase activity was blocked with 90% methanol: 3% hydrogen peroxide and 
antigens unmasked by microwaving in 10mM sodium citrate buffer (pH6.0). Sections 
were then reacted with primary antibody overnight and a bridge rabbit anti-goat 
antibody before final detection using the Envision
+
 (Rabbit) Kit (Dako K4010) 
following the manufacturers instructions. Primary antibodies were goat anti-mouse 
ephrin-B2 (R&D Systems AF496) used at 1:500; goat anti-mouse EphB2 (R&D 
Systems AF467) used at 1:1000; rabbit anti-goat (Dako Z0228) used at 1:400. 
Antibody incubation and pre-incubation blocking were carried out in 1% bovine serum 
albumin in PBS at room temperature. Following a diaminobenzidine colour reaction, 
sections were dehydrated and mounted. 
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5.4. RESULTS 
5.4.1. Morphology of the Foxg1-/- eye. 
The morphology of the Foxg1
-/-
 eye was examined at E15.5 during the peak period of 
retinal axon projections. The aim was to test the hypothesis that the Foxg1
-/-
 retina 
displays severe anatomical abnormalities, particularly of the RGC layer, which might 
contribute to the increased ipsilateral routing of RGC axons. Haematoxylin and eosin 
staining revealed that the organisation of the Foxg1 null retina resembles that of the 
wild type: it possesses an optic fibre layer (OFL) where RGC axons collect and 
fasciculate en route to the optic chiasm, a RGC layer, a denser outer retinal layer and 
retinal pigment epithelium (Figure 3C, D). Although Foxg1-/- eyes lack a clear optic 
stalk structure, axons were visible leaving the retina medially through an optic nerve-
like channel (Figure 3F) that resembles the wild type optic nerve (Figure 3A) but is 
instead surrounded by retinal tissue that is extended towards the midline (arrows in 
Figure 3F). Anteriorly, the Foxg1
-/-
 retina is tilted towards the ventral surface of the 
brain and displays a distinctive coloboma ventrally where the optic vesicle has failed to 
close (Figure 3H, I, J), leaving a gap in the RPE and retina. In comparison to an anterior 
wild type section where the RGC axons form a neat OFL (Figure 3G), the
Foxg1
-/-
 axons and RGCs fill a wider area that extends medially (Figure 3I). It is 
unclear whether folding of the retina in these anterior sections resulted in the eye being 
sectioned in a different plane to the wild type. Apart from these anterior-most regions, 
the Foxg1
-/-
 retina retains features of the wild type retina, particularly in extremely 
posterior sections (Figure 3K).  
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Figure 3. Morphology of the Foxg1-/- eye.  
Haematoxylin (purple) and eosin (pink) staining of coronal 10µm-thick wax 
sections of (A, D, G) wild type and (B, C, E, F, H, I, J, K) Foxg1lacZ/lacZ E15.5 
embryos. Haematoxylin labels cell nuclei, whereas eosin stains the cytoplasm, 
axons and cell membranes. (A) Wild type eye showing axons leaving the eye 
through the optic nerve (on). (B) Posterior section of a Foxg1lacZ/lacZ eye 
showing the medial bulge in the retina that becomes more severe anteriorly. 
(E) Foxg1
lacZ/lacZ
 eye showing axons medially (arrow). (F) Foxg1
lacZ/lacZ
 eye 
sectioned just posterior to (E) showing axons leaving the retina medially 
through an optic nerve-like structure. Arrows point to the medial extension of 
the retina that is visible dorsal to the retinal axons. (C, D) High power 
magnification of boxed areas in (B) and (A) respectively showing the optic 
fibre layer (OFL) where axons from the RGC layer accumulate and fasciculate 
as they leave the eye. (G) Wild type anterior eye showing RPE surrounding 
the entire retina. (H, I) Anterior sections of a Foxg1
lacZ/lacZ
 eye showing a 
ventral gap in the RPE and retina called a coloboma (col) where the optic 
vesicle has failed to close. Also note the ventral rotation of the eyes in these 
anterior sections. (I) Section anterior to (H): axons (a) occupy an area 
medially behind the lens and dorsal to the coloboma and the RGC layer is less 
organised. (J) Section anterior to (I) showing a wider gap in the RPE and 
retina. (K) Posterior Foxg1lacZ/lacZ eye with a continuous RPE. Abbreviations: 
r, retina; l, lens; RGCs, retinal ganglion cells; col, coloboma; on, optic nerve; 
rpe, retinal pigment epithelium; OFL, optic fibre layer; a, axons. Scale bars: 




















































5.4.2. Transcriptional activation of Foxg1 in Foxg1LacZ reporter mice. 
5.4.2.1. Transcriptional activation of Foxg1 in the E14.5 Foxg1lacZ/+ retina. 
In dorsal-most sections through the E14.5 Foxg1
lacZ/+ 
retina, lacZ staining was found 
throughout all layers of the nasal and temporal retina but was slightly more prominent 
nasally in all E14.5 retinas examined (Figure 4A). Moving ventrally, strong lacZ 
staining was still observed nasally in all retinal layers but a lacZ-negative region was 
seen in the temporal retina (Figure 4D, G, J). In increasingly ventral retinal sections of 
Foxg1
lacZ/+ 
embryos, the lacZ-negative region expanded progressively towards nasal or 
anterior regions (Fig. 4M, P) until staining was absent from the entire retina (Fig. 4S). 
In dorsal and ventral sections, lacZ staining was found in all layers of the nasal retina. 
However, staining was most intense in the RGC layer (Figure 5C) compared to the 
outer retinal layers. The E13.5 and E15.5 Foxg1
lacZ/+ 
retina exhibited the same lacZ 
staining pattern as for E14.5 (data not shown).  
5.4.2.2. Morphological variation between Foxg1lacZ/lacZ eyes. 
For a given embryonic age, Foxg1
lacZ/lacZ
 eyes exhibited morphological variation in the 
degree of folding and medial extension of the retina between different embryos from 
different litters, between embryos from the same litter and even between the eyes of the 
same embryo, adding to previous observations of variability between Foxg1 null eyes 
(Huh et al., 1999). Figure 4 shows an example of morphological variation within the 
same Foxg1
lacZ/lacZ
 embryo. Equally-spaced dorsal to ventral sections through one eye 
are shown in Figures 4B, E, H, K, N, Q, T and an equivalent dorsal to ventral series 
through the other eye is shown in Figures 4C, F, I, L, O, R, W. In Foxg1
lacZ/+
 embryos, 
the symmetry of the retina made the nasal-temporal divide simple to place, along a line 
that bisected the optic stalk. In dorsal sections, the Foxg1lacZ/lacZ retina tended to be 
more symmetrical, facilitating placement of the nasal-temporal dividing line.  
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Figure 4. Transcriptional activation of Foxg1 in the retina at E14.5.  
X-gal staining (blue) of E14.5 Foxg1
lacZ/+ 
embryos (A, D, G, J, M, P, S) and 
Foxg1lacZ/lacZ embryos (B, C, E, F, H, I, K, L, N, O, Q, R, T, U - W). Adjacent 
Foxg1lacZ/lacZ images in each row represent eyes from the same embryo at 
equivalent dorsal-ventral levels that appear different due to a slight asymmetry 
in the sectioning. All sections are 10m-thick horizontal cryostat sections and 
nuclei are counterstained with Nuclear Fast Red (pink). Foxg1
lacZ/+ 
embryos 
possess one functional copy of the Foxg1 allele and are phenotypically 
normal. Foxg1
lacZ/lacZ
 embryos cannot produce Foxg1 protein. The Foxg1
lacZ
reporter allele reveals sites where Foxg1 is transcriptionally active via the 
production of lacZ protein, which turns X-gal blue. (A) In the Foxg1
lacZ/+
 eye, 
extremely dorsal sections reveal lacZ staining throughout all layers of the 
nasal and temporal retina. (D, G) Dorsal sections through the same Foxg1
lacZ/+ 
eye show lacZ staining predominantly in the nasal retina but also a lacZ-
negative region in temporal retina that becomes larger as sections move 
ventrally. (J) In central Foxg1
lacZ/+ 
sections the nasal half of the retina is lacZ-
positive. (M, P) Moving ventrally, the nasal lacZ-stained area becomes 
smaller and increasingly restricted to the anterior-most region of the nasal 
retina until it disappears in extremely ventral sections (S). (B, C) In 
Foxg1lacZ/lacZ embryos, extremely dorsal retinas show scattered lacZ staining 
mainly in the temporal retina with a few nasal lacZ-positive cells. (E, F, H) 
Dorsal Foxg1
lacZ/lacZ
 sections ventral to (B, C) show strong lacZ staining in the 
temporal retina, particularly in the inner RGC layer. Less staining is present 
nasally. (I, K, L) In dorsocentral sections, lacZ staining is prominent in the 
temporal RGC layer but appears more scattered and less concentrated in outer 
retinal layers. Staining is strong throughout all layers of the nasal medially-
extended retina and also near the nasal ciliary marginal zone (I, L). (N, Q) 
Ventrally, temporal staining decreases, whilst nasal staining in the medial 
loops of the extended retina remains strong. (O, R) Ventral Foxg1
lacZ/lacZ
 eyes 
cut at a slightly different angle to (N, Q) such that nasal staining in the 
medially extended retina is present in more dorsal sections (I, L). (T, W) In 
ventral-most sections of Foxg1
lacZ/lacZ
 eyes, there are very few lacZ-stained 
cells. High power magnifications of (T) showing (U) temporal and (V) nasal 
retina with arrows pointing to some lacZ-positive cells. Scale bars: 200µm in 
A – T & W, 50µm in U, V. Abbreviations: N, nasal; T, temporal; l, lens; er, 
extended retina; a, retinal axons; tel, telencephalon; rpe, retinal pigment 


























































































Figure 5. Foxg1 activation in the E14.5 retina.  
X-gal staining of E14.5 Foxg1
lacZ/+ 
embryos (A – C) and Foxg1
lacZ/lacZ 
embryos (D - I) counterstained with Nuclear Fast Red. All sections are 
horizontal cryostat sections. (A) Foxg1lacZ/+ section just dorsal to the level of 
the optic stalk showing lacZ staining throughout the nasal retina with a few 
scattered cells temporally. High power magnifications of the (B) temporal and 
(C) nasal retina that are depicted as boxed regions in (A). (B) LacZ-positive 
cells are scarce in the temporal RGC layer of the retina. (C) In nasal retina, 
lacZ-positive cells are found throughout all retinal layers but staining is 
particularly strong (very dark blue) in the RGC layer. The white dotted line 
delineates the border between the RGCs and outer retinal layers. (D) An 
equivalent dorsal Foxg1
lacZ/lacZ 
section to (A) showing lacZ staining 
temporally. (E) High power magnification of boxed area in the temporal retina 
of (D) showing strong lacZ staining in the RGC layer but more scattered 
weaker staining in outer layers. (F) Foxg1
lacZ/lacZ
 section ventral to (D). High 
power magnifications of (G) nasal and (H) temporal retina that are boxed in 
(F). (G) LacZ-positive stripes, one to a few cells wide, spanning the extended 
retina are visible nasally. (H) Temporally, LacZ-expressing cells are found 
mainly in the RGC layer but also in the outermost retinal layer. (I) 
Foxg1lacZ/lacZ nasal region of the medial extended retina showing dense lacZ 
staining spanning the retina.  
Scale bars: 200µm in A, D, F; 100µm in B, C, E, G, H, I. Abbreviations: N, 
nasal; T, temporal; l, lens; er, extended retina; r, retina; rpe, retinal pigment 












































However, in ventral sections, the medial folding of the anterior retina was more 
pronounced in all embryos examined. In these instances, the dividing line between 
nasal and temporal retina was placed at roughly a 60 degree angle to the anterior-
posterior axis of the brain. 
5.4.2.3. Transcriptional activation of Foxg1 in the E14.5 Foxg1lacZ/lacZ
retina. 
The variation in the appearance of the Foxg1
lacZ/lacZ
 retina meant that the lacZ staining 
pattern in eyes sectioned at equivalent dorsal-ventral locations also showed a degree of 
variability. Nevertheless, the lacZ staining patterns of different Foxg1
lacZ/lacZ
 eyes from 
E13.5 to E15.5 showed common reproducible features that did not appear random. In 
the E14.5 Foxg1lacZ/lacZ dorsal retina, scattered lacZ staining was found in the temporal 
retina with less dense staining nasally. This is essentially a mirror image of the Foxg1
activation pattern in Foxg1
lacZ/+ 
dorsal retina (compare Figures 4A, D with Figures 4B, 
E). Dorsally, the most intense lacZ expression was found in the RGC layer, resembling 
that found in the Foxg1
lacZ/+ 
nasal retina, with sparser, weaker staining in the outer 
retina (Figure 5E). Moving ventrally but remaining in the dorsal retina, Foxg1lacZ/lacZ
embryos displayed strong, dense lacZ expression in the temporal RGC layer with 
weaker, more scattered expression in outer layers (Figures 4E, F, H). In the same 
sections, lacZ-positive cells were rarely found in the nasal retina. Foxg1 activation in 
the ventral Foxg1 null retina resembled that of the Foxg1
lacZ/+ 
retina with lacZ staining 
becoming increasingly restricted to the nasal medially-extended retina, whereas 
staining in temporal RGCs decreased (Figures 4K, L, N, O, Q). Foxg1 activation 
spanned the nasal extended retina whereas in temporal retina, lacZ-expressing cells 
were mainly found in the inner retinal layer (Figures 5G, H, I). Radial lacZ-positive 
stripes one to a few cells wide were observed nasally in the extended retina (Figures 5F, 
G) and the medial loop of the nasal extended retina consistently displayed intense lacZ 
staining (Figures 4K, N, Q & 5I). In extremely ventral sections, very few lacZ-positive 
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cells were observed in the nasal or temporal retina (Figures 4T, U, V, W). There 
appeared to be a slight temporal bias in the location of these sparse cells (compare 
Figures 4U & V). In both Foxg1lacZ/+ and Foxg1lacZ/lacZ embryos, lacZ staining was also 
observed in the lens, telencephalon, optic chiasm midline (see Chapter 6) and superior 
colliculus. 
At E13.5 (Figure 6) and E15.5 (Figure 7), lacZ staining of Foxg1
lacZ/lacZ
 embryos 
revealed a similar pattern of Foxg1 activation compared to E14.5 Foxg1lacZ/lacZ retinas. 
The morphology of the Foxg1 null eye at E15.5 resembled that of the eye at E14.5 
more closely compared to E13.5. Morphological variability between eyes within the 
same embryo is demonstrated at E15.5 in a dorsal-ventral series through one eye in 
Figures 7C, F, I, L, O and an equivalent series through the other eye in Figures 7D, G, 
J, M, P. Dorsal-most sections exhibited strong lacZ staining in posterior temporal retina 
with less dense staining nasally at E15.5 (Figs. 7C, D) and E13.5 (Fig. 6A). Moving 
ventrally through the E15.5 (Figs 7E - J) and E13.5 (Figs. 6C, D) eye, lacZ staining was 
consistently strong in the inner RGC layer of the nasal and temporal retina with 
scattered staining in other retinal layers. Ventral sections of the E15.5 retina showed a 
reduction in both the number and density of lacZ-positive cells situated in temporal 
retina (Figs. 7L, M). This was not apparent at E13.5, where strongly lacZ-expressing 
cells were still found in ventrotemporal regions (Figs. 6I, J). However, in the E13.5 
central retina, a nasal bias in staining was observed particularly in the medial part of the 
extended retina (Figs. 6H, I). In the E13.5 and E15.5 ventral retina, temporal lacZ-
expressing cells were mainly found in the RGC layer with outer layers containing fewer 
lacZ-positive cells (Figs. 6H, I, J & 7L, M). However, the E13.5 retina displayed 
stronger temporal staining than at E15.5. Ventronasally, the medially extended retina 
stained strongly for lacZ at both ages (Figs. 6G, H, I & 7M, P). In ventral-most 
sections, only a few lacZ-expressing cells were found scattered throughout the nasal 
and temporal retina (Figs 6K & 7O) and there appeared to be a slight temporal bias in 
their location (Figs. 6K, L, M) as for ventral E14.5 retinas. 
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Figure 6. Transcriptional activation in the E13.5 Foxg1lacZ/lacZ
retina. 
X-gal staining of E13.5 Foxg1lacZ/lacZ embryos counterstained with Nuclear 
Fast Red. All sections are horizontal cryostat sections. Sections are ordered in 
a dorsal-ventral series from (A) most dorsal to (K) most ventral. (A) 
Extremely dorsal section showing lacZ staining scattered throughout temporal 
retina and partly in the nasal retina. (B) Section ventral to (B) showing 
staining laterally in temporal and nasal regions. (C) Strong lacZ staining is 
present in the nasal retina (arrows) and in the inner RGC layer of the 
peripheral temporal retina. Scattered staining is found in outer temporal retinal 
layers. (D) LacZ staining predominates in the inner retinal layers in both 
temporal and nasal regions. (E) Section ventral to (D) showing axons (a) 
leaving the eye and growing medially along the extended retina. (F, G) High 
power magnifications of boxed areas in (E). (F) Temporally, scattered lacZ-
positive cells are found mainly in the inner retinal layers with a few in the 
outermost layers. (G) Nasally, strong, dense lacZ staining is concentrated in 
the medial extended retina. (H, I) Ventral sections showing strong, dense 
staining throughout the nasal retina. Strong staining is found in the inner 
temporal retina layers but medial regions are mostly lacZ-negative. (J) Section 
ventral to (I). In temporal regions, lacZ staining spreads into all retinal layers 
but remains strongest in the inner retina. Nasal regions have less stain. (K) 
Extremely ventral section. (L, M) High power magnifications of temporal and 
nasal retina shown as boxed regions in (K). LacZ-positive cells are observed 
more frequently in temporal retina (L) than nasal retina (M). Abbreviations: 
N, nasal; T, temporal; l, lens; rpe, retinal pigment epithelium; a, axons. Scale 





















































Figure 7. Transcriptional activation of Foxg1 in the Foxg1lacZ/lacZ
eye at E15.5. 
X-gal staining of 10m-thick cryostat sections through a E15.5 Foxg1lacZ/lacZ
embryo. Brown DAB staining indicates the location of Zic2 protein 
expression, which is expressed strongly in the anterior dorsal thalamus, 
particularly medially, parts of the ventral thalamus and also in the retina. All 
sections are cut horizontally. (A, C, F, I, L) Dorsal to ventral sections through 
a Foxg1
lacZ/lacZ
brain at E15.5. In these images the right eye (magnified in E, 
H, K, N) is ventral to the left eye (magnified in B, D, G, J, M). (A, B) Dorsal 
section showing scattered lacZ staining in the nasal and temporal retina. (C – 
E) Dorsal and (F – H) dorsocentral retinal sections showing staining in nasal 
and temporal regions including the medially-elongated retina (er). LacZ
staining is particularly strong in the RGC layer in all sections. (I – K) Ventral 
sections showing staining predominantly in the nasal extended retina, 
including the RGC layer (arrows in J & K). The nasal staining bias is more 
obvious in section (K), which is ventral to (J). Scattered lacZ-positive cells are 
mainly present in the RGC layer of the temporal retina. (L – N) Ventral retinal 
sections. (M) Scattered lacZ-positive cells in the inner nasal and temporal 
layer. (N) Section ventral to (M) showing staining mainly in the nasal 
extended retina. (P) Ventral section to (N) showing scattered lacZ staining 
mainly in the temporal retina (R) but not in nasal retina (Q). Abbreviations: A, 
anterior; P, posterior; D, dorsal; V, ventral; er, extended retina; l, lens; tel, 
telencephalon; th, thalamus. Scale bars: 400µm in A, C, F, I, L; 100µm in B, 
D, E, G, H, J, K, M, N. 
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In summary, these results indicate that in Foxg1
lacZ/+ 
embryos that are phenotypically 
indistinguishable from wild types, Foxg1 is expressed in nasal and temporal parts of the 
dorsal retina, with most widespread expression dorsonasally. The Foxg1 expression 
domain becomes increasingly restricted to nasal regions in the ventral retina. In 
Foxg1
lacZ/lacZ 
eyes, Foxg1 activation is more widespread in the temporal retina but less 
widespread in dorsonasal regions compared to Foxg1
lacZ/+
 embryos.  
5.4.3. Lineage tracing of Foxg1 expression in the retina. 
LacZ-staining of retinal sections from mice carrying the Foxg1
lacZ
 allele revealed only a 
snapshot of Foxg1 transcriptional activation at a given time-point or developmental 
stage. Therefore, lacZ-negative cells could have activated Foxg1 at a previous point in 
time during development but subsequently turned it off. In order to discover whether a 
given retinal cell or any of its descendants had ever expressed Foxg1, lineage tracing 
was performed using floxed ROSA26 reporter mice (Mao et al., 1999). This line of 
mice contains a  galactosidase-neomycin phosphotransferase fusion gene (geo)-
trapped ROSA26 locus modified such that geo is ubiquitously expressed only after 
Cre-mediated excision of loxP-flanked DNA sequences. ROSA26 mice were crossed 
with Foxg1
Cre/+
 mice that express cre recombinase in cells where the Foxg1 promoter is 
active (Hebert & McConnell, 2000). LacZ staining of the embryos was used to reveal 
cells & their descendants in which Foxg1 was activated at any time during their lineage 
due to cre-mediated recombination and excision of a stop codon upstream of the geo
reporter allele. The matings generated compound heterozygous embryos that contained 




 embryos are 
phenotypically normal and lacZ staining revealed cells and their descendants that have 
expressed Foxg1 at any time during their lineage. Foxg1
Cre/Cre
 embryos cannot produce 
functional Foxg1 protein due to the insertion of a cre recombinase cassette in the Foxg1
coding sequence (Hebert & McConnell, 2000). Therefore, lacZ staining of Foxg1
Cre/Cre
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embryos revealed cells in which the Foxg1 promoter has ever been active and would 
normally produce Foxg1 protein.  
5.4.3.1. Foxg1 expression in Foxg1Cre/+ ; ROSA26 embryos. 
In the dorsal retina, Foxg1
Cre/+
 ; ROSA26 embryos displayed lacZ staining nasally 
(Figs. 8A-D, I, J). In the most dorsal sections, lacZ staining was seen in the nasal and 
temporal retina (Fig. 8A). A lacZ-negative region appeared in the lateral part of the 
temporal retina (Fig. 8B, I) and this expanded medially as sections became increasingly 
ventral (Figs. 8C, D, J). In the dorsotemporal retina, radial columns of lacZ-expressing 
cells, that were mostly one- to two-cells wide, were observed spanning the retina from 
the inner to outer layers. These radial stripes are likely to be radial clones of cells 
arising from single lacZ-positive retinal progenitors (Reese et al., 1999). Examination 
of serial sections revealed that these radial stripes were not confined to one part of the 
retina. In the central retina at the level of the optic stalk, half of the retina was lacZ-
positive and half was mostly lacZ-negative apart from a few, scattered lacZ-stained 
cells. The lens (Figs. 8C, D, E) and nasal part of the optic stalk (Fig. 8K) also exhibited 
strong staining. Ventral to the optic stalk, nasal lacZ staining was reduced gradually as 
sections became more ventral (Figs. 8F - H, L, M, N) and the boundary between lacZ-
positive and -negative regions shifted nasally (anteriorly). LacZ-stained cells were 
observed scattered in the temporal retina as in dorsal sections. In ventral-most sections, 
both the nasal and temporal retina displayed scattered lacZ-positive cells, although 
there was a nasal bias in their distribution (Fig. 8N). In the nasal retina, lacZ-staining of 
the retina was particularly prominent in the outer-most layer and also the inner retinal 
layer where RGCs are found (Figs. 8J, K, L).  
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Figure 8. Lineage tracing of retinal cells that have expressed 
Foxg1 using E14.5 Foxg1Cre/+; R26RS embryos. 
X-gal staining of horizontally-sectioned Foxg1Cre/+; R26RS eyes reveals 
retinal cells and their descendants that have expressed Foxg1 at any time 
during their development. Staining is widespread in dorsal sections but 
becomes increasingly restricted to the anterior-most nasal retina in ventral 
sections. (A – H) Dorsal to ventral series of X-gal-stained sections through a 
Foxg1
Cre/+
; R26RS eye. (I – M) High power magnifications of (B), (D), (E) 
and (G). (A) Dorsal-most section showing uniform staining for lacZ in nasal 
and temporal retina. (B, C, D, I) Sections ventral to (A) showing uniform 
staining in the nasal retina. The lacZ-negative region in the temporal retina 
grows progressively larger as the sections become more ventral. (B, I) Small 
areas of lacZ-negative regions in the posterior-most temporal retina (indicated 
with an arrow in I. (J) Radial columns of lacZ-positive cells spanning the 
temporal retina (arrows indicate some examples). (E, K) Section at the level of 
the optic stalk showing staining in the nasal retina and optic stalk and in a few 
radial columns temporally (arrows indicate some examples). (F, G, L) Ventral 
sections show lacZ staining increasingly restricted to the anterior-most nasal 
retina as the lacZ-negative region becomes larger. (H, M) Ventral-most 
section showing the complete absence of lacZ-staining in the retina. In (M) 
the dotted line outlines the lacZ-negative retina. Scale bars: 400µm in A – H; 
150µm in I – M. Abbreviations: A, anterior; P, posterior; N, nasal; T, 












Figure 8. Lineage tracing at E14.5 using










































5.4.3.2. Foxg1 activation in Foxg1Cre/Cre ; ROSA26 embryos. 
In dorsal-most sections, lacZ staining in Foxg1Cre/Cre ; ROSA26 embryos resembled that 
seen in Foxg1
Cre/+
 ; ROSA26 embryos with strong LacZ-staining in the whole of the 
dorsal retina (Fig. 9A, B). In dorsal sections, lacZ staining was seen throughout the 
nasal retina including the medially extended retina but lacZ-negative regions were 
observed in the lateral regions of the temporal retina, adjacent to the CMZ (arrowheads 
in Figs 9C - F). In the central retina, temporal LacZ-positive radial stripes were 
observed and lacZ-staining was found throughout the nasal retina as in Foxg1
Cre/+
 ; 
ROSA26 embryos (compare Figs. 9H & 8K). This lacZ-staining pattern was maintained 
in ventral sections: the nasal retina exhibited strong lacZ-staining throughout, whereas 
radial stripes of lacZ-expressing cells were present temporally (Figs. 9I - L). In the 
most medial parts of the extended retina, lacZ staining was strong throughout both 
nasal and temporal regions (Figs. 9B - M). In ventral-most sections, scattered lacZ-
expressing cells were found in nasal and temporal retina, whereas the medially 
extended retina showed strong lacZ-staining throughout (Fig. 9M).  
To summarise the lineage-tracing findings, cells in the ventrotemporal retina that would 
not normally express Foxg1 show Foxg1 activation in Foxg1 null embryos. 
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Figure 9. Lineage tracing of Foxg1 activation in retinal cells of 
E14.5 Foxg1Cre/Cre; R26RS embryos. 
Foxg1Cre/Cre; R26RS embryos cannot produce Foxg1 protein. X-gal staining of 
horizontally-sectioned Foxg1Cre/Cre; R26RS eyes reveals retinal cells and their 
descendants in which Foxg1 has been transcriptionally active at any time 
during their development. All sections are horizontal. (A - M) Sequence 
through the eye from most dorsal (A) to most ventral (M). Sections C, G, H, 
M are counterstained with Nuclear Fast Red. (A - F) Dorsal sections showing 
widespread lacZ staining over the entire retina. (A) Most dorsal section 
showing uniform lacZ staining. (C - F) Weaker staining is seen dorsolaterally 
(marked by arrowheads). (G, H) Sections of central retina showing staining 
predominantly in nasal retina. In temporal retina, radial columns of lacZ 
stained cells are observed (a few are marked with arrows in (H)). (I - M) 
Ventral sections showing staining predominantly in the nasal retina. In the 
ventral retina, lacZ staining is more patchy. (M) High power magnification of 
ventral-most retina showing patchy lacZ staining in the retina with strong 
staining in the extended retina. Abbreviations: l, lens; r, retina; er, extended 























Figure 9. Lineage tracing at E14.5 using





















5.4.4. Dorsoventral polarity. 
Dorsoventral polarity was investigated using EphB2 and ephrin-B2 at E13.5 and E16.5 
since these developmental ages span the peak period during which many RGCs project. 
Contralateral RGC axons start to project approximately one to two days earlier than 
ipsilateral RGC axons (Colello & Guillery, 1990; Guillery et al., 1995; Marcus et al., 
1995). At E13.5 contralateral RGCs have already started to project their axons towards 
the chiasm, whereas the formation of the permanent ipsilateral projection is still in its 
early stages (Sretavan, 1990). By E16.5, many contralateral and ipsilateral RGC axons 
have traversed the chiasm midline.  









gradient (Fig. 10A). These dorsoventral gradients were present 
in the Foxg1
-/-
retina at the same age with the medial extended retina showing levels of 
EphB2 and ephrin-B2 intermediate between the dorsal- and ventral-most regions (Figs. 
10C, G). At E16.5, the wild type and Foxg1
-/-
retina exhibited the same dorsal
[high]
 to 
ventral[low]  ephrin-B2 gradient as at E13.5 with strongest expression in the dorsolateral 
retina (Figs. 10B, D, D’). At the same age in wild type (Fig. 10F) and Foxg1
-/-
 embryos 
(Fig. 10H, H’), EphB2 was expressed equally in the dorsal and ventral retina, with 
slightly higher levels ventrolaterally, suggesting that the ventral retina is not expanded 
in Foxg1 nulls. In wild type and Foxg1
-/-
 E16.5 embryos, the optic chiasm and optic 
tracts stained strongly for EphB2 protein suggestive of EphB2 expression by navigating 
RGC axons (Fig. 10I, K). In addition, the wild type optic nerve displayed EphB2 
expression as did the Foxg1
-/-
 elongated retina.  
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Figure 10. The expression patterns of EphB2 and ephrin-B2 are 
maintained in the developing retina of Foxg1-/- embryos. Ephrin-B2 
(A – D) and EphB2 immunohistochemistry (E – L) in wild type (A, B, E, F, I, 
K) and Foxg1-/- embryos (C, D, G, H, J, L). Figures published in Pratt et al., 
2004. (A – H) Coronal sections (dorsal is pointing upwards); (I – L) horizontal





 gradient at E13.5 in the developing retina 
of a (A) wild type and (C) Foxg1
-/-
 embryo. The gradient is maintained at 
E16.5 in both (B) the wild type and (D, D’) the Foxg1
-/-
 retina. (D’) section 
anterior to (D) showing a more pronounced ephrin-B2 gradient compared to 





 gradient in the E13.5 retina in both (E) the wild type and (G) 
the Foxg1
-/-
 retina. At E16.5, these gradients are more shallow than at E13.5 
in both the (F) wild type and (H, H’) Foxg1
-/-
 retina. (H’) is anterior to (H) and 
shows a greater difference between strong EphB2 expression ventrolaterally 
and weak expression dorsolaterally. (E, F, I) The optic nerve (on) stains 
strongly for EphB2 protein consistent with EphB2 expression by navigating 
RGC axons. (I, K) In the wild type at E16.5, EphB2 is expressed in the optic 
nerve as it leaves the retina (r) and approaches the optic chiasm (oc) to emerge 
into the optic tract (ot) (boxed area in I). (J, L) In the Foxg1-/-embryo, EphB2 
is expressed in the elongated retina (er), at the optic chiasm and in the optic 
tract as it emerges from the chiasm (boxed area in J). (I – L) White dashed 
line indicates the position of the midline. Abbreviations: er, extended retina; l, 
lens; r, retina; rpe, retinal pigment epithelium; on, optic nerve; ot, optic tract; 
oc, optic chiasm. Scale bars: 100µm in A - H; 200µm in I - L. [Note: E16.5 
immunohistochemistry (Figures B, D, F, H, I - L) was performed by Dr 


























































5.5.1. The morphology of the Foxg1-/- retina retains many normal features. 
Despite abnormal folding of the Foxg1
-/-
 retina anteriorly, in more posterior regions, 
cellular differentiation of the retinal layers into the inner RGC layer and outer layers 
resembled the wild type (this Chapter and Huh et al., 1999). In addition, despite lacking 
a normal optic stalk, Foxg1
-/-
 retinal axons were observed leaving the retina from a 
medial opening in the eye where they formed an optic nerve-like structure that 
channeled axons towards the midline of the brain. These observations agree with and 
add detail to findings from previous DiI tracing experiments in this laboratory showing 
that retinal axons leave the eyes and form optic tracts (Pratt et al., 2002). These 
similarities with the wild type are remarkable considering the squashed, elongated 
appearance of the Foxg1-/- retina.  
Nevertheless, the Foxg1 null retina showed retinal abnormalities in anterior regions, 
particularly surrounding the ventral coloboma where the optic cup failed to close, as 
reported previously (Huh et al., 1999). The RGC layer occupied a wider area in this 
region. However, since the abnormal folding of the retina primarily occurs in anterior 
regions, this could lead to sectioning through the RGC layer at a different angle from 
that of the wild type. A better way of visualizing the RGC layer would be to 
fluorescently label Brn3a or Brn3b proteins that are expressed in almost all RGCs in the 
intact Foxg1
-/- 
eye. The eye could then be scanned in 3-dimensions using confocal 
microscopy and a 3-dimensional image of the RGC layer reconstructed on a computer. 
This would eliminate sectioning difficulties and determine whether the anterior regions 
of the retina show greater abnormalities in the organization of the RGC layer. If 3-
dimensional images reveal anterior defects in the RGC layer, a hypothetical cause of 
this could be defective retinal patterning along the AP axis because anterior regions 
normally express Foxg1 in the wild type (Hatini et al., 1994; Xuan et al., 1995; Huh et 
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al., 1999; Dou et al., 1999). In contrast, the organisation of the posterior retina, which 
does not normally express Foxg1, resembled the wild type more closely.  
In agreement with previous studies, the retinal pigment epithelium does not completely 
surround the extended retina, particularly in ventral and medial regions (Huh et al., 
1999). It is not known whether the absence of RPE along some regions of the Foxg1
null retina affects its development and thus presents a tantalizing area for future 
research. Similarly the slight ventral rotation of the Foxg1-/- eye and the abnormally 
small lens, both of which have been previously described (Hatini et al., 1994; Xuan et 
al., 1995; Dou et al., 1999; Huh et al., 1999), could potentially affect the expression of 
regulatory genes both within and outside the retina, contributing to its abnormal 
development. Since it is difficult to separate primary defects that are directly caused by 
the absence of Foxg1 from secondary defects that are knock-on effects resulting from 
the primary abnormalities in Foxg1
-/-
 embryos, it would be informative to conditionally 
knock out Foxg1 in the eye after it has developed normally. This is a project that is 
currently being pursued in this laboratory and promises to open more avenues of 
research that are not possible using Foxg1 null embryos alone.  




 embryos, when RGC axons are navigating the optic chiasm, lacZ staining 
revealed that transcriptional activation of Foxg1 occurs predominantly in the nasal 
retina with strong Foxg1 expression in RGCs, which project axons to the optic chiasm. 
Foxg1 expression was most widespread in dorsal retina, covering nasal and temporal 
regions. Foxg1 was only expressed in a few cells in the rest of the temporal retina and 
lineage tracing revealed that most temporal cells and their descendants never express 
Foxg1. These observations hint at the possibility of a cell autonomous role for Foxg1 in 
the guidance of retinal axons from the nasal retina, whereas this is not as plausible for 
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the temporal retina, the majority of whose cells do not express Foxg1 throughout 
development. 
The Foxg1 expression pattern described here is similar but not identical to that found 
previously using Foxg1
LacZ
 reporter mice (Huh et al., 1999) and by in situ hybridisation 
(Hatini et al., 1994). However, most of these previous descriptions state that Foxg1 is 
limited to the nasal retina until E12.5 (Figure 11A), whereas this chapter presents new 
findings of fairly substantial Foxg1 expression in the dorsotemporal retina from E13.5, 
with the border between Foxg1-positive and Foxg1-negative regions running at an 
angle to the NT axis (Figure 11Bi). The difference could be due to spatiotemporal 
changes in Foxg1 expression between E12.5, the latest age described in earlier studies, 
and E13.5-E14.5 (this Chapter). Alternatively, previous studies may have used a 
slightly different plane of section, such that the NT axis is angled relative to the one 
shown here. Regardless of these differences, this is the first comprehensive description 
of Foxg1 expression through the entire retina at E14.5.  
All the Foxg1
lacZ/lacZ
 retinas examined for this chapter displayed morphological 
variation, between and within embryos, consistent with previous reports (Huh et al., 
1999). Nevertheless, consistent trends in the lacZ staining patterns were observed. A 
schematic diagram of the pattern of Foxg1 activation is shown in Figure 11Bii. 
Foxg1
lacZ/lacZ
 retinas displayed a similar Foxg1 activation pattern to Foxg1
LacZ
heterozygotes in mid - ventral retinal sections where nasal lacZ staining predominated. 
Therefore, nasotemporal polarity appeared to be maintained in some retinal locations. 
The presence of blue lacZ-positive cells showed that cells that would normally express 
Foxg1 were present in Foxg1
-/-
 retinas, ruling out a simple deletion of nasal cells. 
However, Foxg1
lacZ/lacZ
 embryos displayed more extensive Foxg1 activation in the 
temporal retina, particularly in dorsal parts but also ventrally, whereas DN regions 
displayed reduced Foxg1 activation relative to Foxg1lacZ/+ embryos. Similar 
observations were made in the lineage tracing experiments with Foxg1 null embryos.  
(A) Foxg1 expression pattern described in the 
literature (optic cup stage until ~ E12.5)
(B) Foxg1 activation at E14.5
Early in eye development until ~ 
E12.5, Foxg1 (blue) is expressed in 
the nasal half of the retina and 
Foxd1 (yellow) is expressed in a 
complementary pattern in the 
temporal retina. Together these 
transcription factors are thought to 
set up nasal-temporal polarity (Hatini
et al., 1994; Huh et al., 1999).
.  
Foxg1LacZ/+
Foxg1 expression (blue) is more 
widely expressed in dorsal retina 
compared to ventral retina. The 
boundary between Foxg1-positive 
and Foxg1-negative regions is 
slanted at an angle to the vertical 
DV axis. Dots represent RGCs.  
Compared to the Foxg1LacZ/+ retina, there 
is no clear divide between Foxg1-
expressing and non-expressing regions. 
The area over which Foxg1 is activated is 
reduced in DN retina but increased in the 
DT and VT quadrants. The VN region 
shows more variable activation possibly 
due to greater morphological 















Together, these findings suggest that cells in the temporal retina that would not 
normally express Foxg1 activate Foxg1 in the Foxg1
-/-
 retina. Also, cells in the 
dorsonasal retina that would normally express Foxg1 in Foxg1lacZ/+ embryos do not 
activate Foxg1 in the Foxg1
-/-
 retina. It is unclear whether the temporal cells that 
ectopically activate Foxg1 have been mis-specified as ‘nasal’ cells through defective 
nasal-temporal patterning or whether they are nasal cells that have migrated abnormally 
into temporal regions. Similarly in the DN retina, cells that fail to activate Foxg1 may 
have been mis-specified as ‘temporal’ cells or they may have migrated from Foxg1-
negative temporal regions. Ideally, a migratory defect would be investigated by 
fluorescently labeling a single cell in the nasal retina within the developing eye, in vitro
or in vivo. Abnormal migration into temporal regions would be visible by fluorescence 
in the temporal retina.  
The alternative explanation to a migratory defect in the Foxg1 null retina is that NT 
patterning is altered. This is not an unexpected occurrence, since the misexpression of 
Foxg1 and Foxd1 homologues in the chick (CBF1 and CBF2) affects their mutual 
expression domains and also the expression of other nasal and temporal patterning 
genes: EphA3, SOHo1, GH6, ephrin A2 and ephrin A5 (Takahashi et al., 2003). In 
order to confirm whether patterning of the retina along the nasal-temporal axis is 
affected by the absence of Foxg1 as suggested by the Foxg1
LacZ
 reporter mice, it would 
be prudent to investigate the nasal-temporal expression patterns of molecules in the 
retina. This would also confirm whether lacZ expression in Foxg1 null embryos 
faithfully reports regions in which Foxg1 is active, as previously found in Foxg1lacZ/+
reporter mice (Xuan et al., 1995). Without further investigation of nasal-temporal 
patterning, it remains possible that Foxg1
LacZ
 is ectopically expressed in the 
Foxg1
lacZ/lacZ
 retina, which would provide misleading evidence for NT disruption. This 
seems unlikely given that lacZ staining in Foxg1
lacZ/lacZ
 embryos was observed in 
tissues that would normally have expressed Foxg1 during development, notably in the 
telencephalon, lens, ventral hypothalamus (see Chapter 6), RPE, nasal epithelium and 
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superior colliculus (this Chapter and Hatini et al., 1994; Huh et al., 1999). These 
findings provide evidence against but cannot exclude the possibility of ectopic Foxg1
activation in the Foxg1lacZ/lacZ retina. Ephrin-A5 is restricted to the nasal retina and it 
would be interesting to see whether its expression pattern resembles that of Foxg1. This 
would be interesting given that CBF1 in chick has been shown to control retinal ephrin-
A5 via a DNA-binding-dependent mechanism (Takahashi et al., 2003). It would also be 
sensible to examine the expression patterns of molecules present in the temporal retina, 
such as Foxd1 and EphA5/EphA6, the latter of which are expressed in a low nasal to 
high temporal gradient. 
Overall, these results warrant a more in-depth investigation of nasotemporal patterning, 
since increased specification of temporal regions could promote more axons to remain 
ipsilateral at the chiasm.  
5.5.3. Expression gradients of EphB2 and ephrin-B2 are maintained along 
the dorsoventral axis in Foxg1 null embryos. 
The EphB2 and ephrin-B2 dorsal-ventral expression gradients were maintained in 
Foxg1
-/-
 embryos at E13.5 and E16.5. Thus it is unlikely, but not impossible, that the 
ventral region of the Foxg1
-/- 
retina is expanded. It remains feasible that EphB2 and 
ephrin-B2 are expressed normally in the absence of Foxg1, whereas the expression of 
other ventral markers may be affected. This could be investigated by examining the 
expression of other dorsally and ventrally expressed molecules, such as the dorsal 
marker Tbx5 and ventral marker Vax2. In fact the bi-axial patterning of the retina is an 
over-simplistic view as several regulatory genes, such as Vax2 and ventroptin, involved 
in retinal polarity are not expressed solely along the DV or NT axis. This is reflected in 
ectopic expression studies of ventroptin or Tbx5 in the chick where both DV and NT 
maps are affected, consistent with their normal expression gradients along both of these 
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axes (Sakuta et al., 2001). Therefore, regulatory transcription factors expressed in the 
retina combine in various ways that are still not fully understood to regulate the 
expression of DV and NT guidance molecules.  
5.5.4. Summary. 
In summary, despite the abnormal squashed and medially-elongated appearance of the 
Foxg1
-/-
 eye, the retinal layers appear to form normally in their correct locations, apart 
from defects in the RGC layer anteriorly that might be either sectioning artifacts caused 
by retinal folding or secondary consequences of retinal patterning defects and which 
might affect axon routing. DV polarity appeared to be maintained in the Foxg1
-/-
 retina 
based on the dorsoventral expression gradients of two molecules known to play roles in 
retinotectal mapping. Cells that would normally express Foxg1 were not present in the 
same nasal-temporal pattern as for wild type embryos, although a nasal bias in Foxg1
activation was observed in more ventral retinal locations. This might suggest either 
defective nasal-temporal patterning of the retina or aberrant migration, both leading to a 
retina in which cells with nasal characteristics are found in temporal regions and vice-
versa. Evidence against a complete breakdown of nasal-temporal polarity comes from 
the co-culture findings that demonstrated significant differences among cultures 
comprised of DN retina and chiasm cells but not among VT retina combinations 
prepared from wild type and Foxg1
-/-
 tissue (see Chapter 3). Also, Pratt et al. (2004) 
showed that a greater proportion of ipsilateral projections still originated from the 
temporal retina as in wild types. Moreover, expression of Zic2 was predominantly 
affected in the nasal region of the Foxg1
-/-
 retina whereas its temporal expression was 
broadly maintained (Chapter 4). Thus it appears that the absence of Foxg1 in vivo and 
in vitro mainly affects the molecular characteristics and axon routing of RGCs from the 
nasal retina in which Foxg1 is normally expressed. Nevertheless, further investigation 
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into nasal-temporal patterning is required to determine whether the Foxg1
-/-
 retina 
shows temporal abnormalities.  
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The co-culture findings in Chapter 3 show that the optic chiasm of Foxg1
-/-
 embryos is 
more inhibitory and/or less attractive to nasal retinal axons. This could occur through the 
increased expression of a repulsive guidance cue, reduced expression of an attractive cue 
or simply through abnormal morphology of the chiasm region. Therefore, the aim of this 
Chapter was to examine the cellular and molecular morphology of the Foxg1
-/-
 chiasm 
and the expression of key molecules known to influence the guidance of retinal axons at 
the chiasm. Throughout the period when retinal axons project, the Foxg1 activation 
pattern and morphology of the Foxg1
-/-
 chiasm region retained many wild type features. 
In Foxg1-/- embryos the expression patterns of the transcription factor Nkx2.2, and of cell 
surface molecules stage-specific embryonic antigen-1 (SSEA-1) and CD44 that are 
expressed by a population of chiasm neurons, were not dissimilar from the wild type. 
Ephrin-B2, which is required for the formation of the ipsilateral projection, was present 
at the Foxg1
-/-
 chiasm midline as for the wild type. In summary, key chiasm cells and 
molecules were present in the Foxg1-/- chiasm and failed to show obvious abnormalities 
in spatial or temporal expression. Nevertheless, this does not rule out a change in the 
expression of other guidance cues at or surrounding the optic chiasm, nor does it rule out 
the possibility of Foxg1
-/-
 retinal axons interacting with chiasm molecules in a different 
manner to wild type axons.  
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6.2. INTRODUCTION
6.2.1. Overview of retinal axon navigation at the developing mouse optic 
chiasm. 
The aims of this chapter were to determine whether the Foxg1
-/-
chiasm architecture is 
maintained and whether molecules expressed by cells at or surrounding the optic chiasm 
in Foxg1
-/-
embryos are present in the wild type conformation. The first retinal axons 
arising from the dorsocentral (DC) retina start to project towards the chiasm from E12 in 
the mouse (Colello & Guillery, 1990). These pioneer axons grow towards the ventral 
midline of the hypothalamus and enter the chiasm region via the optic stalks. The first 
axons project both contralaterally and ipsilaterally in a stochastic manner, although the 
ipsilateral projection is only transient at this stage and uncrossed axons enter the optic 
tract directly rather than contacting midline cells (Colello & Guillery, 1990; Guillery et 
al., 1995; Marcus et al., 1995). From E13 - E15, many RGC axons project towards and 
across the chiasm. Since RGC differentiation proceeds radially outwards from 
dorsocentral to peripheral retina (Drager, 1985; Reese and Colello, 1992), contralateral 
projections from RGCs located over the entire retina form prior to E14.5, when 
permanent ipsilateral projections begin to arise from the VT retina (Colello & Guillery, 
1990). During the peak phase of retinal axon divergence between E14 and E16, in vitro
and live imaging (Godement et al., 1994; Sretavan & Reichardt, 1993) has revealed that 
the chiasm region is generally inhibitory to axons and that this inhibition can be 
attributed to cells (Wang et al., 1995), membranes (Wizenmann et al., 1993) and the 
secretion of a diffusible factor that inhibits axon growth from all retinal regions (Wang et 
al., 1996).  
A midline specialisation of radial glial cells contacts all retinal axons in the chiasm 
region (Marcus et al., 1995). Contacts between navigating growth cones and glial 
processes have been shown to be crucial for the formation of the permanent ipsilateral 
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projection from VT retina. Recently, it was shown that repulsion between EphB1 
receptors on VT axons and ephrin-B2 present on midline radial glia is the main 
mechanism by which the permanent uncrossed projection develops (Nakagawa et al., 
2000; Williams et al., 2003). It is only after contacting the midline radial glia that axons 
‘decide’ whether to cross into the contralateral tract or remain ipsilateral. Videos of 
axons in brain preparations revealed that the growth of retinal axons through the chiasm 
is retarded, during which their growth cones increase in complexity as their filopodia 
constantly extend and retract (Godement et al., 1994; Sretavan & Reichardt, 1993). The 
slowing of axons as they enter the chiasm is probably due to the growth-inhibitory 
chiasm environment. Ipsilateral axons have complex filopodia that become simpler upon 
entering the ipsilateral optic tract. Constant growth cone remodelling and complex 
growth cone morphology is thought to be associated with axons sampling and integrating 
diffusible and cell surface guidance cues prior to committing themselves to a given 
trajectory.  
6.2.2. SSEA-1 & CD44. 
Stage-specific embryonic antigen-1 (SSEA-1) and CD44 are cell surface carbohydrate 
moieties on glycoproteins and glycolipids that are expressed by a specialized group of 
early-differentiating neurons immediately posterior to the developing optic chiasm and 
both molecules have been implicated in influencing the paths taken by navigating retinal 
axons throughout development of the retinofugal pathway (Sretavan et al., 1995; 
Sretavan et al, 1994; Marcus & Mason, 1995; (Kruger et al., 1998); Lin et al., 2005). 
SSEA-1 is thought to be essential for the formation of the characteristic ‘X’-shape by 
retinal axons at the chiasm (Mason & Sretavan, 1997; Erskine et al., 2000; Runko & 
Kaprielian, 2002). At E12.5, SSEA-1 neurons are expressed in an inverted ‘V’-shape, 
with the tip of the ‘V’ pointing anteriorly. RGC axons grow towards, contact and then 
travel along the surfaces of SSEA-1-positive neurons but not through them. As 
development proceeds, axons are added progressively to more anterior locations, such 
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that the bundle of axons develops from posterior to anterior (Sretavan et al., 1994; 
Marcus & Mason, 1995). From E13 – E16, the expression pattern of SSEA-1 becomes 
more elaborate, concomitant with the peak period of axon growth through the optic 
chiasm (Lin et al., 2005). At these later ages, SSEA-1-expressing neurons are 
increasingly found adjacent to retinal axons at the chiasmatic midline and along the 
region where axons enter the optic tracts and therefore, are present in the appropriate 
locations to influence axon growth.  
SSEA-1 neurons have been shown to provide repulsive guidance cues to retinal axons in 
vitro (Sretavan et al., 1994; Marcus & Mason, 1995) and the addition of SSEA-1 to 
retinal explants is capable of inhibiting neurite outgrowth equally from both dorsonasal 
and ventrotemporal regions. Therefore, an expansion of the SSEA-1 population 
anteriorly might repel a greater proportion of retinal axons into the ipsilateral tract and 
reduce the proportion that is able to cross the midline. This possibility was addressed by 
immunohistochemical detection of SSEA-1 during early chiasm development at E13.5 
and later at E15.5, when more axons have passed through the chiasm. 
The cell surface transmembrane glycoprotein CD44 occupies a more restricted area 
compared with SSEA-1 and is expressed by more central chiasm neurons (Lin et al., 
2005). The expression domains of SSEA-1 and CD44 overlap at the chiasm midline, 
including the raphe of midline glia but laterally, chiasm neurons express only SSEA-1. 
Eliminating CD44-immunoreactive neurons by complement-mediated antibody ablation 
prevents axons from entering the chiasm (Sretavan et al., 1995). However, this study 
eliminated the CD44-bearing neurons and did not address the effects of CD44 itself on 
retinal axons. In vitro experiments in the mouse demonstrated that CD44 inhibits 
outgrowth of axons from retinal explants (Sretavan et al., 1994). In semi-intact 
retinofugal pathway explants, anti-CD44 antibodies reduced the contralateral projection 
but left the ipsilateral projection unaffected at E13 (Lin et al., 2003). In E15 explants, 
anti-CD44 treatment reduced the uncrossed projection but left the contralateral projection 
unaffected. The authors concluded that at early stages in retinofugal development, CD44 
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promotes the midline crossing of axons but at later stages, CD44 is required for the 
formation of the permanent ipsilateral projection. Therefore, one hypothesis for the 
increased ipsilateral projection of Foxg1-/- embryos is that increased CD44 expression in 
the ventral diencephalon at E15.5 produces a chiasm environment that is less conducive 
to axon crossing. This hypothesis was tested by investigating CD44 protein expression 
using a monoclonal CD44 antibody. 
6.2.3. Nkx2.2. 
A number of regulatory genes are expressed in the diencephalon in cells surrounding or 
located at the chiasm midline, some of which have been implicated in controlling the 
trajectory of retinal axons at the midline (Marcus et al., 1999). One such molecule is the 
transcription factor Nkx2.2, which is expressed by cells and radial glia at the midline of 
the optic chiasm where axons decussate and also in the SSEA-1/CD44-expressing 
neuronal array (Marcus et al., 1999). Nkx2.2 protein expression was investigated at the 
Foxg1
-/-
chiasm to see whether Nkx2.2-expressing chiasm cells were present in their 
correct locations. Abnormalities in the distribution of Nkx2.2-expressing cells, such as 
disorganisation or an expansion/reduction, may suggest abnormal interactions between 
retinal axons and key cells at the chiasm, which might alter their trajectory.  
6.2.4. Ephrin-B2. 
Ephrin-B2 is expressed by midline radial glia at the mouse optic chiasm (Williams et al., 
2003). In Xenopus and mice, the appearance or upregulation of ephrin-B2 expression 
around the chiasm region has been linked to the appearance of the ipsilateral projection 
(Nakagawa et al., 2000; Williams et al., 2003). In a semi-intact visual pathway explant, 
inhibition of ephrin-B2 activity by soluble EphB4-Fc completely abolished the formation 
of ipsilateral projections showing that ephrin-B2 is necessary for the ipsilateral projection 
to form (Williams et al., 2003). Williams et al. (2003) also showed that ephrin-B2 is 
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selectively inhibitory to VT retinal axons, which express EphB1 that is responsible for 
their repulsion by ephrin-B2-expressing radial glia at the chiasm midline. At E13.5 in the 
mouse, when ipsilateral projections from the VT retina start to enter the chiasm region, 
ephrin-B2 is weakly expressed at the chiasm. Ephrin-B2 expression increases up until 
E16.5 during the key period when the majority of RGCs project axons towards the optic 
chiasm (Williams et al., 2003). It follows that an increase in expression of ephrin-B2 at 









) allele in which coding sequences are replaced by a LacZ 
cassette (Xuan et al., 1995). Foxg1
LacZ
 is a predicted null allele (designated Foxg1
-/-
) 
(Xuan et al., 1995; Hebert and McConnell, 2000). Foxg1 homozygous mutants 
(Foxg1
LacZ/LacZ
) were identified by their hypoplastic telencephalon and distorted eyes. 
Heterozygous embryos (i.e. Foxg1LacZ/+) were identified by PCR genotyping: they were 
indistinguishable morphologically from wild types (Xuan et al., 1995; Huh et al., 1999) 
and no RGC axon projection defects were observed at the optic chiasm. 
Dissections: Pregnant females were terminally anaesthetized and E13.5, E14.5 or E15.5 
embryos removed by caesarian section in ice-cold PBS. 
PCR genotyping Foxg1 alleles: Tails were removed from the embryos to obtain tissue for 
genotyping. The Foxg1
LacZ
 allele was detected with primers LacZ F2 5’-TTG AAC TGC 
CTG AAC TAC CG-3’ and LacZ R2 5’-CCT GAC TGG CGG TTA AAT TG-3’. 
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Cycling conditions: 96°C for 2 minutes followed by [96°C for 30 seconds, 58.5°C for 30 
seconds, and 72°C for 30 seconds] for 35 cycles.  
6.3.2. H & E staining. 
Wax-embedded embryo heads were cut into 10µm-thick coronal sections, collected onto 
poly-l-lysine-coated slides and dried overnight in a 37ºC incubator. Wax sections were 
dewaxed in two changes of xylene and then dehydrated through a series of alcohol 
solutions: 100%, 95%, 90%, 70% and finally distilled water. Haematoxylin and eosin 
(1% aqueous) solutions were filtered prior to use. Sections were immersed in the filtered 
Harris Hematoxylin for 2 minutes followed by a rinse in tap water until the water turned 
clear. Sections were immersed in eosin stain for 3 minutes, dipped in tap water, 
transferred to potassium aluminium sulphate for 2 minutes and then rinsed in tap water. 
Sections were dehydrated in a series of ascending alcohol solutions (70%, 90%, 95%, 
100% x2), cleared in 2 changes of xylene and mounted using DPX.  





embryonic heads were dissected and fixed for 1 hour 
at 4°C in 4% paraformaldehyde, 0.02% NP40, 0.01% sodium deoxycholate, 5 mM 
EGTA, 2mM MgCl2 in phosphatebuffered saline (PBS). In some cases, heads were 
equilibrated in 30% sucrose/PBS and sectioned (10µm) on a cryostat and collected onto 
Superfrost Plus slides. Tissues were rinsed several times in wash buffer (2 mM MgCl2, 
0.02% NP40, 0.01% sodium deoxycholate in PBS), transferred to staining solution (wash 
buffer supplemented with 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide 
and 1 mg/ml X-gal), and stained overnight (cryostat sections on slides) or for 2 days with 
agitation (wholemounts) at 37°C in darkness. Staining was stopped with 20 mM EDTA 
in PBS. Wholemounts were processed to wax, sectioned (10µm) using a microtome and 
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mounted onto poly-l-lysine-coated slides. Cryostat sections were counterstained with 
Nuclear Fast Red. 
6.3.4. Immunohistochemistry. 
Ephrin-B2: immunohistochemistry was performed on wax sections essentially as 
described by Batlle et al. (2002). E13.5 and E16.5 embryo heads were fixed in 4% 
paraformaldehyde in phosphate buffer high salt (PBHS) (0.04M phosphate, 0.03M NaCl, 
pH7.0) at 4
o
C with shaking overnight and processed to wax. 10µm sections were cut and 
floated onto polylysine coated glass slides. After rehydration, endogenous peroxidase 
activity was blocked with 90% methanol: 3% hydrogen peroxide and antigens unmasked 
by microwaving in 10mM sodium citrate buffer (pH6.0). Sections were then reacted with 
primary antibody goat anti-mouse ephrin-B2 (R&D Systems AF496) (1:500 dilution) 
overnight, followed by incubation with a bridge rabbit anti-goat antibody (Dako Z0228)  
used at a 1:400 dilution, before final detection using the Envision
+
 (Rabbit) Kit (Dako 
K4010) following the manufacturers instructions. Antibody incubation and pre-
incubation blocking were carried out in 1% bovine serum albumin in PBS at room 
temperature. Following a diaminobenzidine colour reaction, sections were dehydrated, 
cleared in xylene and mounted using DPX. 
SSEA-1 and Nkx2.2: immunohistochemistry was performed as described previously on 
10µm wax sections (SSEA-1: Marcus & Mason, 1995; Nkx2.2: Pratt et al., 2004) except 
that detection of the primary antibody was carried out using the Envision+ (Mouse) Kit 
(Dako K4006) following the manufacturer’s instructions. Primary antibodies were mouse 
monoclonal anti-Nkx2.2 antibody (Developmental Studies Hybridoma Bank, USA 
74.5A5) used at 1:30 and mouse monoclonal anti-SSEA1 antibody (Developmental 
Studies Hybridoma Bank, USA MC-480). Following a diaminobenzidine colour reaction, 
sections were dehydrated, cleared in xylene and mounted using DPX. 
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SSEA-1 and CD44: Standard immunohistochemistry protocols were followed. E15.5 
embryo heads were fixed overnight in 4% paraformaldehyde in PBS, processed to wax, 
and sectioned at a thickness of 10m. Sections were dewaxed in xylene and rehydrated 
through an alcohol series. Endogenous peroxidase activity was blocked with 90% 
methanol: 3% hydrogen peroxide. Antigens were unmasked by microwaving in 10mM 
sodium citrate buffer, pH 6, before reacting overnight with the primary antibody. 
Double-immunofluorescence immunohistochemistry was performed on wax sections 
blocked for 1 h at room temperature with 2% goat serum in 1% bovine serum albumin 
and PBS using the following primary antibodies: mouse monoclonal anti-stage-specific 
embryonic antigen 1 (anti-SSEA1) antibody (MC-480; Developmental Studies 
Hybridoma Bank) used at 1:50 and rat anti-CD44 IgG (IM7; PharMingen, San Diego, 
CA) used at 1:50. The primary incubation was performed overnight at 4°C. After several 
washes in PBS, slides were incubated in goat anti-rat Alexa Fluor 488 and goat anti-
mouse Alexa Fluor 568 fluorescent secondary antibodies (A-11006, A-11004; 
Invitrogen), used at 1:150, for 45 min in the dark. Slides were washed with PBS, 
counterstained with 1:2000 TOPRO3 (Invitrogen), mounted in Mowiol and visualized 
using a Leica TCSNT confocal microscope. 
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6.4. RESULTS 
6.4.1. Optic chiasm morphology is relatively normal in Foxg1 null embryos. 
Haematoxylin and eosin tissue staining was used to reveal the cellular morphology of the 
ventral hypothalamus and chiasm region at E15.5, the peak time at which axons cross the 
midline. Anterior to posterior sections through the chiasm failed to show any obvious 
disruptions to the cellular organisation. In anterior sections, the palisade of cells at the 
floor of the third ventricle was present in an equivalent location in wild type and Foxg1
null embryos (Figs. 1A, B). The anterior chiasm of wild type and Foxg1-/- embryos 
consistently revealed a group of midline cells bordered dorsally by the third ventricle and 
ventrally by the pial surface, and these cells appeared to contact retinal axons. Mid-
chiasm (Figs. 1C, D) and posterior chiasm (Figs. 1E, F) sections failed to show major 
differences in chiasm anatomy, although Foxg1
-/-
retinal axons appeared to be less 
fasciculated than those of the wild type, particularly in posterior regions (Fig. 1F). This 
resembles the wider area occupied by DiI at the Foxg1
-/-
 chiasm (Pratt et al., 2004). In 
Foxg1
-/-
 and wild type mid-chiasm sections, cells at the floor of the third ventricle dorsal 
to the axons appear to be the cell bodies of midline radial glia that are known to be 
located in this region (Marcus et al., 1995). However, specific markers for radial glia 
would need to be used to confirm this. The Foxg1-/- retinal axons approached the ventral 
midline of the hypothalamus in a similar manner to wild type axons (compare Figs. 1A & 
B and 1G & H). The most obvious difference was that the Foxg1
-/-
 retinal axons were 
visible over a wider latero-medial area compared to wild type axons, presumably due to 
the lack of an optic stalk in the former. 
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Figure 1. Morphology of the optic chiasm at E15.5. 
Haematoxylin (purple) and eosin (pink) staining through the E15.5 optic 
chiasm from posterior to anterior in a (A, C, E, G, I) wild type and (B, D, F, 
H, J) Foxg1LacZ/LacZ embryo. Note that in Foxg1LacZ/LacZ sections, the right side 
is slightly anterior to the left and in wild type sections, the left is slightly 
anterior to the right. All sections are wax and cut in the coronal plane with 
dorsal pointing upwards. Arrows point towards the midline. Anterior chiasm 
sections in a (A) wild type and (B) Foxg1
-/-
 embryo showing axons 
approaching the midline laterally. A group of midline cells contact wild type 
and Foxg1
-/-
 retinal axons. Mid-chiasm (C, D) and posterior chiasm (E, F) 
sections do not show major differences in chiasm anatomy. Cell bodies at the 
floor of the third ventricle and dorsal to retinal axons are observed in wild 
type and Foxg1
-/-
 chiasms. (D, F) In the Foxg1
LacZ/LacZ
 chiasm, axons tend to 
be less fasciculated than in the wild type. Low power images of (G, I) wild 
type and Foxg1
-/-
 brains (H, J). (G, H) Anterior to the chiasm, axons (marked 
with an asterisk) are visible lateral to the midline. (H) The Foxg1
-/-
hypoplastic telencephalon (tel) lacks ventral regions that are present in the 
wild type (vtel in (G)). (J, H) Axons at the posterior chiasm. (H) Foxg1-/-
axons occupy a wider area dorsoventrally and laterally. Abbreviations: D, 


















































6.4.2. Foxg1 activation occurs in similar chiasm regions in Foxg1-/- and wild 
type embryos. 
Reporter mice carrying the Foxg1
LacZ
 reporter allele were used to investigate Foxg1
activation at the optic chiasm of Foxg1
LacZ/LacZ
 embryos. In sagittal sections at the brain 
midline, E14.5 Foxg1
LacZ/+ 
embryos displayed strong uniform lacZ staining in anterior 
forebrain regions, including the telencephalon, ganglionic eminences, nasal epithelium, 
Rathke’s pouch and anterior hypothalamic regions (Figure 2A). Equivalent Foxg1LacZ/LacZ
sections showed staining in the hypolastic telencephalon, Rathke’s pouch, anterior 
hypothalamus and also a structure previously described as the vestigial ventral 




embryos, Foxg1 activation occurred in the anterior chiasm, revealed by strong lacZ 





 chiasm, although scattered lacZ-expressing cells were 
visible. Foxg1
LacZ/+ 
embryos displayed a clearer boundary between the posterior and 
anterior lacZ-expressing region compared to Foxg1
LacZ/LacZ
 embryos. In order to 
investigate Foxg1 activation in greater detail and to obtain a clearer 3-dimensional 
representation, lacZ staining was performed on horizontal and coronal cryostat sections 
at E14.5 (Figure 3). Confirming the sagittal lacZ staining results, Foxg1 activation was 
mainly restricted to anterior chiasm regions in both Foxg1
LacZ/+ 
and Foxg1 null embryos 
(Figure 3). Foxg1 activation in the anterior Foxg1
LacZ/LacZ
 chiasm was reduced relative to 
Foxg1
LacZ/+ 
embryos latero-medially (compare Figures 3C, E, G to 3D, F, H). However, 
lacZ staining was stronger in postero-lateral regions of the Foxg1LacZ/LacZ hypothalamus. 
In more ventral regions, fewer lacZ-expressing cells were visible in both the Foxg1
LacZ/+ 
(Figure 3I) and Foxg1
LacZ/LacZ
 (Fig. 3J, K) chiasm and lacZ-positive cells extended 
posteriorly along the midline.  
















Figure 2. Foxg1 activation at the optic chiasm.
X-gal staining of E14.5 cryostat sections from a (A, C) Foxg1LacZ/+ and (B, D) 
Foxg1LacZ/LacZ embryo cut in the sagittal plane through the optic chiasm midline. 
Foxg1LacZ/+ sections are counterstained with Nuclear Fast Red. (A) Foxg1LacZ/+
midline section showing lacZ staining mainly in anterior brain regions: the 
telencephalon (tel), ganglionic eminences (ge), ventral diencephalon and 
Rathke’s pouch (rp). (B) Equivalent Foxg1LacZ/LacZ section to (A) showing lacZ
staining in the telencephalon, telencephalic neuroepithelium (arrow head), nasal 
epithelium (ne) and Rathke’s pouch (rp). (C, D) High power magnifications of the 
optic chiasm midline shown as boxed areas in (A) and (B). (C) In the Foxg1LacZ/+
chiasm, strong lacZ staining is present anteriorly and separated from the weaker 
staining posterior chiasm region by a sharp boundary delineated by an arrow. (D) 
In the Foxg1LacZ/LacZ chiasm, lacZ staining is found anteriorly but not posteriorly 
after the arrow. The boundary between lacZ-positive and lacZ-negative regions 
appears less clear than in the Foxg1LacZ/+ chiasm. Abbreviations: a, axons; d, 
diencephalon; D, dorsal; V, ventral, A, anterior; P, posterior. Scale bars: 100m 
in A - C; 50m in D. 
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Figure 3. Foxg1 activation at the optic chiasm. 
X-gal staining of E14.5 cryostat sections from (A, C, E, G, I, L, O) 
Foxg1LacZ/+ and (B, D, F, H, J, K, M, N, P) Foxg1LacZ/LacZ embryos. Serial 
horizontal sections through the same embryo: (A, C, E, G, I) Foxg1LacZ/+ and 
(B, D, F, H, J, K) Foxg1LacZ/LacZ. Serial coronal sections through the same 
embryo: (L, O) Foxg1LacZ/+ and (M, N, P) Foxg1LacZ/LacZ. All sections are 
counterstained with Nuclear Fast Red. Black arrows point to the chiasm 
midline. (A) Foxg1
LacZ/+
 and (B) Foxg1
LacZ/LacZ
 low power magnification 
images to show the plane of section. All Foxg1
LacZ/LacZ
 images are ventral to 
(B). All Foxg1
LacZ/+
 images are ventral to (A) apart from (C), which is a high 
power magnification of the chiasm region. (C – H) Strong lacZ staining is 
visible in cells in the anterior chiasm region in both (C, E, G) Foxg1
LacZ/+
 and 
(D, F, H) Foxg1
LacZ/LacZ
 embryos. LacZ staining in the Foxg1
LacZ/LacZ
 chiasm 
occupies a narrower lateral – medial area compared to equivalent wild type 
sections. Fewer lacZ-expressing cells are seen ventrally in both the (I) 
Foxg1
LacZ/+
 and (J, K) Foxg1
LacZ/LacZ
 chiasm and lacZ-positive cells are found 
extending posteriorly along the midline. (K) is a high power magnification of 
the ventral chiasm midline in a section ventral to (J). (D, F, K) Axons (a) are 
visible laterally and anteriorly to the lacZ-positive cells in the Foxg1LacZ/LacZ
chiasm but are not obvious in the Foxg1LacZ/+ chiasm, presumably due to the 
intensity of lacZ staining obscuring them. In coronal sections in the (L) 
Foxg1
LacZ/+
 and (M) Foxg1
LacZ/LacZ
 anterior chiasm, lacZ staining is present at 
the midline dorsal to the axons and also among the dorsal-most part of the 
axon bundle. (N) is posterior to (M) and shows a narrowing of the lacZ 




embryos display fewer lacZ-expressing cells at the 
midline. Scale bars: A - J: 200m, K – P, 50m. Abbreviations: A, anterior; p, 
posterior; D, dorsal; V, ventral; hy, hypothalamus; a, axons; os, optic stalk; oc, 
optic chiasm, r, retina. Note: Figures (L) and (O) were kindly provided by Dr 
Thomas Pratt.  










































































In horizontal sections, axons (pale pink) were visible adjacent to the lacZ-positive cells 
laterally in the Foxg1
LacZ/LacZ
 chiasm (Figs. 3D, F) and also posteriorly along the lateral 
thalamus (asterisks in Figs. 3F, H). Axons were not visible in Foxg1LacZ/+ embryos, 
presumably due to the intensity of lacZ staining obscuring them and the tighter 





 anterior chiasm, lacZ-positive cells were visible at the 
midline dorsal to the axons where they were found amongst the dorsal-most regions of 
the retinal axon bundle (Figs. 3L, M). In posterior chiasm regions, Foxg1LacZ/+ and 
Foxg1
LacZ/LacZ 
embryos displayed fewer lacZ-expressing cells at the midline (Figs. 3N, O, 
P). 
6.4.3. SSEA-1 and CD44 are expressed at the Foxg1-/- optic chiasm in 
similar locations to the wild type. 
At E13.5, SSEA1-positive neurons were arrayed posterior to the future optic chiasm in 
wild type (Figs. 4A, C, D) and Foxg1
-/-
 (Figs. 4B, E) embryos in an inverted ‘V’ shape, 
with no evidence of an anterior expansion in the mutant. In the Foxg1-/- chiasm, the 
population of SSEA-1 neurons extended towards the lateral walls of the diencephalon as 
in the wild type (Figs. 4 C, D, E). Also, the cellular morphology of SSEA-1-positive 
neurons did not differ between Foxg1
-/-
 and wild type chiasms (Figs. 4F, G). The 
posterior domains of SSEA-1 expression appeared to be wider in the Foxg1 null 
diencephalon (Fig. 4E) compared to wild type embryos (Fig. 4C). One explanation for a 
wider SSEA-1 expression domain is that the molecular patterning of the posterior chiasm 
region is altered in Foxg1
-/-
 embryos. Alternatively, the spatial expression pattern of 
SSEA-1 may be distorted as a result of abnormal morphological development of the
Foxg1
-/-
 ventral diencephalon.  
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Figure 4. SSEA-1 expression at the optic chiasm. SSEA-1 protein 
expression at the (A, C, D, F) wild type and (B, E, G) Foxg1
-/-
 chiasm at 
E13.5. Sections are horizontal, anterior is up. Immunohistochemistry was 
performed using antibodies for SSEA-1. Downward-pointing arrows point 
towards the midline. (A) Wild type section through the optic chiasm showing 
SSEA-1-positive neurons arrayed in an inverted ‘V’-shape. SSEA-1 
expression is also evident in the optic nerves (on). (B) SSEA-1 expression in 
the Foxg1
-/-
 optic nerve (on*). Note that the plane of section is slightly tilted 
such that the left side is ventral to the right. The SSEA-1-positive ‘arm’ of the 
‘V’ is visible on the right side, but is less clear on the left, which is further 
ventral. (C, D) Wild type and (E) Foxg1
-/-
 sections dorsal to (A) and (B) 
showing strong bilaterally symmetrical SSEA-1 expression posterior to the 
third ventricle. Expression extends postero-laterally in (C) and (E). Midline 
arrows in (C) and (E) point to the tip of the ‘V’. (D) Wild type section dorsal 
to (C) showing SSEA-1 expression laterally on neuronal processes (black 
arrow) that is also visible in Foxg1 nulls, shown by short arrows in (B) and 
(E). (F, G) High magnification showing the morphology of SSEA-1 neurons 
in (F) wild type and (G) Foxg1-/- posterior chiasm. (H) Wild type section 
showing SSEA-1 expression in cells of the optic stalk (see arrow). 
Abbreviations: on, optic nerve; os, optic stalk; r, retina; l, lens. Scale bars: A, 


































Figure 4. SSEA-1 expression at the optic chiasm
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In coronal sections, at E15.5, SSEA-1 was expressed on cell surfaces and neuronal 
processes in the wild type and Foxg1
-/-
 anterior lateral hypothalamus (Figs. 5C, F). CD44 
expression was weakly expressed dorso-laterally to SSEA-1. In a section just posterior to 
the point where axons decussate, SSEA-1 and CD44 were observed on neuronal 
processes at the midline, dorsal to retinal axons (Figs. 5I – N). CD44 expression 
appeared to be slightly stronger in Foxg1
-/-
 embryos and occupy a wider region, although 
this may be related to morphological differences between the Foxg1 null and wild type 
diencephalon. In general, SSEA-1 and CD44 did not co-localise apart from small areas 
where their expression domains overlapped. In the posterior wild type and Foxg1
-/- 
chiasm, SSEA-1 and CD44 expression was reduced at the midline but expression 
remained laterally (Figs. 5O – Z). High power magnifications showed that CD44 
expression on cell surfaces and neuronal processes was present medially in comparison 
to SSEA-1 that was located in more lateral regions (compare Figs. 5V, Y to 5U, X). 
Examination of serial sections of wild type and Foxg1
-/-
embryos at E15.5 failed to show 
obvious differences in SSEA-1 expression. However, CD44 expression appeared to be 
slightly stronger in Foxg1
-/-
 mid-chiasm sections than in wild types (compare Figs. 5J, M 
& 5P, S). 
6.4.4. Nkx2.2 expression is maintained at the Foxg1-/- chiasm. 
The transcription factor Nkx2.2 was chosen as a suitable optic chiasm marker because 
RGC axons normally grow through a domain of Nkx2.2 expression at the midline 
(Marcus et al., 1999). As for SSEA-1 and CD44, perturbations in Nkx2.2 expression 
might suggest abnormal development of the Foxg1
-/-
 chiasm. Nkx2.2 expression was 
found at the wild type (Fig. 6E, G, I) and Foxg1
-/-
(Fig. 6F, H, J) optic chiasm. In Foxg1 
nulls there was no obvious spatial shift in the expression pattern of Nkx2.2, indicating 
that cells in the Foxg1
-/-
 optic chiasm are able to express the regulatory gene Nkx2.2 
normally. In conclusion, expression of Nkx2.2 as well as SSEA-1 appears relatively  
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Figure 5. SSEA-1 and CD44 expression at the optic chiasm. 
SSEA-1 (red) and CD44 (green) immunohistochemistry at the optic chiasm of 
(A, C-E, I – K, O – Q, U – W) wild type and (B, F – H, L – N, R – T, X - Z) 
Foxg1-/-embryos at E15.5. Sections are arranged in rows from anterior to 
posterior. All sections are coronal and nuclei are counterstained with TO-
PRO-3 (blue). White arrows point to the midline. Anterior sections through a 
(A) wild type and (B) Foxg1
-/-
 chiasm showing the absence of SSEA-1 and 
CD44 protein at the midline. Axons (a) are visible as TO-PRO-3-negative 
regions approaching the midline laterally in both the wild type and mutant. (C 
– E) Wild type and (F – H) Foxg1
-/-
anterior chiasm just posterior to (A) & (B). 
Note that in the Foxg1
-/-
 embryo, the right side is slightly posterior to the left. 
(C, F) SSEA-1 and CD44 (small white arrows in D, G) are visible in the 
lateral regions of the hypothalamus where CD44 is found dorso-laterally in 
relation to SSEA-1. In a section just posterior to the point where axons 
decussate, wild types (I – K) and Foxg1 nulls (L – N) both display CD44 and 
SSEA-1 on neuronal processes lateral to and at the midline dorsal to axons. 
CD44 expression is more restricted to the midline, whereas SSEA-1 extends 
further laterally. (K, N) There is some co-localisation (yellow) between 
SSEA-1 and CD44 where their expression domains overlap near the midline 
but they do not co-localise extensively. (O – Q) Wild type and (R – T) Foxg1-
/- sections just posterior to (I – N) showing a reduction in SSEA-1 and CD44 
directly at the midline. (U – W) and (X – Z) High power magnifications of (O 
– Q) and (R – T) showing stronger lateral expression of SSEA-1 and CD44 
but weak midline expression. Abbreviations: D, dorsal; V, ventral; a, axons. 
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Figure 6. Nkx2.2 expression at the optic chiasm. 
Nkx2.2 protein expression revealed by DAB at the (A, B, E, G, I)
wild type and (C, D, F, H, J) Foxg1-/- optic chiasm at E13.5. All 
sections are horizontal with anterior pointing upwards. (A – D) 
Low power magnifications of equivalent ventral (A, C) and dorsal
(B, D) sections in a wild type (A, B) and (C, D) Foxg1-/- embryo. 
(E – J) Series of high power magnifications of the chiasm region 
from ventral (E, F) to dorsal (I, J) show Nkx2.2 expression in cells 
directly at and lateral to the wild type and Foxg1-/- midline. 
Abbreviations: A, anterior; P, posterior; or, optic recess. Scale 





 embryos at the time when RGC axons are starting to project and 
interact with cells and guidance molecules at the optic chiasm. 
6.4.5. Ephrin-B2 expression is maintained at the Foxg1-/- chiasm. 
Ephrin-B2 is expressed by a palisade of midline radial glial cells at the chiasm, which 
control RGC axon divergence (Marcus & Mason, 1995; Marcus et al., 1995; Nakagawa 
et al., 2000; Williams et al., 2003). Although the shape of the diencephalon was slightly 
abnormal in Foxg1 null embryos, expression of ephrin-B2 was maintained at both E13.5 
(Figures 7A - D) and E16.5 (Figures 7E – H) at the chiasm midline. Strong ephrin-B2 
expression was observed in the ventricular epithelium of the third ventricle at E13.5 
(Figs. 7B, D) and E16.5 (Figs. 7E - H) and in horizontal sections the expression domain 
of ephrin-B2 spread laterally in more anterior regions (Figures 7E, H). Weak ephrin-B2 
expression was seen in wild type and Foxg1
-/-
retinal axons at E16.5 (Figs. 7F, G) and in 
the wild type optic nerve (Fig. 7I).  
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Figure 7. Ephrin-B2 expression at the optic chiasm. 
Ephrin-B2 protein expression at the E13.5 and E16.5 (A, B, E, F) wild type and 
(C, D, G, H) Foxg1-/- chiasm. (A – D, F, G) are cut coronally, (E, H) are horizontal. 
(A, B) In the wild type at E13.5, ephrin-B2 is expressed in dorsal regions of the 
developing forebrain and eye and ventrally at the hypothalamus midline. (C) In the 
E13.5 Foxg1-/- embryos, ephrin-B2 is expressed in the hypoplastic telencephalon
(tel*) and ventral hypothalamus. (B) Wild type and (D) Foxg1-/- high power 
magnifications of the ventral hypothalamus shown as boxed areas in (A) and (B) 
showing ephrin-B2 expression at the midline. (E, I) E16.5 wild type section 
showing ephrin-B2-expressing midline cells abutting the optic nerve. (E) High 
power magnification of chiasm region in (I). (H) E16.5 Foxg1-/- section equivalent 
to (E). As in (E), strong ephrin-B2 expression is present in the ventricular 
epithelium of the 3rd ventricle and spreads laterally in more anterior regions. 
Coronal sections of the E16.5 wild type (F) and Foxg1-/- (G) chiasm showing 
midline ephrin-B2 expression dorsal to axons that express ephrin-B2 weakly. 
Abbreviations: e, eye; cc, cerebral cortex; vtel, ventral telencephalon; tel*, mutant 
telencephalon; hy, hypothalamus. Scale bars: A, C, I: 200m, B, D, E – H: 50m. 
[Note: Immunohistochemical staining at E16.5 shown in Figures (E - I) was 




During retinofugal development in Foxg1
-/-
 embryos, the presence of a chiasm that 
resembles the wild type in morphology and the presence of RGC axons in their expected 
location relative to the ventral hypothalamus indicate that Foxg1 expression is not 
essential for chiasm formation. This contrasts with achiasmatic animals that completely 
lack a physical chiasm structure (Williams et al., 1994) and also differs from the agenesis 
of the chiasm region in Pax2 mutants (Torres et al., 1996). The lack of major anatomical 
abnormalities at the Foxg1
-/-
 chiasm is surprising given the morphological defects of the 
eyes, hypoplastic telencephalon, unusually wide third ventricle and associated changes in 
the angle of the ventricular zone of the diencephalon away from the vertical relative to 
wild types. The latter may be due to the reduced size of the Foxg1
-/-
 telencephalon, which 
lacks ventral tissue that may normally constrain the wild type diencephalon. The wider 
area and reduced fasciculation of Foxg1
-/-
 retinal axons (this Chapter and Pratt et al., 
2004) compared to wild type axons suggest either a fasciculation defect or simply the 
lack of a narrow channel to funnel axons to the midline, a role that is usually served by 
the optic stalk. The wide area occupied by retinal axons at the Foxg1
-/-
 chiasm shares 
similarities with the dispersal of RGC axons over a larger region of the ventral surface of 
the diencephalon in GAP-43 mutants (Sretavan and Kruger, 1998). However, GAP-43
RGC axons are unable to form optic tracts after they leave the chiasm, unlike those of 
Foxg1 null embryos.  
6.5.1. Foxg1 activation in the Foxg1 null hypothalamus occurs in anterior 





 embryos displayed Foxg1 activation in cells of the anterior 
chiasm, including at the midline. Detailed examination of serial sections in the horizontal 






 embryos. These findings support those of the histological 
analysis showing that mutant chiasms are similar morphologically to Foxg1-expressing 
chiasms and that cells that would normally express Foxg1 have not been deleted in 
Foxg1 null embryos.  
6.5.2. The expression patterns of SSEA-1, CD44 and Nkx2.2 are broadly 
maintained in Foxg1-/- embryos. 
The expression patterns of SSEA-1, CD44 on Foxg1
-/-
 chiasm neurons and of Nkx2.2 in 
Foxg1
-/-
 chiasm cells displayed a similar pattern to those of wild type embryos, although 
their expression domains appeared slightly wider. In order to determine whether the 
wider spatial expression of these posterior chiasm markers is a consequence of abnormal 
molecular patterning of the chiasm or distortion of the Foxg1
-/-
 diencephalon, Foxg1
could be conditionally knocked out specifically in cells of the ventral hypothalamus once 
it has formed. Any changes in SSEA-1, CD44 and Nkx2.2 expression could then be 
attributed to molecular changes rather than distorted chiasm morphology. 
There were indications that CD44 expression was slightly stronger in the Foxg1
-/-
 chiasm 
neurons. Since immunohistochemistry is not an accurate method of quantifying protein 
expression and the fact that other embryonic ages were not examined due to a lack of 
Foxg1
-/-
 tissue, it would be interesting to investigate the possibility of greater CD44 
protein expression at the E13.5 to E16.5 Foxg1-/- chiasm quantitatively by Western 
blotting. Investigation of more brains at these ages would also eliminate the possibility of 
variation in the intensity of antibody staining between wild type and Foxg1
-/-
 embryos. 
This is considered unlikely given that wild type and Foxg1
-/-
 embryos were processed in 
parallel under identical conditions. It is tempting to speculate that the stronger expression 
of CD44 in the Foxg1-/- diencephalon at E15.5, demonstrated by brighter antibody 
staining, might be responsible for the increased ipsilateral routing of retinal axons. 
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Evidence for this comes from previous findings of a reduced ipsilateral projection in 
brain slices of the E15.5 mouse visual pathway when CD44 was disrupted (Lin et al., 
2003). Interestingly, the ipsilateral projection is unaffected at earlier ages prior to the 
formation of the permanent ipsilateral projection, yet CD44 is critical for the decussation 
of contralateral axons. This implies that CD44 specifically promotes the uncrossed 
routing of axons and that the response of retinal axons to chiasmatic CD44 varies with 
developmental age.  
Although the spatiotemporal expression patterns of SSEA-1, CD44 and Nkx2.2 did not 
show major differences between Foxg1
-/-
 and wild type embryos, it remains possible that 
Foxg1
-/-
 retinal axons interact with chiasm cells and neurons in a different way to wild 
types, for example, by following a different path along the borders of their expression 
domains. An interesting follow-up experiment would be to fluorescently label a few 
RGC axons using focal DiI or rhodamine-dextran injections in the Foxg1
-/-
 and wild type 
retina. Combined with immunohistochemistry for the chiasm molecules mentioned in 
this chapter it would be possible to observe how ipsilateral and contralateral axons 
interact with these chiasm markers in a similar way to that used by Erskine et al. (2000).  
Another way in which Foxg1
-/-
 retinal axons could behave differently at the chiasm 
despite apparently normal expression of chiasm molecules is through exposure to a 
different environment. A recent study showed that selective inhibition of retinal axons 
from the VT retina to chondroitin sulphate only occurred when axons were grown in the 
presence of laminin and polylysine that supports growth but not in their absence (Cheung 
et al., 2005). Laminin-1 can convert netrin-mediated attraction of Xenopus retinal growth 
cones to repulsion by changes in cAMP levels (Hopker et al., 1999; Shewan et al., 2002). 
Foxg1
-/-
 embryos never develop an optic stalk, where axons normally contact laminin 
deposits from astroglial cells (Liesi and Silver, 1988) and other molecules, including 
CSPGs, HSPGs and SSEA-1. These interactions may normally prime retinal axons from 
different regions in the retina to interact in characteristic ways with guidance cues and 
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cells at the chiasm, rather like road signs providing directional information to motorists 
prior to junctions. In the absence of pathway-derived experience from the optic stalk, 
Foxg1-/- retinal axons may diverge abnormally despite experiencing a relatively normal 
molecular environment at and surrounding the chiasm midline itself. However, this 
hypothesis is thought to be unlikely because in Chapter 3, Foxg1
-/-
 retinal explants co-
cultured with Foxg1
-/-
 chiasm cells still displayed reduced axon outgrowth relative to 
control co-cultures, even though the Foxg1-expressing retinal axons do not grow through 
an optic stalk and the only factors influencing axon growth were those present in the 
retina or chiasm.  
Investigation of Shh expression at the chiasm is an area for future work because Shh has 
been shown to be involved in the guidance of retinal axons at the optic chiasm (Trousse 
et al., 2001) and recently it has been shown to act as an axon guidance molecule itself 
(Charron et al., 2003). Shh is also important for proper morphogenesis of the retina and 
optic stalk (Dakubo et al., 2003), structures that develop abnormally in Foxg1
-/-
 embryos, 
raising the possibility that the expression of Shh is altered in the forebrain of the Foxg1
null mouse. Previous findings revealed that Shh mRNA was maintained in the Foxg1
-/-
ventral diencephalon despite loss of Shh expression from the Foxg1-/- telencephalon at 
E10.5 (Huh et al., 1999). However, the expression pattern of Shh in the chiasm region at 
later embryonic ages during the period of retinal axon navigation through the chiasm is 
unknown, as is the expression pattern of Shh expression in the Foxg1 null eye. Increased 
Shh expression around the chiasm region has previously been associated with a 100% 
ipsilateral projection in Pax2 null embryos (Torres et al., 1996). In order to test the 
hypothesis of altered Shh expression at the Foxg1
-/-
 chiasm, Shh qRT PCR on chiasm 
tissue and immunohistochemistry for Shh protein would be required. A read-out of Shh 
signalling could also be assessed by measuring transcript levels of the Shh receptors 
patched (Ptch) and Gli by qRT PCR. 
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6.5.3. Ephrin-B2. 
Immunohistochemistry revealed that the expression pattern of ephrin-B2 at the Foxg1-/-
optic chiasm is not altered or dramatically expanded compared to wild types at E13.5 or 
E16.5, although the shape of the Foxg1
-/-
 chiasm is slightly different (published in Pratt 
et al., 2004). Ephrin-B2 is expressed by midline radial glia and at high power 
magnifications, the ephrin-B2-expressing glial cell processes were observed running 
dorso-ventrally in wild types. The presence of ephrin-B2 expression in Foxg1-/- chiasm 
cells indirectly suggests that the midline glial specialization is present as in the wild type. 
Nevertheless, given more time and access to Foxg1 null embryos, it would be prudent to 
confirm the presence of these glial cells using standard radial glial markers, such as RC2 
and GLAST (Marcus et al., 1995). Immunohistochemistry is at best only semi-
quantitative (staining intensity can only be compared on the same section), the possibility 
remains that the quantitative expression of ephrin-B2 increases. This can be resolved 
using quantitative real-time PCR and Western blots to quantify mRNA and protein levels 
respectively. 
Chiasm neurons are a heterogeneous population in terms of surface antigen expression. 
In addition to SSEA-1 and CD44, they also express chondroitin sulphate (Chung et al., 
2000b) and the growth-promoting molecules L1 and NCAM (Sretavan et al., 1994; 
Lustig et al., 2001). These molecules are all prime candidates for influencing the route 
taken by retinal axons and may regulate the availability of growth-inhibitory and growth-
promoting cues to axons. Enzymatic removal of chondroitin moieties in the E13.5 mouse 
results in the stalling or misrouting of the majority of axons (Chung et al., 2000a, 2000b). 
However, when chondroitin is eliminated at later ages, the ipsilateral projection is 
reduced but contralateral axons remain unaffected. It follows that an increased ipsilateral 
projection could result if the expression of chondroitin sulphate proteoglycans (CS-PGs) 
increases at the chiasm. However, it is unlikely that the situation is so straightforward 
since CS-PGs are also expressed in the retina (Chung et al., 2000b), have been shown to 
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maintain fiber order in the optic nerve (Leung et al., 2003) and the addition of exogenous 
CS-PGs can disrupt axons in similar ways to CS-PG removal (Anderson et al., 1998; 
Walz et al., 2002). Chiasm neurons also express heparan sulphate, which are 
glycosaminoglycan polysaccharides that are found on a structurally diverse group of 
extracellular matrix proteins called heparan sulphate proteoglycans (HSPGs). 
Modifications to the sulphation status of heparan sulphate have been shown to affect the 
response of navigating growth cones to Slit2, a guidance molecule expressed around the 
chiasm (Pratt et al., 2006). In fact, heparan sulphate is one of the sugar moieties present 
on CD44 and has been shown to sequester axon growth-promoting factors (Bennett et al., 
1995; Chung et al., 2001; Jones et al., 2000; Lin et al., 2002; Walz et al., 1997). The lack 
of antibodies for HSPGs and their huge structural diversity rendered it unfeasible to 
conduct a comprehensive investigation of HSPG expression at the Foxg1
-/-
 chiasm. 
Nevertheless, all these chiasm molecules are suitable candidates for future study and 
given the diversity of molecules expressed in the vicinity of the chiasm, it is probable 
that a variety of different cues, rather than a single ‘master cue’, is required for axon 
divergence at the midline.  
6.5.4. Slits. 
Slit proteins are expressed in the ventral diencephalon (Erskine et al., 2000; Pratt et al., 
2006) but are absent from the ventral midline and have not been associated with 
ipsilateral-contralateral axon pathfinding at the chiasm. However, they are involved in 
channeling retinal axons and preventing them from wandering inappropriately from their 
correct tracts into neighbouring tissue (Plump, 2002; Pratt et al., 2006; Thompson et al., 
2006a, 2006b). Moreover, expanded Slit2 expression has been shown to affect the 
routing of retinal axons in Foxd1 null embryos, which display an increased ipsilateral 
projection among other projection abnormalities (Herrera et al., 2004). Examination of 
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Slit2 spatial and temporal expression at the chiasm as well as quantification using qRT 
PCR is a project for the near future.   
In conclusion, no obvious defects in the cellular and molecular architecture of the  
Foxg1
-/-
 chiasm were observed during the period when retinal axons project to the 
chiasm. This does not exclude a chiasm abnormality but rules out changes in a couple of 
major players in retinal axon guidance.  
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CHAPTER 7: The expression profile of Foxg1 protein.
7.1. ABSTRACT 
Foxg1 protein expression was more widespread but found in the same locations as the 
pattern of Foxg1 mRNA expression observed previously by in situ hybridization and in 
Foxg1
LacZ
 reporter mice. In the retina, Foxg1 protein was expressed more widely than 
the mRNA with expression throughout all retinal layers, although some sections 
revealed slightly stronger expression in the nasal retina, resembling Foxg1
LacZ
 reporter 
expression. Foxg1 protein appeared to be more strongly expressed in the retina at E13.5 
compared to the later age of E14.5. Foxg1 protein was expressed in both cells and 
axons at the optic chiasm, the latter of which suggests a more direct role in the guidance 
of axons from within the growth cone. It is not known whether Foxg1 is expressed in 
both contralateral and ipsilateral axons or if its expression is restricted to nasal RGC 
axons in which Foxg1 is most prominent. Future investigation into the exact role(s) of 
Foxg1 in retinal axons and its interacting partners will help to further understanding of 
the functions of this transcription factor in axon guidance.  
7.2. INTRODUCTION 
Axons navigate over large distances with the consequence that the distance between 
growth cones and their cell bodies becomes larger as axons grow further from their 
origins towards their targets. The growth cone often has to make rapid steering 
decisions upon encountering a new molecular or cellular environment and it is unlikely 
that such a swift response could occur if navigation relied on protein synthesis from the 
cell body alone (Campbell and Holt, 2001). Growth cones that are cut off from their 
axons and cell bodies are still capable of growing in culture, showing that they can steer 
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independently in the absence of a connection with the cell body (Shaw and Bray, 1977). 
Growth cones from retinal axons can also steer correctly in vivo following separation 
from their cell bodies (Harris et al., 1987). These early studies prompted investigations 
into the contents of growth cones leading to findings that they contain mRNAs (Crino 
and Eberwine, 1996) as well as machinery for translation (Crino and Eberwine, 1996; 
Davis et al., 1992) and protein degradation (Campbell & Holt, 2001). The hypothesis 
that growth cones synthesize proteins locally in order to steer directionally in response 
to axon guidance cues was supported by in vitro findings in which growth cone steering 
was abolished by inhibiting protein synthesis (Campbell & Holt, 2001).  
Recent findings have shown that Foxg1 protein is present in Xenopus olfactory axons 
and also in the mouse E15.5 cortex where it can be regulated post-translationally 
(Regad et al., 2007). This raises the possibility that Foxg1 protein is also present in 
retinal axons where it could influence guidance decisions by the navigating growth 
cone. The availability of a Foxg1 antibody made it possible to compare the expression 
patterns of Foxg1 mRNA and protein in the developing mouse forebrain. These 
observations are the first known descriptions of the localization of Foxg1 protein in the 
mouse retina and ventral diencephalon. 
7.3. METHODS 
7.3.1. Mice. 
Wild type (CBA) embryos were taken at E13.5 and E14.5. 
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7.3.2. Foxg1 immunohistochemistry. 
Immunohistochemistry on 10m thick wax sections was conducted as for Nkx2.2. 
Slides were blocked in 5% goat serum, 0.2% BSA and 0.1% Triton-X-100 in PBS. 
Primary antibody incubation: sections were reacted with the rabbit polyclonal Foxg1 
antibody (Abcam ab18259, 1:30 dilution) overnight at 4°C followed by final detection 
using the Envision+ (Rabbit) Kit (Dako K4010) following the manufacturers instructions.  
7.4. RESULTS 
The expression of Foxg1 protein was investigated by immunohistochemistry at E13.5 
and E14.5. Foxg1 expression was observed in the wild type retina, anterior ventral 
hypothalamus and optic chiasm region, optic stalks, lens, nasal epithelium (Figure 1), 
telencephalon and ganglionic eminences (Figure 2). As expected, Foxg1 protein was 
absent from all Foxg1
-/-
forebrain structures at E14.5 (Fig. 3). Most importantly for this 
thesis, close examination of serial sections showed that Foxg1 expression was absent 
from the eyes, anterior thalamus and hypoplastic telencephalon (Fig. 3A). Although 
some weak DAB staining was observed in the hindbrain, at higher magnifications this 
appeared to be non-specific (Fig. 3B). The low background for this antibody also 
improved confidence in the validity of Foxg1-expressing regions observed in the wild 
type embryos.  
7.4.1. Foxg1 expression in the retina. 
In the E13.5 wild type retina, Foxg1 protein was found in all layers of the retina. 
However, in some dorsal and ventral regions, a shallow high nasal to low temporal  
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Figure 1. Foxg1 expression in the eyes, optic chiasm cells and 
retinal axons. 
Foxg1 immunohistochemistry revealed by DAB staining. (A - N, Q - S) E13.5 
and (O, P) E14.5 wild type embryos. All sections are horizontal. Vertical 
arrows in (Q, R, S) indicate the position of the midline. (A - G) Ventral to 
dorsal series showing Foxg1 expression in the retina, anterior ventral 
hypothalamus, optic stalks, lens and nasal epithelium. (D - G) Foxg1 
expression is limited to the anterior diencephalon. (H, I) Ventral retina 
showing Foxg1 expression in all retinal layers. Strong expression is seen 
nasally in the outermost retinal layer adjacent to the RPE. (J) Weak staining 
visible in the optic nerve. (K) Medial retinal section just dorsal to the optic 
stalks showing expression in all retinal layers and the lens. (L, M) Dorsal 
retina showing a low to high temporal to nasal shallow gradient. (N) Section 
dorsal to (M) showing strong expression medially with weaker expression in 
outer layers and laterally. (O, P) E14.5 retinas. Section (P) is dorsal to (O). 
(O) Ventral retina showing Foxg1 expression limited to the outermost nasal 
retinal layer. (P) Foxg1 expression in all retinal layers but slightly stronger 
expression nasolaterally. (Q) Foxg1 expression in axons in the ventral optic 
chiasm and in a few cells at the midline posterior to axons. (R) Dorsal to (Q) 
showing axons entering the optic tract in the lateral hypothalamus. (S) Nuclear 
Foxg1 expression in anterior chiasm cells. Abbreviations: r, retina; l, lens; hy, 
hypothalamus; on, optic nerve; d, diencephalon; ne, nasal epithelium; RP, 
Rathke’s pouch; V3, 3rd ventricle; N, nasal; T, temporal. Scale bars: A - G, S: 
200m, H - N, O, P, Q, R: 100m. 









































































Figure 2. Foxg1 expression in the telencephalon. 
Foxg1 immunohistochemistry in wild type embryos. (A, B) Coronal E13.5 
sections. (C) Horizontal E14.5 section. (A, B) E13.5 embryos show strong 
Foxg1 expression in the telencephalon and weaker expression in the 
ganglionic eminences. (B) section posterior to (A) showing telencephalic 
expression. (C) Horizontal E14.5 section through the dorsal brain showing 
telencephalic expression. Abbreviations: tel, telencephalon; GE, ganglionic 
eminence; r, retina; on, optic nerve; d, diencephalon; dt, dorsal thalamus. D, 
dorsal; V, ventral; A, anterior; P, posterior. Scale bars: A, B: 200µm, C: 
100µm, D: 500µm. 
Figure 3. Foxg1 protein expression is absent from Foxg1-/-
embryos. 
Foxg1 immunohistochemistry performed on an E14.5 Foxg1-/- embryo. 
Sections are horizontal and are not counterstained. (A) Anterior brain 
structures, including the eyes, anterior thalamus and hypoplastic telencephalon 
lack Foxg1 protein. The borders of the thalamus and left telencephalon are 
marked with a dotted line. (B) Posterior to (A) but sectioned at the same 
dorsoventral level, showing weak non-specific staining in the hindbrain but 
not in the thalamus. The thalamus-hindbrain border is shown with a dotted 
line. Abbreviations: RPE, retinal pigment epithelium; tel; telencephalon; t, 

































gradient was observed (Figs. 1L, M). Ventrally, strong expression was found 
concentrated in the outermost layer of the nasal retina adjacent to the RPE (Figs. 1H, I).  
In medial sections at the level of the optic stalks, Foxg1 was expressed in the entire 
retina, although the outer retinal layers tended to show stronger expression. In the 
E14.5 wild type retina, strong expression in the outermost nasal retinal cells was 
observed ventrally, whereas weaker expression was seen in the ventrotemporal region 
(Fig. 1O). Foxg1 expression was not as strong in the E14.5 retina compared to the 
E13.5 retina, particularly in the VT retina (compare Figs. 1H & 1O). In more medial 
sections, Foxg1 was located in all retinal layers, although the outer layers expressed 
protein more strongly as at E13.5 (Fig. 1P). The strongest expression was found 
laterally in the region of the CMZ in nasal retina.  
7.4.2. Foxg1 expression in optic chiasm cells. 
Foxg1 protein was also expressed by cells of the anterior hypothalamus, including the 
optic chiasm region (Figs. 1D - G, S). There was an obvious boundary between the 
Foxg1-expressing anterior hypothalamus and Foxg1-negative posterior regions of the 
diencephalon (Figs. 1D - G). Foxg1 was localized within the nuclei of chiasm cells 
(Fig. 1S). 
7.4.3. Foxg1 expression in retinal axons. 
Foxg1 was also expressed in retinal axons in the optic nerve (Fig. 1C, J), at the ventral 
optic chiasm (Fig. 1Q) and in the optic tracts (Fig. 1R) at E13.5 and E14.5.  
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7.5. DISCUSSION 
7.5.1. Foxg1 protein is widespread in the retina.  
Restriction of Foxg1 protein to anterior regions of the hypothalamus, including the 
future optic chiasm, mirrors the results observed in Foxg1
LacZ
 reporter mice (Chapter 6 
this thesis) and by in situ hybridization (Hatini et al., 1994; Huh et al., 1999). However, 
in the eyes, expression of Foxg1 protein was more widespread in the retina than 
predicted from expression of the Foxg1
LacZ
 reporter allele and previous in situ 
hybridization findings (Chapter 5, Hatini et al., 1994; Huh et al., 1999). A nasal bias 
was observed in some dorsal and ventral sections, but in sections midway between the 
dorsal and ventral surfaces, Foxg1 appeared to be expressed evenly across nasal and 
temporal retina. Foxg1 protein did not appear to be located in the nucleus in the retina 
and neither was it concentrated in the RGC layer. In fact, at E14.5, protein levels in the 
inner retinal layer were noticeably weaker compared to outer layers, which is the 
inverse of the pattern of mRNA expression, which showed strongest staining in the 
RGC layer (Chapter 5). These observations imply that Foxg1 protein diffuses away 
from sites of Foxg1 mRNA transcription and translation, influencing cells that never 
express Foxg1 non-autonomously. At E13.5, Foxg1 protein was expressed more 
strongly in the retina, particularly in VT regions, compared to E14.5 retinas. In Chapter 
4 it was hypothesized that Foxg1 might repress Zic2 in the nasal retina based on the 
finding of an increased proportion of Zic2-expressing RGCs in the Foxg1 null nasal 
retina only. The reduction in levels of Foxg1 protein in the VT retina from E13.5 to 
E14.5 coincides with the onset of Zic2 expression in the VT periphery (Herrera et al., 
2003). Further detailed Foxg1 immunohistochemical and quantitative analyses (using 
Western blotting) are required at these embryonic ages to study this phenomenon in 
greater depth and to ensure that the observation of reduced Foxg1 protein at E14.5 is 
reproducible. Performing double immunohistochemistry to visualize the location of 
both Foxg1 and Zic2 proteins and Western blotting to quantify levels of Foxg1 and 
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Zic2 proteins in the retina would be ideal to investigate whether there are actual 
changes in the levels and/or spatial expression domains of these two proteins during 
development and if so, whether they are spatiotemporally correlated.  
7.5.2. Foxg1 protein is present in retinal axons. 
Foxg1 was found in retinal axons in the optic nerves, at the chiasm and in the optic 
tracts. At present, the role of Foxg1 in axons remains speculative. It is plausible that 
Foxg1 protein is transported along axons from the cell body of RGCs where Foxg1 
mRNA is located (Chapter 5; Hatini et al., 1994; Pratt et al., 2004), perhaps influencing 
the navigating growth cone. It is unlikely that Foxg1 protein is synthesized locally 
within the growth cone because no evidence (in the literature or this thesis) exists of 
Foxg1 mRNA in retinal axons. The results presented here cannot tell whether Foxg1 
protein is located within the growth cone of axons. This could be examined by 
fluorescence immunohistochemistry for Foxg1 and confocal imaging at high 
magnifications to visualize whether Foxg1 is actually present in the growth cone. If 
Foxg1 is present within the axon and growth cone, the question of whether Foxg1 is 
synthesized locally within growth cones could be addressed by applying inhibitors of 
protein synthesis, such as cycloheximide, to growth cones separated from their retinal 
axons. If Foxg1 protein is still detected following cycloheximide treatment, it is more 
likely that Foxg1 protein is synthesized in the RGC and transported along axons rather 
than locally within the growth cone.   
Foxg1 has been shown to have both DNA-dependent and DNA-independent 
mechanisms of action in controlling progenitor cell proliferation and differentiation in 
the neocortex (Hanashima et al., 2002) and also in nasal-temporal patterning in the 
chick retina (Takahashi et al., 2003; Yamagata et al., 1999; Yuasa et al., 1996). It is not 
known whether both DNA-binding and DNA-binding-independent mechanisms apply 
in the mouse retina and/or optic chiasm, since no studies to date have investigated this. 
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If so, Foxg1 may play a dual role both as a transcription factor and as a protein that has 
DNA-independent effects in the guidance of retinal axons, as discovered for En-2 
(Brunet et al., 2005; Collinson et al., 2004; Collinson et al., 2000; Joliot and Prochiantz, 
2004; Lesaffre et al., 2007; Prochiantz, 2000; Prochiantz and Joliot, 2003). The 
expression of Foxg1 protein across the whole retina suggests that Foxg1 diffuses from 
its site of production to retinal cells that do not express Foxg1, where Foxg1 protein 
could potentially have DNA-binding-independent effects.  
Within retinal axons, Foxg1 may regulate the translation of local mRNAs, leading to 
the synthesis of a particular complement of proteins that participate in the signaling 
cascades resulting from guidance cue and receptor binding, or the production of 
receptors inserted into the leading edge of the growth cone. A transcription factor that 
has been reported to play a role in retinotectal mapping via internalization into retinal 
growth cones and the subsequent local synthesis of new proteins is the homeoprotein 
Engrailed-2 (En-2) (Brunet et al., 2005; Itasaki et al., 1991; Itasaki and Nakamura, 
1996; Joyner and Martin, 1987; Retaux and Harris, 1996). In Xenopus, the presence of 
Engrailed-2 protein in retinal axon growth cones was associated with a growth cone 
turning reponse that occurred even when axons were separated from their cell bodies 
but was abolished when protein synthesis was inhibited, demonstrating that local 
protein synthesis rather than transcriptional activity was responsible (Brunet et al., 
2005). This study could provide clues as to Foxg1’s mode of action in retinal axons.  
It is also possible that Foxg1 protein is required in retinal axons for proper retinotectal 
mapping along the anterior-posterior axis of the tectum/superior colliculus. Previous 
experiments in chick in which CBF1, the chick homologue of Foxg1, was misexpressed 
in the temporal retina, led to retinotectal projection defects, demonstrating that Foxg1 
influences tectal mapping from the retina (Yuasa et al., 1996; Takahashi et al., 2003). It 
is possible that the presence of Foxg1 in axons produces a differential response in nasal 
and temporal retinal axons to cells in the superior colliculus, influencing their final 
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termination zones. This mechanism of retinotectal guidance is also thought to be used 
by the En-2 protein within growth cones, which might produce an attractive or 
repulsive response in nasal and temporal retinal axons respectively to an En-2 
expression gradient along the anterior-posterior tectum (Brunet et al., 2005). In order to 
invoke hypotheses that concern differential effects of Foxg1 protein in nasal and 
temporal axons, it is crucial to investigate whether Foxg1 protein is present in all retinal 
axons or just contralateral axons that originate from Foxg1-expressing RGCs. This 
question could be studied using rhodamine dextran to backlabel axons from one optic 
tract followed by Foxg1 fluorescence immunohistochemistry. If axons in the ipsilateral 
optic nerve never co-label with Foxg1-immunoreactive axons and if axons in the 
contralateral optic nerve always co-label with Foxg1-immunoreactive axons, this would 
show that Foxg1 is present exclusively in contralateral RGCs. If Foxg1 is present in all 
axons, both ipsilateral and contralateral, then perhaps it controls their guidance in 
different ways, as for En-2.   
7.5.3. Summary. 
In summary, the presence of Foxg1 in axons as well as in cells along the retinotectal 
pathway supports previous reports that this transcription factor is involved in the 
guidance of retinal axons (Pratt et al., 2002, 2004) and in the morphogenesis and 
patterning of anterior forebrain regions, most notably the eyes and telencephalon 
(Hatini et al., 1994; Xuan et al., 1995; Huh et al., 1999). The presence of Foxg1 protein 
in axons suggests that, like En-2, this transcription factor could control retinal axon 
guidance directly from within the growth cone. Other molecules also multi-task in this 
way, including the transcription factor Pax6 (Ericson et al., 1997); Mastick et al., 1997; 
Pratt et al., 2000; Pratt et al., 2002) and the diffusible proteins from the Wnt (Hall et al., 
2000; Yoshikawa et al., 2003), bone morphogenetic protein (BMP) (Augsburger et al., 
1999) and hedgehog (Charron et al., 2003) families. The close association between 
transcription factor expression domains and the paths of early axons (Marcus et al., 
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1999; Macdonald et al., 1994) raises the possibility that more examples of transcription 
factors with axon guidance roles will arise in the future.  
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CHAPTER 8: FINAL DISCUSSION 
8.1. SUMMARY 
The retina-chiasm co-cultures revealed that in the absence of Foxg1 in the Foxg1-/- retina 
or chiasm, the behaviour of DN retinal axons becomes more ipsilateral in character. It 
was speculated that this could be caused by increased expression of an ipsilateral 
determinant, confirmed in Chapter 4 by Zic2 expression analysis, or the reduction of a 
contralateral determinant in DN retina. Increased expression of the ipsilateral 
determinant Zic2 suggested that the Foxg1-/- retina had become more ventral or temporal 
in character, leading to increased specification of ipsilateral RGCs. This hypothesis of 
altered retinal patterning was addressed in Chapter 5, which revealed normal dorso-
ventral patterning of the retina but could not confirm whether naso-temporal patterning 
was altered. At the optic chiasm, candidates for expression studies were chosen based on 
the hypotheses that a repulsive guidance cue is increased or that important cells and 
neurons in the chiasm region show morphological defects when Foxg1 is absent in vivo. 
However, Chapter 6 revealed that the optic chiasm of Foxg1
-/-
 embryos shares many 
morphological, cellular and molecular features with that of wild types and failed to show 
expanded domains of expression for a couple of key repulsive guidance cues. Chapter 7 
examined the distribution of Foxg1 protein in the developing eye and chiasm regions and 
discovered that it is present more widely in the eye than suggested by its pattern of 
mRNA expression. Additionally Foxg1 protein was observed in axons where it could 
influence axon navigation in multiple ways. 
The following paragraphs discuss these findings in greater detail and provide a model 
hypothesizing how Foxg1 directs retinal axon divergence at the optic chiasm based on 
the new findings presented in this thesis. 
272
8.2. Foxg1 influences the guidance of dorsonasal axons from within the 
retina and at the chiasm. 
The in vitro co-cultures of wild type retina and wild type chiasm (described in Chapter 3) 
reproduced previous findings that VT axons grow significantly less well than DN axons 
in the presence of chiasm cells (Herrera et al., 2004; Herrera et al., 2003; Marcus et al., 
1995; Marcus and Mason, 1995; Marcus et al., 1996b; Wang et al., 1995). Low axon 
outgrowth reflected the selective repulsion of axons from the VT retina in the presence of 
chiasm cells reflecting their ipsilateral routing in vivo. These reproducible findings 
bolstered confidence in the validity of the co-culture method as an in vitro representation 





DN retinal axons grew less well on Foxg1-/- chiasm cells compared to control co-cultures 
consisting entirely of wild type DN retina and chiasm. These in vitro findings mirrored 
the increased ipsilateral projection observed from the nasal retina of Foxg1 null embryos 
(Pratt et al., 2004). The possibility that Foxg1
-/-
 retinal axons grow inherently less well 
than their Foxg1-expressing counterparts is thought unlikely given that the absence of 
Foxg1 had no effect on the degree of axon outgrowth from DN or VT retinal explants 
grown in the absence of chiasm cells.  




 co-cultures failed to 
show a significant difference in outgrowth compared to the wild type-only controls. 
Given that Foxg1 is absent from the VT retina (Hatini et al., 1994; Huh et al., 1999; 
Chapter 5 of this thesis), any influence of Foxg1 on the guidance of VT axons would 
suggest a non-autonomous influence. However, this possibility cannot be eliminated and 





 co-cultures relative to control co-cultures of VT retina may suggest a 
small non-autonomous influence. As discussed in Chapter 3, it is possible that the co-
culture experiment might not reveal an influence of Foxg1 in the guidance of VT retinal 
axons due to its inability to discriminate between low outgrowth and very low outgrowth 
from VT retina in co-culture. However, if the co-culture findings are taken at face-value, 
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indicating that Foxg1 is not involved (even non-autonomously) in the navigation of VT 
RGC axons, it is conceivable that the increased projection from the Foxg1
-/-
 temporal 
retina previously described is caused by loss of Foxg1 at the chiasm, which could 
potentially alter the guidance of retinal axons from the entire retina. This possibility was 
investigated in Chapter 6. 
The Foxg1-/-  Foxg1-/- co-cultures prepared from DN retina did not show whether the 
loss of Foxg1 from the retina or the chiasm region produced the reduction in axon 
outgrowth. This was investigated by mixing and matching control (Foxg1-expressing) 
and Foxg1
-/-
 retinal explants and chiasm cells and vice-versa. The control  Foxg1
-/-
 co-
cultures prepared from DN retina supported a requirement for Foxg1 in DN retina and 
also showed a requirement for Foxg1 in optic chiasm cells for the guidance of DN retinal 
axons. Identical co-cultures of control and Foxg1
-/-
 tissue, using explants from VT retina 
instead of DN retina, failed to show any significant differences relative to the VT control 
co-cultures, again suggesting that Foxg1 is not involved in VT axon guidance.  
It is important to remember the limitations of this in vitro co-culture experiment as for 
any other in vitro system. The in vivo situation can only be reconstructed up to a point 
and so in vitro systems will not recreate the exact in vivo environment encountered by 
growing axons. In vitro, dissociation of the chiasm abolished the 3-dimensional chiasm 
structure, which produced a more homogeneous environment for retinal axons, possibly 
influencing their divergence by altering the cellular and molecular environment (Baker, 
1990; Baker and Jeffery, 1989; Marcus and Mason, 1995; Reese and Baker, 1990; 1992). 
Therefore, it would be ideal to repeat these cultures using whole chiasm explants, 
maintaining their 3D structure.   
In summary, the co-cultures suggest that Foxg1 normally promotes the midline crossing 
of DN retinal axons and that Foxg1 exerts its influence autonomously from within the 
DN retina and also non-autonomously at the chiasm. 
274
8.3. The Foxg1-/- nasal retina contains an increased number of RGCs 
expressing the ipsilateral determinant Zic2. 
Chapter 4 showed a significant increase in the proportion of RGCs expressing the 
ipsilateral determinant Zic2 in the Foxg1
-/-
 nasal retina, providing a molecular 
explanation for the increased ipsilateral routing of Foxg1
-/-
 nasal retinal axons and in 
vitro co-culture results presented in this thesis. Foxg1-/- retinas contained similar numbers 
of RGCs compared to those of wild types, excluding the possibility that a larger number 
of RGCs produced a corresponding increase in the number of Zic2-positive cells in the 
nasal retina, whilst maintaining a wild type proportion of Zic2-expressing cells. It is 
crucial to confirm whether the Foxg1
-/-
 RGCs that ectopically express Zic2 in the nasal 
retina are the same RGCs that project ipsilaterally in abnormally large numbers at the 
Foxg1
-/-
 chiasm. This can be achieved by using rhodamine dextran to backlabel 
contralateral and ipsilateral axons from one optic tract followed by Zic2 
immunohistochemistry on the ipsilateral and contralateral retina (Herrera et al., 2003). 
Herrera et al. showed that in the wild type VT retina, colocalisation with Zic2 only 
occurred in a small percentage of backlabeled RGCs in the ipsilateral eye due to 
downregulation of Zic2 in retinal axons upon crossing the chiasm midline. However, the 
technique was sufficiently powerful to reach the conclusion that only ipsilateral RGCs, 
but never contralateral RGCs, express Zic2. If there is a direct association between Zic2 
expression and the increased uncrossed axon trajectory in Foxg1 null mice, backlabeled 
ipsilateral RGCs should colocalise with Zic2-expressing RGCs in the nasal retina. 
Numbers of Zic2-positive RGCs did not increase in the Foxg1
-/-
 temporal retina. The 
temporal retina normally expresses Foxg1 only in dorsal regions in the wild type 
(Chapter 5). Nevertheless, the Foxg1
-/-
 VT quadrant showed a decrease in the proportion 
of Zic2-positive RGCs at E14.5, which was significant using DAB 
immunohistochemistry. The DT quadrant showed a small but significant increase in 
Zic2-positive RGCs at E14.5 and E16.5 (Figure 12, Chapter 4). Although these findings 
hint at possible changes in the temporal retina, the most obvious and consistent finding of 
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Chapter 4 was the increase in Zic2-expressing RGCs in the nasal retina, which was 
reproducible using both chromogenic and fluorescent detection methods for Zic2 protein. 
The fact that altered Zic2 expression is primarily a feature of the Foxg1-/- nasal retina, 
where the majority of cells normally express Foxg1, suggests that Foxg1 primarily acts 
autonomously in Foxg1-expressing cells to specify a contralateral path in nasal RGC 
axons by regulating the proportion of RGCs expressing Zic2 protein.  
8.3.1. Hypotheses to explain the altered proportion of Zic2-expressing 
RGCs in the Foxg1 null retina. 
Hypothesis 1: Foxg1 normally represses Zic2 in Foxg1-expressing RGCs, 
thereby preventing an ipsilateral program. In Foxg1 null embryos, 
repression of Zic2 is relieved in the nasal retina.  
Based on the results shown in Chapter 4 it was hypothesized that Foxg1 might normally 
repress Zic2 in the Foxg1-expressing nasal retina, thus repressing an ipsilateral program 
in nasal axons. The hypothesis that Foxg1 represses Zic2 may explain why Zic2 is 
mostly confined to the VT retina, where Foxg1 mRNA is not found (as shown in Chapter 
5), but only weakly expressed in RGCs and other retinal layers in DN, DT and VN retina 
where Foxg1 mRNA is normally present (Chapters 4 & 5).  
A transcription factor that has been shown to repress Zic2 specifically in VT RGCs and 
prevent the ipsilateral routing of their axons is Islet-2 (Pak et al., 2004). Thus Foxg1 and 
Islet-2 may repress Zic2 in the nasal and VT retina respectively (see Chapter 4, Figure 
18). Foxg1 is known to act as a transcriptional repressor in vitro (Dou et al., 2000; Yao et 
al., 2001; Hardcastle & Papalopulu, 2000; Castella et al., 2000). Transcriptional 
repression of Zic2 may occur directly, via binding of Foxg1 to Zic2 or indirectly via 
Foxg1-mediated transcriptional regulation of genes whose products have a repressive 
effect on Zic2.  
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Regardless of whether Foxg1 represses Zic2 directly or indirectly, in Foxg1 null 
embryos, the repressive effect of Foxg1 on Zic2 in the nasal retina would be relieved, 
activating its expression in nasal RGCs. There is convincing in vitro and in vivo evidence 
that links EphB1 expression in the VTC to the ipsilateral projection (Williams et al., 
2003). Zic2 is thought to be required for EphB1 expression based on reports that Zic2 
and EphB1 normally co-localise in the VT retina (Pak et al., 2004) and increased or 
reduced expression of Zic2 produces a corresponding increase or reduction in EphB1
expression (Williams et al., 2003; Pak et al., 2004; Williams et al., 2006). Therefore, 
nasal RGCs that ectopically express Zic2 might activate EphB1 leading to the repulsion 
of EphB1-bearing retinal axons upon contact with ephrin-B2-expressing midline radial 
glia at the chiasm (Williams et al., 2003). If this hypothesis is true, the proportion of 
EphB1-expressing RGCs in the Foxg1-/- nasal retina should increase reflecting the greater 
proportion of Zic2-expressing RGCs in Foxg1 null embryos. Moreover, nasal RGCs that 
ectopically express EphB1 should co-localise with Zic2 (Pak et al., 2004). This theory 
could be tested by in situ hybridization for EphB1 followed by Zic2 
immunohistochemistry or by two-colour in situ hybridization for EphB1 and Zic2 in the 
Foxg1 null retina.  
In order to understand the mechanism by which Foxg1 exerts its repressive effects, 
coimmunoprecipitation (Ransone, 1995) could be used to identify the proteins that Foxg1 
binds to. To test the validity of a direct interaction between the Zic2 promoter and Foxg1, 
chromatin immunoprecipitation could be utilized (Solomon and Varshavsky, 1985). 
Chromatin immunoprecipitation enables analysis of the interaction of proteins with 
specific chromatin regions. In vivo footprinting could also be used to map the precise 
DNA sequences to which Foxg1 binds in vivo (Becker et al., 1993; Grange et al., 1997).  
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Hypothesis 2: Foxd1 is ectopically expressed in the nasal retina of Foxg1
null embryos producing an increase in Zic2-expressing RGCs.  
An explanation for the VT-restricted expression of Zic2 in wild type embryos is that 
activation of Zic2 expression requires the transcription factor Foxd1, which is expressed 
in the VT retina and affects the ipsilateral-contralateral ratio (Herrera et al., 2004). Any 
influence by Foxd1 is thought to be indirect because the VT domain of Foxd1 expression 
in the retina has been shown to extend beyond the region occupied by Zic2-expressing 
cells in the VTC in the peripheral retina (Herrera et al., 2004). In wild type mouse 
embryos, Foxg1 may normally repress Foxd1 in the nasal retina, as demonstrated in the 
developing chick embryo (Takahashi et al., 2003). This would limit Foxd1 to temporal 
regions where it might activate Zic2 expression and is an example of Foxg1 repressing 
Zic2 indirectly via repression of Foxd1 (Hypothesis 1). In the Foxg1 null retina, ectopic 
activation of Foxd1 is expected to occur in nasal regions that normally express Foxg1
through the absence of repression by Foxg1, resulting in the ectopic expression of Zic2 in 
these areas. There is evidence for aberrant expression of Foxd1 in the Foxg1 null retina 
in the mouse at E10.5 (Huh et al., 1999). In order to test the validity of this hypothesis, 
the spatial distribution of Foxd1 mRNA in relation to Foxg1 and Zic2 could be examined 
by two-colour in situ hybridization for Foxd1 and Foxg1 followed by Zic2 
immunohistochemistry at E14.5, when Zic2 appears in the VT retina. The relative 
orientations of the expression domains of Foxg1 and Foxd1 have not been investigated to 
date within the same retina in an E14.5 wild type embryo. Therefore, a wild type control 
is crucial. In the Foxg1
-/-
 retina, two-colour in situ hybridization for Foxd1 and Zic2 or in 
situ hybridization for Foxd1 followed by Zic2 immunohistochemistry would be expected 
to show ectopic expression of Foxd1 and Zic2 in the nasal retina and overlapping 
expression domains.  
Ectopic Foxd1 expression in the Foxg1-/- nasal retina may also come about via disrupted 
nasal-temporal patterning. Parts of the retina that would normally express Foxg1 might 
be respecified as ‘temporal’ regions. Since Foxd1 is expressed in the temporal retina at 
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early embryonic ages, the misspecification of nasal RGCs as temporal RGCs might result 
in the ectopic expression of Foxd1 in the nasal retina, which might in turn activate Zic2
expression.  
In order to distinguish between hypothesis (1): whether Foxg1 represses Zic2 and 
hypothesis (2): whether Foxd1 activates Zic2, Foxg1 or Foxd1 could be ectopically 
expressed in regions of the wild type retina from which they are normally absent or 
alternatively Foxg1 or Foxd1 could be blocked in the wild type retina by RNAi (Fire et 
al., 1998). In order to see whether Zic2 expression is eliminated, reduced or elevated, 
Zic2 protein could be visualized using immunohistochemistry and protein levels 
quantified by Western blot or Zic2 mRNA quantified by qRT PCR. Foxd1 expression 
levels would have to be monitored following manipulation of Foxg1 and vice-versa to 
see if they are altered in response to overexpression or elimination of Foxg1 or Foxd1 as 
suggested by previous reports (Herrera et al., 2004; Takahashi et al., 2003; Huh et al., 
1999; Yamagata et al., 1999). In order to eliminate possible changes in Foxg1 protein 
levels when testing for a regulatory effect of Foxd1 on Zic2, Foxd1 could be 
overexpressed or eliminated in the Foxg1-/- eye and the effect on Zic2 expression studied.  
Hypothesis 3: Aberrant migration of Zic2-expressing RGCs from 
ventrotemporal to nasal regions of the Foxg1 null retina produces an 
increased proportion of nasal Zic2-expressing RGCs.
Cells in the Foxg1
-/-
 temporal retina may migrate abnormally into the nasal retina. This 
hypothesis was suggested by the finding of a reduction in the number of RGCs activating 
Foxg1 in DN regions (Chapter 5), which might suggest the presence of cells with 
‘temporal’ characteristics. The aberrant migration of RGCs from temporal to nasal 
regions might lead to the redistribution of Zic2-expressing cells in nasal regions. The 
proportion of Zic2-expressing cells was reduced in the VT quadrant at E14.5 and this 
was significant using DAB immunohistochemistry (Figure 12B, Chapter 4). This VT 
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reduction in Zic2 may be linked to increased activation of Foxg1 in this quadrant 
(Chapter 5), resulting in the VT region containing more cells with ‘nasal’ characteristics. 
Thus the VT reduction in Zic2-expressing RGCs may be caused by VT cells leaving this 
region and migrating to the nasal retina and/or through nasal cells abnormally entering 
the VT quadrant, thus reducing the proportion of Zic2-expressing cells.  
This hypothesis is probably the least likely out of all the three possibilities explaining 
changes in the proportion of Zic2-positive RGCs. The main drawback is that a migratory 
defect cannot account for the overall increase in the number of Zic2-expressing cells in 
the Foxg1
-/-
 retina. Defective intraretinal migration might be expected to produce a 
random mixing of nasal and temporal cells and a corresponding random distribution in 
Zic2-positive cells. However, Zic2 did not appear to be randomly distributed over the 
Foxg1 null retina. Instead Zic2 was mainly confined to peripheral DN and VN retinal 
quadrants. Also, some degree of nasal-temporal polarity is maintained in the Foxg1-/-
retina because the majority of ipsilateral projections still arise from the temporal retina 
(Pratt et al., 2004). The hypothesis of abnormal migration could be tested by 
fluorescently tagging single cells in the intact Foxg1-/- nasal or temporal retina in vitro
and following their progress through development.  
8.4. Dorsoventral retinal patterning appears to be maintained in the Foxg1-/-
eye. 
Despite the abnormal squashed, medially-elongated appearance of the Foxg1
-/-
 retina, the 
main retinal layers were maintained. This corroborates findings in Chapter 4 that retinal 
ganglion cells are present in an equivalent location to wild types in the inner retinal layer. 
The RGC layer covered a larger area in anterior-most regions but abnormal folding of the
Foxg1
-/-
 retina in this region could have resulted in the RGC layer being sectioned at an 
angle (Chapter 5). A 3-dimensional image of the Foxg1 null eye would help distinguish 
true morphological defects from sectioning artifacts.  
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There was no evidence for disrupted dorsoventral patterning, analysed by ephrin-B2 and 
EphB2 protein gradients along the DV axis (this thesis, published in Pratt et al., 2004). It 
is possible, but considered unlikely, that ephrin-B2 and EphB2 gradients are maintained 
in the Foxg1
-/-
 retina despite abnormal DV patterning. Given more time, this hypothesis 
could be tested by conducting a thorough expression analysis of EphA, ephrin-As and the 
other EphB and ephrin-Bs in the eye and perhaps some of the earlier markers of DV 
polarity, such as Vax and Tbx5. If the expression gradients of these molecules are 
maintained as normal in the Foxg1-/- eye, this would strengthen the findings of normal 
DV patterning presented here and weaken the argument for an expanded ventral retina 
contributing to the increased ipsilateral projections.  
8.5. Foxg1 expression is hypothesized to show spatiotemporal changes 
during development. 
From E13.5 in Foxg1LacZ/+ eyes, the Foxg1LacZ reporter revealed that Foxg1 is most 
widely expressed nasally and temporally in the dorsal retina with expression becoming 
increasingly restricted to nasal regions in ventral retina, such that the ventrotemporal 
quadrant does not express Foxg1 (Chapter 5). This result differs from previous reports 
claiming that Foxg1 was restricted to the nasal half of the retina (Hatini et al., 1994; Huh 
et al., 1999). These studies examined Foxg1 mRNA expression using the same Foxg1LacZ
reporter mice and also in situ hybridization. The mRNA expression pattern also differed 
from the spatial pattern of Foxg1 protein in the retina (Chapter 7), which was more 
widespread and covered much of the temporal retina. Similarly, Huh et al. (1999) 
reported that nasal-temporal patterning was maintained in the retina of Foxg1
LacZ/LacZ
embryos. However, in observations presented in this thesis Foxg1LacZ/LacZ eyes 
consistently lacked a clear boundary between nasal Foxg1-expressing and temporal 
Foxg1-negative regions. Moreover, an increase in the number of RGCs activating Foxg1
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was observed in temporal regions of the Foxg1 null retina, whereas a reduction in RGCs 
activating Foxg1 was seen in dorsonasal regions. 
There are a number of possibilities that could explain the discrepancies between these 





 embryos prior to or at E12.5 rather than 
embryos between E13.5 and E15.5. Therefore, it is plausible that the spatial pattern of 
Foxg1 activation changes between E12 and E14. In Foxg1
LacZ/+
embryos, Foxg1 might be 
restricted to nasal regions at earlier ages until E12.5 followed by a change in expression 
pattern later on in development to the one described here (see Figure 11, Chapter 5).  
In the Foxg1
LacZ/LacZ
 eye, the presence of cells that activate Foxg1 in temporal regions 
where Foxg1 is not usually expressed in the wild type, suggests that either temporal cells 
are misspecified as ‘nasal’, suggesting a nasal-temporal patterning defect, or that nasal 
cells are able to migrate abnormally to the temporal retina. In the latter instance, 
nasotemporal patterning might be set up as normal in the Foxg1 null embryo but then 
migratory defects affect the position of nasal cells at the ages examined in this thesis. 
These two hypotheses cannot be distinguished at present. Considered in isolation, the 
Foxg1
LacZ/LacZ
 results suggest a breakdown of nasal-temporal polarity. However, it would 
be wise to corroborate the Foxg1
LacZ/LacZ
 findings to exclude the possibility of ectopic 
activation of the Foxg1
LacZ
 reporter. Moreover, the Foxg1
LacZ
 reporter only marks cells 
that are predominantly found in the nasal retina. Therefore, the hypothesis of disrupted 
NT patterning could be examined further by investigating the expression of more nasal 
and temporal patterning genes and their proteins in the retina, such as EphA3, SOHo1, 
GH6, ephrin A2 and ephrin A5 nasally (Takahashi et al., 2003) and Foxd1 and 
EphA5/EphA6 temporally (Flanagan, 2006). The hypothesis of abnormal migration 
could be examined by fluorescently labeling and tracing the migration of single cells in 
the nasal or temporal retina.  
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Another possible reason for discrepancies between this thesis and previous studies lies in 
the use of slightly different planes of section, which might alter the regions that are 
defined as nasal and temporal retina. In other words, Foxg1 expression might not change 
between E12.5 and E14.5 but only appears to do so due to sectioning differences. An 
additional explanation that primarily concerns Foxg1
LacZ/+
 embryos is the possibility that 
the developing wild type retina tilts such that the NT axis changes orientation during 
development. Finally, there may be differences in the placement of the nasal-temporal 
axis between this thesis and previous studies, such that there is no discrepancy between 
the findings. One solution to address these problems would be to perform whole-mount 




 eyes or Foxg1 fluorescent in situ
hybridization on the eyes of Foxg1
LacZ/+
 embryos. This would provide a 3-dimensional 
view of the eye and areas in which Foxg1 is expressed or transcriptionally activated, 
which would also have the advantage of eliminating problems of tissue distortion that 
can be associated with processing. More importantly, a double in situ hybridization for 
Foxg1 and Foxd1 mRNA would enable their expression patterns to be visualized in 
relation to one another within the same wild type retina. This would facilitate mapping of 
the eye with reference to both their expression domains, rather than using the expression 
pattern of Foxg1 or Foxd1 alone to position the nasal-temporal axis. The choroid fissure 
in the wild type ventral retina could also be used as a reference point to see whether the 
retina changes orientation during development. In addition, a 3-dimensional Foxg1 null 
eye would provide a clearer picture of retinal folding and the degree of morphological 
variation between eyes than is possible in 2-dimensions alone.   
8.5.1. Foxg1 may specify a ‘contralateral’ domain within the nasal retina. 
If whole-mount studies of Foxg1 expression reveal a spatiotemporal change between 
early and later stages of eye development, then this appears to coincide with the 
spatiotemporal change in Foxd1 expression from the temporal half of the retina at early 
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stages of eye development (Hatini et al., 1994; Huh et al., 1999) to restricted expression 
in the VT retinal quadrant at around E14.5 (Herrera et al., 2004) (See Figure 1). These 
changes in Foxg1 and Foxd1 might be coincidental. Alternatively, the shift in Foxg1
expression at E13.5/E14.5, such that Foxg1 occupies the DT retina, might cause the 
restriction of Foxd1 to the VT retina, given that Foxg1 represses Foxd1 (Yamagata et al., 
1999; Takahashi et al., 2003).  
Interestingly, Foxd1, and now Foxg1 (this thesis), alter their spatiotemporal expression 
patterns at E13.5 - E14.5, which coincides with the projection of many contralateral and 
the first permanent ipsilateral axons out of the retina. One hypothesis for this 
spatiotemporal change is that at early developmental stages these two forkhead 
transcription factors are involved in nasal-temporal patterning (Figure 1A), whereas at 
later stages from E13.5 - E14.5, Foxg1 activation in the nasal retina demarcates a 
‘contralateral domain’ that produces contralateral RGC axons and Foxd1 activation in 
VT retina demarcates an ‘ipsilateral domain’ that produces ipsilateral RGC axons (Figure 
1B). This hypothesis could still apply if Foxg1 is not shown to change its spatial 
expression pattern (ie. if no discrepancies exist between previous studies and this thesis).   
Foxg1 can hypothetically affect the contralateral or ipsilateral routing of RGC axons in a 
number of different ways. These possibilities can be viewed in a hierarchical manner 
from the requirement for Foxg1 in a whole region, such as the entire anterior forebrain or 
the retina or optic chiasm, right down to the details of which molecules interact with 
Foxg1 in a given cell or axon and whether this interaction is direct or indirect. Numerous 
studies have shown that Foxg1 acts as a classical transcription factor, which binds DNA 
and influences the transcription of certain genes (Hanashima et al., 2002; Yao et al., 
2001; Hardcastle & Papalopulu, 2000; Castella et al., 2000) but Foxg1 can also influence 
molecules in the retina in a DNA-binding-independent fashion (Yamagata et al., 1999; 
Takahashi et al., 2003). These DNA-dependent and DNA-independent mechanisms of 
action add complexity to the potential myriad effects that Foxg1 could have upon the 
guidance of retinal axons at the optic chiasm.  
Figure 1. Hypothesised changes in the roles of Foxg1 and 
Foxd1 during eye development
From ~ E14.5, Foxg1 (blue circles) is expressed in half of the retina, most 
widely in DN retina but declining towards VT retina where it is absent. Its 
expression defines a ‘contralateral domain’ and RGCs (depicted as circles) 
within it project contralaterally. This might occur via Foxg1 repression of Zic2. 
Foxd1 (yellow circles) is expressed in VT retina and defines an ‘ipsilateral 
domain’. Zic2-expressing RGCs (green circles) are highly concentrated in the 
VTC in peripheral VT retina (Herrera et al., 2003) but are also found in other 
regions of the temporal and nasal retina (Chapter 4, this thesis). An unknown 
regulator (denoted as ‘X’) activates Zic2 expression and it is thought that Foxd1 
may be required upstream of ‘X’ for Zic2 activation (Herrera et al., 2004). Black 
circles indicate contralateral RGCs that express Isl2, which represses Zic2 
within the VTC (Pak et al., 2004). Abbreviations: Ipsi = ipsilateral RGCs, Contra 
= contralateral RGCs, VTC = ventrotemporal crescent.
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The following paragraphs describe the possible ways in which Foxg1 may control 
contralateral-ipsilateral axon navigation from (1) the retina, (2) within axons and (3) at 
the optic chiasm. These three possibilities are not mutually exclusive, as the co-culture 
experiments in this thesis suggest (Chapter 3) and it is likely that they act in combination.  
8.5.2. Control from the retina.  
Foxg1 may influence the contralateral-ipsilateral routing from the first time it is 
expressed in the optic cup by setting up nasal-temporal polarity in the retina. The 
specification of a ‘contralateral domain’ within much of the nasal retina at E13.5/E14.5 
might then result in Foxg1 promoting the contralateral routing, or preventing the 
ipsilateral routing, of axons that project from RGCs that express Foxg1 themselves. This 
can be described as a cell-autonomous mode of action within RGCs because Foxg1 
affects the same cells in which it is expressed. Foxg1 might also influence the routing of 
axons that project from RGCs that do not express Foxg1, for example those in the VT 
retina. This can be described as a non-autonomous mode of action within RGCs because 
Foxg1 affects cells in which it is not expressed.  
The findings presented in Chapter 4 suggest that Foxg1 prevents an uncrossed path in 
axons that originate from Foxg1-expressing nasal RGCs, via repression of Zic2. Within 
Foxg1-expressing RGCs, the repression of Zic2 by Foxg1 is thought to be cell-
autonomous because Zic2-expressing cells increase in RGCs of the Foxg1-/- nasal and 
dorsotemporal retina that would normally express Foxg1. However, there are hints at 
non-autonomous effects by Foxg1 on Zic2 in the VT quadrant, which showed a slight 
decrease in Zic2-expressing cells at E14.5. Earlier in this discussion it was hypothesized 
that the abnormal proportion of Zic2-expressing RGCs in these quadrants may be fully or 
partly explained by defective nasal-temporal patterning of the retina or by defective 
migration when Foxg1 is absent.  
Another layer of complexity is added by considering the multiple ways through which 
Foxg1 might repress Zic2 and other downstream target genes that influence axon 
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navigation. Repression by Foxg1 could occur via DNA-binding-dependent or DNA-
binding-independent means. In terms of DNA-binding, Foxg1 might repress Zic2 either 
(1) directly via binding to the Zic2 promoter or (2) indirectly via transcriptional 
repression of another gene that represses Zic2. The DNA-independent mechanism could 
take the form of a direct protein-protein interaction between Foxg1 and Zic2 or an 
interaction between Foxg1 and a molecule that is required for regulating Zic2, such that 
Foxg1 represses Zic2 indirectly. Although Zic2 was used as an example here, Foxg1 
potentially affects other target genes or molecules in this way.  
It remains plausible that Foxg1 promotes the crossing of retinal axons projecting from 
Foxg1-expressing RGCs by regulating expression of ‘contralateral determinants’ that 
result in axons growing across the chiasm midline. However, no such contralateral 
determinant has been discovered in the literature. The only known molecules expressed 
by contralateral RGCs, Nr-CAM and Islet-2, affect the crossing of axons produced later 
than the onset of the Foxg1
-/-
 axon projection defect in the case of Nr-CAM (Williams et 
al., 2006) or the crossing of axons within the VT retina only in the case of Islet-2 (Pak et 
al., 2004). Therefore, it is unlikely that altered expression of Nr-CAM or Islet-2 is 
responsible for the increased ipsilateral projection in Foxg1 null embryos. In order to 
completely rule out this hypothesis, protein and mRNA expression patterns of Nr-CAM 
and Islet-2 could be investigated in the developing Foxg1
-/-
 retina by 
immunohistochemistry or in situ hybridization respectively.  
8.5.3. Control from within retinal axons. 
Chapter 7 showed that Foxg1 protein was found in retinal axons. An interesting area for 
future investigation would be to determine whether Foxg1 protein is confined to 
contralateral axons only that arise from Foxg1-expressing RGCs or whether it is also 
found in ipsilateral (VT) axons. If Foxg1 is found in all axons, does it influence their 
navigation differentially and if so what is/are the mechanism(s) involved? It is unknown 
whether Foxg1 protein is locally synthesized within the growing axon or whether protein 
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is made in the cell bodies of RGCs and then transported along axons to their tips. Within 
the cell bodies of RGCs, Foxg1 protein may act as a transcription factor to mediate 
receptor-ligand signaling at the growth cone via the transcriptional regulation of 
downstream effectors. For example, transcriptional regulation by Foxg1 may ultimately 
lead to the production of a particular complement of receptors that cause the growth cone 
to steer in a particular manner. Foxg1 protein in navigating axons may have numerous 
actions, particularly since Foxg1 is known to have DNA-independent effects (Yuasa et 
al., 1996; Yamagata et al., 1999; Hanashima et al., 2002; Takahashi et al., 2003). Within 
the growth cone, Foxg1 might affect the cytoskeleton and influence the extension or 
retraction of filopodia or perhaps Foxg1 protein is transported retrogradely from the 
growth cone to the RGC cell body where it can act as a transcription factor. All these 
possibilities are speculative at present and demand further experiments, some of which 
are discussed in Chapter 7 of this thesis. The answers to these questions will help to 
unravel the mechanism through which Foxg1 affects axon navigation.  
8.5.4. The Foxg1-/- chiasm retains many wild type characteristics. 
The presence of an optic chiasm in Foxg1
-/-
 embryos that retains many wild type 
anatomical and molecular features showed that Foxg1 is not required for chiasm 
formation (Chapter 6). Expression of the Foxg1LacZ reporter in Foxg1 null embryos 
revealed Foxg1 activation in anterior hypothalamic cells corresponding to the location of 
Foxg1-expressing cells in wild types. This demonstrated that cells that would normally 
express Foxg1 are present in Foxg1
-/-
 embryos and can still respond to cues that activate 
Foxg1 expression. Also previous DiI tracing studies revealed that Foxg1
-/-
 axons 
decussate in an ‘X’-shape at the chiasm midline, which is reminiscent of the shape 
formed by wild type axons at the optic chiasm, although Foxg1
-/-
 axons appear less 
fasciculated (Pratt et al., 2004).  
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The midline cytoarchitecture of the Foxg1
-/-
 chiasm appeared grossly normal. A palisade 
of cells that expressed ephrin-B2, a molecule known to be expressed by midline radial 
glia, was maintained at the Foxg1-/- midline. However, the presence of these midline 
radial glial cells needs to be confirmed using a specific radial glial marker, such as RC2 
(Godement et al., 1994).  
The cell-surface glycoproteins SSEA-1 and CD44 and the transcription factor Nkx2.2 
were all present in their expected locations in the ventral diencephalon. This suggests that 
the population of early-differentiating neurons that are required for establishing the 
chiasm architecture and inhibiting the growth of retinal axons into inappropriate regions 
of the diencephalon are present as normal in Foxg1 null embryos. However, it is 
conceivable that Foxg1-/- contralateral and ipsilateral axons interact or position 
themselves abnormally in relation to these chiasm molecules, producing misrouting at the 
midline; a possibility that should be investigated in the near future. Observations of 
slightly stronger expression of CD44 at the chiasm midline warrant more detailed 
investigation in the future, encompassing a greater range of embryonic ages and 
quantitation by Western-blotting. Since the presence of CD44 in the ventral diencephalon 
has been reported to promote the ipsilateral routing of axons (Lin et al., 2003, 2005), it is 
plausible that increased CD44 expression plays a role in repelling more nasal and 
temporal RGC axons into the uncrossed tract, explaining the increased ipsilateral 
projection from the entire Foxg1
-/-
retina.  
A change in Foxd1 expression at the chiasm may also affect axon guidance by affecting 
the cellular and/or molecular environment encountered by growing axons. No studies to 
date have explored Foxd1 expression patterns around the chiasm in Foxg1 null mice. 
Foxd1
-/-
embryos display an increased ipsilateral projection from the entire retina, which 
was attributed to expanded Slit2 expression in the diencephalon (Herrera et al., 2004). 
Perhaps an expansion in Foxd1 expression at the Foxg1-/- chiasm results in abnormalities 
in the expression of chiasm or diencephalic guidance cues, such as Slit2, thereby 
increasing the proportion of uncrossed axons. This hypothesis could be tested by 
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comparing Foxd1 and Slit2 expression in Foxg1 null versus wild type embryos from 
E13.5 – E16.5 by in situ hybridization, quantitative RT PCR and Western-blotting. 
Many more extracellular matrix molecules affect axon guidance but time limitations did 
not permit exhaustive expression analyses of these. Therefore, it remains a possibility 
that the expression of some of these molecules is altered in the Foxg1
-/-
 ventral 
diencephalon or midline, altering the uncrossed projection. A microarray comparison of 
wild type and Foxg1
-/-
 cDNA taken from the retina and chiasm would enable a 
comprehensive survey of differences in expression levels in these regions of the embryo. 
This would identify whether the expression of certain genes is altered relative to the wild 
type retina or chiasm and provide candidates for functional analyses.  
8.6. Foxg1 could regulate expression of a midline chemoattractant. 
One way in which Foxg1 could promote axon crossing is through the positive regulation 
of a midline chemoattractant, such that in Foxg1’s absence, the midline is less attractive 
to axons resulting in a greater number of axons being diverted into the ipsilateral tract. 
The reason for focusing on inhibitory or chemorepulsive molecules at the chiasm is due 
to the paucity of diffusible chemoattractants identified to date. These constitute members 
of three families: Netrins, scatter factor/hepatocyte growth factors (SF/HGF), 
neurotrophins (Ebens et al., 1996; O'Connor and Tessier-Lavigne, 1999; Tessier-Lavigne 
and Goodman, 1996). Recently Shh was added to this list due to its chemoattractive 
properties towards commissural spinal axons (Charron et al., 2003). It is likely that more 
chemoattractants will be found in the future but in the meantime an interesting extension 
of the chiasm expression studies would be to investigate the protein or mRNA expression 
patterns of some of these molecules. Moreover Foxg1
-/-
 retinal explants could be cultured 
in the presence of netrin, Shh and other chemoattractive candidates to test whether the 
growth of their axons is altered compared to those from wild type retinas.  
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In summary, Foxg1 appears to have roles in eye and forebrain morphogenesis, roles in 
the guidance of retinal axons from the retina and at the chiasm and also, hypothetically, a 
role in axon guidance from within navigating axons themselves.  
8.7. An emerging picture of the regulatory and molecular control of 
contralateral-ipsilateral divergence at the optic chiasm. 
Over the past decade, a picture has gradually emerged in which the source of ipsilateral 
projections, the VTC in the VT retina, appears to be molecularly distinct from other 
regions in the developing retina from E13 onwards. Zic2 is thought to program VT RGCs 
to project ipsilaterally via the expression of EphB1 that is repelled by ephrin-B2-
expressing midline radial glia at the chiasm (Herrera et al., 2003; Williams et al., 2003). 
Nr-CAM is expressed by contralateral RGCs in the entire retina, apart from in the VT 
Zic2-expressing region (Williams et al., 2006) and appears to suppress ipsilateral 
projections from the VT retina only at late embryonic stages. Isl2 is expressed by only a 
subset of contralateral RGCs that includes a few in the VT retina (Pak et al., 2004). In the 
VTC, Isl2-expressing RGCs are thought to suppress Zic2 and EphB1 expression, 
allowing them to project contralaterally. The results presented in this thesis add to this 
knowledge by showing that Foxg1 is required autonomously within the nasal retina but 
also at the chiasm for the contralateral guidance of nasal retinal axons. These findings led 
to the hypothesis that Foxg1 might influence the contralateral-ipsilateral ratio by setting 
up a contralateral domain within the nasal retina in which Zic2 and the ipsilateral 
program is repressed and that this part of the retina is distinct from the VT region where 
Foxd1 and Zic2 are expressed. Foxg1 may also direct guidance more directly from within 
nasal RGCs or non-autonomously within RGCs that never express Foxg1 or within the 
growth cones of axons that contain Foxg1 protein. Finally, a slight change in CD44 
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expression was seen at the Foxg1
-/-
 chiasm. Further molecular changes may be revealed 
in the future as plenty of candidate molecules remain to be explored. 
Despite this knowledge, many questions remain as to how these molecules control the 
guidance of ipsilateral and contralateral axons at the chiasm midline. For example, is the 
contralateral path a default route that needs to be suppressed in the VTC by Zic2 for 
ipsilateral projections to form? If so, how do the earliest transient ipsilateral projections 
form prior to Zic2-expressing RGCs appearing in the retina? Also, how and why do these 
early projections turn away directly into the uncrossed optic tract without contacting 
neuroepithelial and glial cells at the chiasm midline? Even though Zic2 and EphB1 
provide an explanation for the majority of ipsilateral projections, other molecules or 




 mice still display a few residual 
uncrossed axons (Herrera et al., 2003; Williams et al., 2003). Also, genes such as Zic2, 
Foxd1, Foxg1 and Nr-CAM are expressed both in the retina and at the chiasm and Nr-
CAM and Foxg1 are also present in axons. The presence of these molecules in multiple 
locations makes it harder to separate their relative contributions to contralateral-
ipsilateral divergence at each of these locations. Also, the recent findings that growth 
cones can alter their response to guidance cues depending on the presence of particular 
molecules in the extracellular environment, such as heparan sulphate proteoglycans, 
opens up the possibility for a whole host of interactions using only a limited number of 
guidance cues (reviewed in Bulow and Hobert, 2004; Charron et al., 2003; Hussain et al., 
2006; Ichijo, 2004; Stein and Tessier-Lavigne, 2001).  
By investigating the influence that Foxg1 has on the contralateral-ipsilateral routing of 
retinal axons at the chiasm, the findings presented here significantly add to increasing 
knowledge about the roles transcription factors play in regulating axon guidance and 
provide a basis for future investigation. 
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During brain development, neurons project axons tipped with
navigating growth cones. Ultimately, these axons reach and
form synaptic connections with their target cells. Axon tracts
connecting brain regions can be divided into two classes
depending on whether they cross the midline. Ipsilateral (or
longitudinal) tracts, such as the thalamocortical tract, connect
regions on the same side of the brain. Contralateral (or
commissural) tracts, such as the corpus callosum, cross the
midline of the brain and connect regions in different halves.
The visual system exhibits both types of tract. Each optic nerve
carries RGC axons from the retina towards the optic chiasm on
the ventral surface of the hypothalamus. At the optic chiasm
some RGC axons progress contralaterally and others progress
ipsilaterally to join the optic tract and grow towards their
targets in the forebrain and midbrain. This way of organising
retinal output results in parts of the brain receiving binocular
input, which is useful for judging positions of objects in space.
The behaviour of a growth cone at a specific point along its
route is defined by its interaction with the cells and molecules
it encounters. In the mouse, RGC axons exit the retina and start
to navigate along the optic stalk (forming the optic nerve) at
embryonic day 11 (E11) (Colello and Guillery, 1990). By
E15.5, the chiasm has acquired its mature configuration
although progressively more axons navigate this route during
subsequent development (Marcus et al., 1995). At the optic
chiasm RGC growth cones respond to cues generated by a
specialised population of midline cells (Wizenmann et al.,
1993; Sretavan and Reichardt, 1993; Marcus et al., 1995).
Their importance is shown by the failure of optic tract
formation in mice with an immunoablated chiasm (Sretavan et
al., 1995) and the development of only ipsilateral projections
in Pax2–/– or Vax1–/– mice with agenesis of the chiasm (Torres
et al., 1996; Hallonet et al., 1999). Contralaterally projecting
RGCs (the majority in mice) are distributed all over the retinal
surface. Ipsilaterally projecting RGCs are concentrated in
ventrotemporal retina and their axons are repelled at the optic
chiasm (Sretavan and Reichardt, 1993; Herrera et al., 2003;
Williams et al., 2003).
Several transcription factors are regionally expressed in the
developing visual system and are poised to regulate the
development of its structures and axonal connections (Torres
et al., 1996; Halonet et al., 1999; Barbieri et al., 2002; Mui et
al., 2002; Wang et al., 2002; de Melo et al., 2003; Herrera et
al., 2003). The winged helix transcription factor Foxg1 is
strongly expressed in the developing nasal retina and optic
stalk, optic chiasm, telencephalon and superior colliculus
(Xuan et al., 1995; Huh et al., 1999; Marcus et al., 1999). The
most obvious anatomical defects in embryos homozygous for
a targeted deletion of Foxg1 are abnormally shaped eyes and a
hypoplastic telencephalon (Xuan et al., 1995; Huh et al., 1999).
During normal development, retinal ganglion cells (RGCs)
project axons along the optic nerve to the optic chiasm on
the ventral surface of the hypothalamus. In rodents, most
RGC growth cones then cross the ventral midline to join
the contralateral optic tract; those that do not cross join
the ipsilateral optic tract. Contralaterally projecting RGCs
are distributed across the retina whereas ipsilaterally
projecting RGCs are concentrated in temporal retina. The
transcription factor Foxg1 (also known as BF1) is
expressed at several key locations along this pathway.
Analysis of Foxg1 expression using lacZ reporter
transgenes shows that Foxg1 is normally expressed in most,
if not all, nasal RGCs but not in most temporal RGCs,
neither at the time they project nor earlier in their lineage.
Foxg1 is also expressed at the optic chiasm. Mice that lack
Foxg1 die at birth and, although the shape of their eyes is
abnormal, their retinas still project axons to the brain via
the optic chiasm. Using anterograde and retrograde tract
tracing, we show that there is an eightfold increase in
the ipsilateral projection in Foxg1–/– embryos. The
distributions of cells expressing the transcription factors
Foxg1 and Nkx2.2, and cell-surface molecules Ephb2,
ephrin B2 and SSEA-1 (Fut4) have been correlated to the
normally developing retinothalamic projection and we
show they are not much altered in the developing Foxg1–/–
retina and optic chiasm. As much of the increased
ipsilateral projection in Foxg1–/– embryos arises from
temporal RGCs that are unlikely to have an autonomous
requirement for Foxg1, we propose that the phenotype
reflects at least in part a requirement for Foxg1 outwith the
RGCs themselves, most likely at the optic chiasm.
Key words: Eye, BF1, Optic chiasm, Retinal ganglion cell axons,
Ipsilateral, Contralateral, Ephb, Ephrin B, Tract tracing, Mouse
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We have shown by injecting tract-tracers into the eyes of these
mutants that the retina projects axons to an optic tract growing
over the surface of the thalamus (Pratt et al., 2002).
To test the potential for Foxg1 to influence axon navigation,
we used carbocyanine dyes to trace retinal axons in mice
carrying a targeted deletion of Foxg1 (Xuan et al., 1995; Hebert
and McConnell, 2000). We found that mice lacking Foxg1 have
an increased ipsilateral projection arising from both nasal and
temporal retina. To characterise this defect, we (1) used lacZ
reporter transgenes to identify potential sites at which Foxg1
expression might influence the navigation of retinofugal axons;
and (2) examined several molecular markers expressed in the
normal retina and optic chiasm, namely the transcription
factors Foxg1 and Nkx2.2, the receptor tyrosine kinase Ephb2
and its ligand ephrin B2, and the stage-specific embryonic
antigen 1 (SSEA-1; Fut4 – Mouse Genome Informatics)
(Marcus et al., 1999; Barbieri et al., 2002; Williams et al.,
2003) in Foxg1–/– embryos.
Materials and methods
Foxg1 alleles and genetic background
To identify cells in which the Foxg1 locus is transcriptionally active,
we exploited the Foxg1tm1M (or Foxg1lacZ) allele in which coding
sequences are replaced by a lacZ cassette (Xuan et al., 1995). For tract
tracing, we used the Foxg1tm1(cre)Skm (or Foxg1Cre) allele in which
coding sequences are replaced by a Cre recombinase cassette (Hebert
and McConnell, 2000). Foxg1Cre and Foxg1lacZ are predicted null
alleles (designated Foxg1–) (Xuan et al., 1995; Hebert and McConnell,
2000). For lineage tracing, we used Gtrosa26tm1Sho (R26RS) reporter
mice (Mao et al., 1999). Cre-mediated recombination in
Foxg1Cre;R26RS embryos irreversibly activates lacZ expression from
the ROSA26 locus (Mao et al., 1999; Hebert and McConnell, 2000).
Tract tracing and lineage tracing experiments used the Foxg1Cre allele
on an albino Swiss Webster background (as described by Hebert and
McConnell, 2000). Other experiments used Foxg1lacZ and/or Foxg1Cre
alleles on a mixed pigmented CBA/C57Bl6/Swiss Webster
background. Foxg1 homozygous mutants (Foxg1Cre/Cre) and
compound heterozygotes (Foxg1Cre/lacZ) were identified by their
hypoplastic telencephalon and distorted eyes. Heterozygous embryos
(i.e. Foxg1+/–) were identified by PCR genotyping: they were
indistinguishable morphologically from wild type (Xuan et al., 1995;
Huh et al., 1999) and we detected no RGC axon projection defects at
the optic chiasm (data not shown).
PCR genotyping Foxg1 alleles
Foxg1+ was detected with primers Foxg1ORFFor 5′-CTG ACG CTC
AAT GGC ATC TA-3′ and Foxg1ORFRev 5′-TTT GAG TCA ACA
CGG AGC TG-3′ which give a product of 438 bp; Foxg1lacZ allele
was detected with primers Foxg1_5′UTRF 5′-GCT GGA CAT GGG
AGA TAG GA-3′ and Foxg1lacZ_ORFR 5′-GAC AGT ATC GGC
CTC AGG AA-3′ which give a 550 bp product; Foxg1Cre allele was
detected with primers NLSCreF 5′-CAT TTG GGC CAG CTA AAC
AT-3′; NLSCreR 5′-ATT CTC CCA CCG TCA GTAC G-3′, which
give a 307 bp product. For all primers, cycling conditions were 96°C
for 2 minutes followed by [96°C for 30 seconds, 58.5°C for 30
seconds and 72°C for 30 seconds] for 35 cycles.
lacZ staining
E14.5 Foxg1lacZ/+ and Foxg1lacZ/Cre embryonic heads were dissected
and fixed for 1 hour at 4°C in 4% paraformaldehyde, 0.02% NP40,
0.01% sodium deoxycholate, 5 mM EGTA, 2mM MgCl2 in phosphate-
buffered saline (PBS). In some cases, heads were equilibrated in 30%
sucrose/PBS and sectioned (10 µm) on a cryostat. Tissues were rinsed
several times in wash buffer (2 mM MgCl2, 0.02% NP40, 0.01%
sodium deoxycholate in PBS), transferred to staining solution (wash
buffer supplemented with 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide and 1 mg/ml X-gal), and stained overnight
(cryostat sections on slides) or for 2 days with agitation (wholemounts)
at 37°C in darkness. Staining was stopped with 20 mM EDTA in PBS.
Some wholemounts were sectioned with a vibratome (200 µm) or
processed to wax, sectioned (10 µm) and mounted. Cryostat sections
were counterstained with Nuclear Fast Red.
Tract tracing
Embryos (E13.5) or heads (E15.5) were fixed at 4°C in 4%
paraformaldehyde in PBS overnight. For retrograde labelling, the back
of the head and tissues overlying the thalamus were removed, and
small DiI or DiA crystals (Molecular Probes) were placed in a line
over the dorsal thalamus on one side to ensure unilateral labelling of
the optic tract. For anterograde labelling, the lens was removed and
the optic cup packed with larger clumps of crystals. Embryos were
returned to 4% paraformaldehyde in PBS in the dark at room
temperature for about one month to allow tracers to diffuse along
axons. Vibratome sections (200 µm) were cleared by sinking in 1:1
glycerol: PBS containing the nuclear counterstain TOPRO3 (0.2 µM,
Molecular Probes) and then 9:1 glycerol:PBS. Sections were stored
at 4°C. Images were acquired using an epifluorescence microscope
and digital camera (Leica Microsystems, Germany) or a TCS NT
confocal microscope (Leica Microsystems, Germany). For
quantification DiI-labelled RGCs were assigned to either nasal or
temporal retina (Fig. 1B,C,J,K) in serial horizontal sections (for
examples of sections used, see Fig. 4). In epifluorescence (TRITC
filter) images (Fig. 3A-J; Fig. 4D-F,K,L) DiI appears orange and
TOPRO3 appears red and in confocal images (Fig. 3K,L; Fig. 4A-
C,G-J,M-O) DiI appears red, DiA is green and TOPRO3 appears blue.
Immunohistochemistry
Ephb2 and ephrin B2 immunohistochemistry was performed as
described (Batlle et al., 2002). Embryos (E13.5) or heads (E16.5) were
fixed overnight in 4% paraformaldehyde in phosphate buffer high salt
(PBHS) [0.04 M phosphate, 0.03 M NaCl (pH7.0)] at 4°C, processed
to wax and sectioned (10 µm). After rehydration, endogenous
peroxidase activity was blocked with 90% methanol:3% hydrogen
peroxide. Antigens were unmasked by microwaving in 10 mM sodium
citrate buffer (pH 6.0) before reacting overnight with primary
antibody followed by a bridge rabbit anti-goat antibody and detection
using the Envision+ (Rabbit) Kit (Dako K4010). Antibody incubation
and pre-incubation blocking were carried out in 1% bovine serum
albumin in PBS at room temperature. SSEA-1 and Nkx2.2
immunohistochemistry was performed as described [SSEA-1 (Marcus
and Mason, 1995), Nkx2.2 (Pratt et al., 2000)] except that detection
of the primary antibody was carried out using the Envision+ (Mouse)
Kit (Dako K4006). Primary antibodies were goat anti-mouse ephrin
B2 (R&D Systems AF496) used at 1:500; goat anti-mouse Ephb2
(R&D Systems AF467) used at 1:1000; rabbit anti-goat (Dako Z0228)
used at 1:400; mouse monoclonal anti-Nkx2.2 antibody (DSHB, USA
74.5A5) used at 1:30; and mouse monoclonal anti-SSEA1 antibody
(DSHB, USA MC-480) was used at 1:50. Following a
diaminobenzidine colour reaction, sections were dehydrated and
mounted.
Results
Foxg1 expression in the developing eye and chiasm
at E14.5 in Foxg1lacZ/+ and Foxg1lacZ/Cre embryos
To identify cells that express Foxg1, we took advantage of
a ‘knock-in’ to the Foxg1 locus in which a lacZ cassette
replaces Foxg1-coding sequences and is expressed in cells
transcriptionally activating the Foxg1 locus. These cells are
stained blue after incubation with X-gal solution (Fig. 1). If
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Fig. 1. Transcriptional activation of
the Foxg1 gene in tissues involved
in RGC axon guidance in E14.5
embryos with and without Foxg1.
Foxg1lacZ/+ embryos have one
functional copy of Foxg1 and are
phenotypically normal.
Foxg1lacZ/Cre embryos are unable to
produce Foxg1 protein. The
Foxg1lacZ allele reports
transcriptional activation of the
Foxg1 gene by expression of lacZ
protein. (A,F,I,N) X-gal stained
brains. (A,F) Foxg1lacZ/+ brain
viewed (A) dorsolaterally to show
staining of the superior colliculus
(sc), dorsal midline and
telencephalon (tel). (F) Ventral
view shows staining in the anterior
part of the ventral hypothalamus
(vh; circled in red).
(I,N) Foxg1lacZ/Cre brain showing
(I) staining in the superior
colliculus, along the dorsal midline
and in the hypoplastic
telencephalon (tel*). (N) A ventral
view shows that, as in Foxg1lacZ/+
embryos, staining is restricted to
anterior ventral hypothalamus. The
yellow oval encloses the mutant
elongated retina (er), which has
remained attached to the brain. The
retinal pigment epithelium (rpe)
has been removed to show that
lacZ staining is far stronger in the
anterior (nasal) retina.
(B-E,G,H,J-M,O,P) X-gal stained
cryostat sections with nuclei
stained red. (B-E,J-M) Sections
through the eye. Both (B-E)
Foxg1lacZ/+ and (J-M) Foxg1lacZ/Cre
retinas exhibit predominantly nasal
(n) lacZ staining, although in both
cases a few stained cells are also
detected in temporal (t) retina. J is
dorsal to K. (K) Nasal staining in
the medial elongation of the mutant
retina. B and J are dorsal to D and
K, respectively. (D,E,L,M) Higher
magnifications of Foxg1lacZ/+ and
Foxg1lacZ/Cre (D,L) temporal and
(E,M) nasal retina, showing
pronounced staining of the nasal
RGC layer. (G,H,O,P) Sections
through the ventral hypothalamus
with paired arrows demarcating its
midline. A population of midline cells overlying bundled
axons at the optic chiasm (oc) stains strongly in both (G)
Foxg1lacZ/+ and (O) Foxg1lacZ/Cre embryos. This dense
midline staining is absent more posteriorly in (H) Foxg1lacZ/+
and (P) Foxg1lacZ/Cre embryos. (Q) The relationship between
Foxg1 expression and the retinofugal tract. Regions
expressing Foxg1 are shaded blue. Ovals represent cell
bodies. The retinofugal tract comprises RGCs (red) projecting axons (black lines) towards the optic chasm and into the brain. l, lens; ot, optic
tract; r, retina; avh, anterior ventral hypothalamus; on, optic nerve. Wholemounts (A,F,I,N) are shown with anterior facing downwards. Cryostat
sections (B-D,J-L) are horizontal with anterior (nasal) at the bottom; (E,G,H,M,O,P) coronal sections. Scale bars: 200 µm in B,C,J,K; 50 µm in
D,EG,H,L,M,O,P.
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these cells possess a functional Foxg1 allele (i.e. in Foxg1lacZ/+
embryos) they can make Foxg1 protein.
We examined Foxg1 expression in Foxg1lacZ/+ embryos at
E14.5, because this is the time at which RGC axons are
navigating the midline. Foxg1 expression was strongest in the
nasal retina (Fig. 1B,C); 51% of nasal cells were lacZ+ in
counts across several sections. By contrast, only a few temporal
cells were lacZ+ (2%) (visible at higher magnifications in Fig.
1D). These findings are consistent with previous results of in
situ hybridisation (Hatini et al., 1994). In the centronasal retina,
staining was particularly prominent in the inner layer occupied
by the RGCs (Fig. 1E). Foxg1 was expressed in the anterior
hypothalamus (Fig. 1F) with a population of expressing cells
at the ventral midline overlying bundled axons at the optic
chiasm (Fig. 1G,H). Foxg1 was also expressed by other
structures encountered (or avoided) by RGC axons, including
the telencephalon, dorsal midline and superior colliculus (Fig.
1A).
We examined lacZ expression in Foxg1lacZ/Cre compound
heterozygotes, which can produce no functional Foxg1 protein,
so as to identify cells in which the mutant gene was
transcriptionally activated at E14.5. As Foxg1lacZ/Cre cells had
the same lacZ gene dose as Foxg1lacZ/+ cells (one copy), lacZ
staining intensity could be directly compared between the two
genotypes. The Foxg1–/– eye is distorted (Fig. 1J,K) with an
abnormally small lens and a medially elongated retina that
extends towards the optic chiasm. The nasal bias of Foxg1
expression in Foxg1lacZ/+ embryos described above was also
apparent in Foxg1lacZ/Cre embryos (see whole mount in Fig. 1N
and sectioned material in Fig. 1J-M). We counted 21% lacZ+
cells in nasal retina compared with only 3% lacZ+ cells in
temporal retina. The reduced count nasally reflects the absence
of lacZ+ cells in outer layers of the Foxg1lacZ/Cre lateral retina
(compare Fig. 1B,C with J,K). Previous work at a younger age,
E12.5, also showed lacZ expression in the eyes of Foxg1lacZ/lacZ
embryos confined mainly to the nasal region of the mutant
retina (Huh et al., 1999). As in Foxg1lacZ/+ embryos, lacZ
staining was prominent in the inner layer of the nasal retina
(compare Fig. 1J-M with B-E). These data show that the
nasotemporal polarity of the retina is maintained in Foxg1–/–
mutants until at least E14.5; this conclusion is further
supported by data presented later.
In E14.5 Foxg1lacZ/Cre compound heterozygotes, the anterior
hypothalamus continued to express Foxg1 around the ventral
midline at the point contacted by the expanded mutant retina
(Fig. 1N). As in Foxg1lacZ/+ embryos, stained cells were
detected at the ventral midline (Fig. 1O,P) indicating that
Foxg1 is not required for the maintenance of this population
of cells at the optic chiasm. lacZ staining was also retained in
the telencephalon, along the dorsal midline and in the superior
colliculus (Fig. 1I).
Lineage tracing of retinal cells that have expressed
Foxg1
The experiments described above show that Foxg1 is expressed
by many nasal RGCs at the time their growth cones are
navigating the chiasm. The few expressing cells we detected in
the temporal retina were near to the lateral lip (or ciliary
margin) of the temporal retina where progenitor cells
proliferate (Perron et al., 1998; Zuber et al., 2003). It was
therefore possible that Foxg1-expressing progenitors might
populate the temporal retina with RGCs, the navigational
responses of which were influenced by transient expression of
Foxg1 earlier in their lineage. Crossing Foxg1Cre/+ mice with
R26RS reporter mice generates embryos in which a Cre
recombinase-mediated recombination event irreversibly
enables lacZ expression from the Rosa26 locus in cells that
express Foxg1 (Mao et al., 1999; Hebert and McConnell,
2000). These cells and their descendants express lacZ protein,
regardless of whether the Foxg1 locus remains active. The lacZ
expression pattern provides a convenient means of visualising
cells whose fate may have been influenced by autonomous
exposure to Foxg1.
As expected, the nasal retina of Foxg1Cre/+; R26RS embryos
exhibited uniform lacZ staining (Fig. 2A-D). Strong staining
was also seen in lens, optic nerve and at the optic chiasm. In
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Fig. 2. Lineage tracing of Foxg1-expressing cells in E14.5 Foxg1Cre/+; R26RS embryos. (A) Thick horizontal section of X-gal-stained facial
whole mount (the eye on the right is sectioned more ventrally). lacZ staining is uniformly intense throughout the lens (l) and nasal (n) retina but
appears patchy in the temporal (t) retina. (B,C) Thick horizontal sections of the eye. (B) Medial section; (C) ventral retina. (D) Thin horizontal
section through the eye showing the distribution of lacZ-stained cells. Broken lines demarcate the position occupied by nasal RGCs (nRGCs)
and temporal RGCs (tRGCs). In the nasal retina, lacZ staining is uniformly strong. In the temporal retina radial columns of lacZ-expressing
cells are embedded in larger areas of non-expressing cells. In B and D, these columns are viewed side-on and in C they are viewed from above.
Arrows in B-D indicate examples of lacZ-stained radial stripes. on, optic nerve. Scale bars: 500 µm in A; 200 µm in B-D.
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the temporal retina of Foxg1Cre/+; R26RS embryos, lacZ
stained cells were found in radial stripes most of which were
one or two cells wide while others were wider (Fig. 2B-D;
arrows indicate radial stripes in temporal retina). A similar
stripy distribution has been described before in chimeras and
arises because the retina is constructed from radially oriented
clones of cells (Reese et al., 1999). Examination of serial
sections though the eyes of six embryos did not reveal any clear
pattern in the size or density of these radial stripes, implying
that the exposure of their ancestors to Foxg1 did not predispose
them to occupy any particular part of the temporal retina. It
was also apparent that most temporal RGCs were located
outside the lacZ-expressing clones. These lacZ-expressing
clones included cells outside the RGC layer showing that
ancestral Foxg1 expression was not restricted to RGCs. We also
detected mosaic activation of lacZ expression in the temporal
retinal pigment epithelium (a derivative of the optic cup, as is
the retina) suggesting that a subpopulation of these cells are
derived from Foxg1-expressing cells.
In conclusion, nasal RGCs express Foxg1 at the time their
axons are negotiating the optic chiasm. By contrast, although
some temporal RGCs are descended from Foxg1-expressing
precursors, the vast majority do not express Foxg1 at this time
and have never expressed Foxg1 at any time in their lineage.
Disruption to RGC axon navigation in embryos
lacking Foxg1
The polarisation of Foxg1 expression in the retina suggests
that it could play an autonomous role in the navigation of
nasal RGC growth cones but is unlikely to play an
autonomous role in the navigation of most temporal RGC
growth cones. Foxg1 may, however, influence the navigation
of both nasal and temporal RGC growth cones by regulating
the properties of the optic chiasm. To test these possibilities,
we used DiI and DiA to trace the RGC projections in embryos
lacking Foxg1.
We examined RGC projections in wild type at E13.5 (Fig.
3A-C) and E15.5 (Fig. 3F-H), over which period the optic
chiasm develops its mature configuration. Progressing through
the brain from rostral to caudal, sections show the injection in
the eye (Fig. 3A,F), the optic nerve approaching the optic
chiasm along the ventral surface of the brain (Fig. 3B,G) and
the optic tract growing dorsally over the thalamus (Fig. 3C,H).
At both ages, the contralateral optic tract is more strongly
labelled, indicating that the majority of RGC axons cross the
midline at the optic chiasm (Fig. 3C,H). Double labelling with
DiI injected into one eye and DiA into the other illustrates the
X-shape formed by RGC axons at the chiasm (Fig. 3K).
Labelling of the optic tract is predominantly from the
Fig. 3. RGC axon navigation in wild-type and Foxg1–/– embryos visualised by anterograde tract tracing at (A-E) E13.5 and (F-L) E15.5. For
each age, progressively more caudal coronal sections of an individual embryo show injections of DiI (red asterisks) (A,F) in wild-type eye (e)
and (D,I) in mutant eye; (B,G,D,I) labelling of optic nerve (on) and optic chiasm (oc); and (C,H,E,J) labelling of optic tracts (ot). (C,H) In the
wild-type optic tracts, contralateral labelling is stronger than the ipsilateral labelling (white arrows). (E,J) In the mutant optic tracts, ipsilateral
labelling appears stronger (white arrows). (K,L) Horizontal sections of embryos in which DiI was injected into one eye and DiA into the other
eye of (K) an E15.5 wild-type and (L) an E15.5 Foxg1–/– embryo (ventral midline is marked by broken white line). (K′) Horizontal sections of
the wild-type optic tract, growing over the diencephalon, from the same embryo as in K showing that each optic tract is predominantly labelled
with dye from the contralateral (con) eye, although some ipsilateral (ips) label is also detectable (appears yellow where dyes overlap).
(L′) Horizontal sections of the mutant optic tract from the same embryo as in L, showing abnormally high levels of red label from the ipsilateral
eye. Scale bars: 500 µm in A-E; 650 µm in F-J; 100 µm in K,K′,L,L′.
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contralateral eye, as shown by cross-sections of the optic tract
as it grows dorsally over the thalamus (Fig. 3K′).
In E13.5 and E15.5 Foxg1–/– embryos many of the general
features of RGC axon navigation were similar to those in wild
type. RGC axons from both eyes converged on the ventral
surface of the hypothalamus where they were sorted into
ipsilateral and contralateral optic tracts growing dorsally over
the thalamus (Fig. 3D,E,I,J). In contrast to the wild-type, the
ipsilateral tract in mutants appeared greatly increased [compare
panels for wild type (Fig. 3C,H) with mutants (Fig. 3E,J);
arrows indicate the ipsilateral tract]. Double labelling with DiI
injected into one eye and DiA into the other indicated that,
although RGC axons converged at the hypothalamic midline,
the balance of midline crossing was shifted in the mutants.
Although many RGC axons still crossed the midline (Fig. 3L),
a large proportion of axons in the optic tracts was labelled from
the ipsilateral eye (Fig. 3L′).
To quantify the shift in the proportion of RGC axons
projecting ipsilaterally and to identify the sites of origin in the
retina of the aberrant ipsilateral projections, we retrogradely
labelled RGCs with DiI or DiA from the thalamus. The
numbers of nasal and temporal RGCs projecting ipsilaterally
and contralaterally were counted in wild-type and mutant
embryos at E15.5. As gene expression studies (Huh et al.,
1999) (present study) indicate that, despite its medial
elongation, the mutant retina does not exhibit greatly disturbed
polarity, mutant eyes were divided into nasal and temporal
halves using the same anatomical criteria as for wild-type eyes.
Wild-type embryos showed the expected patterns of
projection. Retrograde label filled the optic tracts, optic chiasm
and optic nerves, and showed most axons originating
contralaterally (Fig. 4A-H). Contralaterally projecting RGCs
were distributed across nasal and temporal retina (Fig. 4F,G).
The much smaller number of ipsilaterally projecting RGCs
were more frequently found temporally (Fig. 4G; Table 1). The
density of labelled RGCs was highest medially, towards the
optic nerve head, and decreased sharply in more lateral retina
(Fig. 4F,G). RGC cell bodies were orientated radially with their
axons projecting towards the optic nerve head along the inner
surface of the retina (Fig. 4H).
In the mutant embryos, retrograde label filled the optic
tracts, optic chiasm and optic nerves as in wild type (Fig. 4I-
O) but many more axons originated ipsilaterally than in wild
type [compare mutant (Fig. 4J) with wild type (Fig. 4C)]. This
increased ipsilateral projection arose from both nasal and
temporal retina (Fig. 4K,K′,M). Counts of ipsilateral RGCs in
serial sections from four mutant and four wild-type E15.5
embryos (Table 1) showed an approximately eightfold increase
in ipsilaterally projecting RGCs from both nasal and temporal
retina in the mutants. There were no significant changes in the
mutants in the numbers of RGCs projecting contralaterally
from the nasal or temporal retina (Table 1). Total numbers of
RGCs counted in the retina were not significantly altered in
mutants. Ipsilaterally and contralaterally projecting RGCs
were intermingled in the nasal and temporal retina (Fig. 4M,
with higher magnification of RGCs in N) showing that all parts
of the mutant retina contain RGCs capable of projecting to
either side of the brain. We did not detect double-labelled cells,
indicating that the increased ipsilateral projection did not result
from large numbers of individual RGCs projecting to both
sides of the brain.
As in the wild type, the majority of mutant RGCs are located
in the inner layer of the retina and are radially orientated with
their axons projecting along the inner surface of the retina
(compare Fig. 4O with Fig. 4H), although the mutant RGCs do
exhibit a broader radial spread. Again, reminiscent of the wild-
type situation, mutant RGC axons fasciculate to form the
mutant correlate of the optic nerve, which exits the elongated
retina at its point of attachment to the ventral brain (seen in
Fig. 4K) and approaches the optic chiasm (seen in a ventral
adjacent section in Fig. 4L). As in the wild type, mutant retinal
axons form an X-shaped chiasm (compare wild types in Fig.
3K, Fig. 4B,C,E with mutants in Fig. 3L, Fig. 4I,J,L), although
their shapes are not identical. Given the distortions to the
mutant eye it is remarkable that its retinal projection retains so
many features in common with the wild type.
Our results in Foxg1–/– mutants indicate an increase in the
proportion of RGCs whose axons are repelled by the midline
and join the ipsilateral optic tract. As in wild type, significantly
more ipsilateral projections originated in temporal retina (χ2
test; Table 1). This finding provides further evidence for the
retention of nasotemporal polarity, as was suggested by the
expression pattern of Foxg1 in mutants (see above).
Expression of Ephb2 and ephrin B2 in the
developing retina
As well as being expressed in the developing retina itself,
Foxg1 is expressed in cells that surround and may influence
the patterns of expression of other genes in the retina as it
develops (Dou et al., 1999). It was possible that in embryos
lacking Foxg1 the patterning of the retina might have been
altered fundamentally and this might have had consequences
for RGC axon navigation. Results above suggested that the
nasotemporal polarity of the Foxg1–/– retina is similar to wild
type. Here, we addressed the nature of the other major axis of
the mutant retina, i.e. dorsoventral. This was important as most
ipsilateral RGC projections normally originate ventrally in the
temporal retina (Drager, 1985) and so a repatterning of
Foxg1–/– retina, such that it adopts a predominantly ventral
character might have explained an increased ipsilateral
projection.
The receptor tyrosine kinase Ephb2 and its ligand ephrin B2
are expressed in complementary dorsoventral gradients in the
developing retina and their distributions in the retina and
chiasm have been related to RGC axon midline crossing
behaviour (Barbieri et al., 2002; Williams et al., 2003). In wild-
type embryos at E13.5 and E16.5, ephrin B2 exhibits a
dorsal[high] to ventral[low] gradient of expression in the retina
with the strongest expression dorsolaterally (Fig. 5A,B). At
E13.5, Ephb2 is expressed throughout the retina in a
ventral[high] to dorsal[low] gradient (Fig. 5E). By E16.5 Ephb2
is more evenly distributed across the retina (Fig. 5F), although
levels still appear to be slightly higher ventrolaterally. Ephb2
is also strongly expressed in the optic nerve, consistent with
expression of Ephb2 protein on the RGC axons (Fig. 5E-F,I-
J). RGC axons continue to express Ephb2 protein as they
approach the optic chiasm and exit into the optic tract (Fig.
5I,J). By contrast, the optic nerve stains weakly for ephrin B2
protein (Fig. 5A,B).
The dorsoventral gradients of Ephb2 and ephrin B2 proteins
are retained in the mutant. In E13.5 Foxg1–/– embryos, the
retina expresses ephrin B2 protein in a dorsal[high] to
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ventral[low] gradient (Fig. 5C) and Ephb2 protein in a
complementary ventral[high] to dorsal[low] gradient (Fig. 5G). At
E16.5, ephrin B2 expression is strongest in the dorsolateral
retina (Fig. 5D) and Ephb2 protein is more evenly distributed
across the retina with slightly higher levels ventrolaterally (Fig.
5H). As in wild types Ephb2 protein is expressed by mutant
RGC axons as they cross the optic chiasm and enter the optic
tracts (Fig. 5K,L).
In the wild type the eye is roughly spherical and is attached
to the ventral surface of the diencephalon by the optic stalk,
whereas the mutant eye lacks an optic stalk and is attached
directly to brain. Perhaps as a mechanical consequence of
this the mutant eye is elongated medially and squashed
dorsoventrally relative to the wild-type eye. To distinguish
whether this is only a change in shape or also involves a change
in retinal volume, we measured retinal area (mm2) in every
20th 10 µm horizontal serial section through the eyes of wild-
type and mutant embryos. As each section was 0.01 mm thick,
retinal volumes approximated to Σ(retinal area × 0.2) mm3.
Average volumes obtained for wild-type (0.86 mm3) and
mutant (0.88 mm3) eyes were very similar. The proportion of
the Foxg1–/– retina that is elongated medially (marked ‘er’ in
Fig. 1K) probably corresponds to the central third of the wild-
type retina. Consistent with this idea, the medial expansion of
Fig. 4. Mapping ipsilateral and
contralateral projecting RGCs in
Foxg1+/+ and Foxg1Cre/Cre
embryos by retrograde tract
tracing from the optic tract
growing over the thalamus at
E15.5. (A-H) Wild type.
(A,B,G) DiI and DiA double-
label experiment showing
predominance of contralateral
(con) projections (A,B) at the
optic chiasm (oc) and (G) in the
retina; an ipsilaterally (ips)
labelled cell (red) is marked with
arrow in G. (C-F,H) Single DiI-
labelling experiments. (C,E) At
the optic chiasm, the majority of
labelling is in the contralateral
optic nerve (on). (D,F) In the
contralateral retina (F) a large
number of labelled cells are
distributed both nasally and
temporally. (D) In the ipsilateral
retina, far fewer cells are labelled.
(I-O) Mutants. (I,M,N) Double-
label experiment showing (I) the
optic chiasm and (M,N)
ipsilaterally (red) and
contralaterally (green) projecting
RGCs in the retina (note the
absence of double labelled,
yellow, RGCs). (J-L,O) Single
label experiment showing
increased ipsilateral labelling
(compared with wild type) in
(K,K′) both nasal (n) and
temporal (t) parts of the elongated
retina (er) and (J-L) their axons in
the mutant correlate of the optic
nerve (on*). (H,O) Higher
magnification showing the
disposition of RGCs in (H) wild-
type and (O) mutant retina. All
sections are horizontal with
anterior (nasal) at the bottom.
Each asterisk indicates which
optic tract was injected with DiI
(red) and DiA (green). Broken
lines indicate the ventral midline.
Scale bars: 500 µm in A; 100 µm
in B,C,G,I,J,M; 200 µm in D-
F,K,L; 50 µm in H,N,O.
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Table 1. RGCs retrogradely labelled by dye placement in the optic tract
Midline crossing behaviour Ipsilateral Contralateral
Temporal Nasal Temporal+ Temporal Nasal Temporal+
Hemiretina of origin retina retina nasal retina retina retina nasal retina
Foxg1+/+ (n=4) 47 24 71 281 371 652
Foxg1–/– (n=4) 341 199 540 257 249 506
P values (t-test, Foxg1+/+ versus Foxg1–/–) 0.003* 0.021* 0.006* 0.84 0.48 0.6
Quantification of ipsilaterally and contralaterally projecting RGCs in nasal and temporal retina of Foxg1+/+ and Foxg1–/– E15.5 embryos. DiI was injected into
the optic tract on one side of the brain. After diffusion of DiI to the retina, serial horizontal sections were examined to determine: (1) the number of RGCs
projecting to the injection site on the same side (ipsilateral) or opposite side (contralateral) of the brain; and (2) the number of RGCs of each class projecting from
the nasal hemiretina or temporal hemiretina. Total RGC counts in serial sections from Foxg1+/+ (n=4) and Foxg1–/– (n=4) embryos are tabulated. A χ2 test was
used to test the null hypothesis that nasal and temporal retina projected equal numbers of ipsilateral axons. The null hypothesis was rejected both for wild type
(χ2=3.73, P<0.05) and mutants (χ2=18.6, P<0.05), indicating that both exhibited a significant temporal bias in the origin of ipsilateral projections. P values
(Student’s t-test) for Foxg1+/+ versus Foxg1–/– comparison for each type of RGC counted are shown in the bottom row (*a significant difference).
Fig. 5. The distributions of Ephb2 and ephrin B2 proteins in the developing retina and its axons are not dramatically altered in the Foxg1–/–
mutant. Ephrin B2 protein forms a dorsolateral[High] to ventrolateral[Low] gradient in the developing retina at E13.5 in (A) the wild-type and (C)
the mutant. This gradient remains at E16.5 in both (B) wild-type and (D) mutant. Ephb2 protein forms a complementary ventrolateral[High] to
dorsolateral[Low] gradient in the developing retina at E13.5 in both (E) wild-type and (G) mutant retina. At E16.5, these gradients are shallower
than at E13.5 in both (F) wild type and (H) mutant. The optic nerve (on) stains strongly for Ephb2 protein consistent with Ephb2 expression by
navigating RGC axons. (I,J) In the wild type, Ephb2 is present in the optic nerve as it leaves the retina (r) and approaches the optic chiasm (oc)
to emerge into the optic tract (ot) (boxed area in I). (K,L) In the mutant, Ephb2 is expressed in the elongated retina (er), at the optic chiasm and
in the mutant optic tract as it emerges from the chiasm (boxed area in K). (A-H) Coronal sections (dorsal is towards the top); (I-L) horizontal
sections (posterior is towards the top). Scale bars: 100 µm in A-H; 200 µm I-L.
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the mutant retina expressed levels of ephrin B2 and Ephb2
intermediate between the extremes of the expression gradients
shown in Fig. 5D,H (data not shown), as did the wild-type
central retina.
These data indicate that, as in the nasotemporal axis,
patterning of the retina along the dorsoventral axis is similar
in Foxg1–/– and in wild-type embryos.
Expression of Nkx2.2, SSEA-1 and ephrin B2 at the
developing chiasm
The presence of cells at the chiasm that turn on Foxg1 in both
Foxg1+/+ and Foxg1–/– embryos (Fig. 1) prompted us to
examine the mutant chiasm in more detail. The expression
patterns of the transcription factor Nkx2.2 and the cell-surface
molecule stage-specific embryonic antigen 1 (SSEA-1) define
stages of normal chiasm development (Marcus and Mason,
1995; Marcus et al., 1999). SSEA-1 is expressed by a
population of early differentiating neurons that provides an
anatomical template to guide RGC axons at the developing
chiasm (Sretavan et al., 1994; Marcus and Mason, 1995;
Sretavan et al., 1995). We speculated that changes in the
distribution of neurons expressing SSEA-1 in the mutant might
perturb RGC axon midline crossing behaviour. However, we
were unable to detect any clear shift in the expression domains
of SSEA-1 between the wild-type (Fig. 7A,C,E) and mutant
(Fig. 7B,D,F) chiasm at E13.5. The transcription factor Nkx2.2
defines a domain through which RGC axons grow at the
midline (Marcus et al., 1999), but we did not find evidence of
differences between Nkx2.2 expression in the wild-type and
mutant (compare Fig. 7G with 7H). Ephrin B2 is expressed by
radial glial cells that form a palisade at the chiasm and control
RGC axon divergence (Marcus and Mason, 1995; Marcus et
al., 1995; Nakagawa et al., 2000; Williams et al., 2003).
Although the shape of the tissues surrounding the optic chiasm
was slightly abnormal in Foxg1 mutants, expression of ephrin
B2 was observed along the ventral midline of the diencephalon
in both wild-type and mutant embryos at E13.5 and E16.5 (Fig.
6). These data show that the mutant chiasm does not show
major defects in the expression of at least three molecules
known to be important for its interaction with RGC axons.
Discussion
Dual role for Foxg1 in eye morphogenesis and RGC
axon guidance
During normal development, the eye field in the anterior neural
plate splits into a right and a left half separated by the
developing floor plate (reviewed by Rubenstein and Beachy,
1998; Rubenstein et al., 1998). On each side, the optic cup
(from which retina and retinal pigment epithelium are derived)
forms laterally, the optic stalk forms medially and the retina
projects axons along the optic stalk to the chiasm. Foxg1 is first
expressed in the surface ectoderm immediately anterior to the
neural plate at around E8 in mice. Over the following day, its
expression appears in the anterior neural plate and, as this
region becomes the anterior neural tube, demarcates the
telencephalic neuroepithelium, optic chiasm and nasal retina
(Hatini et al., 1994; Xuan et al., 1995; Dou et al., 1999; Huh
et al., 1999). The domain of Foxg1 expression in nasal retina
includes the locations of projecting RGCs. Only a few cells in
the temporal retina, which are located towards the ciliary
margin, express Foxg1. Our data show that most RGCs in the
temporal retina are descended from lineages in which Foxg1
has never been expressed. These expression patterns indicate
that Foxg1 is unlikely to have a significant cell autonomous
effect on the development of cells in temporal retina, but may
have such an effect on cells in nasal retina.
Our results show that Foxg1 is required to ensure a normal
ipsilateral projection from RGCs. The Foxg1–/– retina produces
an increased ipsilateral projection, arising from RGCs located
Fig. 6. Ephrin B2 protein is expressed at the ventral hypothalamic midline in both the Foxg1–/– mutant and the wild type. (A,B,E,F) Wild type.
(A,B) At E13.5, ephrin B2 expression is most widespread in the more dorsal structures in the developing forebrain and eye (e). Ventrally ephrin
B2 is detected at the ventral hypothalamic (ht) midline (B shows area boxed in A at higher power). (E,F) At E16.5, ephrin B2 protein is
detected at the optic chiasm (oc) where expressing cells contact the optic nerve (on). (F) Higher magnification of the optic chiasm.
(C,D,G,H) Mutant. (C,D) At E13.5, ephrin B2 is expressed in the hypoplastic telencephalon (tel*) and in the developing eye (see Fig. 5).
Ephrin B2 is also detected at the hypothalamic midline (D shows area boxed in C at higher power). (G,H) At E16.5 ephrin B2 expression
persists at the mutant optic chiasm where it contacts Ephb2-expressing axons (section in H is adjacent to the Ephb2 stained section shown in
Fig. 5L). Paired arrows indicate the ventral hypothalamic midline. (A-D,F,G) Coronal sections with dorsal towards the top. (E,H) Horizontal
sections with posterior towards the top. cc, cerebral cortex; vtel, ventral telencephalon. Scale bars: 200 µm in A,C,E; 50 µm in B,D,F-H.
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both nasally and temporally. Given the expression patterns
discussed above, abnormal development of RGC axons from
both nasal and temporal territories argues against a completely
cell-autonomous role for Foxg1 in the control of RGC
projections. Foxg1 may autonomously regulate the behaviour
of nasal RGC growth cones at the optic chiasm, e.g. by
influencing their expression of cell surface molecules, but this
can not be the case for most temporal RGCs.
The eyes of mice lacking Foxg1 have an abnormal shape
(Xuan et al., 1995; Huh et al., 1999) (present study). A striking
feature of the Foxg1–/– phenotype is the lack of an optic stalk
connecting the retina to the brain. This could result in the retina
becoming stretched medially as the head grows. Consistent
with this, the overall volume and patterning of gene expression
along its nasotemporal and dorsoventral axes are similar to
wild-type retina. This argues against a fundamental
repatterning of the retina in the absence of Foxg1. Changes in
Foxg1–/– retinal morphology might also be secondary to
defective development of the lens, which expresses Foxg1
early in its formation and is smaller than normal in mutants
(Figs 2, 5) (Hatini et al., 1994; Xuan et al., 1995; Dou et al.,
1999; Huh et al., 1999). Previous studies have shown that,
although lens is not necessary to instruct the differentiation of
neuroretina, it does influence the morphology of the retina
either mechanically or molecularly (Ashery-Padan et al.,
2000).
Foxg1 can be added to the growing list of proteins with a
dual role in tissue morphogenesis and axon growth and
morphology. Others on this list include transcription factors
such as Pax6 (Ericson et al., 1997; Mastick et al., 1997; Pratt
et al., 2000; Pratt et al., 2002) and secreted proteins of the Wnt
(Hall et al., 2000; Yoshikawa et al., 2003), bone morphogenetic
protein (BMP) (Augsburger et al., 1999) and hedgehog
(Charron et al., 2003) families. Enzymes involved in regulating
the sulphation status of extracellular heparan sulphate
proteoglycans are implicated in Shh, Wnt and BMP signalling,
tissue morphogenesis (Merry and Wilson, 2002; McLaughlin
et al., 2003a) and RGC axon guidance (Walz et al., 1997; Irie
et al., 2002).
Foxg1 may act at the optic chiasm to control RGC
growth cone navigation
The simplest explanation of our finding an increased ipsilateral
projection in embryos lacking Foxg1 is that Foxg1 normally
regulates the proportions of crossed and uncrossed projections
by a direct action on both temporal and nasal axons at the
chiasm itself. In the chick, Foxg1 has been shown to
autonomously regulate the retinotectal mapping of RGC axons
(Yuasa et al., 1996) and it is possible that in the mouse Foxg1
expression by RGCs is involved in retinotectal mapping rather
than in regulating midline crossing at the optic chiasm.
In the wild-type the diencephalon is surrounded on each side
by a large telencephalic vesicle. This physical support is
missing in the mutant, which has a hypoplastic telencephalon
and, as a consequence, the diencephalon adopts a more
‘open’ conformation. Nevertheless, we found that many
morphological and molecular features of the wild-type chiasm
were retained in the mutant. The normal developing chiasm has
been characterised in terms of the expression of transcription
factors and regulatory molecules whose expression domains
coincide with navigating RGC axons (Marcus et al., 1999;
Nakagawa et al., 2000; Williams et al., 2003). We did not detect
any gross abnormalities in the distribution of cells expressing
the transcription factors Foxg1 or Nkx2.2 or of cells expressing
cell surface molecules SSEA-1 or ephrin B2 at the developing
chiasm. Despite its elongated shape, the mutant eye projects a
correlate of the optic nerve, which converges to form the optic
chiasm. It is extremely unlikely that anatomical alterations of
the mutant eye or brain are solely responsible for the alterations
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Fig. 7. Patterning of the chiasm at E13.5. Sections are horizontal,
anterior is upwards. Immunohistochemistry was performed using
antibodies for SSEA-1 (A-F) and Nkx2.2 (G,H). (A) Wild-type
section through the optic chiasm showing SSEA-1-positive neurons
arrayed in an inverted ‘V’-shape. Arrow indicates the tip of the ‘V’.
SSEA-1 expression is also evident in the optic nerves (on). (B) A
Foxg1–/– section equivalent to (A) showing SSEA-1 expression in the
mutant correlate of the optic nerve (on*). Note that the plane of
section is slightly tilted such that the left side is ventral to the right.
The SSEA-1-positive ‘arm’ of the ‘V’ is visible on the right side, but
is less clear on the left, which is further ventral. (C,D) Immediately
dorsal to the optic chiasm, wild-type and Foxg1–/– embryos show
bilaterally symmetrical SSEA-1 expression posterior to the third
ventricle. SSEA-1 expression extends posteriorly and laterally in
both C and D. (E,F) High magnification showing the morphology of
SSEA-1 neurons in the wild type and Foxg1–/– mutant. (G,H) In the
wild type and Foxg1–/– mutant, Nkx2.2 is expressed at the posterior
optic chiasm, where it overlaps partly with SSEA-1 expression.
Broken lines indicate the position of the midline. Scale bar: 200 µm
in A,B; 100 µm in C,D,G,H; 50 µm in E,F.
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in the balance of ipsilateral and contralateral projections. Taken
together, these findings point to a more specific defect causing
the change in RGC axon midline crossing in mutants.
The mechanisms that regulate RGC growth cone navigation
at the normal optic chiasm are not well understood, although
it is known that Ephb and ephrin B family members are likely
to participate in regulating midline crossing of RGC growth
cones (Nakagawa et al., 2000; Barbieri et al., 2002; Williams
et al., 2003). We did not detect obvious alterations in the
distributions of Ephb2 and ephrin B2 protein in the mutant
retina and optic chiasm but this does not necessarily preclude
a role for Foxg1 in the control of Ephb/ephrin B signalling.
There are several precedents for a particular receptor/ligand
interaction leading to either attraction or repulsion depending
on other factors. The presence of the extracellular matrix
molecule laminin has been shown to convert the attraction of
RGC growth cones towards a source of netrin to a repulsion of
RGC growth cones away from a source of netrin (Hopker et
al., 1999). Levels of an intracellular guanylate cyclase control
the response of neocortical growth cones to a Sema3a gradient
(Polleux et al., 2000). Although an analagous mechanism has
not been demonstrated for Ephb/ephrin B signalling it appears
that Ephb-expressing axons can be either attracted or repelled
by ephrin B in different situations (McLaughlin et al., 2003b;
Hindges et al., 2002).
Foxg1 may, therefore, regulate expression at the optic
chiasm of one or more of a potentially very large number of
modulators of signalling pathways activated by, for example,
Ephb/ephrin B. The identification of transcriptional targets of
Foxg1 will allow a systematic survey of these possibilities. The
final choice made by each RGC growth cone whether to go
ipsilateral or contralateral at the optic chiasm probably depends
on the balance between attractive and repulsive signals at the
chiasm and the nature of the response of each growth cone to
those signals. Most probably loss of Foxg1 promotes ipsilateral
projections at the optic chiasm by perturbing these balances.
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